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Synopsis
St r a te g ie s  for  A bsolute  Q uantificatio n  in Pro teo m ics
The protein composition of a biological entity; its proteome, is the subject of study in proteomics. 
Proteomics in turn can be conceptually subdivided into the identification of proteins present, 
characterisation of function and interactions with other proteins, and protein quantification. As an 
example, proteins associated with the onset and progression of disease, once identified and 
characterised may be quantified, detecting minor fluctuations in abundance to facilitate diagnosis and 
treatment. For systems biology and global comparisons across multiple platforms, absolute protein 
quantification is preferred, rather than measuring the abundance of proteins relative to a second cellular 
state. To achieve this, techniques based on well established precepts of stable isotope dilution have 
been developed. These involve the incorporation of naturally occurring stable isotopes into differential 
labels to compare protein abundance of two or more samples, or internal standards added in known 
amounts. Proteolytic digestion of differentially labelled samples creates a peptide that elicits a known 
mass shift on mass spectrometric analysis. Using the peptide as a surrogate for the protein of interest, 
the signal intensity of unlabelled and labelled ions can be reconciled to measure relative abundance. 
For absolute protein quantification, stable isotopes are incorporated into synthetic proteotypic peptides 
for use as internal standards designed to mimic native peptides formed by proteolysis. However, for the 
absolute quantification of several proteins in a biological system, a stable isotope labelled peptide would 
have to be synthesised, at relatively high cost, for each protein to be quantified.
To create a multiplexed method for protein quantification, de novo gene design has been used to create 
and express artificial proteins (QconCATs) that comprise a concatenation of proteotypic peptides. Upon 
complete proteolytic digestion, each peptide was produced in equimolar amounts, permitting absolute 
quantification of multiple proteins in a single experiment. One QconCAT protein contained a tryptic 
peptide from each of twenty proteins present in the soluble fraction of chicken skeletal muscle. 
Optimised DNA sequences encoding these peptides were concatenated and inserted into a vector for 
high level expression in E.coli. The protein was expressed in a minimal medium enriched with stable 
isotopes, or containing selectively labelled amino acids, creating an equimolar series of uniformly 
labelled proteotypic peptides. The labelled QconCAT protein, purified by affinity chromatography and 
quantified was added to a homogenised muscle preparation in a known amount prior to proteolytic 
digestion with trypsin.
The goal of this study was to define the deployment, sources of error and statistical behavior of a 
QconCAT analysis. Analytical challenges to exploring the proteome, particularly for absolute 
quantification were addressed including proteolysis of analyte and internal standard proteins, sample 
complexity, dynamic range, and ionisation in mass spectrometry. As anticipated, the QconCAT was 
completely digested at a rate far higher than the analyte proteins, confirming the applicability of such 
artificial proteins for multiplexed quantification. In addition, this demonstrates further application of 
readily digested QconCAT proteins to assessment of proteolysis kinetics in the analyte system. 
Alternative mass spectrometric approaches with and without prior reversed phase separation have been 
investigated, particularly LC-ESI-ToF MS and MALDI-ToF MS for analysis of tryptic peptides. This has 
established the use of QconCAT technology for absolute quantification using various methods of 
detection and analysis. Accuracy and reproducibility of the QconCAT method in addition to the nature of 
technical variance compared with biological variance have been assessed in a complete study involving 
six time points during growth with four birds at each time point for both broiler and layer strains. 
Absolute quantification using the QconCAT method was equivalent to alternative strategies tested, 
including the single synthetic peptide approach. This thesis concludes that QconCATs offer a new and 
efficient approach to precise and simultaneous absolute quantification of multiple proteins.
As an extension, additional applications of QconCAT technology have been investigated including the 
robustness for use to quantify the same proteins in other species, absolute quantification of post- 
translational modifications, and quantification of protein abundance normalisation during enrichment 
with peptide library beads. This highlights the diversity of QconCAT technology and its advantages over 
alternative strategies for absolute quantification.
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Introduction
1. In t r o d u c t io n  to  Q u a n t it a t iv e  P r o t e o m ic s
1.1 ‘O m ic s ’ T echnologies  an d  th e  Pro teo m e
1.1.1 Why proteomics?
Dramatic advances in genomics, transcriptomics and proteomics in the 21st century have driven 
understanding of biological systems into the relatively new era of ‘system biology’. Discoveries 
from all three disciplines contribute information in different forms, with different outcomes, but 
can be used in concert, providing a systems-wide viewpoint used to decipher the complexities 
and interactions of biological systems. First and foremost, genomics; the study of the entire 
genome of an organism, has revolutionised biological studies of different species, by 
sequencing their DNA, defining the number of genes, and mapping genetic variation, including 
the interaction between genes, and their influence on phenotype. Genome sequencing of entire 
organisms now takes place in the laboratory on a daily basis (for example Seedorf et al., 2008), 
an achievement that could only have been dreamt of, even a few years ago. These analyses 
have prompted functional genomic studies, in which DNA/RNA microarrays are used to monitor 
changes in expression, or single nucleotide polymorphisms (SNPs) for single genes, or to 
profile thousands of genes simultaneously. SNPs can be identified with little or no prior 
knowledge of expressed phenotype, and can predict whether this polymorphism will have an 
effect on gene expression. To delve further into the biological ‘meaning’, profiling studies using 
mRNA expression; transcriptomics, have revealed that the products of expressed genes; 
proteins, are not necessarily expressed in strict correlation with the cognate mRNA, and also 
have uncharacterised functions, that cannot be predicted from the genome (Galperin and 
Koonin, 2004). This holds the potential for another dimension of information useful in a systems 
biology context and merits the study of the entire proteome of an organism, proteomics, which 
aims to characterise the function manifested by changes in gene expression in different cellular 
states (deHoog and Mann, 2004). Protein abundance depends not only on the levels of mRNA 
present, but also on events that occur during translation, for example alternative splicing or 
point mutations, and subsequent changes to the mature protein product including regulated 
degradation and protein stability through post-translational modifications or protein-protein 
interactions. Proteomics can measure the downstream consequences of cellular events, 
making the transition into ‘systems biology’, and combining data from changes in signalling 
events through transcription, translation and post-translational modification to metabolic
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alterations (Julka and Regnier, 2004). Both transcriptomics and proteomics can provide 
quantitative expression data, although correlation between protein and mRNA abundance is 
weak (for example, Gygi eta!., 1999). However, simultaneous analysis can be used to predict 
the sources of discrepancy as these are two-fold; biological factors, such as alterations during, 
or after translation, or technical limitations (Nie et a!., 2006). The relationship between mRNA 
and protein abundance can be highly informative for example, the investigation of protein 
turnover kinetics, where protein synthesis is largely directed by mRNA expression, and protein 
degradation by the concentration of expressed protein in the cell or tissue (Yu et al., 2007). 
This has prompted the development of a web based tool (http://proteomics.gersteinlab.org) in 
which datasets of both mRNA expression and protein abundance are available for comparison. 
However, these comparisons are currently limited, primarily by access to appropriate resources 
and often, expression analysis is undertaken at one level or the other. The advantages of 
studying mRNA expression include the requirement for less starting material due to 
amplification strategies, and faster analysis times for high throughput; expression profiling of 
thousands of genes simultaneously permit the transition of ‘discovery’ to ‘browsing’ mode 
where transcripts are identified and quantified in a single experiment (Aebersold, 2003). This is 
a long-term goal for proteomics in order to translate relevant discoveries to clinical diagnostics, 
but the leap in magnitude from genes (around 20,000-25,000 in the human genome; 
International human genome sequencing consortium, 2004) to proteins (in excess of 500,000 in 
human serum, Anderson and Anderson, 2002) provides a considerable challenge for current 
technology. Limitations of transcriptomics include questionable reproducibility across different 
platforms and between different laboratories, but most essentially that quantitative analysis of 
mRNA is not often reflected at the protein level. This is particularly observed for extracellular 
proteins, for example in blood and other body fluids, as mRNA measurements of a particular 
cell type or tissue are not relevant throughout the whole body. For clinical research, global 
quantitative proteomic profiling is essential for diagnosis and assessment of treatment 
regimens. As such, strategies for absolute quantification where protein abundance is 
expressed as number of molecules; the principal focus of this thesis, are in development, 
allowing systems-wide measurement of protein expression levels that is comparable to mRNA 
approaches (Cox and Mann, 2007).
1.1.2 The nature of proteomics
There are fundamentally three ‘sub-types’ of proteomic analysis; identification, characterisation 
and quantification. It is vital to know what the proteins are, discover what they do, how they
2
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interact with each other and their environment, and finally to measure the abundance of 
particular proteins and how this may change and influence other processes, for example 
interactions with other proteins.
Identification
The molecular weight of native proteins can be determined by gel-based separation methods, 
or direct mass spectrometry (MS) analysis. However, for protein identification, analysis of 
molecular weight is not sufficient and strategies must delve further into the protein structure to 
ascertain the sequence of individual amino acids. Consequently, analysis of individual proteins 
and complex mixtures of proteins in biological systems is driven by two different philosophies; 
‘top down’ proteomics in which intact proteins are analysed by MS and fragmented directly, as 
individual proteins or in complex mixtures, and ‘bottom up’ proteomics in which proteins are 
first digested into peptides, using a protease, for example trypsin, prior to analysis by MS and 
fragmentation to determine amino acid sequences. For top-down proteomics, intact proteins 
must be analysed directly; this has previously involved molecular weight determination using 
gel based methods which have limited dynamic and molecular weight range, but could permit 
ambiguous assignments of post-translational modifications in addition to a measure of protein 
purity. For the more sensitive and informative technique of MS, development of soft ionisation 
techniques in the 1980’s, in which samples are transferred into the gas phase without extensive 
fragmentation, allowed proteins and peptides to be analysed in this way. This form of ionisation 
permitted transfer of large molecules into the gas phase without affecting their integrity. For 
intact protein analysis with fragmentation for protein identification and characterisation, proteins 
separated by gel electrophoresis, or alternative strategies requiring solubilisation of protein 
mixtures in-solution, are not compatible. By contrast, peptides are soluble and simple to 
separate prior to direct MS analysis, but provide an extra dimension of complexity. Additionally, 
digesting a complex mixture of proteins into peptides loses connectivity to the parent proteins, 
particularly important to ascertain the location of post-translational modifications on specific 
proteins. However, despite this, protein identification has become predominantly peptide based 
over the last 20 years (Cañas et at., 2006). Instrumentation and strategies for MS analysis of 
intact proteins are also developing, and are becoming widely used in the proteomics 
community. The ability to fragment intact proteins provides excellent opportunities for analysis 
of post-translational modifications and will be discussed in the context of protein 
characterisation. For peptide-based protein identification, following MS analysis of proteolysed 
proteins, peptide masses are used to create a ‘fingerprint’ of the protein that they have been
3
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digested from. These data are used to search databases of theoretical enzymatic digests of 
proteins that have previously been identified and for which the amino acid sequences are 
known. The success of this technique will depend on the mass accuracy delivered by the mass 
spectrometer, the relationship between the assigned and unassigned peaks in the mass 
spectrum and the size of the database used. For protein identification, advances were made in 
the analysis of small samples, complex mixtures of proteins and determination of peptide 
amino acid sequences by tandem MS in which the peptide ion is fragmented in the mass 
spectrometer into its constituent amino acids. For complex mixtures of proteins, where 
additional information is required for protein identification, sequence data from fragmentation of 
peptides by tandem MS are also used to search databases and provide confident assignments 
of protein identification. More detailed discussion on the development of strategies for protein 
identification will be given in section 1.3.
Characterisation
Characterisation proteomics is the first step in functional protein discovery; investigating the 
downstream effects of signalling events and protein interactions, for example those driven by 
post-translational modifications. Post-translational modifications include proteolytic cleavage of 
part of the sequence, for example removal of a signal peptide or initiator methionine residue, 
adduction of chemical groups, for example by acetylation, phosphorylation or glycosylation, or 
the formation of inter- or intra-peptide linkages, for example disulphide bonds. These affect the 
behaviour of the modified proteins, altering their function or causing them to interact in a 
different way with other proteins. Various approaches have been applied to characterise these 
modifications, both targeted and on a larger scale. Of the emerging technologies in this field, 
top-down proteomics using MS is becoming increasingly popular for characterisation of 
proteins and proteomes. The determination of the molecular mass of intact proteins by MS is 
best achieved using high resolution instruments (Jensen etal, 1999) but complex mixtures of 
proteins can also be resolved (at lower resolution) using bench-top instruments (Hayter et al., 
2003). With significant advances in instrumentation, top-down proteomics is currently beginning 
to offer complementary information to peptide based approaches using a combination of 
molecular mass determination and fragmentation of the intact protein (Claverol etal., 2003). In 
particular, this methodology is used to characterise proteins that are post-translationally 
modified and the interactions between proteins in various biological systems, for example 
different cell states after drug treatment or genetic manipulation (Cox and Mann, 2007; Siuti 
and Kelleher, 2007). For analysis of post-translational modifications in a mixture of proteins,
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this approach retains connectivity with the parent protein (rather than the loss associated with 
digesting to peptides), facilitating assignment of modifications to specific proteins. Upon 
fragmentation, ions are easily reconciled to the parent protein, enabling the location of 
modification to be detected. With most post-translational modifications resulting in variations in 
molecular mass and net charge of the protein, isoforms can be separated using 2D gel 
electrophoresis, and are observed as proteins with similar molecular mass but varying 
isoelectric point. For example, adduction of acetyl- groups by acetylation of e-amino groups of 
lysine residues results in a mass increase of 42Da per acetyl- group, and a decrease in net 
charge of -1. The decrease in net charge, reflected in the isoelectric point of each isoform will 
be detected by gel electrophoresis, but this does not provide information as to the specific 
identification and location of the modification, and moreover does not give an accurate 
measurement of molecular mass with and without modification. For acetylation, each protein 
spot on a gel may be a mixture of molecules in which the total number of acetyl- groups is the 
same, but the sites of acetylation vary. For mono-acetylated proteins, the modification could be 
at a number of different lysine residues, the specificity of which may be functionally significant 
(Turner, 2002). To characterise protein isoforms, intact proteins may be analysed by MS 
directly or by a combination of extraction via passive elution from SDS gels and removal of 
SDS prior to MS analysis of the intact protein. This confirms molecular mass and predicts the 
likely nature and number of post-translational modifications based on mass differences 
between isoforms. Successive rounds of protein fragmentation confirm labile modifications, for 
example phosphorylation as sequential loss of one or more phosphate ions from the intact 
protein precursor indicates mono- or di-phosphorylation. These ions may be fragmented further 
in the mass spectrometer to confirm tentative assignments of multiple modifications and reveal 
information about the order in which certain modifications have occurred. To ascertain the 
location of modifications, proteins are digested in-solution and peptide ions are fragmented, 
revealing sequence differences relating to the modification (Claverol et at., 2003). This 
combines bottom-up approaches with top-down, as both strategies offer distinct advantages for 
protein identification and characterisation, and are likely to co-evolve for global proteomic 
analysis, rather than domination of the field by one or the other (Chait, 2006). As this 
technology is still developing, there are many challenges that must be overcome if its use is to 
become widespread. Firstly is the importance of high mass accuracy requiring specialist mass 
spectrometers, thus limiting their application in many proteomics facilities. Concomitantly is the 
limited amount of intact mass data currently in proteomics databases, although this is likely to 
improve substantially over the next few years. On the sample preparation side, top-down
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proteomic strategies require a considerably greater amount of starting material to complete 
multiple analyses. However, this is matched with an increase in the amount of complementary 
data, for example, characterisation of protein isoforms with similar intact mass values, based 
on fragmentation patterns in tandem MS. With continued development to instrumentation, and 
software tools for data processing, a combination of top-down and bottom-up techniques will 
become high-throughput for the characterisation of post-translational modifications on proteins 
within cellular pathways (Siuti and Kelleher, 2007).
Quantification
The identity and function of a protein does not provide sufficient information to define the extent 
of change in protein abundance in response to various stimuli, in different physiological or 
pathological states. It is imperative that protein abundance can be quantified for a 
comprehensive understanding of biological systems in addition to the therapeutic benefits for 
example, the discovery of markers for disease (Sebastiano et a!., 2003). Quantification 
strategies fall into two categories; relative quantification in which proteins are quantified in 
one state relative to a second state, for example a fold change difference in protein abundance 
between two physiological conditions, or absolute quantification in which protein abundance 
is measured explicitly, for example as nmol per gram of tissue. Early methods for quantification 
proteomics consisted of quantifying fold changes from proteins separated by gel 
electrophoresis (for example, Luftig et at., 1974). This allowed the identification of small 
numbers of proteins associated with the onset and progression of disease, in addition to any 
related changes in expression. With advancing techniques in sample processing and MS, 
quantification proteomics is at the forefront of systems biology research and detailed discussion 
on developments in this field will be given in section 1.5.
1.2 Sta b le  Iso to pes  and  th eir  S ignificance  for  Pro teo m ics
Stable isotopes are naturally occurring, non-radioactive forms of an element containing a 
different number of neutrons which give rise to a difference in mass. Stable isotopes of the 
same element have the same number of protons and consequently, the same chemical 
properties. For proteomics, the most commonly used are stable isotopes of the elements 
carbon, nitrogen, oxygen, hydrogen and sulphur. Due to the similar chemical characteristics of 
stable isotopes of the same element, they are used in place of the more abundant isotope as a 
diagnostic tool whereby the mass difference can be distinguished using MS.
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1.2.1 Isotope abundance
Most biologically relevant elements have two or more stable isotopes with the lightest being in 
greatest abundance. As such, stable isotopes of a particular element giving rise to an increase 
in mass are often referred to colloquially as ‘heavy’, and the same expression will be used in 
this thesis. The natural abundance of stable isotopes most commonly used in proteomics is 
given in Table 1 (www.isotrace.co.nz), although this is subject to variation (Gannes et al., 
1998). Deuterium; [2H], the stable isotope of hydrogen is used as an isotopic tracer, for 
example in ‘heavy’ water to study metabolic pathways with analysis by MS. For proteomics, 
[2H] is used to label chemicals, for example trideuteroacetate, to differentially label two samples 
(one with acetate, one with trideuteroacetate) during acetylation of peptides (Ji et a!., 2000). 
[180 ], the stable isotope of [160 ] lends itself to climate research in which isotope ratio in layers 
of ice from different years can provide information, for example the original temperature of 
precipitation. [180 ] is also widely used in proteomic research to label peptides during proteolysis 
for quantitative comparisons of two samples (Yao et at., 2001). Both isotopes of oxygen and 
hydrogen are used in biochemical research for incorporation into organic molecules to monitor 
changes under particular conditions, or to facilitate structural determination, for example of 
proteins, carbohydrates and nucleic acids. Stable isotopes of carbon; [13C] and nitrogen; [15N] 
are also commonly used in biochemical research, particularly for metabolic labelling with 
subsequent metabolic flux analysis (Yang et al., 2005), quantitative proteomic analysis (Wu et 
a!., 2004), and as internal standards in mass spectrometry (Gerber et al., 2003). Detailed 
discussion on stable isotope labelling strategies for protein quantification is given in section 1.5.
1.2.2 The ability of MS to resolve isotopically labelled peptides
The natural abundance of the stable isotope [13C], is reflected in mass spectra of all organic 
compounds, including peptides (Figure 1a). For a peptide containing several carbon atoms, 
1.1% of these will be [13C] rather than [12C]; this corresponds to 1.1% for each carbon atom; for 
a molecule containing 100 carbon atoms (approximately 10-20 amino acids), there will also be 
a peak 1D heavier in mass (M+1) and 110% of the height of the main peak (100x1.1). In a 
mass spectrum of a peptide, this can be use to determine the number of carbon atoms. A 
‘peptide envelope’ also contains a peak corresponding to the peptide containing two (M+2) or 
more [13C] atoms, the intensity of which depends on the number of carbon atoms in the 
peptide. These isotopic peaks are separated by a constant mass to charge ratio (m/z) which is 
used to infer the mass of the peptide following ionisation and detection by MS. The charge 
state of the ion; the number of protons [H+] bound to the peptide during ionisation can be
7
Elem ent Stable isotope Abundance on Earth (%, w/w)
Hydrogen, [1H1 Deuterium, [2H1 0.03
Carbon, [12C] Carbon, f13Cl 1.2
Oxygen, i1BOl Oxygen, f BOl 0.2
Nitrogen, |14N] Nitrogen, r^Nl 0.39
Sulphur, pS] Sulphur, pS] 0.78
Sulphur, [^S] 4.55
Sulphur, [36Sl 0.02
Table 1. Natural abundance of stable isotopes most commonly used in proteomics
www. isotracer.co. nz
T3 p e g ,  [12C43]
6m/z
T3 [15N12], [12C49]
1049.55
◄--------------------------------
12m/z
Figure 1. Stable isotope labelling of a tryptic peptide.
The tryptic peptide (labelled T3) of sequence GFLIDGYPR [M+H]+ 1037.57m/z, and empirical formula 
C49H73N12O13 labelled with [13C6]-arginine (a) and [15N] (b).
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directly inferred by measuring the exact distance between adjacent isotopic components. This 
principle can also be used to test the efficiency of isotopic modification of peptides and 
proteins, for example if all [14N] atoms are replaced with [15N], the abundance of a peak 1 Da 
lighter in mass than the main peptide ion (M-1) resulting from a single [14N] atom can be used to 
report the purity and efficiency of labelling with the heavy isotope (for example, Krijgsveld eta!., 
2003, Figure 1b).
1.2.3 Mass isotopomer distribution analysis
For proteomics, stable isotopes are used in conjunction with MS to monitor and measure 
changes in abundance at the protein level in biological systems, for example in response to 
fluctuations in physiological or pathological condition (Hellerstein, 2004). The presence or 
absence of certain stable isotopes can also contribute extra information to a biological study, 
for example interpretation of peptide envelopes in mass spectra can be used to report the 
number of carbon atoms in a peptide and incorporating stable isotope labelled tags that target 
specific amino acids can be used to count the number of that residue in the peptide in 
accordance with the mass offset from the analyte. This information can add an extra dimension 
to protein identification and consequently techniques have been developed to incorporate 
multiple stable isotopes (for example [13C] and [15N]) into proteins creating alternative 
modifications at the peptide level which can be distinguished by mass spectrometry (Snijders et 
al., 2005). Stable isotopes are used for mass isotopomer distribution analysis by measuring 
incorporated stable isotope label in the precursor pool and tracing the distribution of the isotope 
label to determine protein dynamics (Papageorgopoulos et al., 1999). For incorporation into 
polymeric protein complexes, precursor subunits are labelled and administered combining 
labelled and unlabelled subunits. Administered precursor subunits are enriched with stable 
isotopes in different ways, for example replacing H2O with [2H2]0 in culture media or solvents 
and the resulting isotopomer profile determined by MS is compared to the expected distribution 
to establish the isotopic enrichment of the precursor pool (Fanara et al., 2004). For proteins 
with high molecular weights that cannot be easily resolved using standard MS instrumentation, 
this analysis can be based at the peptide level using selectively labelled amino acids to 
determine mass isotopomer distributions. The rate of incorporation of the labelled peptide will 
represent synthesis of the intact protein. This can provide useful information to understand the 
dynamics of biological systems, in addition to therapeutic benefits, including the use of stable 
isotopes to monitor the response of polymeric molecules to certain drug treatments (Fanara et 
al., 2004).
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1.2.4 Quantitative proteomics
MS is not inherently quantitative, particularly for peptides, as there are many factors 
contributing to the loss and generation of ions (discussed in section 1.3.2 and 1.4.2). 
Consequently, quantitative proteomics often employs stable isotope labelling to compare 
protein abundance across multiple samples (Cox and Mann, 2007). Stable isotopes have been 
used in this way for over 30 years when they replaced the use of hazardous radioactive 
isotopes for quantitative analysis, (for example, Weinkam eta!., 1978; Browne, 1986). This can 
take the form of tags containing stable isotopes which are attached to proteins or peptides 
through targeting of specific amino acid residues, functional groups or through enzyme 
catalysed reactions, labelling of whole proteomes through metabolic incorporation of stable 
isotopes, or using isotopically labelled internal standards (Cafias et al., 2006). These strategies 
measure changes in protein abundance at the level of mass spectrometric analysis with 
peptide isoforms separated in mass spectra according to the m/z difference of the stable 
isotope used (Figure 1). There are several important considerations when designing a stable 
isotope labelling experiment for quantification of proteins (Julka and Regnier, 2004); firstly is 
whether all peptides, or selected peptides are tagged. The advantage of a global approach is 
that all peptides are potential candidates for quantification, however selecting specific amino 
acids or functional groups can incorporate a significant degree of simplification of the proteome 
simultaneously, providing that important peptides or proteins are not discounted, thus losing 
vital information. It is also important to consider the mass window between peptide isoforms, as 
quantification will become complicated by overlapping isotope envelopes of other peptide 
species, or from the [13C] peaks of the light isotope. Labelling must also be quantitative; if 
basing abundance on relative signals in MS, it is important that the labelling strategy does not 
produce a difference in signal that may be incorrectly assigned to the natural abundance of the 
peptide. It may also be beneficial to multiplex quantification for more than two samples, or more 
than one analyte, thus quantifying the abundance of several proteins simultaneously. For this, it 
is important that processing between different samples is consistent, with particular attention to 
sample processing after labelling for differentially labelled samples. When designing or 
developing such technologies, it is beneficial to consider how useful the strategy will be for the 
quantification of proteins in a variety of organisms and using alternative methods of analysis, 
for example MS platforms.
I
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Differential labelling strategies
Stable isotopes of carbon [13C], hydrogen [2H], nitrogen [15N] and oxygen [180 ] are most 
commonly used in labelling strategies for proteomics and protein quantification, each offering 
distinct advantages. Deuterium [2H] is commonly used to label many chemicals, for example 
‘heavy’ water, or selected amino acids, as a relatively inexpensive strategy for stable isotope 
labelling. A drawback of this label is that for use in samples where a peptide separation step is 
required prior to mass spectral analysis, isoforms containing ‘heavy’ and ‘light’ hydrogen do not 
co-elute when separated by reversed phase; deuterium labelled peptides elute first, as the 
deuteron is much smaller than the proton, and less hydrophobic (Zhang et al, 2001). 
Strategies for proteome simplification will be discussed in section 1.4.2. The degree of 
separation between the two isotopomers depends on the number of deuterium atoms 
incorporated into the labelled peptide (the greater number of deuterium atoms, the greater the 
resolution of the two peptides), but for quantification of protein abundance based on MS signal 
intensity, it is vital that the entire signals from both heavy and light isotopic variants are 
analysed simultaneously. Consequently, the chromatographic separation of deuterated and 
non-deuterated peptides could cause considerable error for protein quantification, and is not an 
appropriate labelling strategy for high throughput protein quantification. In addition, deuterons, 
are not necessarily metabolically stable, for example after in-vivo metabolic incorporation, the 
a-carbon deuterium may be lost by transamination (Pratt et al., 2002). As an alternative, [13C] 
and [15N] are becoming more widely used, for example [13C]glucose or [15N]H4CI as metabolic 
precursors, although this incorporates a varying number of stable isotope labels into each 
peptide, which can complicate analyses. Alternatively, amino acids are selectively labelled, for 
example [13Ce]arginine giving a 6Da mass offset from each arginine terminated peptide, or 
[13C6][15N4]arginine, giving a 10Da mass offset. For this approach, incorporation of one stable 
isotope, for example [13C] is preferred to minimise cost, and to provide a sufficient mass offset 
(>4Da) from the unlabelled peptide (reviewed by Beynon and Pratt, 2005). [12C] and [13C] 
labelled peptides do not resolve during reversed-phase chromatography, even on incorporation 
of multiple [13C] atoms (Zhang and Regnier, 2002). Stable isotopes [180 ] and [15N] also show 
no chromatographic differences relative to their light isotope; [15N] is commonly used as a 
metabolic labelling strategy for cells in culture that are grown in [15N] enriched media and [180 ] 
is also used to label water that is the solvent in a proteolytic digestion reaction, incorporating a 
labelled oxygen atom onto the carboxyl group of a peptide formed during amide bond 
hydrolysis (reviewed by Julka and Regnier, 2004).
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Internal standards
Stable Isotopes are also used to create Internal standards for protein quantification by MS to 
compensate for variation in sample preparation and analysis. The principle of internal 
standardisation is employed to establish the relationship between a measured physicochemical 
response to an analyte and the amount of analyte producing the response. To achieve this, 
internal standardisation methods have been developed using radioactive isotopes (for example 
Byrne and Benedik, 1997), although stable isotopes are preferred for biochemical analysis of 
proteins and peptides using mass spectrometry. This is necessary as signal intensity in MS e.g. 
MALDI-ToF MS does not give an indication of quantity of analyte due to ionisation and other 
effects. In many analytical systems, external standardisation is carried out using a series of 
calibration standards of known concentration. These are chromatographed or analysed 
separately from the samples and the data are used to convert detected responses for the 
samples into accurate masses or concentrations. To determine the absolute amount of an 
analyte protein, internal standards should be chemically identical and show the same behaviour 
as the analyte but they must also be discrim inate, for example by MS. Providing this is the 
case, a known amount of an internal standard is added to all analyte samples and the response 
of analyte and standard is compared for absolute quantification, compensating for variations in 
sample size, preparation and other parameters. This technique has been developed for 
quantitative proteomic studies in which a standard is added to a biological sample, the 
chemical and physical properties of which are taken to be representative of the native analyte. 
For these analyses, the most commonly used surrogates are isotopically modified versions of 
the analytes (Gerber et al., 2003). Since these peptides are identical apart from the heavy 
isotope, they have identical ionisation efficiencies in MS, thus relative MS signals between the 
two can be used as a measure of their absolute abundance. In this way, the use of stable 
isotopes permits absolute rather than relative protein quantification acquiring unambiguous 
information in a systems biology context that is comparable across multiple platforms. The use 
of stable isotopes to achieve absolute quantification of proteins in biological systems and a 
more detailed description of the evolution and application of these methods is discussed in 
section 1.5.
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1.3 Pr o tein  Identification
1.3.1 Gel electrophoresis
A mixture of proteins can be simply resolved and visualised using sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) in one or two dimensions; a separation 
technique based on the movement of charged molecules in an electric field. Dissimilar 
molecules migrate at different rates, separating the components of a mixture. The 
electrophoretic mobility depends on charge, size, shape and strength of electric field. As such, 
proteins can be separated according to molecular weight, which may be affected by higher 
order protein folding, post-translational modifications and other factors. Most proteins carry a 
net negative charge, depending on the numbers of positively and negatively charged amino 
acid side chains at a given pH. Gel based electrophoresis methods use a supporting medium 
(e.g. acrylamide) which provides a cross linked matrix and acts as a filter that proteins must 
pass through. This increases resistance and minimises the effects of convection currents and 
diffusion of protein molecules within the buffer solution. To denature protein structure prior to 
separation, the anionic detergent sodium dodecyl sulphate (SDS) is mixed with the sample 
ensuring that each protein has a negative charge that is proportional to its mass. For 
identification proteomics, proteins are separated according to molecular weight only (1D SDS- 
PAGE) or separated by charge in one dimension and molecular weight in another (2D SDS- 
PAGE). This affords a considerable degree of protein separation allowing protein expression 
across different samples to be compared. Separation in two dimensions can also give an 
indication of some post-translational modifications that introduce variation in molecular weight 
or net charge of the protein, for example acetylation (discussed in section 1.1.2) and 
phosphorylation.
1.3.2 Mass Spectrometry
Proteins, either in-solution, or after excision from a polyacrylamide gel, are digested into 
peptides for analysis by mass spectrometry (a detailed discussion of this process is given in 
section 1.4.1). Peptides are simpler to analyse than proteins as they have lower charge states 
following ionisation and their mass to charge (m/z) values are compatible with most 
instrumentation. There are three main processes of MS, ionisation and transfer of ions into the 
gas phase (from solid or liquid), discrimination of ions (usually by separation or selection) 
based on their mass to charge ratio (m/z), and detection. To achieve this, there are three main 
components of a mass spectrometer, the ion source which creates charged particles and
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transfers analytes into the gas phase, a mass analyser which separates ions according to their 
m/z, and the detector which detects the ions of different m/z values in order to generate a mass 
spectrum.
Two predominant forms of ionisation are effective for proteins and peptides, both developed in 
the late 1980’s. Matrix assisted laser desorption/ ionisation (MALDI; Hillenkamp et al., 
1991) ionises peptides from the solid phase, and electrospray ionisation (ESI; Fenn et al, 
1989) creates peptide ions from samples entering the mass spectrometer in solution (Figure 2). 
The principle of ionisation for both types of ion source is fundamentally the same, as analyte 
molecules are transferred to the gas phase and ionised. As analytes enter the gas phase, they 
encounter proton donors [H+] from the matrix (MALDI), or carrier solution (ESI), giving them a 
positive charge (some applications of mass spectrometry also detect deprotonated/negatively 
charged ions). MALDI usually adds a single proton [H+] to each peptide, usually on the basic C- 
terminal residue lysine or arginine for proteins digested with trypsin, thus the entire signal from 
that peptide is contained within a single entity [M+H]+. Occasionally, MALDI may produce 
doubly [M+2H]2+ or triply [M+3H]3+ ions for multiple charge sites, whereas with ESI, several 
charges may be applied to peptides and proteins, depending on their mass and available 
protonation sites. For tryptic peptides, ESI usually results in the formation of doubly charged 
ions, with protons sequestered on the C-terminal basic amino acid arginine or lysine, and on 
the N-terminus. However, peptides containing a missed cleavage site, for example -ArgPro-, or 
histidine residues, may be multiply charged in ESI. Both ESI and MALDI ion sources have been 
coupled to various forms of mass analyser and detection system, thus producing a wide variety 
of different instruments offering individual analytical strengths. There are three main 
specifications of a mass spectrometer that deliver different performance from each instrument; 
sensitivity, mass accuracy and resolution.
Sensitivity is dependent a great deal on ionisation, ion transmission and detection. For 
complex mixtures of peptides, ESI confers greater relative sensitivity than MALDI due to 
ionisation suppression effects in MALDI, although it is more susceptible to impurities, for 
example salts used in buffers and solvents (Yang et al., 2007). Both forms of ionisation favour 
different peptides; MALDI favours basic residues and the side chains of certain amino acids, 
whereas ESI favours hydrophobic amino acids (Stapels et al., 2004). As such, for protein 
identification, the two forms of ionisation offer complementary techniques (Stapels et al., 2004). 
The presence of multiply charged ions may complicate mass spectra when using ESI over
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Figure 2. Ionisation by MALDI and ESI for mass spectrometry.
For protein identification by mass spectrometry, ionisation is achieved by a) matrix assisted laser 
desorption/ionisation (MALDI) or b) electrospray ionisation (ESI). MALDI is a solid phase 
technique in which analyte sample is mixed with an acidic matrix and dried on a target plate. The 
matrix absorbs energy at the wavelength of an applied laser, causing analyte molecules to be 
irradiated, vaporised into the gas phase and ionised (protonated; [M+H]+). For ESI, sample 
containing peptides is sprayed from a high voltage needle into the electrospray source which is 
maintained at a constant potential difference across the sample cone. Solvent evaporates as a 
dry gas, for example nitrogen is applied causing the charge density of each droplet to increase. 
Eventually the charge density reaches a critical level (the ‘Rayleigh’ limit) and ions are ejected 
and enter the mass spectrometer.
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MALDI and the signal from any particular ionised species may be distributed over several 
charge states. While this may increase analysis time by confirming the charge state of each 
anayte:internal standard pair, peptide ions in different charge states should behave in the same 
way, thus not compromising quantification.
Resolution; the ability to distinguish between ions of different m/z in a mass spectrum, is 
largely dependent on the mass analyser and will indirectly confer mass accuracy. The 
capacity of an instrument to distinguish between two signals that are close together is 
dependent on the mass of the compound and the width of the mass spectral peak measured at 
different intensities. As a standard measurement of resolution, the full width of the peak is 
taken at half the maximum height (FWHM) and divided by the mass; the better the resolution, 
the more accurate the m/z and inferred mass value (Figure 3). To achieve high resolution and 
mass accuracy appropriate for various applications, modern mass spectrometers use several 
types of mass analysers; principally time of flight, quadrupoles, ion traps and ion cyclotron 
resonators (the relative merits and drawbacks in terms of resolution and mass accuracy are 
reviewed by Balogh, 2004).
Time of flight mass analysers (ToF; Stephens, 1946, Figure 4a) employ a flight, or drift tube 
along which ions travel following acceleration from the source with kinetic energy directly 
related to their mass and velocity (KE=1/2mv2); smaller ions travel along the flight tube faster 
than larger ions with less kinetic energy. As all the ions travel the same distance with the same 
kinetic energy, the time taken can be measured as a direct result of their mass. Resolution is 
dependent on the distribution of flight times for ions of the same m/z, which is a direct result of 
slight fluctuations in kinetic energy as ions are released into the flight tube. To increase the 
resolution of ToF analysers, flight tubes are typically lengthened using a device called a 
‘reflectron’ or ‘ion mirror1 which is added to the top of the flight tube. This is a focusing device 
that creates an electrostatic field, deflecting the ions off axis to the detector. The reflectron 
compensates for small differences in kinetic energy of ions with the same m/z, as those with 
greater kinetic energy travel further into the reflectron. Consequently, ions of the same m/z 
reach the detector simultaneously, dramatically improving instrument resolution from around
8,000 to 15,000 (FWHM). The reflectron restricts the mass of the molecules that can be 
analysed by MS as ions with large m/z values (>5000) cannot be sufficiently deflected by the 
reflectron, thus decreasing sensitivity and resolution significantly. Resolution can be improved 
using MALDI and ToF MS by delaying the pulse of ion extraction, focusing the ions immediately
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Figure 3. Resolution of peptide mass spectra.
For mass spectrometry, resolution is a measure of the ability to distinguish between ions of 
different m/z in a mass spectrum. The capacity of an instrument to distinguish between two 
signals that are close together is dependent on the mass of the compound and the width of the 
mass spectral peak measured at different intensities. As a standard measurement of resolution, 
the full width of the peak is taken at half the maximum height (FWHM) and divided by the mass.
To achieve high resolution and mass accuracy appropriate for various applications, modern mass 
spectrometers use several types of mass analysers with resolution ranging from 4,000 
(quadrupoles) to 106 (FT-ICR). Resolution from 1,000 to 100,000 is illustrated for a peptide of 
sequence GFLIDGYPR, mass 1036.54Da (images created by MSIsotope; http://prospector.ucsf.edu/).
reflectron
(not detected)
Figure 4. Time of flight and quadrupole mass analysers.
a) Time of flight with reflectron; once ionised, the mass to charge ratio (m/z) of ions can be 
detected in a time of flight (ToF) mass analyser. Ions are accelerated from the source with a 
kinetic energy dependent on their mass and velocity (KE=1/ 2mv2). Measurement of the time taken 
for each ion to reach the detector is indicative of its mass at its particular charge state; lighter 
ions travel faster with greater kinetic energy and reach the detector first. To improve resolution of 
the resulting mass spectrum, flight tubes often incorporate reflectrons or ion mirrors that lengthen 
the path of the travelling ions. Ions with the same m/z and varying kinetic energy are reflected to
a different extent as ions with greater kinetic energy travel further into the reflectron, 
compensating for slight differences in flight time, causing them to reach the detector 
simultaneously.
b) Ions are separated according to their mass to charge ratio in a quadrupole using electric fields 
created by four oppositely charged rods. The electric field is created by a fixed direct current and 
alternating radio frequency across the rods, through which ions of a particular m/z will have stable 
trajectories, allowing them to pass through to the detector. (Image taken from www.bris.ac.uk).
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following ionisation. This generates ions with a significantly smaller kinetic energy distribution 
so that all ions of the same m/z enter the flight tube at the same time, and with the same kinetic 
energy. Delayed pulsed extraction is set for the mass range at which optimal resolution is 
required, with effects significantly diminished above m/z values of 30,000. Resolution of ToF 
instruments is typically in the range of 10,000 with peaks derived from the same peptide 
showing clear baseline separation for the carbon-isotopes, and mass accuracy of 200ppm 
(1000Da±0.2Da). For reflectron ToF instruments, resolution of up to 15,000 can be achieved 
with mass accuracy of 10ppm±0.01 Da).
Quadrupole mass analysers (see reference for quadrupole ion trap; Figure 4b) separate ions 
due to the electric fields created by four parallel rods. Opposite rods are electrically connected 
in parallel to a radio frequency generator, and direct current. This creates an oscillating electric 
field allowing only ions with stable trajectories; measured as a function of time and position of 
the ion from the centre of the rods to pass through and reach the detector. The radio frequency 
field applied across the quadrupole transmits ions of a specific m/z, allowing only these to pass 
through and reach the detector. Scanning the RF field allows a broad m/z range (100-4000) 
with typical resolutions of around 4,000.
The quadrupole ion trap (QIT; Paul, 1990, Figure 5a) exists in linear and three-dimensional 
forms (March, 2000). In contrast to standard quadrupoles, ions are retained inside the trap and 
will remain so for the time taken to perform standard MS experiments. A three dimensional 
quadrupole consists of a ring electrode and two hyperbolic endcap electrodes, ‘trapping’ the 
ions on a three-dimensional trajectory within a radio frequency quadrupole field. All ions enter 
the trap and a resonant frequency of dynamic amplitude can be applied to the quadrupole to 
destabilise successive ion trajectories, thus expelling ions of a selected mass. In these 
instruments, resolution is inversely related to scanning speed; lower scan speeds increase the 
density of data points per unit m/z, thus increasing resolution. For high throughput, higher 
scanning speeds are needed, thus sacrificing superior resolution (typically around 8-10,000, 
although resolution of 30,000 can be achieved with lower scanning speeds) and sensitivity, as 
only a limited number of ions can be retained in the trap at one time. A linear ion trap retains 
ions along the axis of a quadrupole to which a combination of two-dimensional radio frequency 
voltages are applied to the rods and a direct current is applied to the end lenses at both sides 
of the trap. This increases the capacity to retain trapped ions, thus increasing sensitivity and 
dynamic range.
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Figure 5. Quadruople ion trap and Ion cyclotron resonance.
a) Quadrupole ion trap: Ions are trapped in an oscillating electric field applied by a radio 
frequency alternating current and a fixed direct current. Specific ions are selectively retained in 
the trap by applying a resonant frequency to the quadrupole that will successively destabilise ion 
trajectories causing ions with a particular mass to charge ratio to be ejected from the trap.
b) Ion cyclotron resonance: Ions are trapped in a magnetic field causing them to oscillate with a 
frequency inversely related to their mass to charge values and directly related to the intensity of 
the magnetic field. The magnitude of their oscillations is increased as an alternating current is 
applied, the frequency of which is detected and transformed to produce a mass spectrum.
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Ion cyclotron resonance (ICR; Hippie eta!., 1949, Figure 5b) traps ions in a cell composed of 
four electrodes in a strong magnetic field. Inside the trap, ions oscillate with a frequency 
inversely related to their m/z values and directly related to the intensity of the magnetic field. A 
radio frequency voltage is applied, increasing the magnitude of oscillation of the ions whilst 
maintaining their frequency. To detect the ion, the frequency is measured with high accuracy 
via the creation of an image current in the detector with the same frequency as the ion. This 
achieves high resolution and subsequent mass accuracy as frequency is easier to measure 
than voltage, which is improved further with a stronger magnetic field. For the simultaneous 
analysis of ions with different m/z values, the measured frequency of the ions is converted into 
a mass spectrum by Fourier transforms (FT). For FTICR (Marshall eta!., 1998) instruments, 
resolution of up to 106 can be achieved using the highly accurate measure of frequency to 
produce mass spectra.
Fourier transform is also used to produce mass spectra from the Orbitrap mass analyser in 
which ions are trapped around a central electrode (Hu et a!., 2005). The static electric field is 
created by this and a barrel-like electrode on the same axis. The frequencies of the ion 
oscillations as they orbit the central electrode are used to measure mass to charge. This by­
passes the need for a superconducting magnet but retains very high resolving power (up to 
150,000) by measuring frequency, and consequently improves confidence of protein 
identifications (Scigelova and Makarov, 2006).
1.3.3 Peptide mass fingerprinting
Analysis of proteins digested into peptides with a specific protease by MS generates a mass 
spectrum in which peptide masses provide a diagnostic fingerprint of the parent protein which 
can be used to search databases of theoretically digested proteins (Pappin et ai, 1993). Mass 
to charge ratios of peptide ions [M+H]+ are used to search databases, for example the protein 
sequence database SwissProt (www.expasy.org/sprot); a biological database containing known 
full-length protein sequences, incorporating a high level of manual annotation, including protein 
function, with a low level of redundancy such that protein products from the same gene are 
included in the same database entry. For mass spectrometry applications, MS data are 
commonly searched against the MS database; MSDB (http://csc- 
fserve.hh.med.ic.ac.uk/msdb.html), a comprehensive, non-identical protein sequence 
database, particularly employed for MSMS data. The confidence of a peptide match upon an 
appropriate database search is represented by a probability score, for example using the
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MOWSE algorithm. The MOWSE (molecular weight search) fragment database was originally 
derived from over 50,000 proteins and included the calculated molecular weights of peptides 
created by a specific proteolytic enzyme (Pappin et al., 1993). A scoring algorithm was also 
developed in which the frequency distribution of peptide masses obtained experimentally within 
a given molecular weight range was compared to the number of potential peptides in the same 
range. This scoring scheme was built into the MOWSE search and the database could be used 
to identify a protein based on 3-4 peptide masses determined by MS. This scoring algorithm 
also takes into account the signal intensity relationship between lower and higher mass 
peptides and their abundance, to facilitate identification. Since the basic model, bioinformatic 
tools have been developed considerably to incorporate complex parameters into the search of 
mass spectrometric data to include modifications at the peptide level and to improve 
confidence of search results. Although the MOWSE scoring system is still used, MS database 
searches use probability based scoring in MASCOT (Perkins et al., 1999) or SEQUEST (Eng et 
al., 1994) search engines, both of which yield similar results (Elias et al., 2005). To increase 
confidence of protein identification, individual properties of proteins and peptides are 
incorporated into the database search. These include mass range, protease used, taxonomy 
(which can be broad, for example ‘mammalia’, or individual species can be searched, 
depending on the availability of sequence data in the database) and instrument parameters, 
including peptide mass tolerance (Zhang and Chait, 2000). Search engines can also 
incorporate expected protease cleavage sites that may have been missed by the enzyme 
(missed cleavages) and modifications, for example oxidation of methionine residues that may 
have occurred during sample preparation or post-translational modifications such as 
deamidation of asparagine residues (www.matrixscience.com). For peptide mass fingerprinting, 
probability based scoring algorithms provide a quantitative measure of the significance of a 
match with confidence of protein identification dependent on availability of protein sequence 
information in the database, spectral quality in terms of signal to noise ratio (the influence of 
background noise in the spectrum), resolution and mass accuracy, with highly accurate mass 
data achieved with FT-ICR MS providing more confident protein identifications (Smith et al., 
2002) and sample processing. In particular, the success of peptide mass fingerprinting 
depends on completeness of proteolytic digestion (discussed in section 1.4.1).
1.3.4 Tandem MS
Identification of proteins by mass alone (peptide mass fingerprinting) is effective for analysis of 
single proteins digested into constituent peptides. However, in complex mixtures of proteins,
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connectivity to the parent protein is lost upon proteolytic digestion and MS analysis. 
Consequently, for protein identification, mass contributes limited information and alternative 
parameters are required, for example structural information. To obtain amino acid sequence 
information using MS, peptide ions (precursors) are fragmented, often by collision with an inert 
gas such as argon or helium (collision induced dissociation; CID). This creates a spectrum 
where each peak (product ion) represents the loss of sequential amino acids, predominantly 
from the N- or C-terminus of the peptide during fragmentation. Individual fragments ions are 
then detected, for example using a ToF mass analyser giving a series of fragment (product) 
ions which can be used to determine the sequence of amino acids in the peptide precursor. 
Most commonly, fragmentation occurs at the amide bond between amino acids with the 
resulting product ion spectrum containing a series of b-ions from the amino terminus of the 
peptide and y-ions from the carboxyl terminus (Figure 6). As such, the amino acid sequence 
can be determined from the mass difference between adjacent peaks in a b- or y-ion series 
relating to the loss of sequential amino acids from the precursor. This fragmentation pattern is 
particularly observed from doubly charged [M+2H]2+ ions, for example tryptic peptide ions 
generated by ESI for which the b-ion series carries the single positive charge from the amino 
terminus and the y-ions, the positive charge from the C-terminus. Fragment ion spectra often 
contain other ions, for example fragmentation may occur at the C-C bond giving rise to a-ions 
(containing the N-terminus) and x-ions (containing the C-terminus), alternatively dissociation 
can occur at the N-C bond giving rise to c-ions (containing the N-terminus) and z-ions 
(containing the C-terminus; Johnson et a!., 1987). Internal cleavage and side-chain 
fragmentation may also occur depending on the peptide sequence, ionisation and 
fragmentation methods. Immonium ions consisting of a single side chain formed through a 
combination of a- and y-type cleavage can also be used to report on the amino acids that are 
present in the peptide.
Precursor ions can also be fragmented by electron capture dissociation (ECD; Zubarev et a!., 
1998) in which a free electron interacts with a multiply protonated molecule, or electron transfer 
dissociation (ETD; Syka et al., 2004) in which electrons are transferred via collision between 
the analyte cations (for example multiply charged peptide ions) and reagent anions (for 
example derived from volatised anthracene). These methods are useful for the analysis of post- 
translational modifications that are lost during fragmentation by CID due to the transfer of 
vibrational energy across all covalent bonds (Siuti and Kelleher, 2007). By contrast, electron 
capture and electron transfer dissociation introduce low energy electrons along the peptide
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Figure 6. Fragmentation of a peptide ion.
For determination of protein primary structure using mass spectrometry, peptide ions are 
fragmented during tandem mass spectrometry. Fragmentation occurs at the amide bond between 
amino acids resulting in a product ion spectrum that contains a series of b-ions from the amino 
terminus of the peptide and y-ions from the carboxyl terminus. The amino acid sequence can be 
determined from the mass difference between adjacent peaks in a b- or y-ion series relating to 
the loss of sequential amino acids from the precursor. Fragment ion spectra will often contain 
other ions, for example fragmentation may occur at the C-C bond giving rise to a-ions (containing 
the N-terminus) and x-ions (containing the C-terminus), alternatively dissociation can occur at the 
N-C bond giving rise to c-ions (containing the N-terminus) and z-ions (containing the C-terminus). 
The diagram above illustrates the b- and y-ions formed from the loss of sequential amino acids 
from the precursor ion during fragmentation of an 8-amino acid peptide, where each block 
represents one amino acid residue.
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backbone, thus fragmentation is not sequence specific. For MALDI based methods, 
fragmentation is often achieved by post-source decay where ions undergo fragmentation during 
time of flight mass analysis (Spengler et at., 1992). Fragment ions are not separated by ToF 
alone as product and precursor ions have the same velocity and reach the detector 
simultaneously. However, in reflectron instruments, product ions are separated by the 
reflectron as they have different kinetic energy values than their precursors. To combine PSD 
with more rigorous fragmentation using MALDI, instruments have been developed which 
incorporate a second ToF analyser and a collision cell to fragment precursor ions, for example 
the AXIMA-ToF2 (Kratos, Manchester, UK). This is useful for combining fragmentation of 
peptides with the benefits of MALDI, for example its high tolerance of salt contamination, and 
peptide sequencing is complementary with ESI-MSMS (Noga et at., 2006). However, ESI 
remains preferable for coupling with quadrupole and ion trap mass analysers for MS and 
MSMS as it delivers a continuous beam of ions, rather than MALDI which produces short 
bursts of ions in a vacuum (reviewed by Mann et at., 2001).
Fragmentation in quadrupole ion trap and ICR mass spectrometers is usually achieved by 
expelling all the ions except the selected precursor. Collision energy is provided through 
introduction of an inert gas, for example helium, causing the ion to fragment. These instruments 
are able to perform multiple stages of MS by fragmentation of precursor ions, interrogation of 
product ions, and subsequent isolation and fragmentation. This technology is compatible with 
ECD for ICR instruments and ETD for quadrupole ion traps for the analysis of post-translational 
modifications.
1.3.5 MSMS ion searching for protein identification
Tandem MS generated fragment ion data can also be used for peptide and protein 
identification to search databases using search engines, for example Mascot and SEQUEST. 
Similar available search tools include XITandem (Craig and Beavis, 2004) which matches 
tandem mass spectra with peptide sequences, and Piums (Samuelsson et at., 2004) which 
uses a combination of peak extraction and protein scoring for confident protein identification. 
This can be achieved for single peptides, but is often highly automated (Tabb eta!., 2002), with 
increased confidence in protein identification with multiple peptide matches. Peptide 
sequencing can also provide information on post-translational modifications to the protein or 
peptide, for example phosphorylation, and can often locate these modifications within the 
amino acid sequence (Yates et at., 1995). The success of ‘de-novo sequencing’ using fragment
19
Introduction
ion spectra will depend on the mass accuracy and resolution of the instrument and how well the 
peptide has been fragmented. However, often small sections of amino acid sequence ‘tags’ are 
sufficient to identify a peptide due to the large amount of sequence data available in universal 
protein sequence databases, for example MSDB. Databases can be searched by comparing 
fragment ion spectra with theoretical spectral data, thus requiring no prior user interpretation 
(MSMS ion search), or to combine the molecular mass of the precursor/peptide ion with a short 
section of the amino acid sequence generated by partial interpretation of the fragment ion 
spectrum (sequence query; Mann and Wilm, 1994). Furthermore, short sections of amino acid 
sequences can be searched using the Basic Local Alignment Search Tool (BLAST), which 
finds regions of local similarity between biological sequences in the protein database, 
(www.ncbi.nlm.nih.gov) and calculates the significance of protein identification matches.
For large-scale protein identification studies based on MSMS data, there are a wide variety of 
MS platforms, in addition to database searching software applications/packages that can be 
used. For systems biology, it is important that these produce reproducible data of the same 
quantity and quality. For MS, most commonly used instruments Q-ToF and QIT, boast different 
performance in terms of mass accuracy, resolution and dynamic range. The extent to which 
data acquired by each instrument is comparable was assessed by Gygi and co-workers (Elias 
et al., 2005) who discovered that 60% of proteins, with less than half of all unique peptides, 
were identified by both instruments. This was improved by replicating analysis of the same 
sample with the same instrument, suggesting that limitations in the number of ions trapped at 
one time in a QIT, and time for each CID event in Q-ToF have a strong influence on the output. 
The extent to which protein identification varied across different sample injections, and different 
instrumentation for analysis prompted development of more stringent validation criteria for 
accurate and reproducible protein identification across multiple platforms, particularly when 
proteins are identified by a single peptide (Chamrad and Meyer, 2005). In an attempt to 
standardise protein identification, bioinformatic tools to handle both MS and tandem MS data 
along with databases of predicted peptide identification and fragmentation patterns are now 
publicly available, pooling resources from different laboratories, for example PeptideAtlas 
(www.peptideatlas.org). In addition, this facilitates the design of protein identification strategies, 
for example PepSeeker (McLaughlin et al., 2006), a database containing pre-determined 
fragmentation information from around 200,000 peptides which can be used collectively to 
predict rules for peptide fragmentation, including relative peak intensity of product ions. These 
resources combine spectral data and database search information, along with instrument and
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software parameters in an attempt to standardise existing protein identification data whilst 
improving future protein identification strategies.
1.4 C ha llen g es  in peptide  b a sed  pro teo m ics
1.4.1 Proteolysis
For identification and subsequent peptide-based quantification, proteins are most often 
digested using the serine protease trypsin. Trypsin is a digestive enzyme which is produced in 
the pancreas as the zymogen, trypsinogen before being transported to the intestine where it is 
cleaved and hence activated by the enzyme enteropeptidase. For experimental purposes 
including peptide mass fingerprinting, trypsin is purified, for example from bovine pancreatic 
trypsinogen, available in high quantities. Cleavage by trypsin is highly specific, taking place at 
the peptide bond on the C-terminal side of the basic residues arginine and lysine, unless they 
are followed by a proline residue. It is the positive charge on these particular residues that 
interacts with the negative charge carried by an aspartic acid residue (Asp 189) in the substrate 
binding site of trypsin. The abundance of cleavage sites in the majority of proteins; 10% 
approximate average abundance of arginine and lysine in eukaryotic proteins (Cagney et al., 
2003), for trypsin digestion generates peptides of an average length compatible with detection 
by most mass spectrometers. For example, a 300 amino acid protein would contain 30 
cleavage sites on average, generating 31 peptides of 10 amino acids each, with an average 
mass of 1000Da. Doubly and triply charged tryptic peptides are easily fragmented using CID, 
with a single proton on both the N- and C-terminus, generating multiple ions (predominantly b- 
and y-ions), and producing good quality data for database searching and protein identification. 
For a 24h incubation, used in most standard digestion protocols, trypsin is most effective at 
37°C, pH7-9 (Roche Diagnostics, Lewes, UK) under these conditions, trypsin autolysis 
products will become sufficiently abundant after 24h to complicate mass spectral analysis, in 
addition to limiting enzyme activity and specificity (Klammer and MacCoss, 2006).
Less commonly used proteases offer alternative cleavage of the peptide bond, which may be 
advantageous to particular experiments (Table 2). These may also be used in experiments 
where conditions are unfavourable for trypsin. Endopeptidase Lys-C cleaves at the carboxyl 
terminus of lysine residues only and is more stable than trypsin. This protease can be used to 
digest proteins that have been previously solubilised in high salt buffers, including strong 
solutions of urea. To generate alternative peptide mass fingerprints that may aid in protein
Enzyme Specificity Optimal pH Mwt (kDa) # fragments Av. Length
Trypsin C-terminal R/K 7-9 23 31 10
A s d -N N-terminal D 6-8 24 13 23
Gluc-C C-terminal E 4-8 29 19 16
Lvs-C C-terminal K 8-9 28 15 20
Arq-C C-terminal R 7-9 27 16 19
Table 2. Commonly used proteases for proteomics.
Proteases typ ica lly used for protein digestion fo r mass spectrom etry analysis are listed with 
specific ity/location o f cleavage, optim al pH, mwt, num ber o f fragm ents expected from a 300 
am ino acid protein, and the average length (num ber o f am ino acids) o f each peptide.
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identification, proteases Asp-N (cleaves at the amino terminus of aspartic acid) and Gluc-C
►
(cleaves at the carboxyl terminus of glutamic acid, and aspartic acid under some conditions) 
are also available. Less specific proteases are also used, but these may generate overlapping 
fragments and are therefore not used as a tool for protein identification by peptide sequencing. 
In several proteomic experiments, combining peptide identification data achieved using a 
combination of proteases often achieves the greatest number of identifications, but increases
I  the workflow considerably (Biringer et at., 2006). Differences in amino acid sequence coverage
from different proteases were attributed to the availability of cleavage sites within the three 
dimensional structure of the protein rather than the enzyme efficiency, although alternative 
proteases to trypsin are more likely to generate larger peptides, beyond the mass range of 
popular instrumentation that are consequently not detected (Table 2).
Factors influencing proteolysis and their consequences
For confident protein identification, efficient digestion to generate all possible peptides for 
analysis by MS is desired. However, this is not always possible, particularly for a complex 
mixture of proteins with varying three dimensional structure and availability of cleavage sites. 
To compensate, missed cleavage peptides retaining one or more hydrolysable bonds can be 
included in database searches for protein identification. Sample processing conditions may 
also be adjusted to improve the efficiency of a protease where possible, as although only a
> small amount of each peptide must be present in order to be detected, a stronger signal is
likely to ensue upon MS if a greater proportion of peptide is present. In addition, there are 
instances in which complete proteolytic cleavage of peptides is essential, for example in 
quantitative proteomics using stable isotope labelled internal standards (introduced in section
1.2.3). For this strategy to provide reliable quantification, the response of the peptide selected, 
in relation to the chemically identical, stable isotope labelled internal standard, must be 
representative of the parent protein, and consequently must be completely cleaved by the 
protease. To assess the extent of proteolytic cleavage of analyte proteins, influential factors 
must be considered. These include sample preparation conditions, for example protease to 
substrate ratio, nature of buffers and solvents, temperature and the time allowed for digestion 
to take place, in addition to substrate composition; primary structure, higher order structure and 
protein folding. Other limiting factors include, non specific proteolysis in vivo or during sample 
processing and autolytic cleavage of the protease, limiting its efficiency within the analyte 
system.
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The majority of sample preparation factors are relatively easy to control, for example proteins 
digested following excision from gels, or in-solution with trypsin are often reduced using thiols 
such as dithiothreitol (DTT) (Lundell and Schreitmuller, 1997) or by heating. This reduces 
disulphide bonds that form between cysteine residues, allowing trypsin access to a greater 
number of potential cleavage sites within the protein. In order to prevent disulphide bonds re­
forming, cysteine residues are alkylated, using, for example iodoacetic acid which causes all 
cysteines to become carboxymethylated. Addition of several denaturing agents, for example 
0.1 M urea or 0.1% (w/v) SDS can improve the activity of trypsin up to 180% (from 100%), by 
allowing the protein to adopt a less rigid tertiary structure to facilitate access to cleavage sites 
(Roche Diagnostics, Lewes, UK). While this may improve digestion efficiency, these reagents 
are often incompatible with downstream analysis, particularly in liquid chromatography and 
ESI-MS. Chaotropes for example urea can result in peptide adducts through the formation of 
isocyanate, limiting use of the data acquired. Denaturing agents used to solubilise proteins 
prior to proteolytic digestion for example urea and guanidine hydrochloride are often used at 
concentrations up to 8M which will significantly reduce activity of trypsin; just 1M GHCI reduces 
trypsin activity to zero (Harris, 1956; Hill eta!., 1958; Roche Diagnostics, Lewes, UK). These 
agents must therefore be removed prior to trypsin digestion. Improved proteolysis can be 
achieved by heating the protein, although this can result in sample loss through protein 
precipitation. Digestion can also be enhanced by increasing the concentration of enzyme but 
this can become expensive if used routinely. Addition of organic solvents including methanol 
and acetonitrile (up to 80% v/v) can be used to aid solubility and unfolding of proteins (Strader 
et a!., 2006), increasing trypsin activity significantly. Alternative methods involving precipitation 
of protein with trichloroacetic acid (TCA) or acetone prior to resolubilisation and trypsin 
digestion have also been effective at denaturing and desalting proteins for more efficient 
proteolysis (Kim et al., 2006). Proteolysis yields a greater number of peptide and protein 
identifications when trypsin has been immobilized on a microcapillary column through which the 
protein mixture to be digested is passed (Klammer and MacCoss, 2006). This provides an 
automated strategy combining sample cleanup, preconcentration and protein digestion with 
increased efficiency and stability of enzyme. Immobilised trypsin can be applied to very low 
concentrations of proteins; however this is most likely due to an increased enzyme to substrate 
ratio as the protein passes over the beads. Although these methods to improve proteolytic 
digestion are effective to a varying degree, it is important to realise that incomplete digestion is 
tolerable for protein identification, providing sufficient peptides in sufficient abundance are 
detected by MS.
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For individual proteins, especially in their native state, certain regions are more susceptible to 
proteolytic cleavage by trypsin than others (Halsey & Harrington, 1973; Ellison et al., 1995). 
despite the majority of lysine and arginine residues on the surface of a protein. Primary 
structure may be influential, with altering polarity and hydrophobicity surrounding the cleavage 
site having a significant impact on the ability for trypsin to cleave (Monigatti and Berndt, 2005). 
Primary sequence in particular has three main influences on trypsin cleavage; the effect of 
proline following an arginine or lysine residue, the effect of the arginine or lysine residue itself 
and that of negatively charged amino acids such as glutamic acid and aspartic acid 
immediately surrounding the cleavage site (Siepen et al, 2007). Enzyme specificity is 
determined by the efficiency of binding to the substrate and catalysis of the reaction (Schechter 
and Berger, 1967) and this is determined by the length of the peptide, and the specific amino 
acids that come into contact with the active site (Figure 7). Consequently, enzyme cleavage 
may be dependent on a larger proportion of the peptide chain other than the two residues 
immediately flanking the cleavage site. In particular, successful cleavage is dependent on the 
nature of the substrate binding with the active site of the enzyme, such that amino acids 
occupying alternate subsites around the active site have the greatest influence on proteolysis 
kinetics (Schechter and Berger, 1967). However, under denaturing conditions, trypsin will 
cleave at nearly every lysine-X or arginine-X bond (Hubbard et al., 1998), thus higher order 
protein structure greatly influences the rate of trypsin digestion. The extent to which trypsin 
digestion will occur in a complex mixture of proteins is less well known although it is believed 
that incomplete digestion is more likely for mixtures of native proteins, due to inadequate 
denaturation, enzyme concentration, incubation time, or due to inhibition by contaminant 
molecules that compete for protease activity (Klammer and MacCoss, 2006).
1.4.2 Sample complexity and dynamic range
The discrepancy between the number of theoretical peptides produced from a tryptic digest of a 
proteome and that detected by MS creates a challenge for proteomics. It is feasible that a 
tryptic digest of a proteome could contain 2.5x106 peptides given that an average protein is 
digested to 20-50 tryptic peptides and a proteome could contain 20-50,000 proteins including 
post-translational modifications. For identification proteomics, highly abundant proteins 
dominate all forms of analysis and those in low abundance are often not detected. The yeast 
proteome contains around 5,000 proteins ranging in abundance from 50 molecules per cell to 
106 (Ghaemmaghami et al., 2003), and the E.coli proteome contains around 4,000 proteins with 
dynamic range of abundance detected from 30 to 90,000 molecules per cell (Lu et al., 2006). In
24
1 trypsin S 3 s 2 S i
(Asp189)
S i ’ S 2’ S 3’
substrate p 2 P l Î P i ’ p 2’ p 3'
(R/K)
cleavage site
G lu -C P1 = E
A rg -C P-, = R
Lys-C P-l = K
A sp-N P-l’ = D
Figure 7. Nomenclature of proteolysis according to Schechter and Berger (1967).
Amino acid residues immediately associated with proteolysis are represented; P 1 -P 3  N-terminal to 
the cleavage site, P^-Pa’ C-terminal. Associated subsites on the protease are similarly 
represented. For the serine protease trypsin which cleaves C-terminal to arginine and lysine 
residues (except in the presence of proline at P-,’), proteolysis is initiated by the formation of a salt 
bridge between Asp189 situated in the pocket of Si and the basic side chain of arg/lys. Amino acid 
residues in P-, position for other commonly used serine proteases, Glu-C, Arg-C and Lys-C in 
I  addition to the metalloprotease, Asp-N are indicated.
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human plasma, the difference in protein abundance covers ten orders of magnitude (Anderson, 
2002) between the most abundant protein, albumin and the least abundant measurable 
proteins. To analyse samples of this complexity, several strategies have been developed. 
These include multidimensional separation of proteins and peptides prior to MS analysis, the 
removal of high abundance proteins, and enrichment of low abundance proteins. These 
strategies can be used to achieve protein profiling directly from complex mixtures without the 
need for gel electrophoresis, and to reduce sample complexity whilst maintaining the integrity 
of the original sample.
Separation of peptides and proteins
Both peptides and proteins can be separated in-solution by liquid chromatography prior to 
detection or further processing. Complex mixtures can be separated according to size, charge 
and hydrophobicity. These separations are predominantly column based, using a carrier 
solvent compatible with the column chemistry used. The most commonly used separation for 
peptides prior to MS analysis is reversed phase high performance liquid chromatography (RP- 
HPLC) where peptides are separated in-solution on the basis of their hydrophobicity. Samples 
are loaded onto a precolumn or ‘trap’ at high flow rate where they are concentrated and 
washed to remove contaminants, including salts. The flow through from this process is diverted 
to waste and the sample is subsequently loaded onto the analytical column. Both the 
precolumn and analytical column are packed with silica based beads with surface bound long 
n-alkyl groups for example n-octadecyl (Cis), covalently bound. Peptides bind to the matrix and 
are eluted using a gradient of an organic solution, for example acetonitrile with the most 
hydrophobic peptides eluting at the end of the gradient in a high concentration of organic 
solvent. To increase separation efficiency and peak capacity for liquid chromatography, longer 
columns were developed. This increases the number of protein identifications, but requires very 
high pressures and is not always appropriate for routine use (Hu etal., 2007). In an alternative 
approach, polymer based monolithic columns are used for the separation of complex mixtures 
of proteins or peptides. These operate at low pressure and can be applied to samples with a 
wide range of pH values. However, the polymer materials may not be stable in some organic 
solvents and may undergo shrinking or swelling. To combine these methods for more efficient 
separation of proteins and peptides, two or more chromatography steps are often employed 
(multi-dimensional protein identification technology; MudPIT). This separates proteins or 
peptides based on two or more different chemical properties, for example reversed phase 
separation of peptides may be coupled with prior ion exchange separation of proteins on the
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basis of net charge using a salt gradient (Washburn et al., 2001). This increases the time for 
analysis of each sample, but allows high throughput identification of many more proteins in 
complex mixtures by MS and has been used for analysis of large molecular complexes (Link et 
al., 1999). MudPIT is also applied to separations by size exclusion, for example to remove high 
molecular weight proteins or peptides, and increase the sensitivity of low molecular weight 
detection, affinity chromatography, for example to selectively recover phosphopeptides or 
hydrophilic interaction. When used, reversed phase chromatography provides the final 
dimension of separation due to solvent compatibility with ESI-MS. SDS-PAGE separation can 
also be used as a further dimension of separation prior to liquid chromatography, or MudPIT 
analyses. This is typically achieved by slicing the entire gel lane into uniformly sized slices, 
digesting each one with trypsin and separating by liquid chromatography prior to MS (“GeLC- 
MS”). This gives an extra dimension of information for protein identification as the approximate 
molecular weight of proteins in each gel slice is known from their position on the gel (Lasonder, 
2002, Steen and Mann, 2004). Peptides can also be separated by isoelectric focusing in­
solution using pH gradient strips (Heller et al., 2005), or using a pH gradient in specficially 
designed media for free-flow electrophoresis (Nissum et al., 2007). Separated peptides are 
removed in-solution, following separation according to charge, and applied directly to HPLC- 
MSMS. This technique compared favourably with GeLC-MSMS for identification of proteins 
from embryonic stem cells, requiring significantly less sample preparation and analysis time 
(Graumann etal., 2007).
Reversed phased high performance liquid chromatography (RP-HPLC) has been coupled with 
electrospray ionisation MS (ESI-MS/MSMS) as an effective online method of combining the two 
techniques of separation prior to fragmentation and mass spectral analysis. However, liquid 
chromatography now provides a simple and effective front end to a variety of mass spectral 
detection systems in order to concentrate and clean up a variety of protein and peptide 
mixtures prior to analysis. The possibility of coupling liquid chromatography to the solid phase 
MS technique of matrix assisted laser desorption/ionisation time of flight MS (MALDI-ToF MS) 
has been tested (Mirgorodskaya et al., 2005) as an off-line method to improve the scope of 
detection by MALDI MS. There are several reasons for combining these techniques, mainly 
that of user discretion, in that interesting fractions can be re-visited a number of times whilst 
acquiring data as the peptides are fixed in the solid phase on the plate. Using MALDI-ToF MS 
to analyse peptides also eliminates the presence of multiply charged species, which often 
complicate electrospray spectra, particularly in highly complex samples. As chromatographic
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behaviour of a peptide is dependent on the amino acid composition and distribution of amino 
acids along the peptide chain, sequence specific factors can be used to predict retention times 
during RP-HPLC. This is advantageous for LC-MALDI data, as when combined with 
information derived from chromatographic retention times to differentiate between peptides, this 
increases the confidence of protein identification by peptide mass fingerprinting significantly 
(Krokhin et al., 2004). Off-line fractionation also offers advantages for ESI, especially for 
MudPIT analyses as separation platforms that are not compatible with MS, or each other can 
be used. In addition, fraction collection is not limited and certain fractions can be preferentially 
selected and re-visited for analysis (Hu et al., 2007).
For identification of proteins in complex mixtures, various techniques for protein and peptide 
separation prior to MS analysis are described. The use of one system over the others is driven 
by availability of resources and compatibility of the samples to be analysed within the detection 
system. However, protein identification across different proteomics workflows gives different 
results, as discussed in section 1.3.5. Comparing protein identification using different 
approaches for protein and peptide separation prior to mass spectral detection is no different; 
for example, identification of more than 1000 proteins using three different methods of protein/ 
peptide separation and analysis, with a comparison of previously published literature, resulted 
in only 46 proteins identified using all four methods, and 195 proteins located in more than one 
dataset (Anderson et al., 2004). The reasons for this are not clear, but possibilities may include 
different methods exposing different subsets of proteins, differences in bioinformatics tools 
incorporating different degrees of error in identification, or individual sample differences for 
different experimental strategies.
Protein enrichment and normalisation
For identification proteomics, there is a wealth of information suppressed beneath the highly 
abundant proteins that dominate all forms of analysis. Several attempts have been made to 
deplete abundant species, for example the most abundant proteins albumin and IgG in plasma, 
resulting in an increased number of protein identifications following LC-MSMS analysis of 
peptide mixtures digested from depleted protein samples (Plavina etal, 2007). However, these 
are often of minimal use in enriching trace proteins, and are not selective in removal of specific 
proteins (Zolotarjova et al., 2005). Alternative methods, including prefractionation and 
enrichment of proteins carrying certain post-translational modifications (Zhang et al., 2007) 
have been developed, but accessing an entire proteome still presents an enormous challenge
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for identification and discovery proteomics. In an attempt to address this challenge, an 
approach to reduce the dynamic range of a complex mixture of proteins has been developed 
whereby high abundance proteins are diminished and removed from the sample and low 
abundance or trace proteins are enriched simultaneously (Thulasiraman etal., 2005, Righetti et 
al., 2006). This methodology uses a library of peptide ligands covalently attached to the surface 
of spherical porous beads, of sufficient heterogeneity to probe different physicochemical 
properties of a protein. A typical library consists of linear hexapeptides based on the 20 
naturally occurring amino acids, which in theory creates 206 (64 million) different ligands. Only 
a small subset of ligands would be able to bind specific proteins. In principle, abundant proteins 
will quickly saturate all of their available binding sites and most will remain unbound whereas 
low abundant proteins will not saturate all of the high affinity ligands and the majority will bind to 
the surface of the beads. Exposure to saturating amounts of all proteins would effectively 
normalise the population of proteins, assuming equal capacity for every protein (Guerrier etal., 
2006). This achieves enrichment of trace proteins relative to proteins present in higher 
abundance. In doing so, the sample cannot be used for quantitative analysis of protein 
abundance but it is a useful tool for protein identification and has been applied to analysis of 
human urine (Castagna et a!., 2005) and serum (Guerrier et al., 2006), as well as cell and 
tissue lysates (Righetti and Boschetti, 2007). The number of proteins captured using peptide 
library beads compares favorably with affinity depletion and liquid chromatography separation 
technologies with the advantage of fewer fractions, shorter analysis time and significant 
enrichment of low abundance proteins (Sennels et al., 2007).
Ionisation efficiency
Upon proteolytic cleavage of a proteome, generation of tryptic peptides in the region of 2.5x106 
would undoubtedly result in a complex mass spectrum, but only a small proportion of the 
expected peptides would be present. Providing the sample is present in sufficient 
concentration, and that tryptic digestion has been driven to completion, the predominant reason 
for this is non-uniform ionisation of all peptides by MALDI or ESI, and the length of time the 
instrument has to detect each ion as it reaches the detector (‘dwell time’) in ESI-MS. Previously 
discussed strategies to reduce sample complexity will also reduce the effects of ion 
suppression as the presence of a few abundant proteins will impair ionisation of those in lower 
abundance, particularly in MALDI-ToF MS (Yang et al., 2007). In addition, the signal from 
peptide ions is often suppressed following MALDI by the matrix itself but this effect can be 
reduced with alternative sample preparation, for example mixing analyte and matrix in solid
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form, rather than applying liquid matrix and allowing co-crystallisation as spots dry (Wang and 
Fitzgerald, 2001). Ion signal from low abundance species is often suppressed by that from 
peptides in higher abundance but even then, certain peptides are known to ionise more 
efficiently than others, with MALDI favouring basic residues and the side chains of certain 
amino acids, whereas ESI favours hydrophobic amino acids (Stapels et al., 2004). 
Consequently, this is dependent on physicochemical properties of individual amino acids, for 
example size, hydrophobicity and charged side chains (Kratzer et al, 1998). This also 
highlights the propensity for peptides containing certain amino acids to ionise, being dependent 
on specific amino acid side chains to a greater extent than overall physicochemical properties 
(Baumgart et al., 2004). In particular for tryptic peptides, MALDI mass spectra are dominated 
(up to 94%) by arginine, rather than lysine terminated peptides (Krause et al., 1999). This is 
attributed to the basicity of the guanidino side chain of arginine, aiding ionisation by MALDI. For 
peptide mass fingerprinting, and improved peptide detection, signal intensity of lysine 
terminated peptides can be enhanced by conversion of the s-amine into a guanidino group with 
the addition of O-methylisourea, forming homoarginine (Kimmel, 1967). This method is used to 
increase coverage of proteins when identified by peptide mass fingerprinting (Hale et al., 2000). 
This also adds an extra dimension of information when comparing modified to un-modified 
mass spectra; mass shifted peptides with an increase in signal intensity, or indeed previously 
unidentified peaks will be predicted to contain lysine residues.
1.5 Q u a ntificatio n  Pro teo m ics
1.5.1 The significance of quantification for proteomics
It is now possible to move forward from identification and characterisation proteomics, to 
quantification proteomics in which the protein target is known and can be quantified. 
Quantification proteomics employs techniques to measure relative quantification, and more 
recently absolute quantification in terms of absolute numbers in a given tissue. This will provide 
much more comprehensive information about individual proteins in biological systems, rather 
than defining the concentrations of proteins relative to a second cellular state. The ability to 
measure minor fluctuations in protein concentrations under different physiological conditions 
and across multiple platforms brings proteomics into the context of ‘systems biology’.
Due to the variable efficiency of ionisation, and detection, MS of peptides is not inherently 
quantitative, thus signal intensity in MS does not serve as a useful predictor of absolute
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abundance, but can be used in combination with internal standardisation using appropriately 
selected, stable isotope labelled internal standards. In combination with a variety of stable 
isotope labelling strategies, proteome simplification and MS, multiple proteins can be quantified 
simultaneously. To achieve absolute quantification based on these precepts, internal standards 
used must be chemically synthesised, identical replicas of analyte peptides to be quantified 
containing appropriately selected stable isotopes for discrimination between the two in MS. The 
evolution of strategies for protein quantification, with and without the use of stable isotope 
labelling, both relative and absolute is discussed in detail below.
1.5.2 Relative quantification
Label free relative quantification using gel electrophoresis
Quantitative proteomics using gel-based methods consists of applying algorithms to gel 
electrophoresis analysis to compare cell populations of different states by detecting spots 
exhibiting higher or lower stain intensity, reflecting differential protein expression. SDS-PAGE 
gels stained, for example with Coomassie Blue are scanned and software programmes are 
used to detect spots and determine semi-quantitative differences in proteins between different 
samples (e.g. TotalLab, Ceredigion, UK). This is based upon the intensity of the stain, relating 
to the amount of bound dye, and hence the amount of protein. Such densitometric analysis can 
be optimised for different instrumentation and stains used (e.g. Vincent eta!., 1997). For the 
comparison of 2D SDS-PAGE gels, spots must be matched on different gels as only one 
sample can be run on a single gel. To improve this, proteins from two different samples may be 
labelled with fluorescent dyes (for example, Cy5 and Cy3) prior to simultaneous separation by 
2D SDS-PAGE using the technique of difference in-gel electrophoresis (DIGE; Unlu et at., 
1997, Viswanathan et ai, 2006). To measure differences in protein abundance, the gel is 
scanned with the excitation wavelength of each dye sequentially, causing fluorescence. This 
approach, while enabling simultaneous detection of multiple proteins in different samples and 
eliminating gel to gel variation for analysis of two samples, is time consuming and is most 
commonly used as a qualitative representation of the two samples. It is also limited to detection 
of high abundance proteins in a complex mixture.
Label free relative quantification using western blotting
Protein abundance can also be measured using western blotting in which proteins are detected 
using antibodies specific to the target protein. For this analysis, proteins are separated using 
gel electrophoresis and transferred to a nitrocellulose membrane where they are probed with
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specific antibodies. Proteins are probed with a primary antibody raised to the protein of interest 
and then with a secondary antibody which binds to the primary antibody and can be labelled 
with a specific probe, resulting in a coloured product to aid detection. Bound probes are 
detected upon exposure to the specific chemical reagent to produce a signal where the 
targeted protein is located on the original SDS-PAGE gel. To measure the abundance of this 
protein, markers of a known amount of a protein significantly separated in molecular weight 
from the analyte are also detected and the intensity or size of the protein band is compared. 
For more sensitive detection, chemiluminescence is used whereby the western blot is 
incubated with a substrate that will cause luminescence when exposed to the secondary 
antibody. The light signal is detected using photographic film, producing an image which can be 
analysed using densitometry to measure protein abundance.
Label free relative quantification using mass spectrometry
For comparative proteomics, methods that achieve relative quantification without stable isotope 
labelling or chemical modification have been designed. Protein identification scores (section
1.3.3) do not provide an accurate prediction of protein abundance, as these are largely based 
on the number of matched sequence fragments and do not incorporate ion signal intensity 
which is affected by the propensity of each peptide to ionise (Ong and Mann, 2005). 
Consequently, label free quantification methods use statistical differences in ion signal 
intensities or chromatographic peak areas as a direct measure of ion signal intensity (number 
of ions detected by the mass spectrometer at a given time) of a particular ion (Higgs et a!., 
2005) between several HPLC-MS analyses of the same samples to predict the relative 
abundance of proteins. This is based on the linear relationship between the signal and 
concentration of analyte in the chromatographic eluent (Lubec and Afjehi-Sadat, 2007). For 
complex samples, accuracy is limited by ion suppression effects, but this may be aided by high 
resolution MS. Extracted ion chromatograms are different for different peptides, but from the 
most intense peptide ions, they can be averaged to give a quantitative measure of the 
abundance of a particular protein. As two or more samples are analysed separately, there is no 
control for variation in sample work-up, thus accuracy is not as high as most stable isotope 
labelling approaches (Cox and Mann, 2007). Flowever, label free quantification produces 
abundance data akin to that achieved using 2D SDS-PAGE and densitometry, thus is effective 
for proteomes that are not analysed easily under these conditions, for example hydrophobic 
membrane proteins, and for low abundance proteins that are not detected by gel 
electrophoresis. Likewise there are many peptides that will not be detected by MS as they lie
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outside the mass range of the instrument used, or those that do not chromatograph well, for 
example those that are highly hydrophobic and may remain bound to a reversed phase column. 
Problems of ionisation can be avoided by comparing an extracted ion chromatogram of the 
same peptide in two or more samples to give an idea of the relative abundance of a particular 
protein, as the peptides should behave in the same way under the same experimental 
conditions (Wang et al., 2006). A significant problem encountered when using the relative 
intensity of the same peptide between samples for quantification is that of extremely complex 
chromatograms and resulting mass spectra. In an attempt to increase the throughput of this 
method, differential MS was developed (dMS; Wiener et al., 2004) as an automated alternative. 
dMS uses multiple LC-MS runs to select peptides that differ significantly between samples for 
MSMS. Such an approach targets only differential expression of particular proteins between 
two samples, thus eliminating uninformative data and reducing analysis time. Data are 
compared at individual retention times and m/z values to reduce the rate of false positives, thus 
utilising as much information as possible from each LC-MS run. This method has been applied 
to high resolution and mass accuracy MS using FTICR-MS (Meng et al., 2006) to measure the 
minimum fold change detectable and the accuracy of the relative ratio calculations. Much 
smaller changes in protein expression were detected of less than two fold, thus the method in 
combination with automated dMS software has potential application to complex mixtures for 
relative protein quantification. An alternative to using integrated extracted ion chromatograms 
for relative quantification without stable isotope labels is to use spectral count. This counts the 
number of spectral copies of peptides detected from a particular protein, or the number of 
tandem mass spectra produced from peptides derived from a particular protein, and relates it to 
the number of expected spectral copies from the observed proteins (Wong et al., 2007). For 
this, it is assumed that the most abundant proteins are most likely to generate peptides in high 
abundance which will be selected for MSMS more frequently. Samples are analysed separately 
using the same data acquisition protocol, and the number of tandem mass spectra 
corresponding to each protein is normalised to account for protein length and the expected 
number of tryptic peptides (Nesvizhskii et al., 2007). Using this method, protein abundance is 
linearly correlated with spectral count over a dynamic range of 100 (Liu et al., 2004). In the 
same study, no correlation was found between percentage sequence coverage and number of 
peptides identified per protein for use as measure of relative abundance. These data suggest 
that for a global profiling experiment in which large differences in protein abundance are 
expected, spectral counting provides a reproducible and reliable strategy for relative 
quantification without stable isotope labels (Zhang et al., 2006). This can be combined with
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analysis of unknown proteins detected in MS where analysis is driven by differential protein 
expression of the same peptide from each sample using computational tools (Nesvizhskii et a!., 
2007). This uses statistical information from differential MS signal intensity of the same peptide 
across multiple samples to target MS analysis for protein identification. This compensates for 
small sample sizes and the limited number of CID events that can take place at a given time, 
but some peptides may be common to more than one protein, thus introducing a degree of 
ambiguity. Label free LC-MSMS experiments are becoming more popular for comparative 
proteomics, with the advantage of relatively low cost (avoiding the use of stable isotopes) and 
the potential to compare multiple samples simultaneously. With significant advances in 
computational tools for statistical analysis and interpretation of data, this may become a highly 
efficient strategy for quantitative proteomics (Wong et at., 2007).
Label free relative quantification using mass tagging
Relative quantification of proteins in two samples can be achieved by differential mass tagging. 
Other than methods of stable isotope incorporation, the derivatisation procedure of 
guanidination has been used prior to relative quantification (Cagney and Emili, 2002) prompting 
the term mass-coded abundance tagging (MCAT). Peptides from two different samples are 
digested with trypsin, prior to modification of one sample with O-methyisourea, guanidinating 
lysine residues. Samples are combined and analysed by reversed-phase LC-MS, upon which 
abundance of lysine peptides in both samples (detected with a mass shift of 42Da according to 
the modification of lysine to homoarginine) is calculated from LC trace intensities of extracted 
ion chromatograms. This approach targets a single amino acid residue for chemical 
modification to report on the abundance of peptides in different samples. However, modification 
by O-methylisourea alters the propensity of lysine peptides to ionise, thus the response of 
lysine and homoarginine terminated peptides in mass spectrometry cannot be used as a 
quantitative measure of relative abundance. This reaction is carried out on the pre-digested 
material, rather than on the intact protein, thus it is important to ensure complete digestion has 
taken place prior to the addition of O-methylisourea in order to use this method for 
quantification.
Stable isotopes: differential labelling/derivatisation
As discussed in section 1.2.4, stable isotope labelling is used in quantitative proteomics to 
assess relative protein abundance between two protein samples. This incorporates a mass 
shift between labelled and unlabelled analytes that can be detected by mass spectrometry. To
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incorporate stable isotopes into relative quantification experiments, methods include metabolic 
labelling, incorporation during digestion, and through the use of isotopically modified chemical 
reagents and chemical tags (Figure 8). Differential labelling involves labelling one sample with 
a ‘heavy’, stable isotope labelled reagent, and another with a ‘light’ unlabelled equivalent. This 
type of labelling may be applied at the protein or peptide level, or during proteolysis of proteins 
to peptides, may be non-specific, or may target selected amino acid residues. As an example 
of non-specific differential labelling, proteins are digested with trypsin using either H2[180 ] or 
H2[0 16] as the buffer for digestion. This incorporates two [180 ] atoms into the C-terminus of all 
tryptic peptides allowing the distinction of labelled and unlabelled peptides from two populations 
(Yao eta!., 2001). This incorporation is stable under normal conditions for MS and tandem MS 
(Schnolzer et a!., 2005) and does not compromise peptide identification efficiency (Lopez- 
Ferrer et al, 2006). Alternative proteases differ in the way that [180 ] can be used; trypsin, 
chymotrypsin, endoproteinase Lys-C and endoproteinase Glu-C incorporate two [180 ] (+4amu) 
into peptides. Once proteolysis is complete, proteases continue to form esters reversibly with 
the C-terminal amino acid. Eventually all of the [160 ] is displaced, the rate of which depends on 
the C-terminal amino acid residue, peptide size, sequence and protease used. This method is 
not universal as a labelling strategy as the C-terminus cannot be labelled. Alternative in vitro 
labelling strategies incorporate stable isotope labels into analytical reagents, treating two 
samples differentially with ‘light’ and ‘heavy’ reagents. There are many examples of this 
technology including acetylation of two peptide mixtures, one with [1H3]acetyl groups and one 
with [2H3]acetyl groups (Ji et al., 2000) in which primary amino groups at the N-terminus and 
the e-amino of lysine are derivatised. When the samples are mixed and analysed by MS, the 
isotope ratio can be measured, allowing detection of the difference in relative concentration of 
that particular peptide. This is a global coding strategy that distinguishes lysine terminated 
tryptic peptides from those that are arginine terminated as they are labelled at both the N- 
terminus and the lysine residue, doubling the mass offset from the unlabelled peptide. Other 
primary amine derivatising agents, for example benzoate ester (Julka and Regnier, 2004) can 
also be labelled, for example with [13C]. This strategy can also be adapted to label only the N- 
terminus of peptides, by blocking the e-amino of lysine with succinic anhydride or guanidination; 
this has the added benefit of improving ionisation of these peptides. In addition, free amino 
groups are targets for differential labelling in the intact protein, using deuterated derivatising 
reagents prior to tryptic digestion and MS analysis (Schmidt et al., 2005). Alkylation (intact 
proteins) and esterification (peptides) are also popular differential labelling targets, with the use 
of deuterated agents such as 4-vinylpyridine which alkylates all -S H  residues following
— Differential labelling/derivatisation
i— Protein
Label free amino groups using [1 2 345H] derivatising agents [1] 
Label cysteine residues with [2H]acrylamide [2]
— Peptide
Label primary amino groups with [2H]acetylating reagents [3] 
Label carboxyl groups by esterification using [2H]methanol [4]
I— Proteolysis
Digest proteins with protease in [18H2]0  [5]
— Tagging
i— Residue selective
Label proteins with the ICAT reagent ([2H] or [13C]), tagging 
cysteine residues [6]
Non-selective
Label proteins with the iTRAQ reagent (isobaric tag), 
tagging primary amino groups [7]
^  Metabolic incorporation
— Residue selective
Incorporate selectively labelled amino acids (e.g. [13C6]arginine) into cell culture [8] 
Incorporate selectively labelled amino acids (e.g. [2H8]valine) into intact animals [9]
*— Non-selective
Incorporate stable isotopes into media (e.g. ([15N]) [10]
Figure 8. Stable isotope labelling strategies for comparative proteomics.
Examples of methods for incorporation of stable isotope labels into proteins and peptides for 
relative protein quantification by mass spectrometry are indicated. These fall into three main 
categories; differential labelling/derivatisation, tagging and metabolic incorporation. For 
discussion of the relative merits of these strategies, refer to text. References indicating examples 
of labelling strategies are given in each case.
[1] Schmidt e t  a l., 2005
[2] Sechi and Chait, 1998
[3] Ji e t  a l., 2000
[4] Goodlett et al., 2001
[5] Yao é ta l . ,  2001
[6] Gygi e t  al., 1999
[7] Ross e t  al., 2004
[8] Ong e t al., 2002
[9] Doherty e t a l., 2005
[10] Snijders e t al., 2005
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disruption of the disulphide bond (Sebastiano et a!., 2003) and methylation of C-terminal 
carboxyl groups of aspartic and glutamic acid using [2H3]methanol. Priorities for selecting the 
appropriate labelling strategy include the cost with which effective labelling can be achieved, 
the ease of label incorporation into target peptides, and detection in the analytical system of 
choice for relative quantification. To provide a global labelling strategy using analytical reagents 
including those discussed above, two or more labels may be incorporated. This combines the 
benefits of alternative methods, for example carboxyl groups labelled using [180 ] during 
proteolysis with primary amine groups labelled by acylation with deuterated 
acetoxysuccinamide (Liu and Regnier, 2002). Using this protocol, the number of primary amine 
and carboxyl groups will be determined from the mass shift relating to the heavy isotope; this 
allows the C-terminal peptide to be distinguished as it will only be labelled with [2H] from 
acylation. However, several of these strategies are nonspecific and can result in incomplete 
labelling, not withstanding the need for high purity reagents. For complex mixtures of peptides 
that require chromatographic separation prior to mass spectrometric analysis, deuterated 
peptides can elute separately in reversed-phase, thus more expensive isotopes of carbon [13C] 
and nitrogen [15N] must be used, or data processing changed.
Stable isotopes: tagging methods
Based on a similar principle to MCAT, stable isotope labelled tags are synthesised that target 
specific amino acids in peptides and proteins. Amino acids such as cysteine are often used due 
to the specific chemistry of its sulphydryl group which can be exploited in both a differential 
labelling approach, for example using deuterated acrylamide to alkylate cysteine residues, or 
as the target for a specifically designed stable isotope labelled tag. This allows simplification of 
the peptide mixture and adds information about the peptide as to the number of the selected 
amino acid included, facilitating database searching and protein identification. Targetting and 
tagging specific amino acids for quantification is the basis of isotope-coded affinity tagging 
(ICAT; Gygi et a!., 1999) in which the samples are treated with isotopically light and heavy 
ICAT reagents. The ICAT reagent consists of a reactive group that is cysteine specific, a 
deuterium labelled linker region and a biotin tag for affinity chromatography and selective 
recovery of bound peptides (Figure 9). This is processed and peptides can then be separated 
and will be distinguished in MS due to the mass shift relating to the heavy label. After 
proteolytic digestion, the labelled peptides are affinity purified using a strepdavidin affinity 
matrix that binds the biotin tag, thereby achieving simplification of the peptide mixture at the 
same time as incorporating the isotopic label. The relative intensities of these peaks can then
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Figure 9. Isotope coded affinity tagging (ICAT).
Samples are treated separately with isotopically light and heavy ICAT reagents and digested with 
a protease, for example trypsin. The ICAT reagent (a) consists of a reactive group that is cysteine 
specific, a stable isotope labelled linker region and a biotin tag for affinity chromatography and 
selective recovery of bound peptides. For the ‘heavy’ reagent, X is replaced with the stable 
isotope, for example deuterium f  H], For relative quantification of protein abundance (b), the two 
samples once labelled are combined and digested, upon which peptides containing cysteine 
residues are isolated and analysed by LC-MS. Quantification is based on relative ion signal 
intensity of stable isotope label tagged peptides which can be distinguished by mass 
spectrometry according to the mass difference between ‘heavy’ and ‘light’ ICAT reagents.
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be used for quantification of the amount of protein in the two cell preparations. Observed peak 
ratios for isotopic analogues are highly accurate as there are no chemical differences between 
the species and they are analysed in the same experiment. Although used successfully in 
combination with multidimensional chromatography to detect and quantify low abundance 
proteins (Gygi et al., 2002), limitations of this method include non-specific binding to the 
strepdavidin affinity matrix, and multiple subsequent reactions at the same site. However, by 
the principle of internal standardisation, providing labelled and unlabelled samples are treated 
in an identical way, problems including selective capture of some cysteine containing peptides 
should be compensated for. This approach also limits the identification of post-translational 
modifications as well as the analysis of proteins and peptides containing no cysteine residues, 
as the affinity tag is cysteine specific. Quantification is also limited to MS only as the tag 
complicates fragmentation spectra, and deuterium isotopes do not permit the use of reversed- 
phase chromatography as the differentially labelled peptides would not co-elute. This has been 
improved through the use of cleavable ICAT reagents prior to MS analysis and co-eluting tags 
using [13C] as the stable isotope label (Li eta!., 2003).
In an alternative strategy that is not selective for specific amino acid residues, isobaric tags for 
relative and absolute quantitation (iTRAQ) have been developed that target primary amino 
groups on the N-terminus and lysine side chains of peptides (Ross et al., 2004). In principle, 
this is a strategy for relative quantification that may be applied to achieve absolute 
quantification if the isobaric tags are incorporated onto synthetic peptides (discussed in section
1.5.3). The tags are labelled and isobaric so that the peptide with incorporated tag is 
indistinguishable through chromatographic separation and MS but that generates a specific 
reporter ion in MSMS spectra. Four tags were initially developed, of mass 114, 115, 116 and 
117Da, permitting the relative quantification of up to four proteins. Each tag contains a reporter 
group, a balance carbonyl group to compensate for the different mass of the reporters and a 
peptide reactive group (Figure 10). Once tagged, up to four samples are mixed and analysed 
by tandem MS upon which fragmentation of the tag attached to peptides gives rise to specific 
low molecular mass reporter ions, the intensity of which relates to the relative amount of the 
peptide in each sample. For this approach, peptide separation is important to avoid co-eluting 
species of similar mass that may compromise quantification. For this reason, the method has 
been combined with LC-MALDI offline for fragmentation by MALDI-ToF/ToF MSMS in addition 
to online separation prior to ESI-Q-ToF MS (Wiese et al., 2007). In the same study, iTRAQ 
reagents were used to label intact proteins prior to initial separation by gel electrophoresis,
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Figure 10. Isobaric tagging for relative and absolute quantitation (iTRAQ).
Samples are labelled with isobaric tags (a) such that the peptide with incorporated tag is 
indistinguishable through chromatographic separation and mass spectrometry but that generates 
a specific reported ion in tandem mass spectra. Tags contain a specific reporter moiety, a 
balance to maintain the same overall mass of the precursor ion and a reactive group to attach to 
primary amines, for example the N-terminus of peptides. For quantification (b), tagged samples 
are mixed and analysed by tandem mass spectrometry upon which fragmentation of the 
precursor ion gives rise to the specific low mass reporter ions, the relative signal intensity of 
which can be used to determine protein abundance.
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proteolytic digestion and MSMS analysis. This approach is more time consuming as 
quantification is dependent on product ion scans, but this is matched with an increased peak 
capacity and signal to noise ratio due to quantification using fragment ions selected from 
specific precursors, providing non related peptide fragment ions are not present in the fragment 
ion spectrum. Consequently, the use of iTRAQ for relative quantification of proteins is highly 
sensitive with low technical variation when compared to biological variation (Gan et al., 2007). 
This strategy is also reproducible across multiple sample injections for analysis by LC-MSMS 
used to maximise number of protein identifications, when combined with quantification in a 
single experiment (Chong et at., 2006). In a similar approach avoiding the use of isobaric tags, 
amino acids may be modified using stable isotopes in such a way that the peptide will have the 
same overall mass but a different incorporated isotope, for example one is labelled with [13C i] 
and the other [15Ni]. This will be distinguished in the immonium ion for the selectively labelled 
amino acids upon tandem MS. The disadvantage of this approach is that a mass difference of 
1 Da may be difficult to distinguish (Julka and Regnier, 2004).
Stable isotopes: metabolic incorporation
Internal standards can be incorporated into the system of interest in-vivo by metabolic 
incorporation of the stable isotope. This can be achieved using stable isotope labelled 
precursors, for example [15N]H4CI as the sole nitrogen source in the media, incorporating [15N] 
into every peptide during synthesis. Proteins differentially labelled in this way are subsequently 
mixed, subjected to proteolytic digestion (with or without prior protein separation, for example 
by gel electrophoresis) and analysed by mass spectrometry (for example, Snijders et al., 2005). 
Alternatively, labelled, essential amino acids can be added to amino acid deficient cell culture 
media (Stable Isotope Labelling by Amino Acids in Cell Culture, SILAC; Ong et al., 2002), and 
are consequently incorporated into all proteins as they are synthesised (Figure 11). In this way, 
the entire population of proteins can be fully labelled at the start of the experiment for 
quantitative comparison with unlabelled populations upon mixing, proteolytic digestion and MS. 
This eliminates the need for chemical labelling and affinity purification, and the method is 
compatible with virtually all cell culture conditions. Labelling with [15N] has limitations, in that 
labelling is not uniform; the number of [15N] atoms introduced into each tryptic peptide will vary 
depending on the amino acid content. It is also more difficult and expensive to make [15N]- 
substituted media for mammalian cell culture (Ong etal, 2002). It is consequently beneficial to 
use stable isotope labelled amino acids such as [13C6]arginine and [13C6]lysine so that each 
tryptic peptide contains a single stable isotope, resulting in a constant mass offset between
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cells grown in media enriched with 
‘light’ amino acids
cells grown in media enriched with 
‘heavy’ amino acids
combine and digest with trypsin
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Figure 11. Stable isotope labelling by amino acids in cell culture (SILAC).
Internal standards can be incorporated into the system of interest in -v ivo  by metabolic 
incorporation of a stable isotope. This can be achieved using stable isotope labelled precursors, 
for example [15N]H4CI as the sole nitrogen source in the media, or labelled, essential amino acids 
can be added to amino acid deficient cell culture media, and are consequently incorporated into 
all proteins as they are synthesised. Material labelled in this way can be combined with that 
grown in the presence of the ‘light’ isotope, digested with trypsin and analysed by mass 
spectrometry. The mass shift relating to the ‘heavy’ isotope label can be distinguished by mass 
spectrometry, and the relative signal intensity of ‘heavy’ and ‘light’ isotopes can be used as a 
measure of protein abundance.
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analyte and standard of 6Da. It is important when designing a SI LAC experiment that the amino 
acid is abundant, essential for growth and is not likely to be altered by further processing, for 
example deamidation of asparagine to aspartic acid. For animal studies, the amino acid used 
must be essential (cannot be synthesised by the organism) and of high natural abundance to 
ensure labelling of the majority of peptides for quantification (Beynon and Pratt, 2005). 
Abundant amino acids such as leucine are often used, labelling approximately 70% of tryptic 
peptides (Ong et at, 2002) and readily available in deuterated form. Leucine labelling in vivo is 
also a useful aid to peptide mass fingerprinting for protein identification as the mass shift 
between unlabelled and labelled versions of the peptide relates to the number of leucine 
residues in the peptide (Pratt et ai., 2002). However, deuterium labelling complicates reversed- 
phase separations, so this is not always the most appropriate strategy. Stable isotope labels 
can also be introduced at the whole animal level to determine rates of protein turnover, for 
example by feeding [15N] enriched diets (Wu et a!., 2004), or deuterated amino acids, for 
example [2Hs]-valine (Doherty et a!., 2005). The difficulty with this approach is that the 
precursor is subject to metabolism which can cause redistribution of label as degradation of 
pre-existing proteins will also contribute to the pool of unlabelled amino acids. The extent of this 
pool dilution effect can be calculated and is stable over an extended labelling period, thus 
allowing it to be taken into account when measuring rates of protein synthesis and degradation 
from incorporation of stable isotope label into the protein pool (Doherty etal., 2005).
As for all quantitative proteomics experiments, regardless of strategy, it is essential that data 
produced are reliable, accurate and reproducible across groups, laboratories and time. To 
make significant advances in systems biology, particularly for biomarker discovery, quantitative 
data must be comparable across multiple platforms and in particular between different research 
institutions and groups with access to alternative instrumentation and resources across the 
world. To this end, The Association of Biomolecular Resource Facilities Proteomics Research 
Group 2006 study’ was designed in which 52 participants generated relative quantification data 
(with and without the employment of stable isotopes) for eight proteins in two mixtures using a 
variety of techniques (Turck etal., 2006). Although insufficient data sets were obtained to draw 
statistically significant conclusions, this study highlighted the range of results that can be 
achieved using alternative relative quantification strategies. In particular, variation between 
data sets, although more consistent for MS based approaches than gel electrophoresis based 
approaches was considerable. This was also a useful exercise to report the need for additional, 
more reliable methods to report and compare quantitative proteomics data. This was
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particularly true for label free quantitative methods, where internal standards are not 
incorporated to measure variation between sample runs, differences in sample collection, 
preparation protocols, experimental design, platform stability and sample stability have 
significant impact on the reproducibility of results, especially as these are most likely to vary 
between laboratories. To compensate for these, algorithms have been designed to compare 
the similarity of mass spectral data, based on resolution, signal intensity, elution profile and 
signal to noise ratio, for example ‘Chaorder’ (Prakash et al., 2006, Prakash et al., 2007). This 
calculates an alignment score with potential application to alternative LC-MS platforms, 
including choice of instrument and chromatography column to assess reproducibility, thus 
reducing bias in comparative proteomics experiments. This technology provides a significant 
advantage to LC-MS analyses for quantitative proteomics in which the use of stable isotopes is 
undesirable, or impractical, but standardisation between experimental platforms is essential.
1.5.3 Absolute quantification
Absolute quantification in proteomics defines the number of molecules of a particular protein, 
rather than relative quantification which defines protein abundance in relation to another 
protein, or the same protein in another sample. In principle, any of the approaches adopted for 
relative quantification may also be used for absolute quantification if appropriate reference 
standards are available for all analytes in known amounts.
Absolute quantification using western blotting
Measurement of protein abundance using non stable isotope labelling methods has previously 
been discussed in the context of relative protein quantification (section 1.5.2). To move from 
relative to absolute quantification avoiding the use of stable isotope labelling, technologies for 
western blot analysis of protein abundance (described in section 1.5.2) use the more sensitive 
technique of fluorescence. Proteins separated by gel electrophoresis and transferred to a 
nitrocellulose membrane are probed with primary antibody, followed by secondary antibody 
carrying a fluorescent label. These labels are excited by light and detected, for example using 
flow cytometry to detect proteins fused with green-fluorescent protein (GFP; Bar-Even et al., 
2006). To measure absolute protein levels, epitope tagged fusion proteins are added to an 
organism’s genome, and proteins containing these fusion tags are subsequently expressed 
under normal conditions, controlled by their natural promoters (Ghaemmaghami et al., 2003). 
Proteins containing the fusion tags are detected using fluorescence microscopy and quantified 
using known amounts of antibodies specific to the epitope contained on the tag. These data
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can be compared to mRNA abundance and translation rate for comprehensive analysis of 
protein metabolism (Belle eta!., 2006).
With increasing knowledge of the peptides most likely to be observed upon MS based on 
ionisation efficiency, retention time during a reversed phase separation and other chemical and 
physical properties (Mallick et a!., 2007), some of the label free strategies previously discussed 
for quantification may also predict absolute protein abundance. By comparing the number of 
peptides detected from a particular protein with its abundance, and correcting for the probability 
of observing each of these based on their composition, absolute protein expression 
measurement may be possible (Lu et al, 2007). Protein abundance measured in this way 
agrees with alternative techniques avoiding stable isotope labels, including western blotting, 
flow cytometry and 2D SDS-PAGE. Data also correlate well with mRNA abundances, allowing 
measurements of mRNA directed gene expression regulation.
Stable isotope labelling for absolute quantification
To use stable isotopes for absolute quantification of individual proteins, the true internal 
standard would be the corresponding protein, expressed in pure and stable isotope labelled 
form and quantified (Brun et al., 2007). This is challenging on many fronts, including the 
expression of a native protein in a heterologous system to effect labelling, purification of the 
protein, and subsequent mass spectrometric analysis of the complex isotopic profile of the 
analyte and standard protein. Rather than adopt a protein-based approach, a strategy for 
absolute quantification using proteotypic peptides as surrogates for the protein of interest has 
emerged, employing stable isotope labelled peptide internal standards as ‘signature’ or 
‘proteotypic’ peptides, chemically synthesised and incorporating stable isotopes (Figure 12). 
This approach initially used a known amount of a chemically synthesised, deuterated peptide 
from apolipoprotein A1 to quantify the absolute amount of the purified protein (Barr etal., 1996) 
and was superseded using [13C] or [15N] labelling of specific amino acids for absolute 
quantification of proteins in complex mixtures, in addition to those that have been 
phosphorylated (Gerber et al., 2003) and later ubiquitinated (Kirkpatrick et al., 2005) post- 
translationally. Internal standard peptides are added to the protein mixture in a known amount 
during proteolytic digestion allowing the ratio of signal intensity between standard and analyte 
in MS to dictate the abundance of the analyte. This method has been widely applied, for 
example to clinical samples in which protein expression changes with disease can be used to 
predict diagnostic biomarkers (Kuhn et al., 2004) and to cells in culture allowing absolute
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Figure 12. Internal standardisation for absolute protein quantification.
For absolute quantification of proteins, a surrogate peptide is selected and an identical copy is 
synthesised with an incorporated stable isotope label. The synthetic peptide internal standard is 
added to digested protein material in a known amount. Upon mass spectrometry analysis, the 
stable isotope labelled internal standard peptide will be distinguished from the surrogate peptide 
from the analyte by the mass shift relating to the ‘heavy’ label. The relative signal intensity of the 
two peptide ions can be used as a measure of absolute abundance of the analyte protein as the 
two peptides will respond in exactly the same way within the mass spectrometer.
Introduction
quantification of proteins in animal tissues (Ishihama et al., 2005). Synthetic peptide 
approaches have also been used to adapt previous quantitative methods, for example iTRAQ 
can be used for absolute quantification if synthetic, stable isotope labelled peptides are tagged 
with the iTRAQ reagents (Ross et al., 2004). These studies highlight the importance of 
versatility of this methodology to alternative biological samples and mass spectral detection 
systems. However, to quantify multiple proteins, each requires at least one stable isotope 
labelled peptide that must be independently synthesised at relatively high cost. Moreover, each 
peptide must be separately purified and quantified (Pan et al., 2005).
To streamline this approach, a novel strategy has been introduced as an efficient alternative to 
the chemical synthesis of multiple stable isotope labelled peptides (Beynon et al., 2005, Pratt et 
al., 2006). The ‘QconCAT’ method uses artificial genes, designed de novo to direct the 
synthesis of novel proteins which are assemblies of signature standard peptides (Q-peptides), 
derived from a number of discrete proteins. Usually, these Q-peptides are arginine or lysine 
terminated at the C-terminus, as they represent tryptic peptides derived from digestion of the 
analyte proteins. The artificial quantification concatamer (QconCAT) protein contains the Q- 
peptides appropriately flanked with added features including an initiator codon, a purification 
tag and protective sacrificial regions. The gene is transformed into and expressed in a 
heterologous system, usually bacterial. The expression strain is grown in chemically defined 
media, uniformly isotopically labelled (for example, using [15N]H4CI as the sole nitrogen source) 
or containing specific stable isotope labelled amino acids at a high isotope enrichment, such 
that the artificial protein becomes fully labelled (Figure 13). The artificial QconCAT protein is 
purified by virtue of the affinity tag and quantified using a suitable procedure (Pratt et al., 2006). 
The QconCAT protein is added to a complex mixture of analyte proteins, and subsequent 
proteolysis releases both the stable isotope labelled standard and the cognate peptide from the 
analyte. The known quantity of standard added can then be used for absolute quantification of 
the analyte. Since quantification of the QconCAT protein will define in absolute terms the 
quantity of each of the surrogate peptides, the QconCAT strategy provides an efficient means 
to multiplex absolute quantification. Tryptic peptides are typically 10-15 amino acids long, thus 
proteotypic Q-peptides from 50 proteins could be encoded in a protein comprising 500-750 
amino acids. To quantify 50 proteins at one Q-peptide per protein, a QconCAT strategy is 
about 15% of the cost of comparable synthetic peptides, and would yield about 250nmol of 
protein compared to 5nmol of each synthetic peptide. The Q-peptides are present, by design, in
Assemble and design gene to
encode concatenated signature peptides
Synthesise gene and insert into expression vector
Express protein labelled with stable isotopes
Assemble and design gene to
encode concatenated signature peptides
Express protein labelled with stable isotopes
Purify and quantify QconCAT protein
Figure 13. The QconCAT strategy for absolute quantification.
Taken from Pratt e t  a !., 2006
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stoichiometrically known amounts (usually equimolar), so that each analyte peptide (and 
therefore protein) is simultaneously quantified.
1.5.4 Challenges for absolute quantification using surrogate peptides 
Proteotypic peptides
Using a synthetic peptide approach requires a great deal of consideration into peptide selection 
and validation, particularly for the analysis of complex protein mixtures in terms of retention 
time by reversed-phase chromatography, ionisation efficiency and fragmentation if using a 
tandem MS approach. Proteotypic peptides are selected based on previous detection within the 
analytical system of choice. These are typically peptides that ionise well in MS (Baumgart et al., 
2004), are unique and relatively abundant (within the analyte system of choice). It is also 
important that these peptides behave in the same way in a complex of mixture of proteins in 
which they will need to be detected for absolute quantification (Pan etal., 2005). Peptides with 
certain physicochemical properties have an increased chance of being detected by MS, and 
this information can be used to develop computational tools to predict proteotypic peptides 
(Mallick et al., 2007), of significant benefit to design of a QconCAT experiment. The order of 
amino acids in each peptide may also influence the probability of preferential detection, thus 
creating many combinations of varying significance. With increasing sharing of data in public 
repositories from more directed analyses, prediction of proteotypic peptides for proteomics will 
be a valuable tool for absolute quantification with and without stable isotope labelling.
Complete proteolysis
Q-peptides are concatenated in the QconCAT protein disconnected from their normal primary 
sequence context, for example T3 from adenylate kinase exists in the QconCAT protein as 
V IR jGFLIDGYPRjVVL, and in the native protein as TSKJ,GFLIDGYPRJ,EVK. This different 
context could influence quantification, as the abundance of a peptide released by proteolysis is 
used to report on the native protein (Kito etal., 2007). However, this can only occur if either the 
QconCAT or the analyte proteins are incompletely digested, such that the yield of each peptide 
is incomplete and the main determinant of the rate of proteolysis of native proteins is primary 
sequence context, not higher order structure. Tightly folded proteins, particularly those with a 
high proportion of beta sheet, are intrinsically resistant to proteolysis (Hubbard etal., 1998; Wu 
etal., 1999). However, it is not expected that QconCATs would adopt tightly folded structures 
as they have no biological function (Pratt et al., 2006). By contrast, unless care is taken in the 
prior denaturation of analyte proteins, their higher order structure would almost certainly
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influence proteolysis, and could impact on absolute quantification. Incomplete analyte digestion 
is as much an issue for quantification using synthetic peptides as those using QconCATs.
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2. A ims and Objectives
>
The aim of this research was the deployment of a QconCAT method for the absolute 
quantification of soluble proteins in chicken skeletal muscle during growth from 1 d to 30d post 
hatch in both broiler (meat producing) and layer (egg producing) strains. This required 
purification of expressed protein (expression and labelling of QconCAT protein was courtesy of 
Dr. D.M. Simpson), co-digestion with analyte proteins, simultaneous detection of analyte and 
f  internal standard peptides by MS, and quantification. Through the execution of this study, the
objective was to provide a rigorous test of the QconCAT method for absolute quantification of 
multiple proteins, incorporating an in-depth assessment of variance within this system.
3. T he QconCAT Strategy for Absolute Quantification of Chicken Skeletal 
Muscle Soluble Proteins
 ^ 3.1 Changing Proteome Dynamics in Chicken Skeletal Muscle
As the demand for quality poultry produce has risen, the drive to produce fast growing, lean 
birds has increased. This is reflected in the dramatic difference in growth rate and consequent 
size between birds selected for meat production (broilers) and those selected for egg 
production (layers; Figure 14). This difference is particularly well documented in the pectoralis 
(breast) muscle which increases in overall size as a percentage of total body weight at a far 
* greater rate in broilers, as does the concentration of protein in the tissue. In fact, the increased
selection pressure on these meat producing birds has led to disproportionate growth of the 
pectoralis muscle compared to overall body weight, comprising approximately 10% of total 
body weight at 45 days of age. By comparison, the pectoralis muscle of layer birds comprises 
only 5-6% of total body weight throughout development (Flannery et al., 1992). Such a high 
growth rate places abnormal and extreme strain on the natural growth and development of the 
^  bird, which in many cases cannot be sustained. This causes bone abnormalities with
repercussions for general health including pulmonary hypertension and ascites (Griffin and 
Goddard, 1994). The amount of poultry meat available to consumers in the United Kingdom is 
continuing to rise, from 1.5 million tonnes in 1995 to 1.7 million tonnes in 2002 
(www.publications.parliament.co.uk). As a result, meat producing birds are bred to gain muscle 
at a very high rate compared to layers. This has serious welfare implications with extra weight 
^ placed on bones and joints causing lameness and joint infection. In addition, broilers that are
unable to walk are more susceptible to pressure sores and skin infections from lying in
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Figure 14. Growth rates of broiler and layer chickens.
Differential growth rates of broiler (meat producing) and layer (egg producing) chickens measured 
as overall body weight (kg) from 0 to 60 days. The inserted photograph depcits the dramatic 
difference in size of a broiler and layer bird at six weeks of age.
Data supplied by Heather McCormack (Roslin Institute).
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excrement. Heart disease and respiratory problems are also common as the additional 
requirement for growth and metabolism increases the demand for oxygen, placing abnormal 
strain on the heart and respiratory system (www.chickens.rspca.org.uk).
To take control of the physiological effects of increased growth of the pectoralis muscle in 
broiler chickens compared to layers, an understanding of the composition and dynamics of the 
proteome of the pectoralis muscle is required. The pectoralis muscle of an adult chicken 
comprises predominantly white, type II glycolytic fibres, generating ATP by glycolysis. The 
soluble fraction of a pectoralis muscle homogenate predominantly contains glycolytic enzymes 
which are sufficiently abundant to dominate most proteomic analyses (Doherty et ai, 2004). 
Subsequently, these may be the most important proteins driving metabolic processes, including 
growth. For this reason, the pectoralis muscle provides a relatively simple tissue with which the 
soluble fraction can be used to identify specific changes in muscle composition responsible for 
the dramatic difference in growth rates of the two strains of chicken.
3.2 QconCAT Design
The QconCAT used in this study was designed as a quantification standard for abundant 
soluble proteins in chicken skeletal muscle. This incorporated the most abundant proteins from 
a muscle homogenate when run on a 1D gel, with one Q-peptide per analyte protein (Table 3, 
Figure 15). Each protein to be quantified was digested in-gel with trypsin and analysed by 
MALDI-ToF MS to identify peptide candidates for incorporation into the QconCAT protein. 
Selection of peptides, where possible, was based on propensity to ionise (those that gave the 
strongest signal on MALDI-ToF MS analysis) and mass range (between 1000 and 2000Da) 
ensuring that each was unique within the set for absolute quantification. The DNA sequence of 
each chosen peptide was concatenated into the QconCAT gene, with short, N- and C-terminal 
extension sequences to protect the true Q peptides for quantification. These included an 
initiator methionine residue and a C-terminal HisTag for purification of the protein (Figure 15). 
The QconCAT gene was subsequently expressed in E.coli, unlabelled, labelled with [15N] using 
[15N]H4CI enriched media, or with incorporated, essential, labelled amino acids 
[13C6]arg/[13Ce]lys (three separate expression strains), from which proteins were expressed in 
inclusion bodies (Pratt eta!., 2006). Proteins were separately purified and quantified for use as 
a set of internal standard peptides upon co-digestion with chicken skeletal muscle soluble 
proteins. Within the QconCAT protein, each peptide is in a strict stoichiometry so that the entire
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Figure 15. Selection of QconCAT peptides and subsequent design of QconCAT gene 
constructed for the absolute quantification of chicken skeletal muscle soluble proteins.
The most abundant proteins analysed by 1D SDS-PAGE were digested in-gel with trypsin prior to 
analysis by MALDI-ToF MS. Abundant, well ionised, unique peptides within the mass range 1000- 
2000Da were selected for incorporation into the QconCAT protein. These were assembled into 
the artificial QconCAT gene which was expressed in E .c o li and labelled with stable isotopes for 
use as a set of internal standards for absolute quantification upon co-digestion with analyte 
proteins. Two examples of proteins selected for incorporation into the QconCAT are beta enolase 
(p eno) from which the tryptic peptide at 1390.85Da was used as a surrogate, and glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) from which the tryptic peptide at 1748.77Da was selected. 
The DNA sequence, translated protein sequence (amino acids) and peptides to be generated by 
proteolysis with trypsin (blue bars) are indicated. The mass of each peptide, and the protein for 
which they are used as surrogate internal standards is given below with peptides from p eno and 
GAPDH indicated by a red arrow, particular features of the QconCAT protein include a non- 
cleavable -ArgPro- site (boxed), N- and C- terminal extensions to protect the true Q-peptides 
(white bars), a purification His Tag (purple bar), and a single cysteine residue for quantification 
(yellow bar). Adapted from Beynon e t  at., 2005.
PeDtide Seauence Parent protein Mass (Da)
T1 MAGK Construct, sacrificial 405.2
T2 VIR Construct, sacrificial 386.25
T3 GFLIDGYPR Adenvlate kinase (AK) 1036.52
T4 WLAYEPVWAIGTGK Triose Dhosohate isomerase (TPI) 1601.87
T5 NLAPYSDELR ADoliDODrotein A1 (AdoA1) 1176.57
T6 GDQLFTATEGR Mvosin bindina Drotein C (MBC) 1193.56
T7 SYELPDGQVITIGNER Beta actin (B act ini 1789.88
T8 QW ESAYEVIR I ac.tate dehvdroaenase B (LDH B) 1291.67
T9 LITGEQLGEIYR Beta enolase (B eno) 1390.74
T10 ATDAESEVASLNR Tronomvosin A (TM A) 1361.63
T11 SLEDQLSEIK Embrvonic mvosin (E mvo) 1160.58
T12 VLYPNDNFFEGK Glvcoaen DhosDhorvlase (GP) 1441.68
T13 GILAADESVGTMGNR Aldolase B (Aldo B) 1489.71
T14 ATDAEAEVASLNR Tronomvosin B (TM B) 1345.64
T15 LQNEVEDLMVDVER Adult mvosin (A mvo) 1687.8
T16 LVSWYDNEFGYSNR Glvceraldehvde 3-DhosDhate dehvdroaenase (GAPDH) 1748.77
T17 ALESPERPFLAILGGAK PhosDhoalvcerate kinase (PGK) 1767.98
T18 QW DSAYEVIK Lactate dehvdroaenase A (LDH At 1249.65
T19 AAVPSG AST GI YE ALELR Abha enolase (a eno) 1803.93
T20 LLPSESALLPAPGSPYGR Actin Dolvmerization inhibitor (API) 1823.97
T21 FGVEQNVDMVFASFIR Pvruvate kinase (PK) 1857.9
T22 GTGGVDTAAVGAVFDISNADR Creatine kinase (CK) 1991.95
T23 AGK Construct 274.15
T24 VICSAEGSK Construct, auantification 892.42
T25 LAAALEHHHHHH Construct, purification tag 1408.68
Table 3. Peptides selected from chicken skeletal muscle soluble proteins represented in the QconCAT protein.
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set of Q-peptides can be quantified in molar terms by determination of the QconCAT protein 
concentration.
3.3 Deployment of the QconCAT Strategy
For internal standardisation, the QconCAT protein was added to chicken skeletal muscle 
soluble fraction in a known amount prior to proteolytic digestion with trypsin. Upon analysis by 
MALDI-ToF MS, the mass spectrometric intensities of the ‘heavy’ stable isotope labelled 
peptide and the unlabelled skeletal muscle peptide in the tissue sample were used to 
accurately quantify each protein. This was conducted to assess the QconCAT method through 
the quantification of changes in protein expression during development of chicken skeletal 
muscle from 1 d to 30d of growth in both broiler and layer strains. Through the full deployment 
of this strategy, sources of variation were established and assessed.
3.3.1 Reliability of a QconCAT method
For a reliable QconCAT method to achieve absolute quantification of proteins, it is imperative 
that the sources of variation and error are assessed and controlled. For quantitative proteomics 
experiments in which proteins are classified as differentially expressed across multiple 
samples, relative variance boundaries must be assessed and applied to distinguish significant 
changes in protein abundance (for example, Pandhal eta!., 2007). For the QconCAT method in 
particular, the difference between variance due to analytical replication and that between 
individual animals has defined the most likely source of variation. Alternative forms of ionisation 
in combination with reversed phase chromatography have also been tested as a measure of 
reproducibility, assessing robustness of this method across multiple platforms. As this is the 
first method to achieve absolute quantification of multiple proteins in a single experiment, it is 
important to test the accuracy of the method, particularly as compared to other methods for 
quantification. For a single protein, the QconCAT method has been compared to absolute 
quantification using a synthetic peptide incorporating a stable isotope label across the 30d of 
growth for the broiler strain. Quantification has also been compared to gel based approaches 
using densitometry of stained protein bands analysed by 1D SDS-PAGE in addition to intact 
mass analysis of proteins in the same sample as measured using ESI. However, as a true 
assessment of accuracy, a purified protein that is represented in the QconCAT for chicken 
skeletal muscle was spiked into a muscle sample in a known amount and subsequently 
quantified using QconCAT.
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3.3.2 Proteolysis
* Completeness of digestion has been quantified for both unlabelled standard and analyte
proteins using completely pre-digested, labelled QconCAT peptides. This analysis has 
monitored the disappearance of intact proteins by 1D SDS-PAGE and appearance of limit 
peptides by MALDI-ToF MS. For analyte proteins where higher order structure is thought to be 
the major cause of incomplete proteolysis, denaturation of the protein by heating has also been 
^ investigated, as has the addition of a small amount of organic solvent to improve the activity of
trypsin.
3.4 Additional Applications of QconCAT
3.4.1 Using QconCAT to quantify skeletal muscle proteins from other species
Relative quantification using differential stable isotope labelling of two species has been 
achieved using shared peptides, analysed by MS following proteolytic digestion (Snijders et al., 
^ 2007). In the same study, in silico analysis of occurrence of shared peptides in multiple species
revealed that, for example 30-50% of peptides are shared between Mus musculus and Homo 
sapiens, offering great potential for cross species quantification using peptide-based strategies 
discussed in section 1.5. Soluble muscle proteins are highly conserved amongst several 
species, sharing many peptides (although not necessarily those incorporated into the 
) QconCAT) and providing an ideal opportunity to test the QconCAT method for quantification of
peptides with subtle amino acid differences. This may have potential benefit to other 
commercially important species, allowing quantification of several proteins under different 
physiological conditions, for example in diseased states. To investigate this, readily available 
samples of mouse and carp soluble muscle proteins were analysed by 1D SDS-PAGE and 
quantification was achieved using MALDI-ToF MS and LC-ESI Q-ToF MS with chicken muscle 
QconCAT as the internal standard.
3.4.2 Quantification of normalisation using Equalizer™ beads
For dynamic range reduction in complex biological samples, the potential merits of Equalizer™ 
beads have been discussed (Thulasiraman et al., 2005, Righetti et al., 2006, section 1.4.2). 
This was applied to the soluble fraction of chicken skeletal muscle prior to analysis by gel 
electrophoresis, trypsin digestion and LC-LTQ MSMS to assess the efficiency of this strategy 
^ for enrichment of low abundance proteins. Absolute quantification by QconCAT provided the
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opportunity to quantify this method of dynamic range reduction, measuring absolute abundance 
of the proteins incorporated into the QconCAT before and after normalisation.
3.4.3 Absolute quantification of the post-translational modification, deamidation using a 
stable isotope labelled synthetic peptide
The post-translational modification deamidation results in conversion of asparagine to aspartic 
acid or isoaspartic acid. This is a non-enzymic process (Robinson and Rudd, 1974; 
www.deamidation.org) and acts to regulate protein degradation (Geiger and Clarke, 1987, 
Friedman et al., 1991, Deverman et al., 2002, Weintraub and Manson, 2004). Factors 
influencing the rate of deamidation include temperature, pH and the nature of the flanking 
amino acids, particularly C-terminal to asparagine (Robinson et al., 2001). Studies using model 
peptides have determined that a glycine residue in this position achieves the highest rate of 
deamidation, but it does not follow that this should be true of the intact protein also. 
Deamidation requires the formation of a cyclic intermediate, for which the peptide backbone 
and side chain of asparagine must adopt a particular conformation. It is likely that the higher 
order structure of native proteins will have a greater influence on this flexibility than can be 
predicted from the amino acid sequence.
Deamidation of a peptide resulting in a mass shift of +0.985Da can be observed in a mass 
spectrum as a complete or partial reaction from detailed analysis of the peptide isotopomer 
distribution compared to the expected profile. From such analysis of chicken skeletal muscle 
soluble proteins digested with trypsin, a peptide from one protein in particular exhibited a 
noticeable and atypical natural isotope distribution profile, consistent with a mixture of an 
asparagine containing peptide and the cognate deamidation product. This peptide was derived 
from the N-terminus of an abundant protein, glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH). Further analysis confirmed that the ‘atypical’ isotope profile is attributable to partial 
deamidation of an asparagine residue and that this is constrained by higher order structure in 
the native protein. The relationship between release of the N-terminal peptide by proteolysis 
and subsequent deamidation of the asparagine residue is complex with both reactions 
exhibiting different rate constants. To construct a comprehensive analysis of the kinetics 
involved, techniques for absolute quantification using a stable isotope labelled synthetic peptide 
of identical sequence were applied. Through direct comparison of the rate of deamidation in the 
model peptide with that observed during proteolysis of the native protein, the absolute effects of 
higher order structure were elucidated. This illustrates a significant application for absolute
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quantification strategies as deamidation of asparagine residues post-proteolysis will influence 
identification, characterisation and quantification proteomics.
4. M a te r ia ls  a n d  M ethods
Materials and Methods
4. Materials and Generic Methods
Details of methods given in this section are generic and are applied to all appropriate 
experiments. Further details, specific to each experiment are given in figure legends of Chapter 
5: ‘Results and Discussion’.
4.1 Materials and Reagents
Trypsin (sequence grade) was obtained from Roche Diagnostics (Lewes, UK). All other 
chemicals and solvents (HPLC grade) were purchased from Sigma-Aldrich Company Ltd 
(Dorset, UK) and VWR International Laboratory Supplies (Poole, UK).
4.2 Preparation and Purification of QconCAT
The artificial QconCAT gene was constructed and synthesised (Beynon et al., 2005; 
supplementary methods) prior to expression in E.coli BL21(ADE3) in mimimal media and stable 
isotope labelling with [15N]H4CI as the sole nitrogen source, or in the presence of [13Ce]lysine 
(100mg/L) and [13Ce]arginine (100mg/L) within a mixture of all other amino acids (unlabelled). 
Expression was induced with isopropyl-p-D-thiogalactopyranoside (IPTG) for up to 6h and the 
cells were harvested by centrifugation at 8000 x g at 4°C for 10 minutes. Inclusion bodies 
containing QconCAT (as proven by digestion with trypsin and MALDI-ToF MS analysis) were 
recovered by breaking cells using BugBuster Protein Extraction Reagent (Novagen, 
Nottingham, UK). Workflow to this point was conducted by Dr. D.M. Simpson and is described 
in detail (Pratt et al., 2006). Inclusion bodies were resuspended in 20mM phosphate buffer, 6M 
guanidinium chloride/8M urea, 0.5M NaCI, 20mM imidazole, pH 7.4. From this solution, [15N] 
labelled, [13Ce]lysine/arginine labelled, and unlabelled QconCAT proteins were purified 
separately by affinity chromatography using a Ni based resin (HisTrap HP Kit, Amersham 
Biosciences, UK). Following sample loading, HisTrap™ columns were washed with 20mM 
phosphate buffer, pH 7.4 prior to elution of the sample with the same buffer containing a higher 
concentration of imidazole (20mM phosphate, 0.5M NaCI, 500mM imidazole, 6M guanidinium 
chloride/8M urea, pH 7.4) during which phase fractions (1mL) were collected. The purified 
QconCAT was desalted by three rounds of dialysis against 100 volumes 10mM ammonium 
bicarbonate, pH 8.5 for 2 h using fresh buffer each time.
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4.3 Preparation of Chicken Skeletal Muscle Soluble Proteins
Chickens (ISA Brown layer and Ross 308 broiler) were grown to 30d post hatch and several 
animals of each strain were culled at 1, 3, 5 ,10, 20 and 30d at which times, pectoralis muscle 
was collected (the above procedures were performed at the Roslin Institute, Edinburgh, UK). 
To isolate the soluble fraction of chicken skeletal muscle, 100mg breast tissue was 
homogenised in 0.9mL 20mM sodium phosphate buffer, pH7.0 containing protease inhibitors 
(Complete Protease Inhibitors, Roche, Lewes, UK). This was centrifuged at 15,000 x g for 45 
minutes at 4°C. The supernatant fraction, containing soluble protein, was then removed. The 
insoluble fraction was homogenised in the same volume of 20mM sodium phosphate buffer, 
pH7.0 and centrifugation at 15,000 x g for 45minutes at 4°C was repeated; the pooled 
supernatant fractions (containing soluble protein) were used for all analyses. The total protein 
concentration of each preparation was measured using a Coomassie Plus Protein Assay 
(Pierce, Northumberland, UK).
4.4 Gel Electrophoresis
One dimensional sodium dodecyl sulphate polyacrylamide gel electrophoresis (1D SDS- 
PAGE)
Prior to separation of proteins by molecular weight, samples were heated to 100°C for 5 min 
with an equal volume of 2X reducing sample buffer (1mL 0.5M Tris buffer, pH 6.8, 1mL 
glycerol, 0.02g sodium dodecyl sulfate (SDS), 0.01 g bromophenol blue, 0.154g dithiothreitol 
(DTT)). This reduces disulphide bonds (DTT), generates protein:SDS complexes, eliminates 
higher order protein structure and allows progression of protein migration to be monitored 
through the gel by adding a blue dye (bromophenol blue). To separate denatured proteins, 
samples were loaded onto one end of a 12.5% (w/v) polyacrylamide reducing gel and an 
electric current was applied across the gel causing the negatively charged proteins to migrate 
towards the cathode (gels were run at 200V for 45 min). Each protein has a constant charge 
density due to the bound SDS and moves differently according to its size, with larger proteins 
encountering more resistance through the gel matrix causing them to run more slowly. 
Following electrophoresis, gels were stained with the dye Coomassie Blue (Bio-Safe:Bio-Rad, 
Hemel Hempstead, UK) overnight followed by approximately 1h incubation with de-stain 
solution containing 10% (v/v) acetic acid and 10% (v/v) methanol.
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Gel image analysis
Gels were imaged using scanning densitometry using an Epson 160 pro flatbed scanner. For 
1D quantification, gel images were converted to black and white TIFF files and band volumes 
were assessed (Total lab TL100 non-linear, 2006).
4.5 Proteolysis
Proteolysis for protein identification and quantification
Proteins were digested to peptides with the protease trypsin; proteins were diluted in 
ammonium bicarbonate (50mM, pH8.8) and incubated with trypsin at a ratio of 100:1-10:1 
(protein:trypsin). For identification, proteins were digested following separation by 1D SDS- 
PAGE; a gel plug or slice containing protein material was excised and de-stained using 50:50 
acetonitile:50mM ammonium bicarbonate, dehydrated with acetonitrile and digested overnight 
with trypsin.
Proteolysis kinetics
To investigate the kinetics of proteolysis for individual peptides, stable isotope labelled internal 
standard peptides were added to the digestion reaction in known amounts. This provided a 
reference standard upon which signal intensity of peptides cleaved from intact proteins was 
reconciled to obtain the rate of digestion. For this, proteins were digested with trypsin and 
samples of this mixture were removed at selected time points where the reaction was stopped 
by addition to a strong acid (10% (v/v) formic acid). Disappearance of intact proteins and 
appearance of limit peptides was monitored by 1D SDS-PAGE and MALDI-ToF MS. This 
method was also used to investigate the effect of denaturing protein structure prior to addition 
of enzyme on proteolysis kinetics of analyte proteins in solution.
4.6 Mass Spectrometry
Two mass spectrometers were used to acquire quantitative data for the research reported in 
this thesis, MALDI-ToF MS (M@LDI, Waters, Manchester, UK) and ESI-Q-ToF MS (Waters, 
Manchester, UK) with some supplementary data obtained using a different MALDI-ToF MS 
instrument (AXIMA MALDI ToF2, Shimadzu, Manchester, UK). In addition, protein identification 
data was acquired using a linear quadrupole ion trap (LTQ, Thermo Scientific, Hemel 
Hempstead, UK). Chromatography platforms are detailed in section 4.7.
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MALDI-ToFMS
The matrix solution (alpha-cyano hydroxycinnamic acid, 10mg/mL in 0.1% (v/v) TFA, 50% (v/v) 
acetonitrile) which absorbs energy at the wavelength of a UV laser irradiating the sample plate 
was spotted over the sample deposited onto a stainless steel target. Upon laser irradiation, 
peptides enter the gas phase, absorbing energy and becoming protonated; predominantly to 
singly charged ions [M+H]+. Ions are accelerated from the source into the flight tube with kinetic 
energy directly related to their mass and velocity (KE=1/2mv2) with smaller ions travelling along 
the flight tube faster than larger ions with less kinetic energy. To improve the resolution of the 
resulting mass spectrum, MALDI-ToF (M@LDI; Waters, Manchester, UK) has a lengthened 
flight tube via the use of a reflectron, or ‘ion mirror’ which reflects the ions off axis to the 
detector. This focuses the ions, compensating for small discrepancies in kinetic energy as ions 
of the same m/z with greater kinetic energy penetrate the reflectron further and consequently 
leave the reflectron at the same time as those with less kinetic energy (of the same m/z). 
Resolution can also be improved using MALDI and ToF MS by delaying the pulse of ion 
extraction, focusing the ions immediately following ionisation. This generates ions with a 
significantly smaller kinetic energy distribution so that all ions of the same m/z enter the flight 
tube at the same time, and with the same kinetic energy. For analysis by MALDI-ToF MS, 
peptide mixtures (1pL) were mixed with an equal volume of a-cyano-hydroxycinnamic acid in 
50% (v/v) acetonitrile, 0.1% (v/v) trifluoroacetic acid on a stainless steel 96 well MALDI target 
and allowed to air dry. A four point calibration of known peptides was carried out to test the 
sensitivity and mass accuracy of the instrument prior to peptide detection over a range of 900- 
3000m/z. For each combined spectrum, 20-30 spectra were acquired (laser energy typically 
30%) with 10 shots per spectrum and a laser firing rate of 5Hz. Data were processed using 
MassLynx software to subtract background noise using polynomial order 10 with 40% of the 
data points below this polynomial curve and a tolerance of 0.01. Spectral data were also 
smoothed by performing two mean smooth operations with a window of three channels. For 
MALDI-ToF MS (AXIMA MALDI ToF2, Shimadzu, Manchester, UK), peptides were analysed 
with the same sample preparation and data acquisition. Spectra were processed using an 
average smooth filter of width two channels and a baseline subtract filter width of 15 channels.
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ESI Q-ToF MS/MSMS
Sample containing peptides or proteins is sprayed from a high voltage needle into the 
electrospray source which is maintained at a constant potential difference across the sample 
cone. Solvent particles containing peptides are forced into the gas phase in the source and 
peptides become protonated; gaining multiple positive charges. Tryptic peptides are typically 
doubly charged [M+2H]2+ although longer peptides and those with other basic residues (for 
example histidine) that can be protonated at additional sites have a higher charge state. 
Charge state is easily determined from the m/z difference between the monoisotopic and the 
first [13C] peak, for example a difference of 0.5m/z units denotes a charge state of two. Ions are 
selected by mass to enter the quadrupole by adjusting the potential across it. The trajectory of 
the ions, as a function of time and position of the ion from the centre of the rods, providing the 
ion is stable in the quadrupole is measured to separate the ions according to their mass to 
charge ratio (m/z). Ions then travel directly to the flight tube and are detected. For tandem mass 
spectrometry, specific ions are selected to pass through the quadrupole, and are collided with 
an inert gas such as argon or helium in a collision cell causing them to fragment. Fragment ions 
pass through to the flight tube and are detected by their m/z. Peptides were acquired over the 
range 400-2000m/z with the capillary voltage set at 1900V, collision energy 10V and sample 
cone at 55V for LC-MS analysis. For LC-MSMS using ESI Q-ToF MS, collision energy was 
increased to 30%.
ESI Q-ToF MS (Waters, Manchester, UK) was also used to analyse intact proteins under the 
same instrument conditions, acquiring over the range 700-1800m/z. Mass spectra produced 
were highly complex with multiple overlapping charge envelopes for each protein. This was 
resolved using deconvolution software, for example MaxENTI maximum entropy software in 
MassLynx to produce a true molecular mass spectrum.
Quadrupole ion trap MSMS
A linear quadrupole ion trap (LTQ, Thermo Scientific, Hemel Hempstead, UK) was used for 
high throughput protein identification by tandem mass spectrometry. Peptides ionised by ESI 
enter the trap where a combination of radio frequency voltages are applied to the rods and a 
direct current is applied to the end lenses at both sides of the trap to destabilise successive ion 
trajectories, thus expelling ions of a selected mass. For fragmentation, selected precursor ions 
are retained inside the trap where collision energy is applied through an inert gas, for example 
helium, causing the peptide ion to fragment. Multiple stages of mass spectrometry by
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subsequent isolation and fragmentation of product ions from the first fragmentation may be 
performed. For protein identification, tryptic peptides were ionised by electrospray, and ions 
were determined over the range 400-1500m/z with the capillary voltage at 50V, spray voltage 
at 1.8kV.
4.7 Liquid Chromatography
Reversed-phase high performance liquid chromatography
Peptides are separated in solution on the basis of their hydrophobicity prior to mass 
spectrometric analysis. This is performed in a column packed with silica based beads with 
surface bound long n-alkyl groups for example n-octadecyl (Cis), covalently bound. Peptides 
bind to the matrix and are eluted using a gradient of an organic solution, for example 
acetonitrile, with the most hydrophobic peptides eluting at the end of the gradient in a high 
concentration of organic solvent. For quantification using ESI Q-ToF MS and MALDI-ToF MS, 
peptides were separated using an EASY-nLC (Proxeon, Denmark) nanoflow system. Nanoflow 
HPLC at 200nL/min was used to resolve peptides (in 0.1% (v/v) formic acid) over a 50 minute 
acetonitrile gradient (0-100%). For ESI Q-ToF MS, peptides were eluted directly from the 
analytical column and infused into the source whereas for MALDI-ToF MS, peptides were 
eluted from the column and manually spotted onto a MALDI target at selected time intervals, 
allowed to dry and covered with matrix. For LTQ-MSMS analysis, peptides from in-solution or 
in-gel digests were separated using an Ultimate 3000 HPLC system (Dionex, UK). Nanoflow 
HPLC at 300nL/min was used to resolve peptides (in 0.1% (v/v) formic acid) over a 60 minute 
acetonitrile gradient (0-100%).
4.8 Protein Identification 
Peptide mass fingerprinting
Analyte proteins were digested in-gel or in-solution with trypsin (as described in section 4.5). 
Peptides were analysed by MALDI-ToF MS and monoisotopic masses were entered into the 
MASCOT search engine. Data were searched against the database MSDB for taxonomy: 
Chordata, variable modifications: oxidation of methionine, protease: trypsin, missed cleavages: 
1, peptide tolerance: 250ppm. MOWSE scores above 65 at probability level, p=0.05 were 
accepted as confident matches. Peptide digestion maps (Beynon, 2005) were created 
indicating sequence coverage, including peptides that were identified as part of a missed 
cleavage.
Materials and Methods
MSMS ion search
Proteins were separated by 1D SDS-PAGE and digested in-gel with trypsin prior to analysis of 
peptides by LC-ESI-LTQ MSMS. MSMS data were searched against MSDB using MASCOT 
with the following parameters; taxonomy: Chordata, protease: trypsin, variable modifications: 
oxidation of methionine, peptide tolerance: 250ppm, MSMS tolerance: 250ppm, peptide 
charge: 1+, 2+ and 3+, instrument: ESI-TRAP, from which only confident identifications 
(MOWSE score>45, p<0.05) were accepted.
4.9 Protein Quantification
Analyte proteins were mixed with QconCAT, or stable isotope labelled internal standard 
peptides and digested with trypsin. Peptides were analysed by MALDI-ToF MS or ESI-Q-ToF 
MS/MSMS from which relative signal intensity of analyte:internal standard was used for 
quantification. For quantification of chicken skeletal muscle soluble proteins using the 
QconCAT method, QconCAT (7pg) and chicken skeletal muscle soluble proteins (70pg) from 
broiler and layer chickens 1d-30d post-hatch (6 time points, 4 birds at each time point), were 
mixed and diluted 10 fold with 50mM ammonium bicarbonate, and 10% (v/v) acetonitrile, prior 
to addition of trypsin (20:1 substrate:protease). The reaction mixture was incubated at 37°C for 
24h after which the digest was incubated with additional trypsin (20:1 substrate:protease) to 
achieve complete digestion and 1pL was analysed by MALDI-ToF MS.
4.10 Normalisation of Chicken Skeletal Muscle Soluble Protein Abundance 
using Equalizer™ Beads
20mg Prospectrum-2 (Louisville, KY, USA) beads were washed in 1mL 50% (v/v) MeOH and 
mixed gently for 10min. Beads were allowed to settle and the supernatant was removed and 
discarded. MeOH 50% (v/v) was added to cover the surface of the beads that were left to swell 
overnight at 4°C. Once swollen, 20mg beads (constituting 100pL settled bed volume) were 
transferred to a 1.5mL Eppendorf tube. Beads were washed in 1 mL double distilled H2O in a 
roller mixer for 30min prior to equilibration by repeated washing in 20mM sodium phosphate 
buffer pH7.0 for 30min. After each wash, beads were left to settle for 5min and the supernatant 
was removed. Approximately 1mL sample containing 25mg, 50mg and 100mg soluble protein 
in three separate experiments was added to the beads and mixed for 2h on a roller mixer. 
Unbound protein was collected as the supernatant fraction after beads had settled for 5min.
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The beads were subsequently washed eight times in 1mL 20mM phosphate buffer and 
supernatant fractions were removed and collected.
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5. Results and Discussion
►
5.1 Design, Preparation, Purification and Analysis of QconCAT and Analyte 
Proteins
5.1.1 Design, preparation and purification of QconCAT
To measure the absolute amount of chicken skeletal muscle soluble proteins during growth of 
V chickens bred for meat (broiler) and those bred for eggs (layer), a group of twenty soluble
proteins was selected to be quantified using a single QconCAT. For each of these, a 
representative peptide was chosen that gave a strong signal in previous MALDI-ToF MS 
analyses of tryptic digests (Beynon et al, 2005; Table 3, section 1.5.2). The peptides were 
used to guide construction of the DNA sequence of the QconCAT, which was synthesised, 
inserted into a pET21a vector and expressed in E.coli grown in labelled ([15N]H4CI) or 
unlabelled ([14N]FUCI) media (Pratt et al., 2006). For QconCAT expression, a typical bacterial 
culture of 200mL was induced at an ODeoo of 0.6-0.8 which generated 5-1 Omg of QconCAT 
after cell breakage, recovery of inclusion bodies and affinity chromatography of 8M urea 
solubilised protein on 1mL NiNTA columns. After induction, the QconCAT protein was visible as 
a major band in 1D SDS-PAGE of a broken cell preparation (work flow to this point conducted 
by Dr. D.M. Simpson) and analysis of QconCAT purification fractions by 1D SDS-PAGE (Figure 
16) revealed a major band at approximately 35kDa as expected from the predicted mass of the 
► protein from its sequence. For purification, inclusion bodies containing expressed QconCAT
protein were solubilised in 8M urea and purified by affinity chromatography using a Ni based 
resin (HisTrap HP Lit, Amersham Biosciences, UK). Following sample loading, columns were 
washed and protein was eluted with 500mM imidazole into five 1mL fractions. For the [15N] 
labelled QconCAT, the protein was contained predominantly in fractions 1-3 and unlabelled 
QconCAT in fractions 1 and 2. Presence of other bands immediately above the main QconCAT 
. band were presumed to be modified products of the same protein and will be discussed in
more detail in section 3.1.1. A small amount of protein material was also eluted in the wash and 
flow through fractions. Protein containing fractions following affinity purification were pooled 
and the protein concentration was determined using a Coomassie-Plus protein assay (Pierce, 
Northumberland, UK). Each fraction was aliquoted to 50pL and stored at -20°C.
►
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Figure 16. QconCAT expression and purification.
The artificia l Q conCAT gene (Beynon e t  a l., 2005) was expressed in E .c o li in m inimal medium 
containing [15N]H4CI as the sole nitrogen source. Expression was induced with isopropyl-p-D- 
th iogalactopyranoside (IPTG) and the cells were harvested by centrifugation at 1400 x g at 4°C 
fo r 15 m inutes. Inclusion bodies containing Q conCAT were recovered by breaking cells using 
BugBuster Protein Extraction Reagent (Novagen, Nottingham, UK). Expression and analysis by 
1D SDS-PAG E before and after induction (a) was com pleted by Dr. D.M. S im pson (Proteom ics 
and Functional G enom ics, University o f Liverpool). Inclusion bodies were re-suspended in 20mM 
phosphate buffer, 8M urea, 0.5M NaCI, 20mM imidazole, pH 7.4. From this solution, labelled (15N) 
and unlabelled Q conC AT proteins were purified separately by affin ity chrom atography using a Ni 
based resin (H isTrap HP Kit, Am ersham  Biosciences, UK). Following sam ple loading, H isTrap™  
colum ns were w ashed with 20mM phosphate buffer, pH 7.4 prior to elution o f the sam ple w ith the 
sam e buffer containing a higher concentration o f im idazole (20mM phosphate, 0.5M NaCI, 
500m M  im idazole, 8M urea, pH 7.4) during which phase five fractions (1mL) were collected and 
analysed by 1D SDS-PAGE (b). The firs t five lanes contain 5pL o f each 1mL fraction o f purified 
[15N] Q conC AT (labelled/heavy; H), the next five contain 5pL o f each 1mL fraction o f purified [14N] 
Q conC AT (unlabelied/light; L). Column washes with binding buffer containing 8M urea and 
colum n flow  through collected when Q conCAT protein was loaded onto H isTrap™  colum ns were 
also analysed and are shown as the last fou r lanes.
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5.1.2 Proteomic Analysis of QconCAT
The intact mass of the protein measured by ESI-Q-ToF MS was 33036Da (Figure 17), this is 
consistent with the predicted mass of 33167Da for the QconCAT protein with the loss of the 
initiator methionine residue from the N terminus (131 Da) by the action of methionine 
aminopeptidase following translation and sufficient synthesis of the protein (Ben-Bassat et al., 
1987). For E.coli proteins, the first amino acid is always N-formylmethionine which results from 
a post acylation modification of the methionine on a specific tRNA. The formyl group is 
removed by the action of a specific formylase yielding an unmodified N-terminal methionine 
which is subsequently removed (Adams and Capecchi, 1966, Adams, 1968). Some adducts 
were observed in the intact mass analysis; the three most intense peaks of greater mass than 
the true QconCAT protein were attributed to addition of one, two and three sodium (Na) groups 
and are presumed to result from salt in the sample preparation, for example NaCI in the binding 
buffer for affinity purification.
Purified, unlabelled QconCAT was subjected to in-solution digestion with trypsin prior to 
analysis of peptides by MALDI-ToF MS (Figure 18). All of the predicted QconCAT peptides 
within the mass range 900-3000m/z were observed, although not of equal intensity, despite 
being present in equal amounts. The influences and effects of ionisation inherent with MALDI- 
ToF MS analysis are crucial for absolute quantification and are discussed in section 3.3. All 
ions in the peptide mass fingerprint of unlabelled QconCAT protein were accounted for except 
peaks at 1275.80m/z and 1233.80m/z, each of which was 17m/z less than the genuine tryptic 
peptides T8 (QVVESAYEVIR) and T18 (QVVESATEVIK), both representing isoforms of lactate 
dehydrogenase. As both of these peptides are of identical sequence apart from the C-terminal 
residue, the most likely event was post-proteolytic modification of the N-terminal glutamic acid 
which had cyclised to form pyroglutamic acid. To confirm this, peptides were analysed by ESI- 
Q-ToF MSMS and the doubly charged peak at 638.4m/z ([M+H]+ 1275.80m/z) was fragmented 
by MSMS and sequenced de novo. The majority of the peptide sequence was allocated from y- 
ions, confirming the identity of this peptide (Figure 19). [15N] labelled QconCAT was also 
digested in-solution with trypsin and analysed by MALDI-ToF MS, allowing comparison of 
labelled and unlabelled mass spectra (Figure 20). [15N] labelled; ‘heavy’ peptides were 
distinguished from unlabelled; ‘light’ peptides by a mass shift dependent on the number of 
nitrogen (N) atoms in each peptide. For example, T12 of sequence VLYPNDNFFEGK, [M+H]+ 
1442.82m/z containing 15N atoms is increased in mass by 15Da due to the ‘heavy’ label.
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Figure 17. ESI-Q-ToF MS analysis of unlabelled QconCAT protein.
QconCAT protein, solubilised and purified in 8M urea, was diluted 100 fold with 1% (v/v) formic 
acid and the intact mass was determined by ESI-Q-ToF MS by direct infusion into a Waters QToF 
(Waters, Manchester, UK). Mass spectra were acquired over the m/z range 700-1800 at 10% 
collision energy with sample cone voltage 55V and capillary voltage 1900V. The combined mass 
spectrum (100 scans) was deconvoluted using the MaxENT 1 maximum entropy algorithm 
(MassLynx) between 32800 and 33400Da at a resolution of 0.1Da/channel to recover the true 
mass of the protein.
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Figure 18. QconCAT protein digested in-solution with trypsin.
The QconCAT protein was purified and digested in-solution. For this, the QconCAT protein was 
diluted to 5pM in 50mM ammonium bicarbonate and digested with trypsin (20:1 
substrate:protease) at 37°C for 24h. Peptides were analysed by MALDI-ToF MS (M@LDI; 
Waters, Manchester, UK). Each peak in the spectrum is the surrogate peptide for a different 
protein as indicated by the peptide map. Peptide ions resulting from chemical modification of N- 
terminal glutamine residues have also been indicated, thus explaining every major ion in the 
spectrum. The protein names, and their abbreviations are: AK: adenylate kinase, TPI: those 
phosphate isomerase, ApoA1: apolipoprotein A1, a Actin alpha actin, a Eno: alpha enolase, p 
Eno: beta enolase, E Myo: embryonic myosin, A Myo: adult myosin, GAPDH: glyceraldehyde 3- 
phosphate dehydrogenase, API: actin polymerisation inhibitor, PK: pyruvate kinase, CK: creatine 
kinase, LDH A: lactate deydrogenæe A, LDH B: lactate dehydrogenase B, GP: glycogen 
phosphorylase, TM A: tropomyosin A and TM B: tropomyosin B.
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Figure 19. Confirmation of pyro-glutamic acid modification to QconCAT peptides.
QconCAT protein was diluted to 5pM in 50mM ammonium bicarbonate and digested with trypsin 
(20:1 substrate:protease) at 37°C for 24h. Peptides were analysed by ESI-Q-ToF MS (Waters, 
Manchester, UK). Doubly charged peptides T8 and T18 representing two isoforms of lactate 
dehydrogenase that differ only in the C-terminal amino acid both gave rise to an ion less 17Da in 
mass. Tandem mass spectrometry was performed on the doubly charged peptide at 638.4m/z 
using 30% collision energy.
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Figure 20. Distinction between unlabelled and [15N] labelled QconCAT peptides in MALDI- 
ToF mass spectra.
Unlabelled (a) and [15N] labelled (b) QconCAT proteins were diluted to 5pM in 50mM ammonium 
bicarbonate and digested with trypsin (20:1 substrate:protease) at 37°C for 24h. Peptides were 
analysed by MALDI-ToF MS. Labelled peptides are ‘heavier’ in mass than their unlabelled 
counterparts according to the number of nitrogen atoms in the peptide. A region of the spectrum 
containing two Q-peptides, T12 and T13 is highlighted and this region is expanded and inserted 
above the main spectrum, indicating the mass offset between ‘heavy’ and ‘light’ peptides.
Results and Discussion
Analysis of QconCAT preparations by 1D SDS-PAGE revealed two major bands, and several 
protein bands in less abundance in the same region as the QconCAT protein. This 
phenomenon was particularly pronounced for samples that had been stored for a considerable 
amount of time in binding buffer containing 8M urea at -20°C, or if freeze thawed several times 
prior to analysis (results not shown). In-gel digestion of the two main bands with trypsin and 
MALDI-ToF MS analysis of the peptides revealed no significant differences in the spectra 
(Figure 21), although there was limited evidence of missed cleavage peptides in the lower of 
the two bands. It was expected that the presence of higher molecular weight bands would be 
caused by aggregation of the protein product, most likely associated with the formation of 
sample contaminant adducts, for example with salts. The mass range of MALDI-ToF MS is not 
sufficient to analyse such products upon trypsin digestion at high resolution and in any case, 
the efficiency and accessibility of trypsin would need to be carefully controlled to ensure these 
are not artifacts of insufficient cleavage other than that resulting from structural impediments. 
However, upon in-solution QconCAT digestion with trypsin and subsequent MALDI-ToF MS 
analysis of peptides, additional ions mass shifted by 43Da from each tryptic peptide were 
apparent. This is consistent with carbamylation of peptides (Figure 22) occurring as the result 
of isocyanic acid formation from urea in equilibrium with ammonium cyanate in solution. 
Isocyanic acid reacts with free amino groups, for example the N-terminus and lysine side 
chains and may compromise quantification, depending on the extent of carbamylation. It was 
therefore essential to remove urea prior to analysis of QconCAT, or to refine the purification 
method so as to eliminate the use of urea in binding and elution buffers. De-salting was carried 
out prior to MS analysis by filtration using Sephadex G25 spun columns. However, this was 
associated with a considerable degree of protein loss and an alternative, C4 MicroTrap™ 
(Presearch, Basingstoke, UK) columns were investigated (Figure 23). This method was 
effective for removing the effects of salts on the QconCAT protein, although evidence of other 
bands in the same region can still be seen on the gel. For quantification, the preparation of 
QconCAT protein must be homogeneous, and consequently other methods were investigated 
to improve purification. These included eluting QconCAT from HisTrap™ columns without urea 
in the buffer. However, the inclusion bodies produced from the expression strain required 
solubilisation, thus QconCAT material was loaded onto HisTrap™ columns within an 8M urea 
solution. In order to elute without urea once the protein had been loaded, the columns were first 
washed with binding buffer containing urea, and then without, before eluting the protein from 
the column in elution buffer without urea. This was successful in producing a homogeneous 
preparation of QconCAT protein (Figure 24). However, since the resulting QconCAT solution
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Figure 22. Carbamylation of QconCAT peptides.
Unlabelled and labelled QconCAT proteins were mixed, diluted to 5pM in 50mM ammonium bicarbonate and 
digested with trypsin (20:1 substrate:protease) at 37°C for 24h and peptides were analysed by MALDI-ToF MS. 
Additional ions present at 43m/z from Q-peptides were attributed to decomposition of urea and subsequent 
carbamylation of peptides.
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Figure 23. Implementation of strategies to de-salt QconCAT protein preparations.
Unlabelled QconCAT purified fractions in 8M urea de-salted with a) sephadex G25 spun columns and b) C4 
MicroTraps™. For sephadex G25 spun columns, 250pL sephadex in a 500pL eppendorf tube was washed 
with ddH20  and spun at 2000 rpm for 2 minutes when sample was added. The sample was recovered in 
the original volume. For C4 Microtrap™ columns, these were washed in 0.1% (v/v) formic acid and the 
sample was eluted in 90% (v/v) acetonitrile/ 0.1% (v/v) formic acid. For SDS-PAGE, samples were dried 
down in a vacuum centrifuge and reconstituted in reducing sample buffer containing SDS.
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did not contain a solubilising agent, the protein was observed to precipitate out of solution both 
relatively rapidly following purification and upon freeze-thawing. To avoid this, the alternative 
solubilising agent guanidine hydrochloride (GHCI) was used and QconCAT was solubilised in 
the same way, replacing 8M urea in all buffers with 6M GHCI during purification. Purified 
protein was eluted from the column in 1mL fractions which were analysed by 1D SDS-PAGE 
(Figure 25). As GHCI reacts with SDS in the sample buffer forming a guanidinium dodecyl 
sulphate complex which precipitates out of solution, GHCI was not compatible with SDS-PAGE, 
and was removed from the sample prior to downstream analysis. This was achieved using 
dialysis against 1 mM ammonium bicarbonate and will be discussed in the context of the next 
iteration of QconCAT expression and purification.
The first QconCAT protein designed for chicken skeletal muscle was labelled by growing the 
expression strain in [15N]H4CI as the sole nitrogen source. Thus each peptide incorporated [15N] 
instead of [14N] with the mass offset of each labelled peptide determined by the number of 
nitrogen atoms in the peptide. Although this provided an efficient labelling strategy, [15N] is a 
non-uniform label for peptides and proteins as the mass difference between each analyte and 
internal standard peptide is sequence dependent and varies for each peptide, making it more 
difficult to distinguish peptide pairs in complex mass spectra. In addition, the relatively high 
natural abundance of [14N] can lead to incomplete labelling. An alternative strategy is to label 
specific amino acids, for example lysine and arginine, with [15N] or [13C]. As both of these amino 
acids contain six carbon atoms, and each tryptic peptide contains only one of these amino 
acids, [13C] labelling of arginine and lysine provides a uniform strategy where the mass offset 
between unlabelled and labelled peptides is a constant 6Da. Stable isotope labels can also be 
used in combination to label specific amino acids, thus providing a specific mass difference 
between ‘light’ and ‘heavy’ peptides, for example [13Ce][15N4]-arginine which is ‘heavier1 by 
10Da than [12C6][15N4]. For tryptic peptides, the exception to the uniform incorporation of stable 
isotope label is the presence of a proline residue next to the cleavage site for trypsin, as in 
tryptic Q-peptide T17 representing the protein phosphoglycerate kinase. Here the peptide 
contains an internal arginine and a C-terminal lysine residue, thus the mass offset is 12Da. The 
QconCAT protein was fully labelled with [13C6]arg/[13C6]lys by growing the expression strain in 
media with all essential amino acids added unlabelled except for lysine and arginine which are 
added labelled with [13C] (labelling carried out by Dr D.M. Simpson). During protein synthesis, 
each lysine and arginine residue was incorporated into the protein in labelled form. QconCAT 
protein both labelled and unlabelled was expressed, solubilised and purified with 8M urea and
co
COo
co
COo
D
Q .
2>
a<1)
Size (kDa) co
[14N] QconCAT
,---------- ^
1 2  3 4
Column washes
200
66.2
45
QconCAT
31
21
3
Cl
£
£<um
[15N] QconCAT Column washes
Figure 24. Purification of QconCAT labelled (H) and unlabelled (L) proteins using HisTrap™ columns 
without prior solubilisation in 8M urea.
QconCAT protein was solubilised in 20mM phosphate buffer, 8M urea, 0.5M NaCI, 20mM imidazole, pH 7.4. 
From this solution, labelled [15N] and unlabelled [14N] QconCAT proteins were purified separately by affinity 
chromatography using a Ni based resin (HisTrap HP Kit, Amersham Biosciences, UK). Following sample 
loading, HisTrap™ columns were washed with 20mM phosphate buffer, pH 7.4 prior to elution of the sample 
with the same buffer containing a higher concentration of imidazole and no urea (20mM phosphate, 0.5M 
NaCI, 500mM imidazole, pH 7.4) during which phase five fractions (1mL) were collected and analysed by 1D 
SDS-PAGE.
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Figure 25. Purification of unlabelled QconCAT protein, solubilised in 6M guanidinium chloride.
QconCAT protein was solubilised in 20mM phosphate buffer, 6M guanidinium chloride, 0.5M NaCI, 20mM 
imidazole, pH 7.4. From this solution, QconCAT protein was purified by affinity chromatography using a Ni 
based resin (HisTrap HP Kit, Amersham Biosciences, UK). Following sample loading, HisTrap™ columns were 
washed with 20mM phosphate buffer, pH 7.4 prior to elution of the sample with the same buffer containing a 
higher concentration of imidazole (20mM phosphate, 6M guanidinium chloride, 0.5M NaCI, 500mM imidazole, 
pH 7.4) during which phase five fractions (1mL) were collected and analysed by 1D SDS-PAGE.
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6M GHCI independently (Figure 26). The preparation with GHCI was much more homogeneous 
when analysed by 1D SDS-PAGE with all of the protein eluting in a single 1mL fraction. 
However, the incompatibility of GHCI with SDS remained apparent, thus GHCI was removed 
from the protein preparation by dialysis against 1mM ammonium bicarbonate (Figure 27a) This 
resulted in a well resolved protein band on the 1D gel although several other faint bands were 
observed. In-gel digestion with trypsin and MALDI-ToF MS analysis of peptides confirmed the 
presence of QconCAT protein fragments in each band (Figure 27b). It is likely that a small 
amount of fragmentation of the intact protein had occurred during sample processing due to the 
denaturing conditions of SDS-PAGE, given that it is unlikely any higher order structure of the 
QconCAT protein exists (see discussion section 3.2.1). When analysed by 1D SDS-PAGE, 
fragments of QconCAT protein were present in very low amounts compared to the intact 
protein, such that they would not contribute a great deal to compromise quantification. To 
quantify this, densitometry was performed on the 1D gel image and 94% of the total protein 
abundance was contributed by the main QconCAT protein band, thus other fragments of 
QconCAT seen at this high protein loading on the gel were not significant. This unlabelled 
QconCAT preparation, solubilised in 6M GHCI and purified was also analysed by ESI-Q-ToF 
MS to recover the intact mass (Figure 28). The deconvoluted mass spectrum only contained 
minor peaks other than the true QconCAT protein (33036Da) and the mass offset could not be 
reconciled to a known pattern of adduction, thus it was concluded that this preparation was 
impacted less by salt contamination. To complete analysis of QconCAT labelled with 
[13C6]arg/[13C6]lys and purified in 6M GHCI, both labelled and unlabelled QconCAT proteins 
were digested in-solution with trypsin and analysed by MALDI-ToF MS. Mass spectra again 
contained a full complement of tryptic peptides of varying signal intensity and ‘light’ and ‘heavy’ 
peptides could be distinguished by their 6m/z offset as highlighted for tryptic Q-peptide T3 
(Figure 29). To compare this labelling strategy with that of [15N] in terms of natural abundance 
of the light isotope ([12C]/[14N]), the isotope profile of the same peptide was examined (Figure 
30). Using [13C] gives rise to a much less significant peak (3% of total) than [15N] (9%) 
appearing at -1 m/z below the monoisotopic peak, thus has less impact on quantification using 
this peptide. This can be overcome by taking into account the entire isotope profile for 
quantification but this may cause more of a problem for complex samples where peptide 
profiles may overlap.
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Figure 26. Purification of [13C6]lys, [13C6]arg-labelled QconCAT protein, solubilised using 8M urea or 6M 
guanidinium chloride.
FCgllys, [13Cg]arg-QconCAT was solubilised in 20mM phosphate buffer, containing either 6M guanidinium 
chloride or 8M urea, 0.5M NaCI, 20mM imidazole, pH 7.4. From this solution, QconCAT proteins were separately 
purified by affinity chromatography using a Ni based resin (HisTrap HP Kit, Amersham Biosciences, UK). 
Following sample loading, HisTrap™ columns were washed with 20mM phosphate buffer, pH 7.4 prior to elution 
of the sample with the same buffer containing a higher concentration of imidazole (20mM phosphate, 6M 
guanidinium chloride or 8M urea, 0.5M NaCI, 500mM imidazole, pH 7.4) during which phase five fractions (1mL) 
were collected and analysed by 1D SDS-PAGE; a) purified in urea, b) purified in guanidinium chloride.
iOnly peptides T8,T9,T14 present in weak spectrum 
All peptides present except His Tag (T25)
All peptides present except His Tag (T25) 
All peptides present
Peptides T9-T22 present, T3-T8 absent, T25 absent 
All peptides present except T4, T5, T7, T10, T11 and T25 
(His Tag).
Only peptides T18-T22 present
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Figure 27. Purification of [13C6]lys, [13C6]arg-QconCAT, solubilised in 6M guanidinium 
i chloride and de-salted by dialysis.
[13C6]lys, [13C6]arg-Q conC AT was solubilised and purified in 6M guanidinium  chloride. Fractions 
containing Q conC AT protein were pooled and de-salted by three rounds o f d ia lysis against 100 
volum es 10mM am m onium  bicarbonate, pH 8.5 fo r 2h using fresh buffer each tim e prior to 
analysis by 1D SDS-PAGE (a). The 1D SDS-PAGE gel image was analysed by densitom etry to 
represent the protein abundance contributed by each visib le band; th is is presented to the left o f 
the 1D analysis in b. For protein identification, plugs were excised from all m ajor visible bands of 
QconCAT analysis after dialysis, and digested overnight in-gel with trypsin. Peptides were 
analysed by M ALDI-ToF MS and Q-peptides identified in m ass spectra w ere recorded (b).
I
100"i 33036.60
Figure 28. Unlabelled QconCAT protein purified in 6M guanidinium chloride.
QconCAT protein, solubilised and purified in 6M guanidinium chloride, was diluted 100 fold with 
1% (v/v) form ic acid and the intact m ass was determ ined by ESI-Q-ToF MS. Mass spectra were 
acquired over the m /z range 700-1800 at 10% collision energy w ith sample cone voltage 55V and 
capillary voltage 1900V. The combined m ass spectrum (100 scans) was deconvoluted using the 
MaxENT 1 maximum entropy algorithm  (M assLynx) between 32800 and 33400Da at a resolution 
o f 0.1Da/channel to  recover the true mass o f the protein.
T 3  ‘L’
6 m/z
Figure 29. Distinction between unlabelled and [13C6]lys, [13C6]arg-labelled QconCAT 
peptides in MALDI-ToF mass spectra.
Unlabelled (a) and [13C6]lys, [13C6]arg-labelled (b) QconCAT proteins were diluted to 5pM in 
50mM ammonium bicarbonate and digested with trypsin (20:1 substrate:protease) at 37°C for 
24h. Peptides were analysed by MALDI-ToF MS. Labelled peptides are ‘heavier’ in mass than 
their unlabelled counterparts by 6Da due to the labelled C-terminal amino acid. A region of the 
spectrum containing the Q-peptide T3 is highlighted and this region is expanded and inserted 
above the main spectrum, indicating the mass offset between ‘heavy’ and ‘light’ peptides.
Label: [15N]H4CI Label: pCJarg, [^CJIys
[M+H]+
1049.54
[M+H]+
1043.54
Figure 30. Isotope distribution of a Q-peptide labelled with [13C6]-arg/lys and [15N] in 
MALDI-ToF mass spectra.
[1SN]-Iabelled and [lSC6]lys, [13C6]arg-labelled Q conC AT proteins were diluted to 5pM in 50mM 
amm onium bicarbonate and digested with trypsin (20:1 substrate:protease) at 37°C fo r 24h prior 
to analysis by MALDI-ToF MS. Zoom ed regions show ing the peptide envelope fo r a single 
peptide (T3; GFLIDG YPR) are illustrated, including the percentage contributed by each peak.
Results and Discussion
5.1.3 Proteomic analysis of chicken skeletal muscle soluble proteins
The QconCAT was designed to include surrogate peptides for quantification of twenty chicken 
skeletal muscle proteins (Table 3, section 1.5.2). As chicken skeletal muscle matures post­
hatch, the protein distribution in the tissue changes dramatically from a large number of 
proteins that are expressed in similar amounts at hatch to relatively few, high abundant proteins 
after 30d of growth (Figure 31). From previous identification studies (Doherty et al., 2004) and 
peptide mass fingerprinting of in-gel digestion with trypsin (Table 4; supplementary figures 1- 
22)), the most abundant proteins present in the soluble fraction of chicken skeletal muscle at 
this stage are predominantly glycolytic enzymes. Other proteins, notably actin, have 
disappeared from the soluble fraction of muscle by 10d of growth, presumably reflecting 
repartitioning and assembly of the myofibrillar apparatus. Finally, serum proteins are detectable 
in muscle preparations at hatch, but rapidly disappear during development. This change is 
most likely ascribed to the increased exclusion of interstitial fluid as the muscle develops 
(McLean et al., 2004). The complexity of the sample is clearly observed from a MALDI-ToF 
mass spectrum of an entire in-solution digest of the soluble fraction of chicken skeletal muscle 
with trypsin (Figure 32). Only the most abundant peptides that ionise well are identified in this 
spectrum although the rich baseline is indicative of a complex sample with such an abundance 
of peptides that most are unable to be resolved. This is also reflected in MALDI-ToF mass 
spectra from in-gel digestion with trypsin of abundant proteins (supplementary figures 1-22), in 
which numerous ions cannot be assigned to the abundant protein indicating the presence of 
multiple proteins in the same location on the 1D gel.
5.2 Proteolysis of QconCAT and Analyte Proteins
5.2.1 Proteolysis of QconCAT
For absolute quantification of proteins using surrogate peptides as internal standards, complete 
proteolysis is essential. For the QconCAT method, the amount of the representative peptide 
selected for each protein is used to report on the amount of protein present. As such, 
incomplete cleavage would cause an under representation of protein amount. As the QconCAT 
protein is to be digested with trypsin to release the internal standard peptides, it is vital that this 
protein is digested efficiently and quickly. It was not expected that the three dimensional 
structure of the recombinant QconCAT protein would impede proteolysis as this is not a 
biological protein. To investigate the propensity of the QconCAT protein to be digested with the 
protease trypsin, QconCAT was digested in-solution with trypsin (20:1 substrate to protease)
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GP 76 Q7ZZK3 98566 G a llu s  aa llu s 11 15
Albumin 113 P19121 71800 G a llu s  aa llu s 12 23
Pvruvate kinase 113 P00548 57847 G a llu s  aa llu s 19 33
B eno 134 P07322 46839 G a llu s  aa llu s 10 33
A actin 72 P68139 42051 G a llu s  aa llu s 6 24
Creatine kinase 148 P00565 43301 G a llu s  a a llu s 12 31
Aldolase
GAPDH 127 P00356 35681 G a llu s  ga llus 9 40
TP I 186 P00940 26620 G a llu s  ga llus 13 43
AK 101 P05081 21683 G a llu s  ga llus 7 41
GP 105 Q7ZZK3 98566 G a llu s  a a llu s 12 15
Albumin 51 P19121 71800 G a llu s  ga llus 3 7
PK 195 P00548 57978 G a llu s  g a llu s 17 38
B eno 75 P07322 46839 G allu s  g a llu s 10 21
PGK 88 P51903 44557 G a llu s  g a llu s 7 24
CK 187 P00565 43301 G a llu s  g a llu s 19 45
Aldolase
GAPDH 135 P00356 35681 G a llu s  g a llu s 16 52
LDH A 189 P00340 36491 G a llu s  g a llu s 22 46
PGM 109 Q5ZLN1 28749 G a llu s  g a llu s 10 40
TPI 176 P00940 26620 G a llu s  g a llu s 13 48
AK 101 P05081 21683 G a llu s  g a llu s 7 41
Table 4. Identification of chicken skeletal muscle soluble proteins by peptide mass 
fingerprinting.
Chicken skeletal muscle soluble proteins were analysed by 1D SDS-PAGE and digested in gel 
with trypsin. Peptides were analysed by M ALDI-ToF MS and m onolsotoplc masses were entered 
into the  M ASCO T search engine. Data were searched against the database MSDB fo r taxonom y: 
Chordata, variable modifications: oxidation o f methionine, protease: trypsin, m issed cleavages: 1, 
peptide to lerance: 250ppm . M O W SE scores above 65 at probability level, p=0.05 were accepted 
as confident m atches. Mass spectra corresponding to identified proteins are presented in 
supplem entary figures (1-22). NB. Muscle type aldolase (A) in chicken is not sequenced and 
incorporated into the database Swissprot. The Q -peptide incorporated fo r th is protein was taken 
from liver type a ldolase (B) and thus is not represented in the soluble fraction o f chicken skeletal 
muscle. The identity o f th is protein was discussed and confirm ed by Dr. J. Hayter (Hayter e t  al. ,  
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Figure 32. Chicken skeletal muscle soluble proteins digested in-solution with trypsin.
C h icken  ske le ta l m usc le  so lub le  p ro te ins  from  a 30d b ro ile r w e re  d ilu ted  10 fo ld  w ith  50m M  
am m on ium  b ica rbona te , p rio r to  add ition  o f tryps in  (20:1 subs tra te :p ro tease ). T h e  reaction 
m ix tu re  w as  incubated  a t 37°C  fo r  24h a fte r w h ich  the  d ig e s t w as incubated  w ith  add itiona l 
tryps in  (20:1 subs tra te :p ro tease ) to  ach ieve  com p le te  d igestion  and 1pL w as ana lysed  by M ALD I- 
ToF  M S.
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and the reaction was stopped at selected time points by the addition of digesting material to
10% (v/v) formic acid. The disappearance of the intact protein was monitored by 1D SDS-
PAGE by drying down the digested mixture to remove the acid and reconstituting in reducing
sample buffer immediately prior to loading. The QconCAT protein had completely disappeared
from the gel after two minutes of digestion with no intermediate fragments visible after this time
(Figure 33a). The appearance of limit peptides was also monitored by MALDI-ToF MS, with all
j  peptides present in the spectrum after one minute of digestion with trypsin (Figure 33b). The
disappearance of incomplete digestion products greater than 2000Da can also be observed as
digestion reaches completion around 8h (464 min). This rapid proteolysis is to be expected as
the QconCAT protein is not a biological entity, is not expected to fold into a complex 3D
structure and therefore does not contain regions inaccessible to trypsin cleavage (Hubbard et
a!., 1991). When the trypsin was reduced to much lower levels (100:1 substrate to protease)
and the digestion reaction was sampled at very short time intervals, there was some evidence
for the appearance of partially digested intermediates, although in-gel digestion of these bands
(1-7) and subsequent MALDI-ToF MS analysis of peptides demonstrated that each band
comprised multiple species (Figure 34), consistent with simultaneous tryptic attack on all
scissile bonds at very similar rates. This was confirmed by digesting QconCAT protein in-
solution with trypsin at the same enzyme to protein ratio (1:100), taking early time points where
digestion was stopped by the addition of 10% (v/v) formic acid and analysing the resulting
( digested mixtures on a 30cm 1D gel, rather than the smaller 7cm gel. When separated through
a larger gel, there were an increased number of visible bands which were presumed to have
overlapped on the smaller gel (Figure 35). To investigate the route of proteolysis further,
peptides from a low concentration trypsin digestion of QconCAT protein in-solution were
analysed by MALDI-ToF MS over 24h. This revealed that some cleavage sites were favoured,
although all expected peptides are present after 30m of digestion under these conditions
(Figure 36). Additionally, some cleavage sites remain resistant to trypsin digestion throughout 
i
the time course of this experiment, for example T5-6 ([M+H]+ 1253.96m/z; 
NLAPYSDELRGDQLFTATEGR). It is predicted that glycine may have an association with 
missed cleavage in tryptic peptides, although not specifically C-terminal to the arg/lys residue 
(Siepen et al, 2007), thus there is no obvious reason for this -ArgGly- cleavage to be 
problematic. In the context of digestion of the QconCAT protein for absolute quantification of 
analyte proteins, proteolysis was so fast even at low concentrations of protease, that further 
*  investigation of the mechanism for digestion in this case was unnecessary.
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Figure 33. Proteolysis of QconCAT with trypsin.
For Q conC AT digestion, 150pg protein was digested with trypsin at a ratio o f trypsin to protein of 
1:20 and stopped at selected tim e points after addition o f enzym e by removing 15pL (containing 
3(jg prote in) and adding to an equal volum e o f 10% (v/v) form ic acid. The fractions were 
subsequently stored at -20°C until the end o f the tim e course. 25pL o f each fraction were dried 
down in a vacuum  centrifuge and reconstituted in 10pL reducing sam ple buffer prior to analysis 
by 1D SDS-PAG E (a). 1pL o f each fraction was analysed by M ALDI-ToF MS (b; overleaf).
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Figure 34. Proteolysis of QconCAT and diagnostic peptide mass fingerprinting of peptides.
QconCAT protein (150pg) was digested with trypsin at an enzyme:protein ratio of 1:00. The 
digestion was stopped at selected time points after addition of enzyme with 10% (v/v) formic acid. 
For gel electrophoresis, fractions from QconCAT protein digestion were dried down in a vacuum 
centrifuge and reconstituted in 10pL reducing sample buffer prior to analysis. Protein bands 
observed after 8s of proteolysis were digested in-gel with trypsin and peptides were analysed by 
MALDI-ToF MS. Peptides observed in each MALDI-ToF mass spectrum are indicated by a 
coloured block, peptides identified joined by a missed cleavage site are indicated with a black line 
under each peptide map.
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Figure 35. Proteolysis of QconCAT and extensive separation of protein fragments by SDS-PAGE.
QconCAT protein (150pg) was digested with trypsin at an enzyme:protein ratio o f 1:00. The digestion was 
stopped at selected time points after addition o f enzyme with 10% (v/v) form ic acid. For gel electrophoresis, 
fractions from QconCAT protein digestion were dried down in a vacuum centrifuge and reconstituted in 10pL 
reducing sample buffer prior to loading onto a 30cm 1D gel.
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Figure 36. Proteolysis of QconCAT and analysis of peptide release.
QconCAT protein (150pg) was digested with trypsin at an enzymeiprotein ratio of 1:00. The 
digestion was stopped at selected time points after addition of enzyme with 10% (v/v) formic acid. 
1pL digested material was analysed by MALDI-ToF MS and peptides present in each spectrum 
are indicated in pink (high abundance ions), blue (low abundance ions; signal intensity less than 
10% of the base peak) and those present as part of a missed cleavage are indicated by a black 
line underneath each peptide map.
Results and Discussion
5.2.2 Proteolysis of chicken skeletal muscle soluble proteins
In contrast to the QconCAT protein, the analyte proteins were expected to have much more 
protracted proteolysis reactions due to the effects of higher order structure and the context of 
complex mixtures of proteins limiting availability of trypsin cleavage sites. For the soluble 
proteins of chicken skeletal muscle, in-solution digestion with trypsin at a ratio of 20:1 
(substrate:protease), with the reaction stopped at selected time points by addition of 10% (v/v) 
formic acid, indicated that many proteins were digested slowly, and even after 24h, undigested 
proteins were clearly visible by 1D SDS-PAGE including beta enolase (p eno), creatine kinase 
(CK) and triose phosphate isomerase (TPI) (Figure 37a). If a low concentration (10% v/v) of 
acetonitrile was included in the digestion reaction, proteolysis was much faster and all bands 
had disappeared by 24h (Figure 37b). The reasons for this are unclear but it is likely that the 
actions of organic solvents during proteolysis are to facilitate denaturation, particularly of 
secondary structure, and increase solubility of native proteins exposing the active site (Russell 
eta!., 2001). When the analyte protein mixture was denatured by heating to 60°C for 1h before 
digestion, the disappearance of intact protein bands when the products were analysed by 1D 
SDS-PAGE suggested that the loss of higher order structure of the substrate proteins caused 
the digestion reaction to be essentially complete within 30min (Figure 38c). This was directly 
compared to analyte protein digestion at an enzyme to substrate ratio of 1:20 and with 10% 
(v/v) added acetonitrile for the same biological sample (Figure 38a&b). Again, addition of 
organic solvent seemed to accelerate the reaction (although this did not seem to be complete 
after 24h) and the majority of proteins had disappeared from the gel following denaturation by 
heating prior to 30min proteolysis with trypsin. Although protein denaturation by heating permits 
much more efficient digestion with trypsin, this could also cause proteins to precipitate out of 
solution and indeed the initial protein profile prior to addition of enzyme is diminished in the 
heat treated sample even though no precipitation was observed (Figure 38c).
For absolute protein quantification using stable isotope labelled internal standard peptides, 
complete proteolysis is vital as the peptide used for quantification must be completely released 
from the protein of interest in order to ascertain its absolute amount. As a tool to quantify this 
release, the rapidly and efficiently digested [13C6]arg/[13C6]lys-labelled QconCAT protein was 
digested to completion in-solution with trypsin. As each peptide exists in equal amounts within 
the QconCAT protein, a known amount of digested material may also be used as an internal 
standard to quantify the release of each peptide from unlabelled QconCAT protein when 
digested with trypsin. To achieve this, a known amount of ‘light’ QconCAT digesting material
QconCAT
r
-acetonitrile
- A . A
+acetonitrile 
________ v _ _
a b
Figure 37. In-solution proteolysis of chicken skeletal muscle soluble proteins with trypsin and the 
effect of added acetonitrile.
50jjg soluble protein from skeletal muscle o f a 30d layer chicken was added to 5pg labelled QconCAT 
protein and digested with trypsin at a ratio o f trypsin to total protein o f 1:20 and stopped at selected time 
points after addition o f enzyme by removing 25pL (containing 6pg protein) and adding to an equal volume 
o f 10% (v/v) form ic acid. The fractions were subsequently stored at -20°C until the end of the time course. 
For gel electrophoresis, fractions were dried down in a vacuum centrifuge and reconstituted in 10pL 
reducing sample buffer prior to analysis by 1D SDS-PAGE (a). Analyte proteins were also digested under 
the same conditions in a solution containing 10% (v/v) acetonitrile (b).
+ acetonitrile 60° C 1h
Figure 38. In-solution proteolysis of chicken skeletal muscle soluble proteins with trypsin, 
the effect of added acetonitrile, and protein denaturation prior to the addition of protease.
50pg soluble protein from skeletal muscle o f a 30d broiler chicken was added to 5pg labelled 
QconCAT and digested with trypsin at a ratio o f trypsin to total protein o f 1:20 and stopped at 
Omin, 30m in and 24h after addition o f enzyme by removing 25pL (containing 6pg protein) and 
adding to  an equal volum e of 10% (v/v) form ic acid. The fractions were subsequently stored at - 
20°C until the end o f the time course. For gel electrophoresis, fractions were dried down in a 
vacuum centrifuge and reconstituted in 10pL reducing sam ple buffer prior to analysis by 1D SDS- 
PAGE (a). Analyte proteins were also digested under the sam e conditions in a solution containing 
10% (v/v) acetonitrile (b) and with addition o f enzyme following a 1h incubation o f the protein at 
60°C (c).
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was removed at selected time points during proteolysis with trypsin at 37°C and added to an 
equal volume of 10% (v/v) formic acid containing an equal amount of pre-digested QconCAT 
‘heavy’ peptides. Peptides at each time point were analysed by MALDI-ToF MS and the extent 
of digestion was calculated by comparing signal intensity of ‘heavy’ (completely digested) to 
‘light’ (digesting) peptides during proteolysis (Figure 39). This confirmed and quantified the 
rapid digestion of the QconCAT protein, for all peptides. To apply this technique for chicken 
skeletal muscle soluble proteins, extended digestion reactions with preparations from 1 d and 
30d birds were devised. As reported previously, the protein expression profiles of these two 
preparations are dramatically different (Figure 31), providing alternative environments for 
proteolysis. The protein preparations were digested with trypsin in-solution, without treatment 
or after denaturation at 60°C for 1 h, and the reaction was stopped at selected time points by 
adding a known proportion to 10% (v/v) formic acid containing a known amount of pre-digested 
QconCAT ‘heavy’ peptides. The appearance of analyte peptides used for quantification was 
monitored by MALDI-ToF MS and quantified (nmol/g tissue) by QconCAT; the amount of 
proteolysis was quantified as nmol/g tissue to put this experiment into the context of absolute 
quantification and to verify that the final value reached for each protein is consistent with that 
achieved for the biological study. To analyse the initial stages of proteolysis, data for 
proteolysis of native and denatured proteins are presented up to 500min (Figure 40), in addition 
to extended digestion times (24h+; Figure 41) to emphasize that complete digestion is 
achieved, and the same quantification value is reached, irrespective of the initial state of the 
analyte protein preparation. In all instances, the analyte proteins were digested between 1.3 
(AK) and 86 (P eno) times faster after denaturation, and in some instances (for example, 
GAPDH from one day muscle) the rate of digestion was very similar. This is consistent with a 
model for proteolysis of the native protein in which the initial proteolytic attack exerts a de­
stabilising effect on the remaining structure, such that the rate of proteolysis is increased; the 
initial proteolysis is effectively rate limiting. The context in which proteins are digested also 
seems to play an important role; in the highly specialised 30d muscle sample, there was 
virtually no digestion of creatine kinase, until 20 hours of proteolysis. Indeed, for all proteins 
studied, the rate of proteolysis of native proteins was diminished in the 30d muscle sample, 
suggesting that the acute specialisation of this tissue, leading to a predominance of relatively 
few proteins, might introduce other factors that impede digestion, such as aggregation into 
supramolecular assemblies or partial inhibition of the trypsin.
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Figure 39. Absolute quantification of unlabelled QconCAT proteolysis.
5(jg unlabelled QconCAT protein were digested involution with trypsin at a ratio of trypsin to 
protein of 1:20 and the reaction was stopped at selected time points during 24h incubation at 
37°C by removing 0.5pg protein and adding an equal volume of 10% (v/v) formic acid containing 
0.5pg pre-digested QconCAT peptides. Each fraction was analysed by MALDI-ToF MS and the 
relative signal intensity of unlabelled and labelled peptides was used to calculate the percentage 
of proteolysis. Digestion was complete (100%) when signal intensity of unlabelled and labelled 
peptides was equal. This was plotted for individual tryptic Q-peptides and percentage proteolysis 
is illustrated for the first 500min of incubation with enzyme. Inserted are zoomed mass spectra for 
the Q-peptide T3 illustrating the increase in abundance of unlabelled peptide during the first 
60min of proteolysis.
AK GAPDH CK (l eno
Time (min)
Figure 40. Quantification of 500min proteolysis of analyte proteins with trypsin using QconCAT.
Chicken skeletal muscle soluble protein (50pg) was digested with trypsin at an enzyme:protein ratio of 1:20 
and stopped at selected time points with 10% (v/v) formic acid and mixed with 0.5pg pre-digested QconCAT 
peptides for quantification. Each fraction was analysed by MALDI-ToF MS. This experiment was repeated 
using protein denatured by incubating at 60°C for 1h prior to trypsin addition for comparison. Data are 
presented for four individual proteins at both 1d and 30d after hatch digested over 500min with trypsin and for 
each, the rate constant (k) for digestion is expressed as h'1 (from first order decay of loss of substrate, S from 
100%; S=100e-kt).
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Figure 41. Quantification of 30h proteolysis of analyte proteins with trypsin using QconCAT.
Chicken skeletal muscle soluble protein (50pg) was digested with trypsin at an enzyme:protein ratio of 1:20 and 
stopped at selected time points with 10% (v/v) formic acid and mixed with 0.5pg pre-digested QconCAT 
peptides for quantification. Each fraction was analysed by MALDI-ToF MS. This experiment was repeated 
using protein denatured by incubating at 60°C for 1h prior to trypsin addition for comparison. Data are 
presented for four individual proteins at both 1d and 30d after hatch digested over 30h with trypsin and for 
each, the rate constant (k) for digestion is expressed as ir1 (from first order decay of loss of substrate, S from 
100%; S=100e'kt)
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5.3 S a m p le  C o m plexity  a n d  Dynam ic  Rang e
5.3.1 Mass Spectrometry for absolute quantification using the QconCAT method
Theoretically, proteolysis of a complex proteome (for example 10,000 proteins) could generate 
105-106 peptides (at approximately 50 tryptic peptides per protein), the dynamic range of which 
will be such that only the most abundant peptides or those that ionise particularly well will be 
detectable. For analysis of the same sample, the most efficiently ionised peptides will vary with 
the use of different instruments. For reliable absolute quantification of proteins using mass 
spectrometry, the QconCAT method must be robust across these platforms. QconCAT was 
added to soluble proteins in chicken skeletal muscle from four chickens at each of six times 
points during growth of both broiler and layer strains in a known amount and peptides derived 
from in-solution digestion with trypsin were analysed using both MALDI-ToF MS and LC-ESI-Q- 
ToF MS for absolute quantification. Due to variation in ionisation, several peptides were only 
identified using one instrument, for example those phosphate isomerase was only observed in 
ESI and glycogen phosphorylase in MALDI (absolute quantification for proteins achieved using 
different instruments is discussed in the context of the biological experiment, section 3.5). 
Several proteins were analysed and quantified in both instruments, permitting a direct 
comparison (Figure 42). Strong, linear correlation of slope 1.05 and R2 0.98 confirmed that 
quantification was reproducible across both platforms. This highlighted the usefulness of using 
a combination of instruments to gain as much information as possible from an analytical 
sample, although in this case identification of six proteins in ESI that had not previously been 
identified in MALDI was predominantly due to the reversed phase separation; discussed in 
section 3.3.2. It was also necessary at this stage to verify the assumption that ionisation of 
different locations on the target plate for MALDI-ToF MS containing the same sample will 
achieve the same mass spectrum following detection. To confirm this, QconCAT peptides, both 
unlabelled and labelled with [13C6]arg/[13C6]lys were mixed in an approximate 1:1 ratio before 
1pL was spotted onto a MALDI target with an equal volume of matrix (a-cyano 
hydroxycinnamic acid). 15 different laser positions on a single sample well were ionised 
independently and 20 spectra were acquired and combined for each location. For six QconCAT 
peptides, the ratio of analyte (‘light’) to standard (‘heavy’) was measured and is presented as 
the mean±standard error of the mean (Figure 43). The observation that L:H ratios for the six 
peptides are not constant is most likely due to inaccuracies with mixing peptides after 
independent proteolysis, rather than co-digestion of proteins where sample processing 
conditions can be more precisely controlled. The reproducibility of MALDI ionisation across the 
target well is clear, thus quantification is not affected by the specific location irradiated by the
67
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(nmol/g tissue)
Figure 42. Absolute quantification of chicken skeletal muscle soluble proteins by MALDI- 
ToF MS and LC-ESI-Q-ToF MS.
Soluble proteins from chicken skeletal m uscle (70pg, n=4, covering 1d to 30d post hatch) were 
ind iv idua lly m ixed with QconCAT protein (7pg) and digested to completion w ith trypsin. The entire 
peptide m ixture was analysed by M ALDI-ToF MS or by nanoflow  reversed phase HPLC prior to 
ESI-Q -ToF MS and the absolute tissue content o f each o f fou r proteins (triose phosphate 
isom erase, glyceraldehyde 3-phosphate dehydrogenase, beta enolase and alpha actin) was 
assessed from relative intensities o f light (analyte) and heavy (standard) pairs. The absolute 
am ount o f each protein was compared using the alternative form s o f mass spectrom etric 
analysis.
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Figure 43. Relative intensity of QconCAT labelled and unlabelled peptides acquired from 
15 different locations on a MALDI target.
Q conC AT unlabelled and labelled peptides were mixed In an approxim ate 1:1 ratio and 1pL was 
spotted onto a MALDI target and mixed w ith 1pL m atrix (a-cyano hydroxycinnam ic acid). 20 
MALDI spectra were acquired and combined from  each o f 15 random ly selected locations on the 
sam ple well and the ratio o f unlabelled:labelled signal intensity was calculated, with the mean ± 
standard error (sem ) plotted fo r 6 Q-peptldes.
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Results and Discussion
laser. Indeed for most MALDI-ToF MS acquired data, spectra are summed across various 
points on the target in a random format to obtain the most stable signal according to user 
discretion.
5.3.2 Challenges for data acquisition and analysis for quantification
Identifying and quantifying as many peptides as possible from a single MALDI-ToF mass 
spectrum is a challenge for proteomics due to the high level of sample complexity often 
encountered. For many peptides, a signal is observed in the mass spectrum but cannot be 
used for absolute quantification as it overlaps with another analyte peptide also contributing 
signal to the peptide envelope. The soluble fraction of chicken skeletal muscle is highly 
complex and contains thousands of proteins. For absolute quantification, these proteins are 
mixed with the QconCAT protein and co-digested with trypsin, resulting in an even more 
complex sample containing far too many peptides to be discretely analysed using MALDI-ToF 
MS. For quantification using the QconCAT method, this may be overcome in part by selecting, 
where possible, peptides that are known to ionise well within the analytical system of choice. 
This was possible for several peptides incorporated into the QconCAT as internal standards for 
chicken skeletal muscle soluble proteins, such that after co-digestion with trypsin and MALDI- 
ToF MS analysis, ten analyte:standard peptide pairs can be isolated from the mass spectrum 
(Figure 44). These were subsequently used for the absolute quantification of ten analyte 
proteins (absolute quantification for proteins achieved is discussed in the context of the 
biological experiment, section 3.5). In the event that previous experience of the analyte system 
is not feasible, it is important that the design of a quantification strategy for proteins considers 
variation in ion signal response which is especially inherent with MALDI-ToF MS analysis 
(Baumgart et a!., 2004). In particular, arginine terminated peptides are known to yield more 
abundant signals than those terminated with lysine (Krause etal., 1999). In a complex MALDI- 
ToF mass spectrum, peptides that are abundant and have a high response factor dominate the 
spectrum. Tryptic Q-peptides T11, T18, T12, T4 and T17 are lysine terminated (Figure 18) and 
it is clear that these peptides have considerably lower signal intensity than those that are 
arginine terminated. The exception is T17 which contains an internal arginine residue adjacent 
to a proline, thus trypsin does not cleave but the presence of arginine increases the basicity of 
the peptide sufficiently for efficient ionisation. To achieve increased signal intensity from lysine 
terminated peptides, guanidination was used to convert lysine into the more basic 
homoarginine by reaction with O-methylisourea (Hale et al, 2000). Guanidination of a tryptic 
digest of unlabelled QconCAT protein was effective at increasing the signal intensity of lysine
1397.73 1749.75
Figure 44. Heavy:light ion pairs for analyte protein quantification in MALDI-ToF MS.
QconCAT protein was added in a 1:10 (Q conCAT:chicken skeletal muscle protein) ratio to 
chicken skeletal muscle soluble fraction sam ples taken from  both broiler and layer strains. The 
mixture w as diluted 10 fold with 50mM am m onium  bicarbonate, and 10% (v/v) acetonitrile was 
added prior to  addition o f trypsin (20:1 substrate:protease). The reaction m ixture was incubated at 
37°C fo r 24h after which the d igest was incubated with additional trypsin (20:1 
substrate:protease) to achieve complete digestion and 1pL was analysed by MALDI-ToF MS. 
Some analyte:standard pairs could be readily recognised by virtue o f their m asses and the 6Da 
separation provided by the terminal [13C6]arginine/lysine labelling, these are highlighted by n  and 
two of w hich (beta enolase, 1391.71m /z and glyceraldehyde 3-phosphate deydrogenase, 
1749.75m/z) are expanded and inserted above the main spectrum.
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terminated peptides in MALDI-ToF MS, with the exception of T17, with the conversion to 
homoarginine causing an increase in mass of 42Da (Figure 45). This increased signal intensity 
was expressed relative to the signal intensity of the base peak, T3 in MALDI-ToF mass spectra 
of guanidinated and non-guanidinated peptides for both labelled and unlabelled QconCAT 
protein digests (Figure 46). It is clear that the signal intensity relative to the base peak in each 
spectrum has significantly increased for lysine terminated peptides T4, T11 and T12, with the 
peak corresponding to guanidinated peptide, T18 overlapping with arginine terminated peak 
T8, thus complicating analyses. It is also evident from this graphical representation of signal 
intensity that the relative signal intensity of tryptic Q-peptide T17 is not affected by 
guanidination to the same extent, thus the internal arginine residue is sufficient for efficient 
ionisation by MALDI. Guanidination was also applied to chicken skeletal muscle soluble 
proteins with added QconCAT tryptic peptides and the subsequent increase in signal intensity 
of lysine terminated peptides was used to quantify an additional two proteins by MALDI-ToF 
MS during growth of muscle in both chicken strains; embryonic myosin and triose phosphate 
isomerase (Figure 47; absolute quantification for proteins achieved is discussed in the context 
of the biological experiment, section 3.5).
As an alternative to chemical modification of complex samples to improve ionisation, a greater 
number of peptides may be detected from a complex sample following peptide separation prior 
to detection by mass spectrometry. Pre-fractionation of peptides is often achieved by liquid 
chromatography separation through a reversed phase gradient packed into a capillary column. 
This separates peptides according to their hydrophobicity which is largely determined by their 
constituent amino acids. Reversed phase high performance liquid chromatography (RP-HPLC) 
of peptides is coupled directly to liquid phase, electrospray ionisation with subsequent mass 
spectral detection. Co-digested chicken skeletal muscle soluble proteins and QconCAT were 
analysed by RP-HPLC-ESI-Q-ToF MS using an EASY-nLC (Proxeon, Denmark) with 
separation of peptides over a 50min gradient of acetonitrile (0-100%) at a flow rate of 
200nL/min. Extracted ion chromatograms demonstrated co-elution of both peptides, for 
example triose phosphate isomerase and beta enolase, where both QconCAT and analyte 
peptides eluted at 26.91 min and 23.08min respectively (Figure 48). Due to the high level of 
sample complexity, extracted ion chromatograms contained peptides of the same m/z eluted at 
different times but mass spectra resulting from these peaks did not contain Q-peptides. For 
absolute quantification, extracted ion chromatograms for unlabelled (analyte) and labelled 
(QconCAT) peptides were used to locate the ions, and the chromatographic boundaries of the
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Figure 45. Guanidination of QconCAT peptides.
Unlabelled QconCAT protein was digested in-solution with trypsin and peptides were analysed by 
MALDI-ToF MS (a). To enhance the signal intensity of lysine terminated peptides in MALDI-ToF 
MS, lysine residues were converted to the more basic homoarginine by guanidination (Hale e t a t., 
2000). This reaction was carried out by drying down the peptide mixture and reconstituting in 
10pL 7M ammonia solution to which was added 5pL 0.5M O-methylisourea (in ddH20). This was 
mixed thoroughly and incubated overnight at room temperature prior to drying down and de­
salting using C18 ZipTips (Millipore, Watford, UK). Guanidinated peptides were analysed by 
MALDI-ToF MS (b). Lysine terminated peptides are indicated in red.
Guanidinated
Control
Figure 46. Relative signal intensity of guanidinated QconCAT peptides.
QconCAT tryptic peptides were guanidinated and analysed by MALDI-ToF MS. Signal intensity of 
all peptides was expressed relative to the base peak in each spectrum; T3. Signal intensity of 
lysine terminated peptides (K; T4. T11, T12 and T17) was compared before (blue bars) and after 
(pink bars) guanidination. Data are expressed as the mean±sem where n=10 (5 1SN labelled, 5 
unlabelled).
Guanidination
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Figure 47. Guanidination of chicken skeletal muscle soluble peptides.
QconCAT protein (7pg) was added to each preparation of chicken skeletal muscle soluble 
fraction (70pg protein) of birds from 1d to 30d post hatching, with four birds at each time point. 
These mixtures were digested with trypsin to completion and guanidinated with O-methylisourea 
overnight. Mixtures were de-salted using C18ZipTips (Millipore, Watford, UK), prior to analysis by 
MALDI-ToF MS. Lysine terminated peptides that were guanidinated were evident from a mass 
shift of 42Da. This is illustrated for the lysine terminated QconCAT peptide representing triose 
phosphate isomerase (before guanidination; [M+H]+ ‘L’ 1602.87, [M+H]+ ‘H’ 1608.87m/z).
Triose phosphate isomerase 
[M +H]+ 1602.87m/z (L)
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[M+H]+ 1391.74m/z (L)
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Figure 48. Chromatographic elution of analyte and internal standard peptides.
QconCAT protein was added in a 1:10 (Q conCATxhicken skeletal muscle protein) ratio to 
chicken skeletal muscle soluble fraction samples taken from both broiler and layer strains. The 
m ixture was diluted 10 fold with 50mM ammonium bicarbonate, and 10% (v/v) acetonitrile was 
added prior to addition o f trypsin (20:1 substrate:protease). The reaction mixture was incubated at 
37°C fo r 24h after which the digest was incubated with additional trypsin (20:1 
substrate:protease) to achieve complete digestion. Peptide mixtures were analysed by LC-ESI-Q- 
ToF MS. Extracted ion chromatograms were performed for both unlabelled analyte and labelled 
internal standard peptides to confirm  elution times. For triose phosphate isomerase, ‘L’ and ‘H ’ Q- 
peptides eluted at 26.91 min and fo r beta enolase, the peptide pair for absolute quantification co­
eluted at 23.08min. This was confirmed by combining the entire area under each peak to produce 
a m ass spectrum. In both instances, extracted ion chromatograms revealed alternative species of 
the same mass eluting at different times but the resulting mass spectrum confirmed that these 
chrom atographic peaks did not contain Q-peptides.
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coincident pair of peptides were used to delineate the combined mass spectra, from which 
peptides were quantified by mass spectrometric intensities of the doubly charged ions; there 
was no evidence of higher charge states, for example [M+3H]3+ corresponding to 
analyte:QconCAT pairs (Figure 49). Correlation between quantification achieved by this 
method and by MALDI-ToF MS was excellent and has been discussed previously (Figure 42, 
section 3.3.1).
For some aspects of quantitative proteomics, MALDI-ToF MS has advantages. Data can be 
accumulated for a variable number of laser shots, ensuring comparable signal intensities 
between replicates. Virtually all of the signal resides in the singly charged [M+H]+ ion, whereas 
with electrospray ionisation, the signal can be distributed over a number of differently charged 
species (although often, as for analysis of trypsin digested chicken skeletal muscle soluble 
proteins, peptides used for absolute quantification were doubly charged; [M+2H]2+). Flowever, 
for complex analytical mixtures, the density of a MALDI-ToF spectrum, coupled with a noisy 
baseline, can compromise quantification. One approach to simplification of MALDI-ToF MS 
analyses relies on prior fractionation of the peptide mixture before deposition of successive 
fractions on the MALDI-ToF target (Mirgorodskaya et ai, 2005). This technique was 
investigated for unlabelled QconCAT peptides and a mixture of [15N] labelled QconCAT and 
unlabelled QconCAT to test its application and ability to separate QconCAT peptides. Peptides 
separated over a 90 minute gradient of acetonitrile (0-100%) were collected onto a MALDI 
target in one minute fractions from 42 to 52 minutes (Figure 50). This gave excellent separation 
and confirmed that QconCAT labelled and unlabelled peptides behave in the same way when 
separated by reversed phase; both eluted at the same time as [15N] does not separate from 
[14N] by reversed phase, and signal intensity ratios of unlabelled to labelled peptides remained 
constant throughout the fractions collected. For the analysis and quantification of chicken 
skeletal muscle soluble proteins, co-digested analyte and standard proteins were separated by 
reversed-phase chromatography with fractions (200nL) collected at one minute intervals onto a 
MALDI target for analysis by MALDI-ToF MS (Figure 51). This provided an efficient detection 
system with peptides fixed in the solid phase for continued interrogation when acquiring data 
for quantification. LC-MALDI-ToF MS was used for analysis of a single chicken skeletal muscle 
sample (30d layer) to highlight the potential benefit of this method. This approach allowed 
quantification of all proteins selected for incorporation into the QconCAT protein and present in 
the analyte system, contributing additional information for quantification. Comparing 
quantification by LC-MALDI-ToF MS with MALDI-ToF MS for ten proteins identified by both
70
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Figure 49. Isolation of analyte:standard peptide pairs by reversed phase chromatography.
Q conC AT protein (7pg) was added to chicken skeletal muscle soluble fraction (70pg protein). 
This m ixture was digested with trypsin and analysed by LC-ESI-Q-ToF MS. All peptide pairs fo r 
quantification were present as doubly charged ions; there was no evidence o f trip ly charged 
species. The upper panel is the total ion chrom atogram  (base peak intensity) o f the elution profile 
from  16 to 29min. The lower panels are the extracted ion chrom atogram s fo r representative 
Q conC AT peptides o f doubly charged ions (beta enolase, 699.6m /z, eluted at 23.08m in, glycogen 
phosphorylase, 725.0m /z, eluted at 23.90m in and those phosphate isomerase, 805.2m /z, eluted 
at 26.91 m in) with corresponding m ass spectra show ing analyte and Q conCAT peptide ion pairs 
used fo r quantification presented as inserts on the right.
T20
Time (min) 
32
42
43
44
45
46
47
48
49
51
52
53
q  jtgHkiAk
T25
1409.85
1362.73 
T10 1379.68
0-U-----,---- ----- - --- - ----,---- ----- ,-----,---- ,---- ,------ --- ,---- - ---1.
Figure 50. Fractionation of QconCAT peptides by LC-MALDI-ToF MS.
Q conC AT proteins both unlabelled and [1SN] labelled w ere mixed in an approxim ate 1:1 ratio  anc 
digested with trypsin. Peptides were analysed by M ALDI-ToF MS (top spectrum ) and were 
separated by reversed phase HPLC (EASY-nLC, Proxeon, Denm ark) over a 60min gradient of 
acetonitrile  (0-100% ) at a flow  rate o f 200nL/m in. Fractions were collected m anually onto a 
M ALDI ta rge t every minute and analysed by M ALDI-ToF MS. M ALDI-ToF mass spectra of 
fractions containing the majority o f eluted Q conCAT peptides are shown.
1342.79
Figure 51. Quantification of chicken skeletal muscle soluble proteins by LC-MALDI-ToF 
MS.
Q conC AT protein (7pg) was added to a preparation o f chicken skeletal muscle soluble fraction 
(70pg prote in) in a ratio o f 1:10. This m ixture was digested with trypsin and analysed by LC- 
M ALDI-ToF MS. Peptides were separated over a 50min reversed phase acetonitrile gradient (0- 
100%) and fractions o f 1min (200nL) were collected d irectly onto a W aters MALDI-ToF target. 
The upper panel is the M ALDI-ToF mass spectrum o f the entire digest, the lower panels illustrate 
three fractions collected from the reversed phase eluate at 23, 25 and 27 min. Representative 
pairs o f analyte: standard peptides are highlighted.
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methods (five of which were quantified as Onmol/g by both methods) confirms that both 
methods of analysis give consistent and comparable quantification (Figure 52).
5.4 Validation of the QconCAT Method
5.4.1 Quantification of unlabelled QconCAT by labelled QconCAT
To use the QconCAT protein as an internal standard for the absolute quantification of chicken 
I skeletal muscle soluble proteins by co-digestion and MS, it is essential that QconCAT added
produces peptides in equivalent amounts. The QconCAT was designed to achieve this, but to 
confirm, [13C6]arg/[13Ce]lys-labelled and unlabelled QconCAT proteins were mixed in known 
ratios from 0 to 1.2 (L:H) and co-digested with trypsin. The resulting signal intensity ratio of 
each peptide pair upon MALDI-ToF MS analysis was detected and the correlation between 
protein ratio added and peptide ratio measured was good with a slope of 0.99 and a correlation 
(R2) of 0.997 (Figure 53). This reinforced that absolute quantification can be achieved by 
adding a known amount of QconCAT protein and basing quantification of analyte proteins on 
the signal intensity of each internal standard peptide.
5.4.2 Variance in the QconCAT method
As an assessment of variance due to the analytical procedure, four identical protein mixtures 
(70pg chicken skeletal muscle with 7pg QconCAT) were digested with trypsin and the 
► surrogate peptides were used to quantify proteins by MALDI-ToF MS. Quantification data were
collected and used to assess analytical variance (Figure 54a). The reproducibility of the method 
was high, and in both instances, the analytical variance was significantly lower than that for 
quantification measured for four different birds of each strain (Figure 54b). For example, the 
analytical variance (CV 6.0%) for (3 eno, n=4) compared favourably to biological variance (CV 
24.0%, p eno, n=4). Increasing the number of analytical replicates to 10 had very little effect on 
analytical variance (CV 6.0% P eno, n=10; Figure 55). To assess the extent to which this is 
affected by the signal intensity of each peptide, particularly for MALDI-ToF MS, in which 
peptides that do not ionise efficiently are often difficult to distinguish from the background 
noise, the coefficient of variation for analytical replicates was compared with the signal intensity 
of each analyte peptide. For five proteins of varying signaknoise ratio in a typical mass 
spectrum of analyte and internal standard peptides, for four analytical replicates, the signal 
intensity of each analyte peptide was expressed as a proportion of the total intensity for the five 
* analyte peptides. This was compared with the coefficient of variation measured for the same
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Figure 52. Consistency of protein quantification using LC-MALDI-ToF MS and MALDI-ToF 
MS.
Q conC AT protein (7pg) w as added to  a preparation o f chicken skeletal m uscle soluble fraction 
(70pg) in a ratio o f 1:10. This m ixture was digested with trypsin and analysed by LC-M ALDI-ToF 
MS o r M ALDI-ToF MS. For a subset o f proteins in a single biological sam ple, quantification 
acquired through d ifferent analytical m odalities was com pared. Five proteins w ere quantified as 
Onmol/g by both m ethods (a actin, ApoA1, E myo and API).
►►
Figure 53. Validation of quantification using a mixture of unlabelled and labelled QconCAT 
proteins
Q conC AT unlabelled (L) and labelled (H) proteins were m ixed in increasing ratios from  0 to 1.2 
(L:H ) and digested in-solution with trypsin at a ratio o f protein:trypsin o f 20:1. Peptides w ere 
analysed by M ALDI-ToF MS and the relative signal intensity o f unlabelled and labelled peptide 
ions w as used to  calculate peptide L:H ratio. Data are presented as m eantsem  (n=17).
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Figure 54. Sources of variance in a QconCAT experiment.
Soluble protein from chicken pectoralis muscle (70pg) was mixed with Q conCAT protein (7pg) in 
four techn ica lly  replicated experim ents and digested to com pletion w ith trypsin. For each protein, 
individual data points are plotted to the left o f mean±sem fo r the sam e bird where n=4 (a) and fo r 
four d iffe ren t birds to demonstrate biological variance (b).
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Figure 55. Sources of variance in a QconCAT experiment.
Soluble protein from chicken pectoralis muscle (70pg) was mixed w ith Q conCAT protein (7pg) in 
10 techn ica lly  replicated experim ents and digested to  com pletion w ith trypsin. For each protein, 
individual data points are plotted to the left o f mean±sem for the sam e bird where n=10.
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analyte peptides when quantified using QconCAT, as an assessment of analytical variance 
(Figure 56). As expected, coefficient of variation is greater for peptides with low signal intensity, 
suggesting that signal:noise ratio of each peptide pair used for quantification has a significant 
impact on the reproducibility of absolute quantification. In this biological study, the criterion for 
using a peptide ion for absolute quantification was user discretion, but these results 
demonstrate that it may be necessary to apply a threshold of signal intensity, below which 
peptide ions are not used for quantification in order to reduce analytical variation. However, 
variation between repeated analyses of the same sample, reflecting the nature of mass 
spectrometry in that each ionisation may vary slightly with time, plate position, presence of 
matrix crystals and other experimental conditions, is so low compared to variation between 
individual animals that the effects are negligible in the context of this biological study.
5.4.3 Accuracy of the QconCAT method
To assess the accuracy of a QconCAT experiment for quantification, a known amount of 
purified proteins adenylate kinase (AK) and glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) from chicken skeletal muscle were independently mixed with a known amount of 
[13C6]arg/[13C6]lys-labelled QconCAT protein and co-digested with trypsin. Signal intensities of 
analyte peptides for these proteins represented in the QconCAT, and QconCAT peptides, were 
used for absolute quantification. The amount of protein added was compared with amount of 
protein measured using QconCAT, giving excellent, linear correlation (R2=0.99 for both 
proteins, Figure 57). To assess accuracy within the analytical environment, a known amount of 
AK was spiked into chicken skeletal muscle soluble fraction from a 30d broiler. The amount of 
AK added was converted into protein concentration as nmol/g tissue and compared with the 
total concentration of AK in the tissue (nmol/g) as quantified using QconCAT (Figure 58). As 
expected, there was a strong correlation (R2=0.9992) with a slope of 1, indicating the lack of 
any systematic quenching effects over an extended dynamic range.
5.4.4 Comparison of the QconCAT method with alternative strategies for absolute 
quantification
Although there is nothing formally different between a chemically synthesised peptide and a 
peptide excised from a QconCAT by proteolysis, quantification was compared using the two 
methods. The synthetic peptide, of sequence LVSWYDNEFGYSNR and mass 1748.77Da 
representing the abundant protein GAPDH, was synthesised by Sigma-Genosys (Dorset, UK) 
and was labelled at the arginine residue with both [13C6] and [15N4] giving a 10Da mass offset
analyte peptide intensity/total intensity for 5 analyte peptides used in each spectrum
Figure 56. Relationship between coefficient of variance and ion signal intensity in MALDI- 
ToF mass spectra.
Soluble protein from  chicken pectoralis muscle (70pg) was mixed w ith QconCAT protein (7pg) in 
fou r technica lly  replicated experim ents and digested to  completion w ith trypsin. For five proteins, 
signal intensity o f analyte peptides is expressed as a ratio o f the total ion count fo r the five 
analyte peptides used in each spectrum and plotted against coeffic ient o f variance for 
quantification o f that particular protein by QconCAT. Signal intensity data are plotted as 
m ea n tse m  fo r the same bird where n=4.
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Figure 57. Accuracy of the QconCAT method using purified proteins.
Purified glycera ldehyde 3-phosphate dehydrogenase (GAPDH; a) and adenylate kinase (AK; b) 
were m ixed in known am ounts from  0.1pg to 1.0pg with labelled Q conC AT protein. Protein 
m ixtures w ere digested in-solution with trypsin at a ratio o f total protein:enzym e o f 20:1. Relative 
signal in tensity o f analyte and internal standard peptide ions was used to quantify the am ount of 
each protein.
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Figure 58. Accuracy of quantification using QconCAT.
Purified adenylate kinase (AK) was added to chicken skeletal m uscle soluble fraction from  a 30d 
broiler. A K  was added from Onmol to 0.02nmol which resulted in a final protein concentration of 
Onmol/g to  300nm ol/g and the am ount o f AK  in the tissue was quantified by adding 0.015nm ol 
Q conC AT prior to digestion w ith trypsin. Proteolysis was allowed to  continue fo r 24h a fte r which 
peptides w ere analysed by M ALDI-ToF MS. The upper panel shows the correlation between AK 
added and tha t quantified in the muscle using QconCAT after digestion with trypsin. Spectra 
show ing the change in M ALDI-ToF mass spectral signal intensity over the range o f protein 
concentra tions used in th is experim ent are shown beneath.
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from the analyte peptide. Initially, a known amount of unlabelled QconCAT was added to a 
known amount of synthetic peptide to compare quantification. QconCAT was used to quantify 
the amount of synthetic peptide (Figure 59). Although correlation was good (R2=0.999), there 
was a consistent under-estimate of the amount of synthetic peptide as calculated by QconCAT. 
This is likely to reflect the way in which the two standards are themselves independently 
quantified but to investigate further, preparations of synthetic peptide were stored under 
different conditions for 24h prior to quantification by QconCAT (Figure 60). Storage in the 
original vial at 4°C in sterile water produced consistent quantification with good correlation and 
the same under-estimate of synthetic peptide amount when quantified in this way. However, 
aliquots of synthetic peptide in 50mM ammonium bicarbonate stored at -20°C in Eppendorf 
tubes produced variable quantification with little correlation, or agreement, even between two 
preparations stored under identical conditions. This suggests that the synthetic peptide 
becomes degraded with freeze-thawing and also that it may stick to the surface of the 
Eppendorf tube. Future preparations of synthetic peptide were maintained in their original vial 
and used upon reconstitution for the most accurate results. By contrast, QconCAT protein is 
stored at -20°C in Eppendorf tubes and consistently delivers the same quantification; this gives 
a distinct advantage over the synthetic peptide approach. Using freshly prepared synthetic 
peptide, quantification of a single protein (GAPDH, which exhibits a dramatic change in 
abundance during post hatching development) using the QconCAT-derived peptide and the 
identical synthetic peptide was compared. Both the synthetic peptide and QconCAT protein 
were added to the same analytical sample such that the three peptides were easily 
distinguished in the mass spectrum. The correlation between data obtained using QconCAT 
and that obtained using the synthetic peptide was high (R2=0.998) (Figure 61), and 
quantification data were consistent using either internal standard. A small consistent 
discrepancy (less than 10%) between the two methods could be attributable to the method of 
quantification used for the two standards. The discrepancy between the synthetic peptide and 
the QconCAT was reduced if the latter was used to quantify the former, but was still present. 
This residual discrepancy is difficult to explain but is not attributable to incomplete digestion of 
the QconCAT (Figure 33, section 3.2.1). In the case of the QconCAT, a protein assay was used 
to determine the amount of protein, as this was the same method used to quantify total protein 
in the analyte. For the synthetic peptide, the quantity supplied by the manufacturer is too small 
for independent quantification, and it was necessary to assume that the quantity in the vial was 
indeed that specified by the manufacturer. The difference between the two standards was 
minor compared to the biological variance within the system, would not contribute significant
Osynthetic peptide added (nmol)
Figure 59. Quantifcation of a synthetic peptide internal standard using QconCAT.
A peptide, of sequence LVSW YDNEFGYSNR and mass 1748.77Da representing the abundant 
protein GAPDH in the QconCAT protein for quantification of chicken skeletal muscle soluble 
proteins, was synthesised by Sigma-Genosys (Dorset, UK) and was labelled at the arginine 
residue with both [13C6] and [15N4] giving a 10Da mass offset from the analyte peptide. 1nmol 
synthetic peptide was reconstituted in 1mL sterile H20 ,  resulting in a final concentration of 
1.76pg/pL. Increasing amounts of synthetic peptide (0.00-0.11 nmol) were added to 0.05nmol 
unlabelled QconCAT protein which was digested over 24h with trypsin. Peptides were analysed 
using MALDI-ToF MS (see inserted spectrum) and the relative signal intensity of QconCAT and 
synthetic peptide ions was used for quantification.
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Figure 60. Quantification of a synthetic peptide internal standard stored under different 
conditions, using QconCAT.
A peptide, of sequence LVSW YDNEFGYSNR and mass 1748.77Da representing the abundant 
protein GAPDH in the QconCAT protein for quantification of chicken skeletal muscle soluble 
proteins, was synthesised by Sigma-Genosys (Dorset, UK) and was labelled at the arginine 
residue with both [13C6] and [15N4] giving a lODa mass offset from the analyte peptide. 1nmol 
synthetic peptide was reconstituted in 1mL solvent, resulting in a final concentration of 1,76pg/pL. 
Increasing amounts of synthetic peptide (0.00-0.11 nmol) were added to 0.05nmol unlabelled 
QconCAT protein which was digested over 24h with trypsin. Peptides were analysed using 
MALDI-ToF MS and the relative signal intensity of QconCAT and synthetic peptide ions was used 
for quantification. For comparison, synthetic peptide was reconstitued in 1ml_ sterile water and 
used immediately (a), or in 50mM ammonium bicarbonate and stored at -20°C prior to use in two 
separate vials (b&c).
y = 1.1189x - 1.3694
GAPDH (nmol/g tissue) 
quantified by synthetic peptide
Figure 61. Comparison of QconCAT and synthetic peptide for quantification.
For one protein (glyceraldehyde 3-phosphate dehydrogenase; GAPDH), quantification was 
achieved relative to a QconCAT peptide and the same peptide chemically synthesised. For both 
methods, the internal standards (2pg QconCAT protein, or 0.05pg synthetic peptide) were added 
to 20pg chicken skeletal muscle soluble protein prior to digestion with trypsin and data were 
acquired using MALDI-ToF MS (see inserted spectrum). Quantification by either method was 
directly compared (a). The time dependent developmental expansion of GAPDH (nmol/g tissue, 
mean±sem, n=4) in broiler was monitored by QconCAT or synthetic peptide (b).
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errors, and would be readily controlled by alternative QconCAT quantification strategies. This 
could include incorporation into each QconCAT protein, a common peptide for internal standard 
quantification by a synthetic peptide that can be labelled or unlabelled, depending on the 
labelling status of the QconCAT protein. This peptide, chosen for its ionisation efficiency in the 
detection system of choice could be used to quantify and normalise all QconCAT data to an 
absolute standard that is common to each one.
Quantification of selected muscle proteins by the QconCAT strategy was also compared with 
densitometric quantification from 1D SDS-PAGE for both broilers and layers (densitometry data 
supplied by I.J. Edwards) for six individual proteins (Figure 62 & 63). Comparisons with some 
proteins, for example enolase for broilers and layers were consistent, while for some, for 
example GAPDH, changes in protein expression were not well matched using the two 
techniques. Overall comparison of proteins quantified using both methods was not favourable 
(R2=0.382; Figure 64). This highlights the difficulty in drawing quantitative data from 1D SDS- 
PAGE as many proteins overlap on the gel, therefore total intensity of a single band will not 
necessarily be a true reflection of a single protein, but more likely multiple proteins. To 
investigate the linearity of stain intensity achieved with a 1D gel, the amount of total protein 
loaded was increased from 0-15pg chicken skeletal muscle soluble proteins and the response 
was measured for five proteins using densitometry of the gel image. The amount of total protein 
loaded was plotted against band volume measured using densitometry with strong correlation 
(average R2=0.959 discounting AK for which stain intensity for lower protein loading was 
insufficient; Figure 65a). The same amount of total protein (0-15 pg) was quantified using 
QconCAT, with similar overall correlation (average R2=0.988) for quantification of the same five 
proteins (Figure 65b). This demonstrates that stain intensity when measured by densitometry 
from a 1D SDS-PAGE gel image is linear, and only marginally less reproducible than QconCAT 
for quantification of an increasing amount of known proteins, providing the stain intensity is 
within sufficient dynamic range for reliable detection. For the individual proteins beta enolase 
(P-eno) and pyruvate kinase (PK), quantification was compared directly for increased protein 
loaded onto a 1D gel (Figure 66). To convert stain intensity into nmol/g, the proportion of 
abundance contributed by each protein was extrapolated to the total amount loaded onto each 
lane of the gel. As previously discussed, correlation was strong using both techniques, 
although the amount of protein was consistently over-estimated using densitometry. Due to the 
high level of protein complexity exhibited here, this is likely due to other proteins of lower 
abundance contributing to the stain intensity at each of these positions on the gel.
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□  QconCAT
Figure 62. Comparison of protein quantification by densitometry and QconCAT.
For six proteins, quantification (nmol/g tissue) was compared using methods o f 1D SDS-PAGE and 
densitometry analysis (closed squares) with QconCAT co-digestion and analysis by MALDI-ToF MS (open 
squares) fo r broiler chickens during growth (densitometry data supplied by I.J. Edwards).
■  densitometry 
□  QconCAT
Figure 63. Comparison of protein quantification by densitometry and QconCAT.
For six proteins, quantification (nmol/g tissue) was compared using methods o f 1D SDS-PAGE and 
densitometry analysis (closed squares) with QconCAT co-digestion and analysis by MALDI-ToF MS (open 
squares) fo r layer chickens during growth (densitometry data supplied by I.J. Edwards).
a>3
Protein quantification by densitometry (nmol/g tissue)
Figure 64. Comparison of protein quantification by densitometry and QconCAT.
For six proteins, quantification (nmol/g tissue) was compared using methods of 1D SDS-PAGE 
and densitometry analysis with QconCAT co-digestion and analysis by MALDI-ToF MS for layer 
and broiler chickens during growth (densitometry data supplied by I.J. Edwards).
300 GAFDH R2=0.9314
QconCAT
Figure 65. Quantification of increasing amount of total protein, by densitometry and the 
QconCAT method.
Chicken skeletal muscle soluble protein was analysed by SDS-PAGE with increasing amounts of 
total protein (pg) loaded onto the gel. The response was measured using densitometry for five 
proteins where the band volume was correlated with the amount of total protein. For each protein, 
the correlation coefficient (R2) is expressed to the right of the graph. The same amount of total 
protein was also analysed by the QconCAT method with peptide analysis by MALDI-ToF MS.
a b
Total protein loaded
1|jg 15pg
Figure 66. Quantification of increasing amount of total protein, by densitometry and the 
QconCAT method.
Chicken skeletal muscle soluble protein was analysed by SDS-PAGE with increasing amounts of 
total protein (pg) loaded onto the gel (a). The amounts of two proteins, beta enolase (p eno) and 
pyruvate kinase (PK; nmol/g tissue) were measured using both QconCAT and densitometry. For 
each protein quantified using both methods, the correlation coefficient (R2) is expressed to the 
right of the graph.
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To assess the extent to which intact mass analysis by ESI-Q-ToF MS reflects relative 
abundance of proteins in complex mixtures, protein quantification using QconCAT was 
compared to relative signal intensity of chicken skeletal muscle soluble proteins from a 30d 
broiler when analysed by ESI-Q-ToF MS (data acquired by Dr. J. Hayter). For seven of the 
most abundant proteins identified in the deconvoluted mass spectrum, protein abundance was 
expressed as a percentage signal intensity of the total intensity of the seven proteins in the 
processed mass spectrum. To compare with absolute quantification by QconCAT, the absolute 
amount of each protein was expressed as a percentage of the total for the seven proteins 
(Figure 67). Correlation between the two techniques was good (R2=0.9264), highlighting the 
potential value of intact mass analysis to give an indication of protein abundance. Relative 
abundance is over-estimated from intact mass analysis by ESI-Q-ToF MS, compared to 
QconCAT, but this is difficult to interpret from the results of a single comparison. If this were a 
consistent observation from several comparisons, of samples varying in complexity and 
abundance of each protein, it may be taken into account for more reliable quantification. 
However, as a measure of relative quantification, this is not necessary, thus intact mass 
analysis provides a more reliable method than densitometry analysis following 1D SDS-PAGE. 
When comparing quantification by all three methods of intact mass analysis by ESI-Q-ToF MS, 
densitometry from 1D SDS-PAGE and QconCAT (Figure 68), it is clear that densitometry does 
not compare well with intact mass (R2=0.4813) or QconCAT (R2=0.5848) and is consequently 
not the method of choice for reliable measurements of relative protein abundance. This is most 
probably due to the different affinity of individual proteins for the stain in addition to co­
migration of multiple proteins through the gel.
5.5 A b so lu te  Q uantificatio n  of C hicken  S keletal  M uscle  S o luble  P roteins
The QconCAT strategy for absolute quantification of known skeletal muscle proteins was 
achieved by adding a known amount of [13Ce]arg/[13C6]lys-labelled QconCAT protein to chicken 
skeletal muscle soluble proteins, digesting with trypsin and comparing signal intensities of 
chicken skeletal muscle peptides with corresponding labelled internal standard peptides in 
mass spectra. QconCAT protein was added in a 1:10 (QconCAT:chicken skeletal muscle 
protein) ratio to chicken skeletal muscle soluble fraction samples taken from both broiler and 
layer strains at six time points during growth. For each time point, four birds were analysed. 
This ratio was selected pragmatically based on the abundance of the major soluble proteins in
50
Protein abundance (% total) ESI-Q-ToF MS
Figure 67. Comparison of quantification using intact mass analysis by ESI-Q-ToF MS and 
the QconCAT method.
Chicken skeletal muscle soluble proteins from a 30d broiler were analysed by ESI-Q-ToF MS. As 
a measure of abundance, the relative signal intensity of each protein peak (when processed to 
give the true mass of each protein using MaxEntl; MassLynx) was expressed as a percentage of 
the total intensity of all seven proteins in the processed mass spectrum (experimental data 
obtained by Dr. J. Hayter). To compare with quantification by QconCAT, the absolute amount of 
each protein was expressed as a percentage of the total for the seven proteins.
protein abundance (% total) ESI-Q-ToF MS protein abundance (% total) QconCAT
Figure 68. Comparison of quantification, using intact mass analysis by ESI-Q-ToF MS, 
SDS-PAGE and densitometry analysis, and the QconCAT method.
Chicken skeletal muscle soluble proteins from a 30d broiler were analysed by ESI-Q-ToF MS. As 
a measure of abundance, the relative signal intensity of each protein peak (when processed to 
give the true mass of each protein using MaxEntl; MassLynx) was expressed as a percentage of 
the total intensity for the processed mass spectrum (experimental data obtained by Dr. J. Hayter). 
To compare with quantification by QconCAT and densitometry analysis of 1D SDS-PAGE 
(experimental data obtained by I.J. Edwards), the absolute amount (QconCAT) and relative 
amount (densitometry) of each protein were expressed as percentages of the total for the seven 
proteins.
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chicken skeletal muscle in all muscle samples from 1-30d growth (Figure 69). After co-digestion 
of chicken skeletal muscle soluble proteins and [13C6]arg/[13C6]lys-labelled QconCAT with 
trypsin, MALDI-ToF MS analysis of peptides produced highly complex mass spectra. However, 
10 out of 20 Q-peptides could be identified in the composite spectrum without further sample 
processing and were therefore used for quantification. For these 10 proteins, for example 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH; Figure 70), the change in protein 
expression was measured during growth from 1 d to 30d post hatch by converting relative signal 
intensities of analyte and internal standard peptide ions into absolute quantities of analyte 
protein, expressed as nmol/g net weight breast muscle tissue. For GAPDH, the dramatic 
increase in protein expression is more apparent when the spectra are normalised to a constant 
intensity of the internal standard. This is compared with 1D SDS-PAGE analysis in which a 
constant 10pg total protein was applied to each lane from birds 1-30d post-hatch. For the 
identification and quantification of further proteins, not quantifiable by MALDI-ToF MS, 
ionisation of lysine terminated peptides was improved by guanidination, permitting 
quantification of embryonic myosin (E myo) and those phosphate isomerase (TPI). 
Furthermore, peptide mixtures (chicken skeletal muscle soluble proteins and QconCAT) were 
analysed by LC-ESI-Q-ToF MS, permitting quantification of five proteins previously quantified 
by MALDI-ToF MS (with and without guanidination), in addition to six proteins previously not 
detected. For absolute quantification of chicken skeletal muscle soluble proteins using the 
QconCAT method for the complete biological study, all proteins quantified by MALDI-ToF MS 
(with and without guanidination) and LC-ESI-Q-ToF MS were expressed as nmol/g of pectoralis 
muscle tissue. Data were obtained during growth from 1 to 30 days post-hatch for four birds at 
each time point for chickens of the layer and broiler strains (Figure 71). For proteins quantified 
using multiple methods of analysis, data have been plotted separately, adjacent to the 
alternative data set and the similarity between the two is clearly represented. Spectral data is 
also included for proteins adenylate kinase (AK), quantified by MALDI-ToF MS, alpha actin, 
quantified by LC-ESI-Q-ToF MS and tropomyosin A (TM A), quantified as Onmol/g tissue by 
LC-ESI-Q-ToF MS. For the biological study, changes in protein expression for 17 proteins 
incorporated into the QconCAT protein for absolute quantification are displayed for both broiler 
and layer chickens. This permitted a simple comparison of individual proteins, highlighting that 
some demonstrate massive pool expansion, whilst others declined to a similar degree. Within 
the realms of this single QconCAT experiment, a measurable dynamic range across all proteins 
was covered, of 10nmol/g to 550nmol/g for a single protein (GAPDH) and as low as 2±1 nmol/g 
(a eno; 1d broiler). Thus, protein concentrations over a 300-fold range were assessed. This
Broiler Broiler 1d + QconCAT Layer
QconCAT 30d
Layer 30d + QconCAT 
( 10:1)
Figure 69. SDS-PAGE analysis of QconCAT and chicken skeletal muscle soluble proteins 
from broiler and layer strains.
1d broiler and 30d layer chicken skeletal muscle was homogenised and the soluble proteins were
analysed by SDS-PAGE. QconCAT protein was added to the skeletal muscle preparation in a 1:10
ratio by total protein concentration and the mixture was analysed by SDS-PAGE.
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Figure 70. Quantification of GAPDH expression in chicken skeletal muscle.
Soluble muscle proteins were prepared from pectoralis skeletal muscle of birds from 1d to 30d 
post hatching. Each sample (70pg of protein) was mixed with a constant amount of QconCAT 
(7pg) and digested to completion with trypsin before analysis by MALDI-ToF MS. The change in 
expression is measured using the relative peak intensity of the analyte and internal standard 
peptide at each time point. The dramatic increase in protein expression is more apparent when 
the spectra are normalised to a constant intensity of the internal standard. This change in protein 
expression is also apparent by 1D SDS-PAGE analysis of chicken skeletal muscle soluble 
proteins, in which a constant 10pg of total protein was applied to each lane. The amount of 
GAPDH at each time point during growth is also expressed as nmol/g tissue as quantified using 
QconCAT.
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Figure 71. Quantification of chicken skeletal muscle protein expression by QconCAT.
Soluble protein derived from broiler and layer chickens (70pg) was mixed with QconCAT protein 
(7pg) and digested to completion with trypsin. The digests were analysed by MALDI-ToF MS 
(with or without guanidination) or LC-ESI-Q-ToF MS. For five proteins (triose phosphate 
isomerase; TPI, alpha actin, beta enolase; p eno, glyceraldehyde 3-phosphate dehydrogenase; 
GAPDH and actin polymerisation inhibitor; API) multiple methods were used to quantify a single 
protein during growth; these data have been plotted separately, adjacent to the alternative data 
set and these have been grouped below the x-axis. Each cluster of data represents six time 
points during growth (1d, 3d, 5d, 10d, 20d and 30d) for four birds of each strain at each time 
point. The data are presented as the absolute tissue amount (nmol/g tissue) and expressed as 
mean±sem. Mass spectra are included for proteins adenylate kinase (AK), alpha actin and 
tropomyosin A (TM A) to highlight the difference in relative signal intensity. For proteins 
expressed as Onmol/g, ions corresponding to analyte peptides were not present in the spectrum 
(see spectral data for TM A).
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quantification can be subtle, for example in monitoring isoform changes from embryonic to 
adult myosin, as well as a change in state from free, soluble protein to that assembled within 
the myofibrillar apparatus (actin). It is also possible to monitor expression of isoforms of the 
same enzyme for which Q-peptides differ only in a single amino acid (lactate dehydrogenases 
A and B). These data were also used for a comparison of protein expression in both broiler and 
layer strains, which demonstrate a dramatic difference in growth rate of the pectoralis muscle 
(section 1.5.1). However, comparing absolute amounts of abundant proteins between broiler 
and layer strains (Figure 72), showed very little or no difference in protein expression during 
growth per gram of muscle tissue. The increased weight gain observed in broiler chickens must 
therefore be attributable to total pool expansion of the breast muscle, rather than an increase in 
the amount of individual proteins relative to the layer.
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Figure 72. Comparison of absolute protein quantification of soluble skeletal muscle proteins in 
broiler and layer chickens.
Absolute quantification of chicken skeletal muscle soluble proteins was achieved using the QconCAT 
method. For six proteins, data for broiler (open squares) and layer (closed squares) strains were 
compared. Each data point is plotted as mean±sem n=4.
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5.6 Additional Applications of QconCAT Technology
5.6.1 Quantification of soluble skeletal muscle proteins in other species
To investigate the application of the QconCAT method for quantification of soluble muscle 
proteins in other species, proteins glyceraldehyde 3-phosphate dehydrogenase (GAPDH), 
pyruvate kinase (PK) and adenylate kinase (AK) purified from rabbit skeletal muscle were 
quantified in known amounts using the QconCAT protein designed for chicken skeletal muscle 
(Figure 73). For GAPDH and PK, sequences of peptides represented in the QconCAT 
designed for chicken skeletal muscle differed by a single amino acid, and AK had the same 
peptide sequence and was used as a control. From 1D SDS-PAGE analysis, AK purified from 
rabbit also contained a considerable amount of creatine kinase (CK; supplementary figure 23); 
the relative proportion of these two proteins was assessed by densitometry to correct for the 
amount of AK added (pmol). For all three proteins, correlation was strong; AK R2=0.998 
slope=0.995, PK R2=0.994 slope=0.981, GAPDH R2=0.990 slope=1.19. The single amino acid 
substitution for GAPDH and PK did not make a significant difference to the quantification but 
this would depend on the amino acid that is substituted, for example if an arginine was 
substituted for a lysine, this would have a much greater effect on the signal intensity relative to 
the standard peptide, as previously discussed (section 3.3.2). To quantify proteins from other 
species in context, soluble skeletal muscle proteins from carp, mouse and chicken were 
analysed by 1D SDS-PAGE (Figure 74). It is clear from this analysis that several skeletal 
muscle proteins are highly conserved among these species and proteins GAPDH and CK were 
identified in carp and mouse samples by in-gel digestion with trypsin and peptide analysis by 
MALDI-ToF MS. Peptide mass fingerprinting (supplementary figures 24&25) highlighted 
sequence differences between species for these proteins, particularly for Q-peptides used for 
quantification of chicken skeletal muscle soluble proteins. For quantification, carp and mouse 
skeletal muscle soluble proteins were independently mixed with a known amount of QconCAT 
and co-digested in-solution with trypsin (protein:trypsin 20:1). Peptides were analysed by LC- 
ESI-Q-ToF MS with reversed-phase peptide separation over a 50min acetonitrile gradient (0- 
100%). Ion chromatograms for GAPDH and CK from both species (carp and mouse) were 
extracted and combined to give mass spectra (Figure 75). The signal intensities of analyte and 
standard peptides were used for quantification. Quantification for these proteins achieved using 
QconCAT was compared to that using densitometry. Given that agreement between these two 
methods for quantification is poor (as previously discussed; section 3.4.4) it is difficult to draw 
reliable conclusions from this cross-species analysis. The two methods for quantification of CK 
and GAPDH in carp and mouse skeletal muscle gave different results, suggesting that although
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Figure 73. Quantification of skeletal muscle proteins from rabbit and chicken by QconCAT.
Purified proteins glyceraldehdye 3-phosphate dehydrogenase (GAPDH), pyruvate kinase (PK) 
and adenylate kinase (AK) from rabbit were analysed by 1D SDS-PAGE, mixed with QconCAT 
and digested in-solution with trypsin. Purified proteins were added from 0-10pmol (AK), 0-15pmol 
(PK), 0-25pmol (GAPDH) to QconCAT protein from 10 to lOOpmol. Peptides were analysed by 
MALDI-ToF MS and the relative signal intensity of analyte and internal standard ions was used 
for quantification. For each protein, GAPDH (a), PK (b) and AK (c), the sequence of the Q-peptide 
in both rabbit and chicken are indicated to the right with amino acid differences highlighted. For 
AK, the 1D SDS-PAGE image was analysed by densitometry to assess the proportion of the two 
main bands. These were identified as unique proteins; creatine kinase (CK) and adenylate kinase 
(AK) by peptide mass fingerprinting and quantification was corrected accordingly (for mass 
spectra and peptide mass fingerprinting see supplementary figure 23).
Figure 74. Skeletal muscle soluble proteins from carp, mouse and chicken.
Soluble skeletal muscle proteins o f mouse and carp (3mg/mL, prepared by L. McDonald and L. McLean) were 
analysed by 1D SDS-PAGE. Proteins creatine kinase (CK) and glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) were identified by in-gel digestion with trypsin and peptide mass fingerprinting by MALDI-ToF MS 
(supplementary figures 24&25). To illustrate corresponding proteins, chicken skeletal muscle soluble proteins 
were analysed simultaneously and CK is indicated by a blue star to the right in each species, and GAPDH a red 
star.
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Figure 75. Analyte: internal standard peptide pairs for cross-species quantification.
Carp and mouse skeletal muscle soluble proteins (15pg, prepared by L. McDonald and L. 
McLean) were co-digested with QconCAT protein (5pg) in solution with trypsin at a ratio of 
protein: enzyme of 20:1. Peptides were analysed by LC-ESI-Q-ToF MS and Q-peptide ions from 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and creatine kinase (CK) with 0, 1 or 2 
amino acid substitutions (highlighted in peptide sequences underneath mass spectra) were used 
for quantification relative to the signal intensity of the corresponding QconCAT peptide ion.
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amino acid substitutions valine for isoleucine and asparagine for aspartic acid, in purified 
proteins GAPDH and PK had no significant effect on ionisation and subsequent quantification 
by QconCAT (Figure 73), the substitution serine for threonine, or two substitutions of alanine 
for serine and glycine (carp CK) and valine and phenylalanine for isoleucine and tyrosine 
(mouse GAPDH) had a significant effect on quantification. Alternative explanations could 
include problems previously discussed for 1D SDS-PAGE and densitometry, for example co­
migration of several proteins to the same location on the gel or incomplete digestion of analyte 
proteins as this was not investigated in this context. Additionally there may be a biological 
explanation, for example proteolytic processing of mature proteins which is documented in carp 
skeletal muscle when animals are acclimated to different temperatures (McLean et al., 2007), 
or stable post-translational modifications impacting on quantification. For a typical QconCAT 
experiment, a comprehensive analysis of analyte proteins would be conducted prior to design 
and implementation of such a strategy, thus ensuring reliable quantitative data. Assessment of 
accuracy in quantification of muscle proteins from other species is difficult, thus conclusions 
that can be drawn from this experiment are limited. However, it is clear that quantification can 
be achieved using QconCAT where the analyte peptide has one amino acid difference as 
achieved for purified proteins from rabbit skeletal muscle. In context there was no way of 
accurately reconciling the quantitative data acquired with the amount of each protein in the 
tissue, thus the extent to which this remained reliable was unknown. This will depend on the 
amino acid difference and how likely this is to affect signal intensity. For many proteins, 
especially those that have highly conserved peptide sequences that only differ by one or two 
amino acids, the effects on quantification could be rigorously tested using a number of purified 
proteins or synthetic peptides containing the specific sequence difference. This could be used 
to adjust signal intensity data, achieving absolute quantification of multiple species using the 
same QconCAT protein. Alternatively this could be built into the design criteria, to select where 
possible peptides that are identical in several species, for example the N-terminal peptide 
which is often the most highly conserved.
5.6.2 Quantification of normalisation using Equalizer™ bead technology
In an approach to reduce dynamic range of complex protein samples, Equalizer™ bead 
technology was developed whereby high abundance proteins are diminished and low 
abundance or trace proteins are enriched simultaneously by binding to a library of ligands 
exposed on the surface of beads (Thulasiraman et al., 2005, Righetti et al., 2006). This 
application, whilst not relevant for quantitative protein analysis, has been tested using the
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soluble fraction of chicken skeletal muscle, with use of the QconCAT protein an ideal 
opportunity to quantify normalisation. For normalisation, 20mg Prospectrum-2 beads were 
washed and swollen in 50% (v/v) methanol, prior to equilibration in 20mM sodium phosphate 
buffer. Chicken skeletal muscle soluble proteins, initially 25mg were exposed to the beads for 
2h, after which beads were washed extensively to remove unbound protein. For efficient 
normalisation, analyte proteins must saturate all available ligand binding sites on the surface of 
the bead library (Guerrier et al., 2006), thus 25mg, 50mg and 100mg total protein were each 
incubated with 20mg beads as described above. Beads were washed to remove unbound 
protein prior to 1D SDS-PAGE analysis of starting material (chicken skeletal muscle soluble 
proteins), beads and unbound protein (Figure 76). Wash fractions containing unbound protein 
were analysed in the same way to ensure that these had been removed (results not shown). 
From 1D SDS-PAGE analysis, protein normalisation was improved with an increased amount 
of protein exposed to the beads, reflecting efficient saturation of ligands carried on the beads, 
resulting in relative enrichment of low abundance proteins, bringing them to the range where 
they can be visualised on a 1D gel. Simultaneously, the highly abundant proteins are 
progressively suppressed and do not dominate the preparation at higher loadings, although at 
lower loadings, they remain abundant. It is apparent that the amount of each protein bound to 
the beads varies, even when 10Omg protein are incubated with 20mg beads, suggesting that 
some proteins may have a greater affinity for the beads. In fact, the most abundant band on the 
gel of normalised material after 10Omg protein was exposed to the beads was not observed 
before normalisation. 1D SDS-PAGE analysis of beads exposed to increasing amounts of 
protein was also used for densitometry analysis of the major gel bands, highlighting the level of 
normalisation compared to the starting material as the dominance of a few abundant proteins in 
the starting material is removed giving rise to many more bands of more equal stain intensity 
(Figure 77). To identify these proteins, particularly those that have changed as a result of 
normalisation, gel lanes containing starting and normalised material were cut into 22 slices and 
each gel slice was digested with trypsin. Peptides were analysed by LC-ESI-LTQ MSMS from 
which peptide sequences were searched against MSDB using the MASCOT search engine. 
Proteins identified with a MOWSE score of greater than 45 were accepted as confident 
identifications (p<0.05; Figure 78, Table 5). After normalisation, many more proteins were 
identified, in particular, the most intense band on the gel in the normalised material (after 
exposure to 100mg total protein) was glucose-6-phosphate isomerase, a protein that was not 
identified without normalisation and thus was greatly enriched following exposure to the beads. 
Although observed in a single experiment, this selective enrichment was also clear upon
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Figure 76. Normalisation of chicken skeletal muscle soluble protein abundance using 
Equalizer ™ beads.
To isolate the soluble fraction o f chicken skeletal muscle, superm arket purchased chicken breast 
tissue (2g) w as homogenised in 18mL 20mM sodium  phosp h a te  buffer, pH7.0 containing 
protease inhibitors (Complete Protease Inhibitors, Roche, Lewes, UK). This was centrifuged at 
15,000 x g  fo r 45 m inutes at 4°C. The supernatant fraction, containing soluble protein, was then 
rem oved. The total protein concentration o f the final preparation was measured using a 
C oom assie  Plus Protein Assay (Pierce, Northum berland, UK). For norm alisation, 20mg 
Prospectrum -2 (Louisville, KY, USA) beads were washed in 1mL 50% (v/v) MeOH and mixed 
gently  fo r 10min. Beads were allowed to settle and the supernatant was removed and discarded. 
MeOH 50% (v/v) was added to cover the surface o f the beads that were left to  swell overnight at 
4°C. O nce swollen, 20mg beads (constituting 100pL settled bed volum e) were transferred to a 
1.5m L Eppendorf tube. Beads were washed in 1mL double distilled H20  on a roller m ixer fo 
30m in prior to  equilibration by repeated washing in 20m M  sodium phosphate buffer pH7.0 for 
30m in. A fter each wash, beads were left to settle fo r 5min and the supernatant was removed. 
Approxim ate ly  1mL sample containing 25m g (a), 50m g (b) and 100mg (c) soluble protein in three 
separate experim ents was added to the beads and mixed fo r 2h on a roller m ixer. Unbound 
protein was collected as the supernatant fraction after beads had settled fo r 5min. The beads 
w ere subsequently washed eight tim es in 1mL 20mM phosphate buffer and supernatant fractions 
w ere rem oved and collected. Starting material, unbound protein, wash fractions and beads 
conta in ing bound, normalised protein were analysed using 1D SDS-PAGE. Equalizer™  beads 
w ere loaded and run directly w ith no prior protein elution.
Figure 77. Densitometry analysis of 1D SDS-PAGE separated chicken skeletal muscle 
soluble proteins normalised using Equalizer™ beads.
D ensitom etry analysis was applied to 1D SDS-PAGE images from starting material and 
norm alised material when 25mg, 50mg and 100mg chicken skeletal m uscle soluble proteins were 
exposed to  20m g Equalizer™  beads. For each analysis, the densitom etry trace m easuring band 
volum e is aligned with the gel image below.
Normalised material
Chicken gizzard actin binding protein
Myomesin, actin binding protein, myofibrillar 
protein
HSP, Myom esin, actin binding protein 
Aminopeptidase, actin binding, HSP
H SP70, IgG, aminopeptidase, molecular chaperone, vinculin
H SP70, IgG, albumin
Phosphoglucomutase 1, PK, collapsin response mediator, 
disulphide isom erase, hemopexin, dystrophin, H SP70_______
Glucose 6-phosphate isomerase, adenysuccinate lyase, 
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PGK, CK, actin A, B eno, glucose 6  phosphate isomerase  
Aldolase, aminopeptidase, GAPDH, B eno
TM  A, G A P D H , LDH, B eno, annexin, CK
LDH, pyruvate dehydrogenase, octaprenyl diphosphate 
synthase, glycerol 3-phosphate dehydrogenase ___
PGK
Tyrosine m onooxygenase activator, protein kinase C inhibitor
Titin, apoA1, ubiquitin hydrolase, HSP25, B actin, A actin, PGK  
AK, H S P 25, myosin light chain 
Troponin C, H SP25
Troponin C, myosin light chain, calmodulin
Calmodulin, PA CSIN3, protein kinase C inhibitor, myosin 
light chain, nebulin
PA CSIN3, haemoglobin alpha, actin, AK, apoA1
Myosin, apoA1, actin, connectin, calmodulin, AK
Starting material
No significant hits
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No significant hits
No significant hits
No significant hits
S  H SP70, albumin
Phosphoglucomutase, PK
B eno, phosphoglucomutase
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p| CK, PGK, aldolase, B eno, 
j |  aspartate aminotransferase
Aldolase, GAPDH, CK, B eno, PGK
G A PD H, LDH, B eno, aldolase, CK
G A PD H, LDH, B eno, aldolase, PGK, 
phosphoglucomutase
CK, B eno, GAPDH, aldolase
B eno, PG M , TP I, aldolase, GAPDH, 
CK, phosphoglucomutase
TP I, titin, B eno, CK
—:—
AK, B eno, CK
Connectin/ titin, B eno
B eno
B eno, superoxide dismutase
B eno, CK
Ubiquitin, aldolase A, Thioredoxin, CK, 
B eno
Figure 78. Identification of normalised proteins using in-gel digestion with trypsin and LC-ESI-LTQ MSMS.
For protein identification, 1D SDS-PAGE separations of starting material and beads containing normalised proteins were 
divided into 22 slices, each of which was de-stained using 50:50 acetonitrile:50mM ammonium bicarbonate, dehydrated 
with acetonitrile and digested overnight in-gel with trypsin. Resulting peptide solutions were diluted 1:50 with 0.1% (v/v) 
formic acid and analysed by LC-ESI-LTQ MSMS using an Ultimate 3000 HPLC system (Dionex, UK) coupled to a LTQ 
(Thermo Finnigan, UK). Nanoflow HPLC at 300nL/min was used to resolve peptides (in 0.1% v/v formic acid) over a 60 
minute acetonitrile gradient (0-100%). Peptides were acquired over the mass range 400-1500m/z with the capillary 
voltage set at 50V, spray voltage at 1.8kV. MSMS data were searched against MSDB using MASCOT from which only 
confident identifications (MOWSE score>45, p<0.05) were accepted, for details see table 5 (overleaf).
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Table 5. Identification of normalised proteins by ‘GeLC-MSMS’.
For protein identification, 1D gel separations of starting material and beads containing normalised 
proteins were divided into 22 slices, each of which was digested in-gel with trypsin. Resulting 
peptide solutions were analysed by LC-ESI-LTQ MSMS and MSMS data were searched against 
MSDB using MASCOT with the following parameters; taxonomy: Chordata, protease: trypsin, 
variable modifications: oxidation of methionine, peptide tolerance: 250ppm, MSMS tolerance: 
250ppm, peptide charge: 1+, 2+ and 3+, instrument: ESI-TRAP, from which only confident 
identifications (MOWSE score>45, p<0.05) were accepted. Data are presented as follows; a) 
chicken skeletal muscle soluble proteins, gel slices 1-12, b) chicken skeletal muscle soluble 
proteins, gel slices 13-22, c) normalised material, gel slices 1-12, d) normalised material, gel 
slices 13-22. Proteins in red are novel to either sample (before and after normalisation).
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13 G lycera ldehvde 3-phosphate dehydrogenase 266 P00356 35550 Gallus aallus 4 6
Creatine k inase 171 P00565 43301 Gallus aallus 8 21
Lacta te  dehydroqenase A 127 P00340 36365 Gallus qallus 6 14
Beta eno lase 102 P07322 46839 Gallus aallus 2 8
Lacta te  dehvdroqenase B 57 P42119 36358 Xenopus laevis 1 3 K .K W D S A Y E V IK .L
Phosphoqlycerate  kinase 54 P51903 44557 Gallus aallus 2 7
Phosphoqlucom utase 49 Q2UZR2 6550 Gallus aallus 3 7
14 Creatine kinase 247 P00565 43301 Gallus aallus 10 21
G lvcera ldehvde 3-phosphate dehydroqenase 213 P00356 35550 Gallus aallus 8 24
Beta eno lase 98 P07322 46839 Gallus aallus 3 8
Aldo lase 80 Q 76BC5 35908 Cephaloscvllium umbratile 1 3 R.LAIM ENANVLAR.Y
15 G lvcera ldehvde 3-phosphate dehvdroqenase 134 P00356 35550 Gallus aallus 4 15
Triose phosphate isomerase 121 P00940 26527 Gallus aallus 4 15
Beta eno lase 107 P07322 46839 Gallus aallus 5 10
Phosphoqlycerate  mutase 95 Q5ZLN1 28749 Gallus aallus 9 35
Aldo lase 76 Q76BC5 35908 Cephaloscvllium umbratile 1 3 R.LAIM ENANVLAR.Y
Phosphoqlucom utase 71 Q2UZR2 6550 Gallus aallus 2 4
C rea tine  k inase 55 P00565 43301 Gallus aallus 3 4
16 Triose phosphate isomerase 638 P00940 26527 Gallus aallus 37 43
Creatine k inase 185 P00565 43301 Gallus aallus 4 13
Titin 134 Q 9IAR9 242090 G allus qallus 5 1
G lu ta th ione  s-transferase 122 P20136 25488 Gallus aallus 2 10
Beta eno lase 89 P07322 46839 Gallus aallus 2 8
17 A denyla te  kinase 203 P05081 21669 Gallus aallus 14 43
Beta eno lase 90 P07322 46839 Gallus aallus 2 8
Creatine kinase 87 P00565 43301 Gallus aallus 4 13
18 Phosphatidyle thanolam ine-b ind inq protein 70 P13696 20714 Bos taurus 1 7 K.LYTLVLTDPDAPSR.K
C onnectin /titin 61 Q9YH41 123994 Gallus aallus 1 1 K.SLVEESQ LPEG R.R
Beta eno lase 59 P07322 46839 Gallus aallus 1 2 R.LITGEQLGEIYR.G
C rea tine  kinase 48 P00565 43301 Gallus aallus 2 6
19 Beta eno lase 65 P07322 46839 Gallus aallus
20 Beta eno lase 62 P07322 46839 Gallus aallus 1 2 R.LITGEQLGEIYR.G
Superoxide dism utase 48 P80566 15563 Gallus aallus 1 9 K.DADRHVG DLGNVTAK.G
21 Beta eno lase 74 P07322 46839 Gallus aallus 1 2 R.G NPTVEVDLHTAK.G
Fatty  acid  b inding protein 79 Q 6DRR5 14807 Gallus aallus 1 5 K.LVDTANFDEYM K.A
22 U b iquitin 96 P62973 17738 Gallus aallus 4 22
A ldo lase  A 85 P04075 39395 Homo sapiens 2 4
Thioredoxin 75 P08629 11562 Gallus aallus 1 12 K.SVGNLADFEAELK.A
C rea tine  kinase 72 P00565 43301 Gallus aallus 4 13
Beta eno lase 62 P07322 46839 Gallus aallus 1 2 R.G NPTVEVDLHTAK.G
b
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1 C h ic k e n  a izza rd  a c tin  b ind in q  Drotein 72 Q 90W F 0 280321 Gallus pallus 2 1
2 M yom e s in 231 Q 90724 182054 Gallus pallus 14 8
A c tin  b in d in q  p ro te in 178 Q 9 0 W F 0 280 324 Gallus pallus 7 2
M y o fib r illa r  p ro te in 66 Q 02173 309091 Gallus pallus 1 1 K .S S E IS E P V F V E A S P G T K .E
3 H eat s h o c k  p ro te in  90 143 Q 2TFN 9 94319 Canls familiaris 4 4
M vo m e s in 83 Q 90724 182054 Gallus pallus 3 2
A c tin  b in d in q  p ro te in 66 Q 90W F 0 280321 Gallus pallus 2 1
4 A m in o p e p tid a s e 329 P 55786 103211 Homo sapiens 24 13
A c tin  b in d in q  p ro te in 62 Q 90W F 0 280321 Gallus pallus 6 2
H e a t s h o c k  p ro te in  90 48 Q 2TFN 9 94319 Canis familiaris 2 2
5 M o le c u la r c h a p e ro n e 482 P11021 72071 Homo sapiens 21 23
Im m u n o q lo b u lin  q am m a 93 S 00390 53581 Gallus pallus 2 6
H eat s h o c k  p ro te in  70 83 Q 3M H M 4 72004 Bos taurus 4 8
A m in o p e p tid a s e 84 P 55786 103211 Homo sapiens 2 2
V in c u lin 56 P 12003 124560 Gallus pallus 2 1
6 H eat s h o c k  p ro te in  70 860 Q 75P J4 70827 Numidia meleapris 61 34
Im m u n o q lo b u lin  qam m a 102 S 0 0390 53581 Gallus pallus 3 6
A lb u m in 88 P19121 69918 Gallus pallus 2 4
7 P h o s p h o q lu c o m u ta s e  1 98 Q ZU ZR 2 66550 Gallus pallus 6 13
P yru va te  k in ase 98 P 0 0 548 57978 Gallus pallus 3 4
C o lla p s in  re sp o n s e  m e d ia to r 98 Q 71SG 1 622 20 Gallus pallus 10 20
D is u lp h id e  iso m e ra se 88 P 09102 57374 Gallus pallus 3 5
H e m o p e x in 62 Q 9 0 W R 3 29366 Gallus pallus 4 3
D ys tro p h in 51 S02041 4 2 2 618 Gallus pallus 1 0 R .S L D LN S IIA E V K .A
H eat s h o c k  p ro te in  70 49 0 7 3 8 8 5 70783 Gallus pallus 3 6
8 G lu c o s e  6 -p h o s p h a te  iso m erase 1140 Q 5ZM U 3 62177 Gallus pallus 74 33
A d e n y s u c c in a te  lyase 247 Q 5U 7A Z 54606 Gallus pallus 15 18
D isu lp h id e  iso m erase 246 P 09102 57374 Gallus pallus 10 16
P h o s p h o q lu c o s e  iso m erase 246 Q 8Q FU1 62057 Brachvdanio rerio 24 9
C a lre ticu lin 84 Q 6E E 32 46851 Gallus pallus 6 23
9 R a b -G D P  d isso c ia tio n  in h ib ito r 155 0 9 3 3 8 2 50651 Gallus pallus 7 14
E lo n q a tio n  fa c to r  1 136 Q 57K M 2 50153 Gallus pallus 8 8
B e ta  e n o la s e 118 P 07322 468 39 Gallus pallus 6 13
H S C 7 0  in te ra c tin q  pro te in 98 Q 5Z LF 0 401 58 Gallus pallus 4 9
O s te o q lyc in 66 Q 9 W 6 H 0 33179 Gallus pallus 1 4 K .LLLL E E L S LA E N R .L
M yo s in  liq h t cha in  k in ase  2 61 Q 7LZ16 871 60 Gallus pallus 3 3
B le o m y c in  h yd ro la se 105 Q 6G L32 52656 Gallus pallus 3 5
10 P h o s p h o q ly c e ra te  k inase 453 P 51903 445 57 Gallus pallus 39 23
C re a tin e  k in a se 196 P 00565 43301 Gallus pallus 18 32
G lu c o s e  6 -p h o s p h a te  iso m erase 150 Q 5ZM U 3 62177 Gallus pallus 8 14
A c tin  A 112 P 68135 405 93 Orvctolapus cuniculus 6 21
O s te o q lyc in 90 Q 9W 6H 0 33179 Gallus pallus 4 13
G e lso lin 82 0 9 3 5 1 0 85832 Gallus pallus 2 4
B e ta  e n o la s e 53 P 07322 468 39 Gallus pallus 2 8
C itra te  syn th a se 46 P 23007 48035 Gallus pallus 1 3 K .G L IY E T S V LD P D E G IR .F
G lu co se  6 -p h o s p h a te  iso m erase 96 Q 5ZM U 3 62177 Gallus pallus 10 22
O s te o q lyc in 91 Q 9W 6H 0 33179 Gallus pallus 2 7
11 A ld o la s e 88 Q 76B C 5 35908 Cephaloscyllium umbratile 2 3
A m in o p e p tid a s e 71 P 55786 103211 Homo sapiens 2 2
G lv c e ra ld e h v d e  3 -p h o s p h a te  iso m erase 81 P 00356 35739 Gallus pallus 1 4 K .LV S W Y D N E F G Y S N R .V
B e ta  e n o la s e 59 P 07322 468 39 Gallus pallus 1 2 R .L ITG E Q L G E IY R .G
12 T ro p o m y o s in  B 306 P 19352 35746 Gallus pallus 17 36
G lv c e ra ld e h v d e  3 -p h o sp h a te  iso m erase 229 P 00356 35739 Gallus pallus 8 21
T ro p o m y o s in  A 220 P 04268 32692 Gallus pallus 12 27
L a c ta te  d e h vd ro q e n a s e  B 125 P 00337 36365 Gallus pallus 3 10
B e ta  e n o la s e 73 P 07322 468 39 Gallus pallus 2 8
A n nex in 72 Q 6B 344 75179 Gallus pallus 5 8
L a c ta te  d e h v d ro q e n a se 212 P 00337 36365 Gallus pallus 3 10
c
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13 P yru va te  d e h y d ro q e n a se 112 Q 3TL86 38930 M us musculus 2 7
G ly c e ro l 3 -p h o sp h a te  deh yd ro g e n a se 109 Q 7T 1E 0 38169 Brach vdanio rerio 5 7
E lo n q a tio n  fa c to r  1 66 Q 6E E 3 0 49811 Gallus qallus 2 3
14 G ly c e ro l 3  p h o sp h a te  d e h yd ro qenase 74 Q 6P 824 38439 Brach vdanio rerio 3 7
P h o s p h o q ly c e ra te  k in ase 62 P 51903 44688 Gallus qallus 4 11
15 T y ro s in e  m o n o o xyq e n a se  a c tiva to r 205 Q 7 Z W 2 0 29054 Brach vdanio rerio 9 35
P ro te in  k in a s e  C in h ib ito r 178 Q 5 F 3 W 6 282 13 Gallus qallus 7 27
P e ro x ire d o x in -6 75 Q 5ZJF4 249 77 Gallus qallus 4 18
B e ta  e n o la s e 50 P 0 7322 468 39 Gallus qallus 1 2 R .L IT G E Q L G E IY R .G
16 C o n n e c tin /titin 287 Q 98918 464 683 Gallus qallus 20 0
A p o lip o p ro te in  A1 130 P 08250 30661 Gallus qallus 7 22
U b iq u itin  h y d ro lase 119 Q 9 P W 6 7 26298 Gallus qallus 6 21
H e a t s h o c k  p ro te in  25 80 Q 00649 21658 Gallus qallus 4 29
B e ta  a c tin 66 Q 6R H R 8 31321 Macaca mulatta 3 11
A lp h a  ac tin 62 P 68135 40593 OrvctolaQus cuniculus 2 10
F K S G 3 0 62 Q 9B Y X 7 41989 Homo sapiens 2 9
P h o sp h o q ly c e ra te  k inase 51 P 51903 44688 Gallus qallus 2 5
P e ro x ire d o x in  6 61 Q 5ZJF4 24961 Gallus qallus 3 11
17 IqE  d e p e n d e n t h is tam in e  re lea s inq  fac to r 120 19518 Gallus qallus 14 35
A d e n y la te  k inase 92 P05081 21669 Gallus qallus 10 36
H e a t s h o c k  p ro te in  25 66 Q 00649 21658 Gallus qallus 5 29
M yo s in  liq h t cha in 60 P 02604 20900 Gallus qallus 1 5 K .IT LS Q V G D IV R .A
18 T ro p o n in  C 250 P 02588 18364 Gallus qallus 6 37
P ro te in  k in a s e  C in h ib ito r 99 Q 5 F 3 W 6 282 13 Gallus qallus 3 12
H e a t s h o c k  p ro te in  25 57 Q 00649 216 58 Gallus qallus 1 6 K .Y T L P P G V E A T A V R .S
19 T ro p o n in  C 395 P 0 2588 18272 Gallus qallus 12 50
M yo s in  liq h t cha in 136 P 02604 16179 Gallus qallus 8 50
C a lm o d u lin 94 Q 6R 52 0 16704 Oreochromis mossam bicus 11 47
20 C a lm o d u lin 226 Q 6R 52 0 16704 Oreochromis mossam bicus 16 59
P A C S IN  3 187 Q 1G 1I6 50711 Gallus qallus 4 5
P ro te in  k in a se  C  in h ib ito r 120 Q 9 I88 2 13750 Gallus qallus 5 28
N e b u lin 106 Q 9D E H 4 276 962 Gallus qallus 5 1
G lyc in e  c le a va q e  sys te m  pro te in  H 81 P 11183 17999 Gallus qallus 4 14
M yo s in  liq h t cha in 76 P 02604 16179 Gallus qallus 1 5 K .IT LS Q V G D IV R .A
A d e n y s u c c in a te  lyase 49 Q 5U 7A Z 54606 Gallus qallus 1 4
21 P A C S IN  3 85 Q 1G 1I6 50711 Gallus qallus 1 3 R .A L Y D Y T G Q E A D E LS F K .A
A p o lip o p ro te in  A1 77 P 08250 30661 Gallus qallus 1 5 K .LA D N L D T LS A A A A K .L
H a e m o q lo b in  a lpha 77 P 0 1994 15288 Gallus qallus 2 10
V im e n tin 66 Q 6P B S 2 51538 Brachvdanio rerio 3 7
A c tin  A 56 P 68135 405 93 Orvctolaqus cuniculus 2 10
22 M yos in 162 P 02604 16179 Gallus qallus 8 45
A p o lip o p ro te in  A1 113 P 08250 30661 Gallus qallus 1 5 K .LA D N L D T LS A A A A K .L
A c tin 67 Q 8M V P 7 26950 Boltenia villosa 2 16
C o n n e c tin 64 PN 0568 148490 Gallus qallus 3 1
C a lm o d u lin 63 P 62144 16827 Anas platvrhvnchos 5 45
A c y lp h o s p h a ta s e 60 P 07032 11151 Gallus qallus 2 29
N e bu lin 56 Q 9D E H 4 276 962 Gallus qallus 4 1
A K 46 P 07032 21669 Gallus qallus 1 1 K .A TE P V IA FY K .G
d
Results and Discussion
incubation of 50mg protein with 20mg beads as a new band of the same molecular weight 
(Figure 76; ~62kDa). This was confirmed by repeated in-gel digestion and LC-MSMS analysis 
(results not shown).
To quantify the degree of normalisation of chicken skeletal muscle soluble proteins using the 
QconCAT approach for absolute quantification, QconCAT protein was added to starting 
material and beads containing normalised protein prior to digestion with trypsin. To ensure 
complete digestion of proteins bound to Equalizer™ beads, vital when using surrogate peptides 
for absolute quantification, digested protein was analysed by 1D SDS-PAGE to monitor the 
complete removal of intact proteins (Figure 79). For absolute quantification, peptides were 
analysed by LC-ESI-Q-ToF MS using relative signal intensity of analyte (‘light’) and internal 
standard (‘heavy’) peaks. This was expressed as nmol/g tissue before and after normalisation 
for beads exposed to 50mg and 100mg of protein. This does not provide quantitative, biological 
data but demonstrates in absolute terms the degree of protein normalisation when both 50mg 
and 100mg of protein were exposed to the ligand library (Figure 80). The extent to which the 
most abundant proteins, for example glyceraldehyde 3-phosphate dehydrogenase (GAPDFI) 
and beta enolase (f$ eno) have been diluted during normalisation is quite striking, being 
reduced from 1340nmol to 20nmol and 420nmol to 24nmol. A couple of proteins have been 
enriched; tropomyosin A (TMA) and actin polymerisation inhibitor (API) as these were 
previously quantified as below the limit of detection (Figure 81). The identity of the peptides 
used for absolute quantification of these two proteins was confirmed by MSMS (Figure 82) 
where both ‘heavy’ and ‘light’ peptides for API co-eluted at 44.30min and were selected for 
fragmentation at 44.40 and 44.42 minutes respectively. Both chromatographic peaks were 
combined to give MSMS spectra for both doubly charged ions and de novo sequencing of both 
confirmed sequence identity, thus normalisation to increase abundance of API in this sample 
was genuine (Figure 83). The y-ion series for both ‘light’ and ‘heavy’ peptide ions also confirms 
the [13C6]arg/[13C6]lys-labelling with a small peak 6Da heavier clearly observed for y-ions 9-13 
for the light isotope, and 6Da lighter for the heavy isotope.
Using the QconCAT protein to quantify the degree of normalisation achieved using Equalizer™ 
beads has demonstrated, in absolute amounts how abundant proteins that previously 
dominated analyses by 1D SDS-PAGE and mass spectrometry were reduced with the majority 
remaining unbound to the beads. This has simultaneously enriched low abundance proteins 
that were previously not identified by gel electrophoresis, with some proteins having a greater
Figure 79. Proteolysis of chicken skeletal muscle soluble proteins and normalised material.
100mg soluble protein from chicken skeletal muscle was normalised using Equalizer™  beads. Chicken skeletal 
muscle soluble proteins and normalised material bound to the ligand library were subjected to proteolysis with 
trypsin in-solution at an approximate ratio o f protein: trypsin o f 20:1. Digestion was allowed to proceed for 24h at 
37°C after which material before and after normalisation was analysed by 1D SDS-PAGE.
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Figure 80. Quantification of normalisation of chicken skeletal muscle soluble proteins 
using QconCAT.
Starting material and beads containing norm alised protein (5pL) were diluted 1:10 w ith 50mM 
am m onium  bicarbonate, to  which Q conCAT protein was added (starting m aterial+150pm ol, 
beads+36pm ol). Protein was digested with trypsin at a ratio o f protein: enzym e o f 20:1 with 
incubation at 37°C fo r 24h after which the d igest was incubated with additional trypsin (20:1 
substrate:protease) to ensure com plete digestion. Peptides were analysed by LC-ESI-Q-ToF MS 
with the  relative intensity o f analyte (light; L) and standard (heavy; H) peaks used fo r absolute 
quantification o f several proteins. Am ount o f protein present before (white bars) and after 
norm alisation o f 50mg protein (black bars) and 100mg protein (grey bars) using 20mg 
Equalizer™  beads is expressed as nmol/g tissue. The inserted graph to the top right o f the main 
data se t are the sam e data highlighting the y axis from 0-30nmol/g.
TM A API
685.01
916.31
Starting material + 150pmol QconCAT
Normalised material + 36pmol QconCAT
L H L H
Figure 81. Analyte and internal standard peptide pairs for two proteins normalised using 
Equalizer™ beads.
For quantification of normalisation, starting material and beads containing normalised protein 
(5pL) were diluted 1:10 with 50mM ammonium bicarbonate, to which QconCAT protein was 
added (starting material+150pmol, beads+36pmol). Protein was digested with trypsin at a ratio of 
protein: enzyme of 20:1 with incubation at 37°C for 24h after which the digest was incubated with 
additional trypsin (20:1 substrate:protease) to ensure complete digestion. Peptides were analysed 
by LC-ESI-Q-ToF MS with the relative intensity of analyte (light; L) and standard (heavy; H) peaks 
used for absolute quantification. For two proteins, tropomyosin A (TM A) and actin polymerisation 
inhibitor (API), mass spectra illustrate the increase in signal intensity of the analyte peptide after 
normalisation.
44.30 46.25
916 [M +2H]2+
Time (m in)
44.40
chrom atographic peak combined to 
g iveM S M S  9 16 [M + 2H ]2+
V j J !
44.42
chrom atographic peak combined to 
give MSMS 9 13 [M + 2H ]2+
Figure 82. Chromatographic confirmation of increase in abundance of API with 
normalisation using Equalizer™ beads.
Peptides from  in-solution digestion w ith trypsin o f norm alised chicken skeletal muscle soluble 
prote ins with Q conCAT protein were analysed by LC-ESI-Q-ToF MSMS using a collision energy 
o f 30%  fo r fragm entation. A  selected ion chrom atogram  for the internal standard peptide at 
916m /z ([M +2H ]2+) revealed a peak at 44.30m in. Chrom atogram s fo r MSMS data acquisition also 
conta ined a peak a t 44.40m in and 44.42m in which when combined gave rise to mass spectra for 
M SMS o f co-eluting internal standard peptide 916m /z ([M+2H]2*) and analyte peptide 913m /z 
([M +2H ]2+).
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Results and Discussion
affinity for the ligand library than others, resulting in greater enrichment, or less reduction in 
abundance and as such, all proteins are not normalised to the same level. This technology is 
not applicable to quantitative analysis of proteomes; however, it will provide a very useful tool 
for protein identification of complex mixtures exhibiting dramatic dynamic range between high 
and low abundance proteins.
5.6.3 Absolute quantification of the post-translational modification, deamidation
From analysis of chicken skeletal muscle soluble proteins, one of the most abundant is 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH), amounting to 11 ± 1 % (mean ±  SEM, 
n=3) of soluble protein when resolved by 1D SDS-PAGE (Figure 31) and analysed by 
densitometry, and up to 500 ± 50 nmol/g (mean ±  SEM, n=4) tissue when analysed using the 
QconCAT method for absolute quantification. MALDI-ToF mass spectra for this protein, 
digested in-gel with trypsin prior to MS analysis were of high quality and gave very high 
probability identification of this protein (Table 4, supplementary figure 18). Close inspection of 
each peptide in the mass spectrum indicated that for most, the observed mass isotopomer 
distribution was as expected, and was in close agreement to the distribution predicted by the 
Mslsotope program (http://prospector.ucsf.edu/). One peptide in particular (VKVGVNGFGR, 
[M+H]+ 1032.58m/z) was notably different from the others; the isotope distribution profile was 
not as predicted (Figure 84). In particular, the relative intensity of the monoisotopic ion 
(1032.59m/z) was diminished, and of lower intensity than the first [13C] isotopomer 
(1033.59m/z); a relative intensity pattern that is unexpected for a peptide of mass 1031.58Da, 
given an empirical formula of C46H78N15O12.
The mass isotopomer envelope is consistent with the analyte being a mixture of two peptides, 
one of monoisotopic 1032.58m/z and a second at a monoisotopic of 1033.58m/z. The higher 
m/z peptide could have been a contaminant or it could have been generated from the peptide 
at 1032.58m/z. If so, the most probable explanation for the mass increase was deamidation of 
the asparagine residue, which, by conversion to an aspartate residue would increase the mass 
by 0.985Da (-NH2 to -OH). To prove that the atypical profile was a consequence of 
deamidation, the peptide mixture was esterified by reacting with acetyl chloride and methanol 
to convert carboxyl groups to their methyl esters, resulting in a mass shift of 14.03Da. As the 
peptide V2 KVGVNGFGR10 would possess a single carboxyl group in the amide form (the alpha 
carboxyl group), and two in the acid form, deconvolution of the atypical peptide into two 
products, one esterified at a single position (+14.03Da), and a second modified in two positions
D ~-I—i
1 0 3 2 .5 9 1 6 1 5 .8 7
|  peptide identified
■  peptide identified as part o f a missed cleavage
1615.87 m/z
Figure 84. Atypical peptide mass spectrum consistent with deamidation.
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH; 1mg/mL diluted to 0.2mg/mL with 50mM 
ammonium bicarbonate) purified from rabbit skeletal muscle (Sigma, Dorset, UK) was digested 
in-solution with trypsin at a substrate:protease ratio of 50:1 by weight, and the masses of the 
resultant tryptic peptides were assessed by MALDI-ToF MS; a coverage map is included at the 
top of the figure with peptides identified represented in pink and those identified as part of a 
missed cleavage in blue. The spectrum of a typical partial cleavage tryptic peptide (T10-11, m/z 
1615.9; indicated on the peptide map) was compared with the mass spectrum predicted by the 
MS-lsotope tool (http://prospector.ucsf.edu/). This behaviour, common to almost all other 
peptides, emphasised the atypical profile observed for the N-terminal partial cleavage peptide 
(T1-2, m/z 1032.6).
Results and Discussion
(+28.06Da) upon esterification would confirm deamidation. When the peptide mixture was 
analysed after esterification, the MALDI-ToF MS ions 1032/1033m/z disappeared, and two new 
ions appeared, one representing the single modified amide (m/z 1032.58+14.03 = 1046.61) 
and the second reflecting the double modified acid (m/z 1033.58+28.06 = 1061.64; Figure 85, 
this analysis was conducted by L. McDonald). This confirmed deamidation of the asparagine 
residue, leading to further investigation, particularly for the impact this might have on protein 
identification, and quantification.
To assess the extent of deamidation in the native protein, and ascertain whether the residue 
had deamidated in vivo, or was an artifact of sample preparation and processing, purified rabbit 
GAPDH (Sigma, Dorset, UK) was digested with trypsin at 37°C over 24h. Proteolysis was 
stopped at selected time points during the digestion reaction by mixing with 10% (v/v) formic 
acid, and the resulting peptides were analysed by MALDI-ToF MS. Deamidation was monitored 
as the partition between acid and amide variants of the peptide in MALDI-ToF mass spectra 
using peak height data and was plotted as a function of time (Figure 86). The N-terminal 
peptide of GAPDH (VKVGVNGFGR) was released within a few minutes and was readily 
detected as the first analyte ion to appear in the MALDI-ToF mass spectrum. In the early 
stages of digestion, the mass spectrum of this peptide was entirely consistent with it being 
exclusively in the amide form (peptide isotopomer was as predicted). However, as time 
progressed during proteolysis, the mass spectrum of the peptide showed that the peptide was 
converted to a mixture of the amide and acid variants, and after 10h of digestion, the peptide 
was over 80% in the acid form. Proteolysis with the protease Asp-N which cleaves N-terminal 
to an aspartic acid residue, was also conducted in the same way with the reaction stopped at 
selected time points during digestion by addition to formic acid. Peptides were analysed by 
MALDI-ToF MS (AXIMA ToF2, Shimadzu, Manchester, UK) with pulsed extraction immediately 
proceeding ionisation set to achieve optimal resolution at 2600m/z (Figure 87). After 30min 
digestion the peptide ion containing the asparagine residue is clear (2602.6m/z; although this is 
overlapping with other peptide species at higher m/z) but by 24h digestion, this peak has 
disappeared, reflecting the cleavage of this peptide N-terminal to the aspartic acid residue as 
this is converted from asparagine by deamidation. Although this experiment does not contribute 
additional information as to the extent of deamidation, it confirms the process continues after 
initial proteolytic attack, and is not exclusive to the tryptic release of the smaller N-terminal 
peptide.
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Figure 85. Esterification of acidic residues in the N-terminal peptide of GAPDH.
Tryptic peptides recovered from an in-gel tryptic d igest o f GAPDFI (purified from  rabbit skeletal 
muscle, S igm a, Dorset, UK) were reacted w ith acetyl ch loride and methanol to  convert acidic 
residues to  the ir corresponding methyl esters. The upper m ass spectrum  is the peptide resulting 
from partial deam idation o f Asn6, thus is a m ixture o f two form s (asparagine containing and 
aspartic acid containing). The lower spectrum , obtained a fte r esterification has resolved the 
peptide into tw o distinct reaction products at 1046.63 m /z and 1061.65 m/z, consistent with the 
addition o f one and two methyl groups (+14.03Da), respectively.
1032.59m/z
Time (min)
Figure 86. Time course of deamidation of the N-terminal peptide of GAPDH.
Purified rabbit skeletal muscle GAPDH (Sigma, Dorset, UK; 1mg/mL diluted to 0.2m g/m L with 
50m M  am m onium  bicarbonate) w as digested with trypsin (trypsin:protein 1:100) over 24h at 
37°C. Proteolysis was stopped at 0, 2, 5, 10, 30, 60, 120, 240, 480 and 1440 min by mixing 10pL 
from the digestion mixture with 10pL 10% (v/v) form ic acid. The resulting peptides were analysed 
by M ALD I-ToF MS and deamidation was monitored during proteolysis fo r the N-terminal peptide 
o f sequence VKVG VNGFG R at 1032.59 m/z. The proportion o f acid and am ide variants was 
assessed from  peak height data, and plotted as a function o f time. Peptide envelopes illustrating 
the conversion o f acid to am ide form  in M ALDI-ToF mass spectra corresponding to tim e points 
over 24h are inserted above the data. The solid line is the tra jectory taken by first order decay 
(y=100e 'kt) fo r the proteolysed GAPDH.
VKVGVNGFGRIGRLVTRAAFNSGKV
Figure 87. Time course of deamidation of the N-terminal peptide of GAPDH during 
proteolysis with Asp-N.
Purified rabbit skeletal muscle GAPDH (Sigma, Dorset, UK; 1mg/mL diluted to 0.2mg/mL with 
50mM ammonium bicarbonate) was digested with Asp-N (protease:protein 1:100) over 24h at 
37°C. Proteolysis was stopped at 0, 2, 5, 10, 30, 60, 120, 240, 480 and 1440 min by mixing 10pL 
from the digestion mixture with 10pL 10% (v/v) formic acid. The resulting peptides were analysed 
by MALDI-ToF MS using a laser energy of 85% with pulsed extraction set to achieve optimal 
resolution at 2600m/z (AXIMA-ToF2, Shimadzu, Manchester, UK). Deamidation was monitored 
as the disappearance of the monoisotopic peak (VKVGVNGFGRIGRLVTRAAFNSGKV: 2602.6 
m/z) as asparagine was converted to aspartic acid causing subsequent cleavage N-terminal to 
the aspartic acid residue by AspN during proteolysis.
Results and Discussion
In order to draw conclusions relating to the extent of deamidation, by investigations of the rate 
of this reaction in the native protein, it was essential to confirm that conversion of asparagine to 
aspartic acid had no effect on the ionisation of this peptide when analysed by MALDI-ToF MS. 
For this, the N-terminal peptide of GAPDFI (of sequence VKVGVNGFGR and mass 1041.59Da) 
was synthesised by Sigma-Genosys (Dorset, UK) and was labelled at the arginine residue with 
both [13C6] and [15N4] giving a 10Da mass offset from the analyte peptide. A proportion of 
synthetic peptide was reconstituted in 50mM ammonium bicarbonate prior to incubation at 
37°C for 24h to allow complete deamidation of asparagine. A further proportion of synthetic 
peptide was reconstituted in 10% (v/v) formic acid to prevent deamidation of asparagine. Fully 
deamidated (100% aspartic acid containing), and non-deamidated (100% asparagine) peptide 
were mixed in known ratios and analysed by MALDI-ToF MS using peak height data to 
calculate the proportion of asparagine and aspartic acid (Figure 88). This analysis confirmed 
that there was no difference in ionisation of asparagine, or aspartic acid containing peptide, 
with a slope of 0.99 and R2 of 1.0. As such, data as to the relative proportion of acid and amide 
variants during deamidation could be used to assess the rate of deamidation.
The first order rate constant for deamidation during proteolysis of purified rabbit GAPDH with 
trypsin (Figure 86) was approximately 0.0017min-1, which was higher than the value derived 
from model peptides -  for the sequence NH2GVNGGOH the first order rate constant was 
previously measured at 0.0004min-1 (Robinson et a!., 2004). Flowever, the buffer conditions for 
the two experiments are not identical; temperature and pH have a large effect on deamidation 
rate. To investigate the effect of temperature on deamidation, the chemically synthesised 
peptide, designed as a stable isotope labelled internal standard for the GAPDH N-terminal 
peptide, was reconstituted in 50mM ammonium bicarbonate, pH 8.8 and incubated for 24h at 
23°C, 37°C and 60°C. During this time, a proportion of each was added to 10% (v/v) formic 
acid to prevent further deamidation and immediately spotted onto a MALDI target with acidic 
matrix (a-cyano hydroxycinnamic acid) and air dried. The proportion of acid and amide variant 
was assessed at each time point from peak height data in MALDI-ToF mass spectra and the 
proportion amide was plotted against time for incubation at each temperature (Figure 89a). For 
deamidation at each incubation temperature, first order decay (y=100e-kt) was applied to 
calculate the rate constant. The effect of temperature on deamidation of this model peptide is 
clear, and to confirm temperature dependence, the data were fitted to the Arrhenius equation 
whereby a plot of ln(k) against 1/T (temperature, Kelvin) gives a straight line (Figure 89b). To 
compare the rate of deamidation in the native protein, with that achieved at the same
VKVGVDGFGR
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Figure 88. Ion signal response in MALDI-ToF MS from asparagine and aspartic acid 
containing peptide.
The N-terminal peptide of GAPDH, of sequence VKVGVNGFGR and mass 1041.59Da, was 
synthesised by Sigma-Genosys (Dorset, UK) and was labelled at the arginine residue with both 
[13C6] and [15N4] giving a 10Da mass offset from the analyte peptide. 1nmol synthetic peptide was 
reconstituted in 1mL 50mM ammonium bicarbonate, of which a proportion was incubated at 37°C 
for 24h permitting complete deamidation of asparagine to aspartic acid. A further 1nmol synthetic 
peptide was reconstituted in 10% (v/v) formic acid and peptide containing asparagine and that 
containing aspartic acid were mixed in known ratios (0-100%). The proportion of acid and amide 
variant was assessed from peak height data and the percentage acid variant added was 
correlated with the percentage of acid measured when the two were mixed and analysed by 
MALDI-ToF MS. Data are presented as mean±sem, n=2 with spectra for 100% amide, 50% 
amide/50% acid and 100% acid presented as inserts.
Figure 89. The effect of temperature on peptide deamidation.
The N-terminal peptide of GAPDH, of sequence VKVGVNGFGR and mass 1041.59Da, was 
synthesised by Sigma-Genosys (Dorset, UK) and was labelled at the arginine residue with both 
[” C6] and [15N4] giving a 10Da mass offset from the analyte peptide. 1nmol synthetic peptide was 
reconstituted in 1mL 50mM ammonium bicarbonate, of which 3x15pL were diluted 1:10 with 
50mM ammonium bicarbonate and incubated at 23°C, 37°C and 60°C for 24h during which time 
10pL peptide was added to an equal volume of 10% (v/v) formic acid at selected time points to 
prevent further deamidation. The proportion of acid and amide variant was assessed at each time 
point from peak height data upon analysis by MALDI-ToF MS and the percentage amide variant 
measured was plotted against time for the incubation at each temperature (a). The solid line is 
the trajectory taken by first order decay (y=100e'kt) for the deamidated peptide. To confirm the 
temperature dependence on the rate of deamidation, the data were fitted to the Arrhenius 
equation whereby a plot of ln(k) for deamidation at each temperature against 1/T gives a straight 
line (b).
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incubation temperature for the synthetic peptide, proportion of amide was plotted against time 
for both (Figure 90) with the rate of deamidation for the native protein, 0.0017min-1 and that 
using a synthetic peptide of the same sequence, was 0.0023min-1. The higher rate of 
deamidation of the synthetic peptide is likely to reflect an association between the partially 
digested protein and the N-terminal peptide, restricting the adoption of a conformation 
favourable for deamidation, thus diminishing the deamidation rate. However it is clear that the 
difference between deamidation in a model peptide and that for the native protein, is that the 
peptide must first be released by proteolysis, and this warranted further investigation into the 
relationship between these two simultaneous processes.
As the N-terminal peptide itself contains an internal tryptic cleavage site (VK -  VGVDGFGR), 
the peptide VKVGVDGFGR (summed across acid or amide forms) decreased slowly during 
proteolysis of the native protein. A model of the sequential first order processes of proteolysis 
{ki) of the native protein (Native) to release the amide form of the peptide (VKVGVNGFGR) 
followed by deamidation (fe) to generate the acid form (VKVGVDGFGR) was created (Figure 
91). This also incorporates the secondary process of proteolysis (fo) of the N-terminal peptide 
containing either acid or amide, to release the ValLys dipeptide. Assuming that the rate of 
deamidation (fe) was independent of the N-terminal ValLys dipeptide and that the rate of tryptic 
removal of the N-terminal dipeptide (ki) was the same, irrespective of whether the peptide was 
in acid or amide form, the change in amount (relative to the initial amount of protein,) of the 
larger peptides (VKVGVNGFGR + VKVGVDGFGR, N+D) as a function of time, is given by:
As part of the same process, the shortened peptide (VGVNGFGR + VGVDGFGR, N’+D) 
appears according to:
N + D -  N,n a tiv e  ( t = 0 ) ( 1)
N'+D '= N (2 )
To use this model to investigate the kinetics of both deamidation and proteolysis, the stable 
isotope labelled synthetic peptide, identical to the N-terminal peptide of GAPDH, with a 10Da 
mass offset relative to the natural peptide due to labelling of arginine with both [13C6] and [15N4],
1032.59m/z
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Figure 90. Time course of deamidation of the N-terminal peptide of GAPDH.
Purified rabbit skeletal muscle GAPDH (Sigma, Dorset, UK; Img/mL diluted to 0.2mg/mL with 
50mM ammonium bicarbonate) was digested with trypsin (trypsin:protein 1:100) over 24h at 
37°C. Proteolysis was stopped at 0, 2, 5, 10, 30, 60, 120, 240, 480 and 1440 min by mixing 10pL 
from the digestion mixture with 10pL 10% (v/v) formic acid. The resulting peptides were analysed 
by MALDI-ToF MS and deamidation was monitored during proteolysis for the N-terminal peptide 
of sequence VKVGVNGFGR at 1032.59 m/z. The proportion of acid and amide variants was 
assessed from peak height data, and plotted as a function of time (closed squares). Peptide 
envelopes illustrating the conversion of acid to amide form in MALDI-ToF mass spectra 
corresponding to time points over 24h are inserted above the data. To compare this with model 
peptide studies, the N-terminal peptide of GAPDH, of sequence VKVGVNGFGR and mass 
1041.59Da, was synthesised by Sigma-Genosys (Dorset, UK) and was labelled at the arginine 
residue with both [13C6] and i N4] giving a 10Da mass offset from the analyte peptide. This 
peptide was incubated in 50mM ammonium bicarbonate at 37°C and a sample of the peptide was 
added to an equal volume of 10% (v/v) formic acid at selected time points. The relative amounts 
of acid and amide variants of the peptide were measured using MALDI-ToF MS and this was 
used to calculate the rate of deamidation; these data are presented as open circles. The solid 
lines are the trajectories taken by first order decay (y=100e'kt) for the synthetic peptide and the 
proteolysed GAPDH.
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Figure 91. Model of proteolysis and deamidation of the N-terminal peptide of GAPDH.
The simultaneous processes of proteolysis and release of the N-terminal peptide of GAPDH 
followed by deamidation of the asparagine residue to aspartic acid were modelled according to 
this scheme. The model also included the subsequent proteolysis of the N-terminal peptide 
(VKVGVNGFGR or VKVGVDGFGR) at the internal lysine residue to generate a dipeptide and 
a truncated peptide (VK+VGVNGFGR or VK+VGVDGFGR). In this scheme, the rate of 
deamidation was assumed to be the same, whether in the full length or truncated N-terminal 
peptide, and that the rate of removal of the N-terminal dipeptide was independent of the 
amide/acid variants.
Results and Discussion
was used to monitor the behaviour of the peptide during proteolysis. For quantification 
(Kirkpatrick et a/., 2005), purified rabbit GAPDH was digested with trypsin and digested 
material was added to a known amount of synthetic peptide in 10% (v/v) formic acid to stop 
digestion and prevent further deamidation at selected time points. Peptides were analysed by 
MALDI-ToF MS and the relative intensities of analyte peptide and internal standard were used 
to quantify the amount of peptide released from the protein, monitoring both the N-terminal 
peptide and the shorter peptide produced from further proteolysis (Figure 92). As conversion of 
asparagine to aspartic acid alters the isotope envelope of the analyte peptide, the composite 
abundance of the entire isotopic envelope for both analyte and internal standard peptide was 
summed in each case. Assuming that the rate of tryptic cleavage is consistent for both acid and 
amide variants, from these equations, the second order rate constants were calculated (first 
order rate constant divided by protease concentration) for initial release of the large peptide (fa) 
and the rate of proteolysis of this large peptide (fe). The value of fa was estimated to be 
1.22±0.025min-1.pM and for fa, 0.50±0.008min-1.pM (trypsin=0.2(xM). As expected, the 
endoproteolytic release of the longer peptide is faster than the release of the N-terminal 
dipeptide, as trypsin is known to act poorly as a dipeptidyl peptidase. However, the release of 
the longer peptide is likely to be suppressed by the three dimensional structure of the protein.
To investigate the effects of the higher order structure of GAPDH on proteolysis and 
subsequent deamidation, we analysed the X-ray crystal structure of rabbit GAPDH (PDB code 
1J0X.PDB). First, we used the tool NickPred (Hubbard, 1998) which although designed to 
predict sites of proteolytic attack, can generate a comprehensive analysis of the environment of 
every residue in a protein sequence. The N-terminal region of GAPDH is rather constrained, 
exhibiting low temperature factors (B-values) and low protrusion and accessibility (results not 
shown). Close inspection of the structure in the vicinity of Asn6 revealed an extensive hydrogen 
bonded network that might be expected to constrain main chain flexibility and to reduce the 
propensity for asparagine deamidation (Figure 93). However, once the peptide was released by 
proteolysis (within the first two minutes of digestion with a low concentration of trypsin, Figure 
94), deamidation proceeded at a higher rate than that predicted from model studies. These 
experiments are consistent with the following propositions; that the residue in the intact protein 
is exclusively in the amide form, secondly that the tryptic fragment containing the amide residue 
can undergo deamidation and thirdly, that deamidation is not an artefact of the mass 
spectrometric analysis. Excision of the peptide from the GAPDH structure relieves the 
constraint in the peptide backbone trajectory, permitting the deamidation reaction to take place.
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Figure 92. Absolute quantification of proteolysis of the GAPDH N-terminus.
Purified rabbit skeletal muscle GAPDH (Sigma, Dorset, UK; 1mg/mL diluted to 0.2mg/mL with 
50mM ammonium bicarbonate) was digested with trypsin (trypsin:protein 1:10) over 24h at 37°C. 
The N-terminal peptide of GAPDH, of sequence VKVGVNGFGR and mass 1041.59Da, was 
synthesised by Sigma-Genosys (Dorset, UK) and was labelled at the arginine residue with both 
[” C6] and [15N4] giving a 10Da mass offset from the analyte peptide. For quantification of 
proteolysis, the synthetic peptide was added to digested material in 10% (v/v) formic acid to stop 
digestion at selected time points. Peptides were analysed by MALDI-ToF MS and the relative 
intensities of analyte peptide and internal standard were used to quantify the amount of peptide 
released from the protein during incubation with trypsin at 37°C. Both the N-terminal peptide 
(VKVGVNGFGRA/KVGVDGFGR; 1032.59 [M+Hf; closed triangles) and the shorter peptide 
produced by further proteolysis (VGVNGFGRA/GVDGFGR; 805.59 [M+H]+; open circles) were 
monitored. As conversion of asparagine to aspartic acid alters the isotope envelope of the analyte 
peptide, the composite abundance of the entire isotopic envelope for both analyte and internal 
standard peptide was summed in each case. The solid lines reflect the fitted curves for the 
transient appearance of the N-terminal peptide (VKVGVNGFGRA/KVGVDGFGR) and the 
truncated product (VGVNGFGR/VGVDGFGR), modelled and fitted as sequential first order 
reactions (see text).
Figure 93. 3D structure of rabbit skeletal muscle GAPDH .
X-ray crystal structure of the N-terminal region of rabbit skeletal muscle GAPDH (PDB code 1J0X) high­
lighting the Asn6Gly7 deamidation site and the local hydrogen bonded environment. The green dashed 
lines denote hydrogen bonds.
2min
5min
10min
30min
1h
2h
5h
8h
17h
24h
ED- -cm -
■ h - c n -
------------- >-m - Œ --------- i- h .----------t-H— .------------ IM Ü f r f f lB — .............. ....................d l — ‘
m ~ --------— -m — —— — - — — h »  .........  c m ^
--------'-HUH----- 1-H|-----1- 1— *------ Ü 9—" 1 K B 1 **-»----------cm —"
» h----— ——— — m um ------cm—"
- ---’-—tu— — >-—♦— m< " ■  cm-■
■++-<----- ^-h ih— 4-**— *-*—■— □>— i  --------cm—*
1 - ----- •—HUB---- —----«—-*..... ..........O -*4-1---------cm—
■0- ■<? -tf> ■O ^  -<£ ^  <4* <4*
□  peptide identified
^  peptide identified as part o f a missed cleavage
Figure 94. Proteolysis of GAPDH with trypsin.
Purified rabbit skeletal muscle GAPDH (Sigma, Dorset, UK; 1mg/mL diluted to 0.2mg/mL with 
50mM ammonium bicarbonate) was digested with trypsin (trypsin;protein 1:500) over 24h at 
37°C. Proteolysis was stopped at 0, 2, 5, 10, 30, 60, 120, 300, 480, 1020 and 1440 min by mixing 
10pL from the digestion mixture with 10pL 10% (v/v) formic acid. The resulting peptides were 
analysed by MALDI-ToF MS and peptides identified independently, or as part of a missed 
cleavage were used to construct peptide maps.
Results and Discussion
It followed therefore that prior denaturation of the protein might permit deamidation prior to 
digestion with trypsin. To confirm this, GAPDH was denatured by heating to 60°C for 1 h before 
proteolysis, a denaturation treatment that was not sufficient to cause the protein to precipitate. 
Subsequently, when trypsin was added, the N-terminal peptide was again released rapidly, and 
the proportion of amide and acid variants of the peptide was assessed as previously described 
(Figure 95). Under these circumstances, the peptide first released was approximately 80% 
amide, with a significant proportion of acid form being measurable. This contrasted markedly 
with proteolysis of the native protein, when the peptide is initially all in the amide form. This 
behaviour most likely reflects the increased conformational flexibility of the peptide in the heat- 
treated protein, such that the peptide could acquire a conformation that allowed deamidation. 
Further, this unfolded and flexible component might be expected to be hypersensitive to 
proteolysis and to be released first. As the digestion proceeded, additional peptide in the amide 
form was released, and the proportion of amide therefore increased transiently, until the 
deamidation reaction dominated the peptide profile. Using the functions derived previously, a 
value for deamidation of 0.0023mm-1 was obtained, in close agreement with that observed 
previously. If the heat-treated peptide was allowed to incubate at 37°C for 24h after the 60min 
denaturation period at 60°C, and then proteolysed with trypsin, the peptide first released was 
now only 50% in the amide form, consistent with extensive deamidation prior to proteolysis, 
consequential to denaturation. Again, as expected, proteolysis led to the slower release of 
peptide that was constrained and unable to deamidate and there was a transient increase in 
the proportion of amide which again decayed at the same rate as observed previously 
(/<2=0.0024mm-1). The behaviour of the system was consistent with the GAPDH preparation 
being 76% in the amide form, and 26% in a denatured form that was then rapidly proteolysed to 
generate the free acid form of the peptide. The effect of denaturation on the availability of the 
N-terminal peptide of GAPDH for deamidation is quite striking and defines the importance of 
monitoring the two processes of proteolysis and deamidation simultaneously, especially as this 
effect is only observed upon loss of higher order structure, and not upon increasing 
concentration of protease (results not shown).
The implications of the post-translational modification are several fold; for protein identification 
by peptide mass fingerprinting, deamidated peptides with a consequent change in isotope 
profile will not be matched to monoisotopic masses in the database for that particular protein, 
causing anomalies for protein identification. For characterisation proteomics, observation of a 
deamidation event may be incorrectly assigned as occurring in vivo when it is likely that
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Figure 95. The effect of denaturing protein structure by heating on the rate of deamidation.
GAPDH (1mg/mL diluted to 0.2mg/mL with 50mM ammonium bicarbonate) purified from rabbit 
skeletal muscle (Sigma, Dorset, UK) was digested with trypsin in-solution at a ratio trypsin:protein 
1:100 at 37°C for24h. Prior to digestion, GAPDH was incubated for 1h at4°C  (open triangles), 1h 
at 60°C (closed squares) and 1h at 60°C followed by 24h at 37°C (open squares). For each, 
deamidation was monitored over 24h of proteolysis and the proportion of acid and amide was 
calculated from the relative peak intensities of the two ions in MALDI-ToF mass spectra.
Results and Discussion
standard conditions for in-gel and in-solution proteolysis may promote deamidation, for which 
the constraining effect of three dimensional structure, limiting availability of potential sites for 
deamidation is apparent. For protein quantification using chemically synthesised internal 
standard peptides containing stable isotopes, or QconCAT proteins, an analyte or internal 
standard peptide seen to deamidate post-proteolysis may still be used by incorporating the 
signal for both acid and amide variants into calculations of relative signal intensity. For this, it is 
important that both asparagine and aspartic acid containing peptide are both ionised to the 
same extent. This information may also be incorporated into design of a QconCAT experiment, 
to avoid peptides containing asparagine, or to carry out preliminary experiments to look for 
deamidation in the analyte system. This investigation of deamidation of the GAPDH N-terminal 
peptide was complicated by the presence of a missed cleavage, and thus quantification based 
on this peptide as an internal standard is not reliable. To confirm the effects of this secondary 
proteolysis, a known amount of GAPDH purified from rabbit muscle was digested with trypsin. 
The stable isotope labelled internal standard peptide used for quantification of deamidation 
(Figure 96) was added prior to the addition of protease, and digestion was stopped at selected 
time points by mixing with 10% (v/v) formic acid. Peptides were analysed by MALDI-ToF MS 
and the entire peak area of the peptide envelopes for both analyte and internal standard was 
summed in each case for quantification based on relative peak intensity. This highlighted that, 
as expected, quantification became progressively worse with longer incubation times with 
trypsin although correlation was always strong, indicating that a correction factor could be 
applied based on the rate of proteolysis at the internal cleavage site, if necessary, although this 
would be undesirable if more suitable peptides are available for quantification.
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Figure 96. Absolute quantification of GAPDH based on a deamidating peptide containing 
an internal trypsin cleavage site.
Purified rabbit skeletal muscle GAPDH (Sigma, Dorset, UK; 1mg/mL diluted to 0.2mg/mL with 
50mM ammonium bicarbonate) was digested with trypsin (trypsimprotein 1:100) in increasing 
amounts from 0 to 54pmol over 24h at 37°C. The N-terminal peptide of GAPDH, of sequence 
VKVGVNGFGR and mass 1041.59Da, was synthesised by Sigma-Genosys (Dorset, UK) and 
was labelled at the arginine residue with both [1JC6] and [15N4] giving a 10Da mass offset from the 
analyte peptide and this was added to GAPDH in increasing amounts from 0 to 8pmol prior to 
addition of trypsin. Proteolysis was stopped at 2, 4, 8 and 24h by mixing 10pL from the digestion 
mixture with 10pL 10% (v/v) formic acid. The resulting peptides were analysed by MALDI-ToF MS 
and the entire peak area of the peptide envelopes for both analyte and internal standard was 
summed in each case for quantification based on relative peak intensity, thus incorporating both 
acid and amide variants.
6. C o n c lu sio n s
Conclusions
C o n c lu sio n s
To develop proteomics as a quantitative science, several strategies have been employed. 
These include gel based methods, western blotting, mass tagging, mass spectrometry with 
prior peptide separation, and standardisation using stable isotope labelled reference molecules. 
To achieve quantification of proteins using the highly sensitive technique of mass spectrometry, 
proteins are most commonly digested into peptides with a specific protease, for example 
trypsin. Mass spectrometry of peptides is not inherently quantitative, thus stable isotopes are 
used to compensate for differences due to effects of ionisation, mass analysis and detection. 
Stable isotopes are incorporated into proteins and peptides by differential labelling, 
incorporation of a labelled ‘tag’, or by metabolic incorporation; for cells in culture or intact 
animals (reviewed by Bantscheff et al., 2007). Strategies that avoid the use of stable isotopes 
for protein quantification are also under development, using either peptide signal intensity, or 
counting the number of fragment ion spectra used to identify a particular protein. For these 
methods, spectral counting is more sensitive for detecting changes in protein abundance but 
calculations of peptide peak area intensity are more accurate for determining protein ratios (Old 
etal, 2005).
To progress from relative quantification to absolute quantification in which proteins are 
expressed as for example, number of molecules per cell, or nmol per gram of tissue, internal 
standards that are either proteins or peptides with incorporated stable isotopes are mixed with 
analyte proteins. For the quantification of individual proteins, the true internal standard would 
be the corresponding protein expressed in both pure and stable isotope labelled form for 
quantification. Although both analyte and internal standard are subjected to the same sample 
processing, efficient expression of multiple native proteins would be challenging, as would 
subsequent purification and MS analysis of complex isotope envelopes. Alternatively, stable 
isotope labelled proteins are used as internal standards for quantification based on limit 
peptides, with the advantage that both analyte and internal standard peptides are present 
within the same sequence context, negating the need to take control of proteolysis separately 
for both analyte and standard proteins (Brun et al., 2007). Alternatively, peptide-based 
approaches using proteotypic peptides as surrogates for the protein of interest have been 
developed. To create the appropriate internal standard, the selected surrogate peptide is 
chemically synthesised with incorporated stable isotopes. This is added to the analyte prior to 
mass spectrometric detection in a known amount and the relative signal intensity of the analyte
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and internal standard peptide Is used for absolute quantification of the native protein. This 
approach is well designed for the quantification of proteins in biological material that cannot be 
pre-labelled but for the quantification of multiple proteins, each would have to be independently 
quantified using a separately synthesised internal standard. To multiplex this approach, a 
peptide is selected from several proteins to be quantified and these sequences are 
concatenated into a synthetic gene which is expressed in a host organism (usually bacterial), 
labelled with stable isotopes, purified and digested with a protease to create a series of internal 
standards in equimolar amounts; the amount of each peptide is given from quantification of the 
recombinant QconCAT (quantification concatamer) protein (Beynon et a!., 2005, Pratt et a!., 
2006). For generation of multiple stable isotope labelled internal standard peptides, biological 
synthesis of recombinant proteins is preferred to chemical synthesis of peptides, the success of 
which is sequence dependent (for example hydrophobic peptides are difficult to synthesise 
chemically). Metabolic labelling is also advantageous for the incorporation of a variety of stable 
isotopes, with straightforward production of unlabelled and labelled QconCAT proteins for use 
in assessing assumptions of the method in addition to absolute quantification of proteins, or as 
a set of multiple internal standards for in vitro labelling.
There are two main components of a QconCAT method, a design phase and an 
implementation phase. The design phase predominantly involves nomination of proteins to be 
quantified, and selection of peptide sequences to incorporate into the QconCAT gene, for 
which there are a number of considerations. First is the protease to be used for peptide 
hydrolysis as this will determine the potential peptides for each protein to be quantified. Most 
proteomics experiments use trypsin as this is a highly specific enzyme cleaving at the C- 
terminus of lysine and arginine residues, generating the majority of peptides within the mass 
range of common instrumentation. The use of an alternative protease, for example Arg-C offers 
advantages, including greater probability of efficient ionisation and production of fewer 
peptides, reducing complexity but there may not be sufficient peptides within the desired mass 
range to select one that is unique for each protein to be quantified. Arg-C is also more 
expensive than trypsin for routine use, an important consideration for experimental design. 
Consequently, protease selection for the QconCAT method can only be determined from the 
specific requirements of the analyte system. For example, hydrophobic membrane proteins, 
especially those spanning the membrane may have limited accessibility to protease cleavage 
sites, in which case solubilisation and alternative cleavage strategies (reviewed by Wu and 
Yates, 2003) may be considered. Selection of Q-peptides is based on uniqueness of mass and
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efficiency of ionisation, with appropriate sites for incorporation of stable isotope(s). As such, 
this can either be predicted on the basis of physicochemical characteristics with prior 
knowledge of the consequences of ionisation for certain amino acids, or from previous 
experience. Strategies for predicting proteotypic peptides are in early stages of development 
(Mallick et al., 2007), although these look promising and would negate the need for preliminary 
investigation for peptide selection. However currently, prior knowledge of analyte peptides 
detected in the analytical environment, particularly using sample preparation protocols and 
instrumentation of choice to ensure that peptides are selected based on their propensity to 
ionise is necessary. Before incorporation into a QconCAT, selected peptides should be 
sequenced to confirm their identity and any possible modifications should be investigated. For 
example, peptides containing methionine are avoided where possible as variable oxidation of 
this residue would compromise quantification based on the signal intensity of the unmodified 
peptide. If it is not appropriate to conduct extensive investigation of potential proteotypic 
peptides prior to incorporation into a QconCAT gene, more than one Q-peptide could be 
selected per protein to improve the chance of reliable quantification using one or the other. It is 
also possible to enhance the ionisation of Q-peptides that are under-represented following MS 
analysis, for example by guanidination of lysine residues (for MALDI-ToF MS). Once the 
peptide sequences for incorporation into the QconCAT gene have been determined, it is 
necessary to optimise the codon sequence for efficient expression in the appropriate vector 
through the formation of stable RNA secondary structure. This is achieved on a trial and error 
basis, with random concatenation in silico and analysis of the predicted transcript for RNA 
secondary structure that might diminish expression; the order of peptides is altered if 
necessary. It is also advantageous to add sacrificial peptide sequences to the N- and C- 
terminus of the QconCAT gene to protect the true quantification peptides from exoproteolytic 
attack during expression. This also provides an opportunity to add an initiator methionine 
residue to the N-terminus, and other desirable features, for example a purification HisTag. 
Henceforth, expression in the vector system (for example E.coli) should be fairly 
straightforward with no higher order folding and this provides the ideal opportunity for 
incorporation of a stable isotope label with supplementation into the medium for E.coli growth. 
The labelling strategy must also be appropriately designed, and the decision must be made 
whether to employ a uniform label to ensure that every peptide is labelled with a different mass 
offset from the analyte peptide (for example [15N]), or to  label specific amino acids, preferably in 
every peptide (for example [13C6]lys/arg for tryptic peptides). It is important that the mass offset 
between analyte and internal standard can be distinguished by mass spectrometry and
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consequently it is advisable that this is greater than 4Da. It is also possible to label QconCAT 
proteins using in vitro labelling strategies if necessary. For the strategy chosen, efficiency of 
labelling can be confirmed from the peptide isotopomer envelope in MS analysis. Once 
designed, the QconCAT method is implemented by expression, labelling and purification prior 
to use as a set of internal standards for absolute quantification.
There are many challenges for absolute quantification, using either the synthetic peptide, or 
QconCAT approach. First, is the selection of the peptides that are to be used as surrogate 
standards for the analyte proteins. In the future this may be possible to predict without prior 
experimental work, based on physicochemical characteristics of peptides and their known 
behaviour in different analytical environments. Currently this is based on previous experience 
of detected peptides, and those that are unique, within a given mass range and ionise most 
efficiently are often chosen. For an unknown analytical system, this could be achieved using a 
one off shotgun proteomics experiment from which a list of signature peptides can be identified 
(for example, Wienkoop and Weckwerth, 2006).
A second challenge for these strategies is the attainment of complete proteolysis of analyte and 
QconCAT proteins, vital for protein quantification based on the amount of a single limit peptide. 
Peptides incorporated into a QconCAT exist in a different sequence context to their native 
environment, and consequently the rate of hydrolysis will be different for analyte and internal 
standard proteins. As QconCAT proteins generally lack higher order structure following 
recombinant expression, they are rapidly digested, independent of peptide order in the 
QconCAT (Mirzaei et a!., 2007). However analyte protein digestion is hindered by higher order 
structure which restricts access to enzymatic cleavage sites, resulting in much slower rates of 
proteolysis (Rivers et al, 2007). For absolute quantification using QconCAT proteins or 
synthetic peptides, it is crucial that complete digestion is achieved. If this is not observed for 
native proteins, analyte proteins must be sufficiently denatured, or conditions, for example 
enzyme concentration, incubation time and presence of organic solvents, must be altered to 
achieve complete proteolysis. The rate of proteolysis of analyte proteins can be derived using 
pre-digested QconCAT labelled peptides, or stable isotope labelled synthetic peptides as 
internal standards, and this is highly recommended to ensure complete digestion is achieved 
for reliable quantification.
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Thirdly, is the challenge of complex biological sample dynamic range of protein abundance, 
which for human plasma covers ten orders of magnitude (Anderson and Anderson, 2002). 
Consequently, only a subset of proteins are analysed, and of those, only a subset of peptides 
are quantifiable. For quantitative proteomics, current strategies have not achieved 
quantification of an entire proteome, and are usually targeted to high abundance proteins. Low 
abundance proteins often provide valuable information, particularly in the discovery of clinically 
relevant biomarkers of disease and these are difficult to detect due to the domination of high 
abundance species in all forms of analysis. Methods to enrich low abundance proteins, or 
deplete proteins in high abundance are effective, but this usually loses quantitative information 
as protein abundance no longer reflects natural expression. In a single experiment, dynamic 
range is limited by capacity and resolution of instrumentation, but also by the abundance range 
that can be quantified using a single internal standard. For quantification using QconCAT in a 
single experiment, dynamic range of abundance covering over two orders of magnitude (0- 
300nmol/g tissue) is quantifiable (Rivers et a!., 2007). For quantification of proteins beyond this 
range in abundance, different amounts of QconCAT protein may be added to the analyte 
sample, quantifying low and high abundance proteins in separate experiments. This will also be 
improved by chromatographic separation of peptides prior to MS analysis to remove 
suppression of higher abundance peptides. In this instance, quantification using stable isotope 
labelled synthetic peptides may be preferred as a different amount of each peptide can be 
added for the quantification of each protein, depending on the natural abundance of the 
analyte.
Another significant challenge for quantitative proteomics is quantification of post-translational 
modifications (reviewed by Chen et a!., 2007). These are often important for regulating cell 
signalling events and protein interactions and are difficult to monitor due to their dynamic and 
often reversible nature, for example phosphorylation. Strategies to quantify phosphorylation 
using stable isotope labelling include incorporation of selectively labelled amino acids that are 
common targets for phosphorylation in cell culture, for example [2H3]serine (Zhu et at., 2002), or 
differentially labelling cell populations phosphorylated to different extents with combinations of 
[13C6] and [15N4] arginine prior to affinity purification of phosphopeptides (Blagoev et a!., 2004). 
Absolute quantification has been achieved using stable isotope labelled synthetic peptides 
(Gerber et ai., 2003), but this was achieved using a synthetic peptide containing the specific 
modification. Such analysis is limited with the QconCAT strategy because it is designed to 
quantify the unmodified analyte peptide. For standard quantification experiments, peptides
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known to be modified post-translation are avoided for incorporation into the QconCAT as a 
partial modification would sequester a proportion of the peptide signal, thus compromising 
quantification. To overcome this for well-characterised, single sites of modification, a peptide 
may be incorporated into the QconCAT in both native and modifiable states. This would permit 
quantification of the amount of modification by comparing relative signal intensities of the two 
analyte peptides with the relevant internal standard. Alternatively, the modified peptide 
sequence could be incorporated into the QconCAT with the analyte peptide quantified before 
and after treatment to remove the modification, for example alkaline phosphatase to hydrolyse 
phosphopeptides.
For quantification of multiple proteins in a complex biological system, the QconCAT approach is 
preferable to the use of several stable isotope labelled synthetic peptides. Many of the 
advantages of this approach have been discussed, with more reliability achieved by mixing 
internal standards with analyte samples at the protein level, controlling effects of sample 
preparation as early as possible. Synthetic peptides are often incorporated after proteolytic 
digestion of analyte; they could also be added at the protein level but they are likely to bind to 
tube walls, become degraded or modified, especially with long incubation times necessary for 
proteolysis (Mirzaei etal., 2007). From calculations of the relative cost of the two methods, the 
synthetic peptide approach is more economical for quantification of less than 10 proteins, but 
for an average QconCAT protein containing 50 peptides, the QconCAT approach is 
approximately 15% of the cost of chemical synthesis of each peptide in stable isotope labelled 
form. Futhermore, a single preparation of QconCAT yields approximately 250nmol of protein 
(and hence Q-peptides), compared to 5x1 nmol typically supplied by the manufacturer of 
synthetic peptides. For the QconCAT method, initial expense of the construction of the 
QconCAT gene is offset by the repeated use of this construct for protein expression, for 
example to test different labelling strategies and produce multiple preparations of the 
recombinant protein. For reliability of quantification using these two strategies, quantification 
has been compared (Rivers et al., 2007, Mirzaei et al., 2007) with similar results achieved for 
both methods. Small discrepancies are attributed to differences in the way that the two internal 
standards are quantified. Quantification of synthetic peptides is achieved using amino acid 
analysis, conducted by the manufacturer. This uses highly sensitive techniques but it is difficult 
to ensure all supplied peptide is recovered into solution and the low quantity of peptide 
provided is not sufficient to quantify by the end user. There are a number of methods for 
quantification of the QconCAT protein, some of which are more sensitive but require sacrifice of
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a greater proportion of protein product. For most analyses, quantification by protein assay is 
sufficient relative to the analyte system, for example compared to biological variance from 
absolute quantification of chicken skeletal muscle soluble proteins, coefficient of variation for 
analytical replicates was very low, and experiments to assess accuracy confirmed the reliability 
of quantification (Rivers et a!., 2007). For application of the QconCAT method across multiple 
platforms, quantifying a range of biological proteins, quantification of the internal standard 
protein must be highly accurate. This could be achieved using a synthetic peptide purchased 
separately (unlabelled) for the quantification of a specific peptide that is incorporated into every 
QconCAT protein. If every QconCAT protein is quantified by the synthetic peptide in MS, 
quantification will be reliable across different laboratories covering a host of different 
applications.
Successful applications of absolute quantification using the QconCAT method are widespread, 
from the analysis of protein expression of different isoforms with single amino acid differences, 
to the assessment of defined peptides in MS and MSMS for instrument validation or 
assessment of ionisation effects. The number of peptides that can be incorporated into a single 
QconCAT is restricted as high-level expression of large proteins is more problematical. 
However, QconCAT proteins are currently in production (unpublished data) containing in the 
region of 100 Q-peptides in the mass range 800-4000Da producing a QconCAT protein of 
approximately 150kDa. For optimal expression, it may be preferable to create two QconCAT 
genes of smaller size but this is under investigation.
The objective of this research was to provide a rigorous test of the QconCAT method for 
absolute quantification of multiple proteins, incorporating an in-depth assessment of variance 
within this system. This method was applied successfully for the quantification of multiple 
proteins in the soluble fraction of chicken skeletal muscle from 0 to 30d growth in both broiler 
and layer strains. Protein abundance was assessed at six time points during growth, with four 
birds at each time point. The QconCAT is robust to the choice of mass spectrometric platform 
used with detection of some proteins only by one instrument, with or without prior 
chromatographic separation. Accuracy of the method was also assessed, in addition to 
variation contributed by biological and analytical replicate experiments. Analytical variance was 
significantly lower than that for quantification data measured for four different birds of each 
strain, for example the analytical variance (CV of 6.0% for (3-enolase, n=4) compared 
favourably to biological variance (CV of 24.0% for p-enolase, n=4). Perhaps the most
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significant limitation of the QconCAT method, is the dynamic range that can be achieved in a 
single experiment, which for absolute quantification of chicken skeletal muscle soluble proteins 
covered two orders of magnitude of protein abundance. This has been discussed in more detail 
previously, and compared to the synthetic peptide method for absolute quantification. Through 
the application of QconCAT to this biological system, some advantages of absolute 
quantification using stable isotope labelled surrogate peptides as internal standards as a 
general tool for quantitative proteomics have emerged. Firstly to quantify the normalisation of 
protein abundance using ligand library beads, and secondly to provide a more detailed insight 
into the post-translational modification, deamidation, ascertaining the relationship between 
higher order protein structure and deamidation (Rivers et al., 2008).
Quantitative strategies, particularly for absolute quantification, and their application have been 
discussed (recently reviewed by Bantscheff et al., 2007). The greatest challenge for these 
approaches, is to achieve the comprehensive quantification of a biological system and future 
work in this area should be directed to achieving this goal. For a QconCAT approach, a 
relatively simple proteome, for example E.coli containing in the region of 4-5,000 proteins 
(strain K12, Swissprot database; www.expasy.org/sprot), with one peptide per protein would 
require 4,500 Q-peptides for quantification. If 100 peptides can be incorporated into a single 
QconCAT protein, this would require 45 QconCAT proteins, each of approximately 100- 
150kDa. This is a relatively small number of gene design and synthesis procedures, relative to 
the chemical synthesis of 4,500 peptides required for the alternative strategy to achieve 
absolute quantification using MS. To achieve this, the QconCAT strategy is the most efficient, 
at 15% of the cost (based on in-house expression, labelling and purification). In addition, once 
the QconCAT genes have been designed, this provides an unlimited resource of multiple 
internal standard peptides that can be expressed with a variety of incorporated stable isotopes. 
For absolute quantification, QconCAT genes can be designed for specific functional groups of 
proteins, for example membrane bound proteins, transporter proteins, or specific enzymes. In 
addition, different QconCAT experiments can be implemented for proteins varying in 
abundance, with appropriately designed labelling strategies for each. As such, this 
methodology has the potential to become the ‘gold-standard’ for global absolute quantification, 
although this technology will still encounter certain challenges. The achievement of 
quantification of an entire proteome using the QconCAT strategy must be in accordance with 
developments in the ability to predict proteotypic peptides for selection and incorporation into 
the QconCAT, a significant advantage for this type of approach, negating the need for
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extensive prior investigation of the analyte system. However, this may require the incorporation 
of two Q-peptides per protein to be quantified, thus doubling the number of QconCAT proteins 
needed for absolute quantification. Furthermore, detection and quantification of 4,500 (or 9,000 
if two Q-peptides per protein are incorporated) peptide pairs requires significant advances in 
statistical treatment and interpretation of quantitative data, such that this approach can become 
automated, and used for high throughput quantification. For large scale programmes, and the 
implementation of the QconCAT strategy for a wide variety of applications across multiple 
platforms, quantification of internal standard proteins, for example incorporation of a universal 
synthetic peptide is essential. As a further obstacle for system-wide quantification using 
QconCAT, sample complexity and dynamic range poses a substantial challenge. To delve 
further into the proteome, MS methods for multiple reaction monitoring using triple quadrupole 
instruments where the intact peptide mass and one or more specific fragment ions in an LC-MS 
experiment are monitored have been developed. This technique essentially uses two mass 
filters to increase specificity and sensitivity for absolute quantification using stable isotope 
labelled reference peptides. This permits a greater dynamic range of protein abundance to be 
detected and quantified, for high (55mg/mL) and medium (1 pig/mL) abundance peptides 
covering 4-5 orders of magnitude (Anderson and Hunter, 2006) and as low as 1-10ng/mL 
without antibody enrichment (Keshishian et at., 2007). This strategy is becoming widely used 
for routine protein quantification, with particular application to clinical diagnostics (for example 
Kirsch et a!., 2007) and its application to quantification using QconCAT proteins has the 
potential to improve the dynamic range of protein abundance quantified in a single experiment 
considerably.
For understanding of complex biological systems to drive the field of ‘systems biology’, 
absolute quantification of proteins is essential. With continued development of the QconCAT 
method for various applications and large-scale proteomic analysis, absolute quantification of 
the entire proteome of an organism is within reach. To realise this goal, particular focus should 
be directed to strategies for predicting proteotypic peptides, computational tools to handle 
substantial amounts of quantitative data, and advances in instrumentation and strategies to 
quantify proteins covering a wide dynamic range of abundance.
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Supplementary figure 1. Peptide map and annotated mass spectrum from in gel digestion and peptide
mass fingerprinting by MALDI-ToF MS for protein identification, figure 31.
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Supplementary figure 14. Peptide map and annotated mass spectrum from in gel digestion and peptide
mass fingerprinting by MALDI-ToF MS for protein identification, figure 31.
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Supplementary figure 15. Peptide map and annotated mass spectrum from in gel digestion and peptide
mass fingerprinting by MALDI-ToF MS for protein identification, figure 31.
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Supplementary figure 16. Peptide map and annotated mass spectrum from in gel digestion and peptide
mass fingerprinting by MALDI-ToF MS for protein identification, figure 31.
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Supplementary figure 17. Peptide map and annotated mass spectrum from in gel digestion and peptide
mass fingerprinting by MALDI-ToF MS for protein identification, figure 31.
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Supplementary figure 18. Peptide map and annotated mass spectrum from in gel digestion and peptide
mass fingerprinting by MALDI-ToF MS for protein identification, figure 31.
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Supplementary figure 19. Peptide map and annotated mass spectrum from in gel digestion and peptide
mass fingerprinting by MALDI-ToF MS for protein identification, figure 31.
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Supplementary figure 21. Peptide map and annotated mass spectrum from in gel digestion and peptide
mass fingerprinting by MALDI-ToF MS for protein identification, figure 31.
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Supplementary figure 22. Peptide map and annotated mass spectrum from in gel digestion and peptide
mass fingerprinting by MALDI-ToF MS for protein identification, figure 31.
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a parallel data-base search engine for real-time peptide mass fingerprinting’ (submitted to 
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spectrometric data for Proteomics’ Bioinformatics 23 (6), 724-731
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responsible for production of several figures, in addition to written sections of the manuscript.
Pratt J. M., Simpson D. M., Doherty M. K., Rivers J., Gaskell S. J. and Beynon R. J. (2006) 'Multiplexed 
absolute quantification for proteomics using concatenated signature peptides encoded by 
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ABSTRACT
Motivation: Peptide Mass Fingerprinting (PMF) is a method for 
protein identification in which a protein is fragmented by a defined 
cleavage protocol (usually proteolysis with trypsin), and the masses 
of these products constitute a 'fingerprint’ that can be searched 
against theoretical fingerprints of all known proteins. In the first 
stage of PMF, the raw mass spectrometric data are processed to 
generate a peptide mass list. In the second stage this protein 
fingerprint is used to search a database of known proteins for the 
best protein match. Although current software solutions can typically 
deliver a match in a relatively short time, a system that can find a 
match in real-time could change the way In which PMF is deployed 
and presented. In a paper published eariier (Bogdan e t a l., 2007) we 
presented a hardware design of a raw mass spectra processor that, 
when implemented in FPGA hardware, achieves almost 170-fold 
speed gain relative to a conventional software implementation run­
ning on a dual processor server. In this paper we present a com­
plementary hardware realisation of a parallel database search en­
gine that, when running on a Xilinx Virtex 2 FPGA at 100MHz, deliv­
ers 1800-fold speed-up compared with an equivalent C software 
routine, running on a 3.06GHz Xeon workstation. The inherent seal- 
ability of the design means that processing speed can be multiplied 
by deploying the design on multiple FPGAs. The database search 
processor and the mass spectra processor, running on a reconfigur­
able computing platform, provide a complete real time PMF protein 
identification solution.
1 INTRODUCTION
O f the four key enabling tools and technologies in proteomics (protein 
separation, mass spectrometry instrumentation, protein databases and data 
processing, analysis and inteipretation) it can be argued that the bioinfor­
matics solutions lag in terms o f performance and throughput. Post­
instrument data processing in particular, is a major bottleneck in the pro­
teomics workflow and as experimental design, instrument performance and 
user skills increase, it is expected this will become worse. A  reasonable 
goal is that the processing and first-level (non interpretative) analysis 
should be completed within the same timeframe as the experiment itself, 
preferably implemented as ‘near-instrument’ capabilities, where the user 
has the option o f  controlling the search parameters and strategies within the 
timeframe and constraints o f the experiment. This largely rules out widely 
distributed multiprocessor computational farms/grids. However, computa­
tional platforms based on a relatively low number o f conven­
'To whom correspondence should be addressed.
tional/multicore microprocessors are unlikely to deliver the speed required 
for real-time processing.
A  solution to this problem, advocated in an earlier paper (Bogdan et al., 
2007), is to implement proteomics data processing algorithms directly in 
hardware, effectively designing dedicated digital processors for every algo­
rithm. Central to this approach is a rather unusual digital device termed a 
Field Programmable Gate Array (FPGA), which allows implementation 
and operation o f  a digital hardware design with the same facility as a con­
ventional computer program. Early uses o f FPGA devices in bio­
computation were to accelerate gene sequence analysis (Fagin et al. 1993). 
FPGAs, which are well suited for high-performance, high-bandwidth and 
parallel processing applications, have been successfully employed to speed 
up D NA sequencing algorithms (Hughey 1996, Guerdoux-Jamet et al., 
1997, Wozniak 1997, Lavenier, 1998, Guccione et al., 2002, Simmler et 
al., 2004). FPGAs were also used in the attempt to accelerate search o f 
substrings similar to a template in a proteome (Marongiu et al., 2003). 
More recently, FPGAs have been used to accelerate sequence database 
searches with MS/MS-derived query peptides (Anish et at., 2005). This 
hardware-based solution can locate a query within the human genome 
about 32 times faster than a software implementation running on a 2.4GHz 
processor. A  hardware sequence alignment tool implemented in FPGA is 
also available (Oliver et al., 2005). FPGA computing is used for comparing 
protein sequences with profile HMMs (Sun et al., 2007). An FPGA based 
BLAST search was used for EST sequencing (Panitz et al., 2007).
In succession to our earlier paper (Bogdan et a!., 2007), the focus in the 
present paper is to use FPGA-based computing to accelerate Peptide Mass 
Fingerprinting. PMF is a protein identification technique in which a pro­
tein is proteolysed using an endopeptidase o f defined specificity (usually 
trypsin) and the masses o f the ensuing limit peptide fragments aTe meas­
ured. The proteins are identified by matching the measured molecular 
masses o f these peptide fragments against theoretical peptide mass profiles 
generated from protein sequence database. PMF is readily delivered at high 
sensitivity through routine instrumentation such as MALDI-ToF mass 
spectrometers and although tandem MS approaches can recover more in­
formation from single peptides, PMF still plays an important role. Indeed, 
as more genomes are sequenced, and cross-species matching methods are 
developed, PMF may assume greater importance for many sub-proteome 
studies.
PMF involves two basic operations. The first is processing o f the raw 
mass spectrum to derive a mass fingerprint, generating a data set in which 
the only variable is the mass o f  each peptide (relative intensities o f  different 
ions are not routinely used in PMF). A  hardware design o f a raw mass 
spectrum processor that performs this operation was presented previously 
(Bogdan et al., 2007). When implemented in FPGA hardware, this solution 
delivered almost 170-fold speed up compared to a conventional software 
implementation running on a dual processor server.
This paper addresses the second basic operation, which uses the peptide 
mass fingerprint to search protein databases for possible matches. Typi­
cally, a correlation score is computed between the database entries and the
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unknown peptide fragment mass list. The matches with the highest score 
are used to generate a candidate list o f  most likely proteins to have gener­
ated the PMF.
This paper describes the design and hardware implementation o f a highly 
parallel database search engine which, when searching the entire MSDB 
database, can generate the final candidate protein list in 240ms. The design, 
which was implemented and run on a Xilinx XC2V8000 FPGA at 
100MHz, achieves an average 1800-fold speed gain compared with an 
equivalent C software implementation, running on a single 3GHz Xeon 
Server with 4GBytes o f  memory.
2 METHODS
To create the raw data used to evaluate the FPGA implementation, single 
proteins were diluted with 50mM ammonium bicarbonate and digested 
with trypsin at a ratio o f  protein: enzyme o f 50:1. Digestion was carried out 
at 37°C for 24h after which time, lpl digested material was spotted onto a 
M ALDI target. This was mixed with lp l a-cyano hydroxycinnamic acid 
matrix and analyzed using a Micromass M @ LD I mass spectrometer (W a­
ters, Manchester, U K ) typically over the m/z range 800-4000.
The designs were implemented and tested on a modular and scalable re- 
configurable hardware platform, consisting o f a FPGA motherboard 
equipped with a Xilinx Virtex-II XC2V8000 FPGA (8 million gates) and 
4Mbytes RAM , communicating with the host PC server via a PCI interface. 
The motherboard has a Xilinx Virtex-II XC2V8000 FPGA, used to imple­
ment user designs -  in our case the spectrum processor. A  second, smaller 
Xilinx Spartan-II FPGA implements the PCI interface protocols between 
the server PC and the FPGA system. Communication between these two 
FPGA devices is at 40MHz on a 32 bit wide data bus. The motherboard can 
be configured to have up to three additional FPGA modules that can be 
plugged into dedicated motherboard slots (Figure 1). At present, only one 
o f these three modules has been used to implement the database search. 
Each FPGA module has one Virtex-II XC2V8000 FPGA device and 1GB 
o f DDR SDRAM that can hold the entire MSDB protein database (cur­
rently the encoded MSDB database is stored on a single module and takes 
about 680MB). Each module is connected with the motherboard FPGA and 
with the other two modules via a 64 bit, 66MHz local bus. This architecture 
enables the implementation o f  parallel searches at FPGA level as well as 
across modules.
The block diagram o f the FPGA implemented database search engine is 
illustrated on Figure 2.
In order to maximize database search speed, the search engine has been 
configured as a set o f 48 identical search processors that can process data­
base records (encoded protein streams) in parallel.
2.1 Database Encoding and Storage
In order to reduce communication overheads, the entire MSDB database 
was encoded and stored in the local 1 GB DDR SDRAM memory available 
on the FPGA module such that searching the database involves only on­
board, local memory access (Figure 1).
The MSDB database is available as plain ASCII text file. In practice, on­
ly 20 unique symbols are needed to encode all aminoacids together with 
some additional standard symbols adopted in the FASTA format. Two 
additional symbols are used to indicate the end o f a protein sequence and 
the end o f  the database. In total there are 28 symbols. These can be coded 
using only 5 bits (25=32 codes) instead o f  the minimum 8 required by the 
ASCn standard, which means that the effective size o f  the encoded data­
base is about 40% smaller than the original.
296 bits ..... y
60 bits------ _ .4 bits. L______ 60 bits .4 bits.
$ bits 6 bits 9 bits 5 bits
MSDB MSDB
RECORD MSDB RECORD MSDB
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Figure 1. Block diagram o f  the multi-FPGA system. Only one FPG A is used to 
implement the database search engine.
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Figure 2. Block diagram o f  the database search engine implemented in FPGA.
Figure 3. Storage o f  the coded database.
The 1GB DDR SDRAM memory available on the FPGA is organized in 4 
banks with a 64-bit wide data bus each. The total data bus width is 256 bits.
Each search engine has a 5-bit wide input, to receive a code-letter at each 
clock cycle from the database. Each memory module is able to supply 12 
data streams o f 5 bits synchronously to the corresponding 12 search en­
gines that connect to the output o f that RAM  bank. The method allows 
division o f the database into 4x12=48 data streams o f  consecutive records 
for parallel processing. Each data stream contains a variable number o f 
complete protein sequences, the unused memory locations, which could not 
hold an entire protein sequence have been padded with zeroes (Figure 3).
2.2. Database Search Processor
Each FPGA search processor performs the following basic operations
• In silico protein digestion and peptide mass calculation according 
to externally specified digestion rules and post-translational modi­
fications (currently only fixed modifications implemented).
• Matching score calculation, based on pre-specified mass tolerance
Search results consist o f  the indexes o f the identified species in the data­
base, the matched masses and the total score.
The block diagram o f the database search processor is presented in Fig­
ure 4. Each search engine is connected to a 5-bit data stream. It reads one 
code every clock cycle from the corresponding memory column and passes
I 2
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it to the digestion unit. The digestion unit is responsible for calculating the 
peptide masses according to the specified digestion rule/parameter. The 
digestion unit calculates the cumulative mass o f the aminoacids received 
until it encounters a cleavage site, protein record delimiter or the end o f 
database marker. The masses o f  individual aminoacids, used to compute the 
peptide masses, are stored into a look-up table as 32 bits fixed-point num­
bers. When calculating the peptide mass, additional PTM rules can be taken 
into account.
Figure 4. Database search processor block diagram.
Figure 5 shows examples o f  cleavage site rules. The aminoacid residues 
o f  the N-terminal side o f  the scissile bond are noted P I, P 2 ,..., P8 and the 
residues o f the C-terminal side are noted as PI*, P2’, ..., P8’ according to 
the Schechter and Berger nomenclature for the description o f the protease 
subsites (Schechter et al. 1967). Cleavage site rules are given according to 
this notation.
[ s c is s il e  b o n d ]
*0— — EP
EXAMPLES OP CLEAVAGE SITE RULES
Enzyme P1 PI* p y
Arg-C R X X
Aap-N X D X
Chymotrypsin 1 F .Y .W X X
Chymotrypsin 2 A.L.M .F.Y.W X X
Clostripa ln R X X
Glu-C 1 E X X
Glu-C 2 0. E X X
Lys-C K X X
Trypsin R .K X no t P X
Thermolysin X A.I.L. M, F.V X n o tP
CNBr M X X
Formlc acld D P X
Figure 5. Examples o f  cleavage site rules
The scoring unit counts the matches between the peptide mass finger­
print supplied externally and the peptide masses streamed out from the 
digestion unit. The precision o f the comparison between the m/z values to 
be searched (X\, X i, ..., X„) and the in-silico computed peptide fragments 
m/z values (Yt)  can be specified by the user-defined parameter R  that holds 
the desired error tolerance (as ppm) which may be dictated by the MS 
instrument accuracy. A  match is found i f
X M i <Yi < X P i,i  =  \,...,n
XM.  =  X,  1- 2 R 106 1 —106 • v - w - w
When a valid peptide fragment mass F,- is computed, it is compared in 
parallel to peptide mass fingerprintX\,Xi, ..., X„). In the current implemen­
tation n=13 so the computed peptide mass YI is compared in parallel with 
13 m/z values. The result o f the comparison is used to generate the basic 
cumulative score for every processed protein.
The number o f m/z values that are used in the search can however be in­
creased at the expense o f increasing the complexity o f  the design o f indi­
vidual search processors. This normally means that the number o f proces­
sors that can be allocated on a single FPGA (currently 48) may need to be 
reduced. Since the search can be easily deployed on multiple FPGA mod­
ules, performance can be preserved or even expanded by adding additional 
modules. Alternatively, the user can decide the best tradeoff between per­
formance and search strategy.
I f  a match is found, the score counter is incremented by one. The posi­
tion o f a match is also recorded in an n-bit (w=13 here) match index word. 
When the end o f a record is found, the record index counter, the score 
counter and the match index register outputs are stored in intermediate 
registers.
I f  a peptide fragment has multiple occurrences in a database record, and 
it is found to match one o f the m/z peaks from the input peptide mass fin­
gerprint list, the score counter is incremented only once, after the first 
occurrence. A  peptide fragment occurrence block is responsible for this 
function.
Each search processor has 3 outputs: a processing end flag that remains 
set after processing ends until the search processor is reset; an output index 
that remains set to the last available FIFO address where the total the num­
ber o f matches is stored and a 39 bits output that contains the results (data­
base index.
Results o f the 48 search engines are collected in dual port RAM  devices 
organized as FIFO structures o f  64 words o f 39 bits each. The user can 
specify a score threshold rso that only the matches that are above a thresh­
old are saved i.e. i f  the score o f  a given match is higher than a programma­
ble threshold r, the corresponding record index and match index are stored 
in the output FIFO.
The basic matching score can be used to implement more sensitive scor­
ing schemes which account for peptide frequency distributions such as 
MOWSE (Pappin et. al. 1993), PIUMS (Samuelsson et al. 2004) or more 
comprehensive Bayesian scoring approaches which also account for the 
individual properties o f the proteins analyzed such as ProFound (Zhang and 
Chait, 2000). These scoring schemes are have not yet been implemented in 
FPGA. Currently these scoring algorithms are run on the PC server. The 
extemalization o f the scoring statistics means that the output o f  the search 
can be rapidly evaluated using different scores, and even developed into a 
consensus score validation scheme.
23 . FPG A implementation
The actual database search design occupies about 99% o f  the FPGA’s 
logic resources, 99% o f the FPGA’s internal RA M  resources and 53% o f 
the FPGA’s I/O resources. The 1GB on-board RAM  is capable o f a data 
rate o f  lOOMHz/cycle which is the processing speed o f the implemented 
database search engines. However the data transfers between the separate 
FPGA devices are at slower speed o f 40MHz. The design includes all nec­
essary control and FIFO structures that implement a 64-bit wide data trans­
fer between the FPGA devices. The FPGA board was installed and tested 
on Single & Dual 3.06 GHz Xeon processor servers with 4GB RAM  under 
Windows XP Professional.
A ll arithmetic operations on the m/z values were performed using 32-bit 
unsigned fixed-point binary number representation o f mass and abundance 
values, with 12 bits after the radix point.
3  RESULTS
3.1 Speed gains
The MSDB database (31/08/2006) was encoded and loaded in the local 
1GB DDR SDRAM module memory. The database contains 3,239,079 
records with 1,079,594,700 effective code letters. I f  the additional separator
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codes are included the encoded database requires 1,082,833,779 symbols 
and occupies 67% o f  the available 1GB.
A  reference C program models the exact computational flow imple­
mented by the hardware design. In tests, the output results o f  both the soft­
ware and FPGA implementation o f the database search engine are identical. 
The C program was run on Single and Dual 3.06GHz Xeon PC servers 
under WindowsXP Professional. In all simulations the FPGA implementa­
tion matched correctly the simulated peptide mass fingerprints
The performance o f both software and hardware (FPGA) designs were 
assessed using a randomly selected database records that were digested in- 
silico using trypsin digestion rules. In each case, the search was carried out 
using 13 peptide m/z values selected randomly from the theoretical protein 
digests. The processing time for the software implementation accounts only 
for the main computational loop, after all variables have been initialized.
The FPGA system performs a complete database search in 240 
(±0.02)ms while the completed average processing time for the C imple­
mentation is 7.2min. As seen in Figure 6, the speed gain o f the FPGA over 
the C software implementation ranges from 1650-1950 fold average speed­
up.
Simulations
Figure 6. Speed gain o f  FPG A vs. C implementation o f  MSDB database search
The average processing time o f the C implementation on a dual proces­
sor server is 6.8min. The average speed gain in this case is 1695. It is worth 
noting that the search time quoted above could be reduced by pre-indexing 
the protein database -  this strategy is employed by commercial software 
solutions. Processing time on FPGA is not dependent o f the peptide mass 
fingerprint data set and has linear dependency with the database size. To 
illustrate this aspect we have performed FPGA searches using only the 
database o f Saccharomyces cerevisiae proteins. This database occupies 
only 0.277% o f the RA M  allocated for the full MSDB. In this case, the 
search time decreased to 0.66ms which represents 0.275% o f the full data­
base search time. In practice various subset databases can be loaded on-the 
fly the memory o f  the FPGA search module to carry out significantly faster 
single-species PM F searches, for example.
3.2 Experimental validation
We have tested the matching accuracy o f the FPGA system using peptide 
mass fingerprints generated from raw MALDI-TOF mass spectra. Raw 
MALDI-TOF data were processed using the mass spectra processor de­
tailed in Bogdan et al. (2007). The PMF consisted o f m/z values selected 
from the identified peak list after the elimination o f known contaminants 
such as trypsin and keratin.
In each case, the search was carried out using the FPGA system implemen­
tation and M ASCOT 0www.matrixscience.com1 with identical search pa­
rameters. In all cases, the same peptide matches were returned by both 
systems. For illustration, Table 1 shows the matching results from a batch 
o f ten mass spectra. Figure 7 shows examples o f raw and processed mass 
spectra for actin (chicken cardiac muscle). Table 2 shows the list o f  m/z 
values used in this particular search.
Protein No Matches -
FPGAMascot
A23022 actin, cardiac muscle - chicken 6
1HBRB chicken hemoglobin, beta chain - chicken 5 
KICHPM pyruvate kinase, muscle - chicken 8
G3P_CHICK Glyceraldehyde-3-phosphate dehydro- 6
genase (GAPDH).- chicken.
S12151 L-lactate dehydrogenase (EC 1.1.1.27) chainA -9 
chicken
PGAM1_CHICK Phosphoglycerate mutase 1 chicken. 4 
ISCHT triose-phosphate isomerase - chicken 7
KICHCM creatine kinase chain M  - chicken 7
HACH1 hemoglobin alpha chain - chicken______________ 5_____________
Table 1. Peptide matches returned by FPGA/Mascot searches for a set 
o f experimental MS data.
Peptide Mass Spectrum
mtz
Figure 7. Example o f raw and processed mass spectrum - actin. The 
PMF used to search the database is indicated by *.
4 DISCUSSION
We have successfully demonstrated that an MSDB PMF database search 
can be implemented in FPGA. I f  the FPGA database search module is 
integrated with the FPGA spectrum processor described in (Bogdan et ah, 
2007) the spectrum processing and database search time is around 241ms. 
This means that the complete hardware PMF solution can process and 
match 4 mass spectra per second. This figure can be enhanced i f  the data­
base search is distributed across multiple FPGAs and even with the current 
board it should be possible to achieve processing speeds o f 12 spectra per 
second. Further expansion is possible i f  more than one FPGA motherboards 
are configured. The current server could hold up to 3 FPGA boards so in 
principle such a reconfigurable computing node can deliver up to 36 PMF 
protein matches per second.
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PMF List (m/z) Matched peptide Error [ppm] 
masses by FPGA 
&  Mascot
1130.63 1130.54 79.6
1198.80
1307.76
1354.74
1364.83 
1374.86
1483.83
1198.70 83.4
1500.81 1500.70 73.3
1515.84
1547.87
1634.90
1515.74 66.0
1791.03 1790.89 78.2
1956.14 1956.04 51.2
Table 2. Example o f experimental PMF (actin) and the corresponding 
matched theroretical peptide masses. Tolerance was set at 250ppm.
As new genome sequences are completed, the size o f the corresponding 
proteome databases will also grow. In our tests, the whole encoded data­
base was loaded into the local memory available on the FPGA search mod­
ule. I f  more than one search modules are included, the database can be split 
and distributed across different search modules. Alternatively, it is rare for 
the experimenter not to know the species with which they are working, and 
a degree o f taxonomic restriction to generate a logically reduced database is 
entirely feasible. Encoded databases can be switched in and out o f FPGA 
RAM  very rapidly (~500ms for the full MSDB). Since the search speed 
increases linearly with database size, sub-setting the database is an efficient 
way o f increasing search speed.
At present the implementation does not include the flexibility to match 
variable post-translational modifications (www.unimod.org). There are 
several strategies that might be employed to permit such modifications, 
either by extension o f  the amino acid types (unmodified or modified) or by 
extension of the database entries to include fixed and variable modifica­
tions. However, the performance o f the current, minimally specified system 
is a powerful advocacy for extension o f the software to include modifica­
tion searching. Additionally, we have deliberately externalized to the 
FPGA the scoring algorithm, as this does not explicitly influence the search 
itself and therefore provides more flexibility for invocation o f alternative 
scoring methods (Piums [Samuelsson et ai. 2004], Peptident [Gattiker et ai. 
2002], MASCOT [Perkins et ai. 1999]), and the possibility o f consensus 
scoring approaches. Further work is underway to further optimize and 
refine the designs and to provide additional features and functionality.
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The 'protein world' exhibits additional complexity caused by post-translational modifications. One such 
process is nonenzymic deamidation of asparagine which is controlled partly by primary sequence, but 
also higher order protein structure. We have studied the deamidation of an N-terminal peptide in muscle 
glyceraldehyde 3-phosphate dehydrogenase to relate three-dimensional structure, proteolysis, and 
deamidation. This work has significant consequences for identification of proteins using peptide mass 
fingerprinting.
K e y w o rd s : D e a m id a tio n  •  p ro te o ly s is  •  p ro te in  s tru c tu re  •  a s p a ra g in e  •  a s p a rtic  ac id  •  p e p tid e  m a s s  
f in g e rp r in t in g
Introduction
The emergence o f new analytical methods for protein 
characterization has led to the recognition that there is an 
additional dimension of complexity in the protein world created 
by a wide range o f post-translational modifications. Some o f 
these modifications are specific and are part o f the obligatory 
maturation process o f a protein, such as the removal o f 
propeptides. Other changes are transient, reversible, and may 
only operate on a subset o f molecules in the protein pool (the 
best understood is phosphorylation). Other irreversible changes, 
such as deamidation or lysine aldehyde mediated cross-linking, 
are nonenzymic, and the longevity o f the protein may be 
reflected in the accumulation o f such changes.
Deamidation o f the side chain o f asparagine residues is a 
nonenzymic process1 (www.deamidation.org). The conversion 
o f asparagine to aspartic acid or isoaspartic acid elicits a local 
change in charge, and has the potential to impose a self-timer 
on protein molecules, altering activity or stability with lifetime 
kinetics.2-5 The ability to include a nonenzymic irreversible 
change into a protein that elicits a small steric change but a 
substantial local alteration in electrostatic potential could 
provide an opportunity to evolve a programmable irreversible 
change o f state into a protein. Most studies on asparagine 
deamidation have been conducted with model peptides6 which 
are essentially devoid o f higher order structure and which 
permit the peptide backbone and side chain to adopt a 
conformation compatible with the cyclic intermediate that is 
required for this reaction to take place. Since the flexibility and 
conformational freedom o f the peptide is modified by the 
nature o f the amino acids, the rate o f deamidation o f model 
peptides is strongly influenced by the flanking residues6 and 
the primary influence on the rate o f asparagine deamidation 
is the amino acid C-terminal to the asparagine residue. From
* To whom correspondence should be addressed. Phone: +44 151 794
4312. Fax:+44 151 794 4243. E-mail: r.beynon@liv.ac.uk.
studies o f model peptides, the highest rate o f deamidation is 
obtained when the carboxyl neighbor is glycine, yielding a half­
time for deamidation o f around 24 h.6 This is probably because 
the lack o f a Q3 atom minimizes steric hindrance and permits 
ready formation o f the five-membered imide conducive to the 
deamidation reaction. The N-terminal neighbor has a minor 
effect on the rate o f deamidation.6 While most o f our under­
standing o f rates o f peptide deamidation has derived from 
short, model peptides, the same sequences, when incorporated 
into protein structures, might acquire a relatively immobile 
backbone trajectory that could constrain the sequence to either 
favor or disfavor deamidation.
The resolution o f modem mass spectrometers used routinely 
in proteomic analyses permits ready resolution o f the monoiso- 
topic peptide-ion from the 13C isotopomer variants, even at 
charge states o f +2 or +3. At this level o f resolution, a 
deamidation event (Asn — Asp) would be readily recognized, 
as it elicits a mass shift o f +0.985 Da (-NH2 =  16.03 to -OH =  
17.01). In circumstances where a peptide exists as a mixture 
o f the amide and cognate acid species, a complex mass 
spectrum would ensue that appears as an atypical isotopomer 
distribution for a peptide o f that mass. It follows that partial 
deamidation events should be readily observed by examination 
o f the atypical profile, particularly without prior chromato­
graphic separation that would resolve the amide and cognate 
acid in chromatographic space.
In the course o f proteomics studies o f soluble proteins in 
skeletal muscle,7 we observed that a peptide from one protein 
in particular exhibited a noticeable and atypical natural isotope 
distribution profile, consistent with a mixture o f an asparagine- 
containing peptide and the cognate deamidation product. This 
peptide was derived from the N-terminus o f an abundant 
protein, glyceraldehyde-3-phosphate dehydrogenase (GAPDH). 
W e present here a comprehensive analysis that confirms that 
the ‘atypical’ isotope profile is in fact attributable to partial 
deamidation o f an asparagine residue. Deamidation o f -AsnGly-
10.1021/prt)70425l CCC: $40.75 ©  2008 American Chemical Society Journal of Proteome Research 2008, 7, 921-927 921
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Figure 1. Atypical peptide mass spectrum consistent with deamidation. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH; 1 mg/mL 
diluted to 0.2 m g/m L with 50 m M  am monium  bicarbonate) purified from  rabbit skeletal muscle (Sigma, Dorset, U.K.) was digested in solution 
with trypsin at a substrate/protease ratio of 100:1 by weight, and the masses of the resultant tryptic peptides were assessed by MALDI-ToF 
mass spectrometry; a coverage map is included at the top of the figure, w ith identified peptides indicated by a shaded block and those 
identified as part of a missed cleavage by an open block. The spectrum of a typical partial cleavage tryptic peptide (T10-11, m /z 1615.9) was 
compared with the mass spectrum predicted by the MS-lsotope tool (http://prospector.ucsf.edu/). This behavior, comm on to almost all other 
peptides, emphasized the atypical profile observed for the N-terminal partial cleavage peptide (T1-2, m /z 1032.6).
sequences occurs during sample preparation in proteomics,8 
and proteolysis conducted at lower pH and temperature will 
minimize artifactual deamidation.9 Here, we show that dea­
midation is constrained by higher order structure and is 
enhanced after release o f that conformational restraint by 
proteolysis. This observation has significance for the identifica­
tion o f deamidation events by protein or peptide mass 
spectrometry10-12 and reinforces the role that protein confor­
mation can play in this process.
Experimental Section
Materials and Reagents. Trypsin (sequence grade) was 
obtained from Roche Diagnostics (Lewes, U.K.). All other 
chemicals and solvents (HPLC grade) were purchased from 
Sigma-Aldrich Company Ltd. (Dorset, U.K.) and VWR Interna­
tional Laboratory Supplies (Leicestershire, U.K.).
One-Dimensional Gel Electrophoresis (1DGE). Purified 
GAPDH from rabbit skeletal muscle (Sigma, Dorset, U.K.) (10 
figi was electrophoresed through a 12.5% polyacrylamide gel 
and visualized with Biosafe Coomassie Brilliant Blue stain (Bio- 
Rad, Hemel Hempstead, U.K.). Gels were destained with a 10% 
acetic acid 10% methanol solution.
In-Gel Trypsin Digestion. Gel plugs containing GAPDH 
(identification confirmed by MALDI-ToF MS, results not shown) 
were excised from  ID  gels using a glass pipet and transferred 
to an Eppendorf tube. To each tube, 25 fiL o f 50 mM am­
monium bicarbonate, pH 8.2, and 50% (v/v) acetonitrile (ACN) 
was added and incubated at 37 °C for 20 min. This process 
was repeated until all o f the stain had been removed. The plugs
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were then washed in 50 mM ammonium bicarbonate, which 
was subsequently discarded. The gel was dehydrated using 5 
fiL o f ACN, and incubation at 37 °C was resumed for 30 min. 
Once dry, the gel was rehydrated in 50 m M  ammonium 
bicarbonate (9 juL) containing trypsin (IfiL o f 100 ng//rL trypsin 
stock reconstituted in 50 mM acetic acid), and digestion was 
allowed to continue overnight at 37 °C; the digestion was halted 
by the addition o f 2 piL o f formic acid.
MALDI-ToF Mass Spectrometry. Peptides were analyzed by 
MALDI-ToF (M@LDI; Waters, Manchester, U.K.) mass spec­
trometry. For this, 1 fiL o f digested material was mixed with 
an equal volume o f a-cyano-hydroxycinnamic acid in 50% (v/ 
v) ACN and 0.1% (v/v) trifluoroacetic acid. This was allowed 
to dry, and peptides were acquired over the range 900-3000 
m lz. For each combined spectrum, 20-30 spectra were ac­
quired (laser energy typically 30%) with 10 shots per spectrum 
and a laser firing rate o f 5 Hz. Data were processed using 
MassLynx software to subtract background noise using poly­
nomial order 10 with 40% o f the data points below this 
polynomial and a tolerance o f 0.01. Spectral data were also 
smoothed by performing two mean smooth operations with a 
window o f three channels. To confirm the assumption that both 
acid and amide forms o f the peptide ionize with equal signal 
response in MALDI-ToF MS, the synthetic peptide for the 
amide form was allowed to fully deamidate (by incubation at 
37 °C) and mixed in a known ratio with asparagine-containing 
peptide in a strong acidic solution to prevent further deami­
dation. The signal response from the two variants was identical.
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Figure 2. Esterification of acidic residues in the N-terminal peptide of GAPDH. Tryptic peptides recovered from an in-gel tryptic digest 
of GAPDH (purified from rabbit skeletal muscle, Sigma, Dorset, U.K.) were reacted with acetyl chloride and methanol to convert acidic 
residues to their corresponding methyl esters. The upper mass spectrum is the peptide resulting from partial deamidation of Asn6, 
thus, is a mixture of two forms (asparagine containing and aspartic acid containing). The lower spectrum, obtained after esterification 
has resolved the peptide into two distinct reaction products at 1046.63 m /z and 1061.65 m/z, consistent with the addition of one and 
two methyl groups (+14.03 Da), respectively.
In-Solution Tryptic Digestion. Soluble protein (purified 
GAPDH; 1 mg/mL) was diluted 10-fold with 50 mM ammonium 
bicarbonate prior to addition o f trypsin (100:1 substrate/ 
protease). The reaction mixture was incubated at 37 °C for 24 h, 
and peptides were analyzed by MALDI-ToF MS.
Esterification o f  Peptides. A  stock solution o f methanol (1 
mL, previously stored at -20  °C for 15 min) and acetyl chloride 
(150 uL) was prepared. An aliquot (10 //L) o f this mixture was 
then added to a dried portion o f the peptide pool recovered 
after in-gel digestion o f the protein. The mixture was incubated 
at room temperature for 45 min prior to drying in a vacuum 
centrifuge. Esterified peptides were analyzed by MALDI-ToF 
MS.
Monitored Proteolysis o f  GAPDH. Digestion reaction mix­
tures with trypsin were stopped at selected time points after 
addition o f enzyme by removing 10 pL  and adding to an equal 
volume o f 10% (v/v) formic acid. The fractions were subse­
quently stored at -2 0  °C until the end o f the time course. 
Peptides were analyzed by MALDI-ToF MS.
Data Processing. The natural isotope profile for the acid 
VKVGVDGFGR and amide VKVGVNGFGR variants o f the 
GAPDH N-terminal peptide were predicted using the MSIso- 
tope tool provided online within the Protein Prospector Package 
(http://prospector.ucsf.edU/ucsfhtml4.0/msiso.htm). The in­
tensities o f each isotopomer peak were added, and the com­
bined theoretical spectrum was compared with the intensities 
derived from the experimental mass spectrum. The sum o f the 
squares o f the deviation between predicted and experimental 
data was used to generate the object function, and the sole 
parameter (PA) was the proportion o f the acidic component 
(by definition, equal to 1 -  PN, where PN is the proportion o f 
amide). The nonlinear optimization function (Solver) within 
Excel was used to obtain the best fit value o f PA. Additionally, 
some samples were analyzed by a high speed spectrum
deconvolution tool, implemented as computer hardware in a 
field programmable gate array.13
Absolute Quantification o f  Proteolysis Using a Stable 
Isotope-Labeled Synthetic Peptide. The N-terminal peptide of 
GAPDH, o f sequence VKVGVNGFGR and neutral mass 1041.59 
Da, was synthesized by Sigma-Genosys (Dorset, U.K.) and was 
labeled at the arginine residue with both [13C6] and [15N4] giving 
a 10 Da mass offset from the analyte peptide. For quantification 
o f proteolysis, the synthetic peptide was added to digested 
material in 10% (v/v) formic acid to stop digestion and deami­
dation. Peptides were analyzed by MALDI-ToF MS, and the 
relative intensities o f analyte peptide and internal standard 
were used to quantify the amount o f peptide released from the 
protein during incubation with trypsin at 37 °C. As conversion 
o f asparagine to aspartic acid alters the isotope envelope o f 
the analyte peptide, the composite abundance o f the entire 
isotopic envelope for both analyte and internal standard 
peptide was summed in each case. These data permitted the 
kinetics o f proteolytic release o f the N-terminal peptide from 
GAPDH to be calculated and were used along with the kinetics 
o f deamidation to investigate the interaction between these two 
alternative processes. The rate o f deamidation was measured 
across the time course o f digestion by calculating the propor­
tion o f acid and amide variants o f the peptide at each time 
point. This was done during proteolysis o f GAPDH and for the 
synthetic peptide, at different temperatures.
Results and Discussion
One o f the most abundant soluble sarcoplasmic proteins in 
skeletal muscle is glyceraldehyde 3-phosphate dehydrogenase, 
amounting to 11 ±  1% (mean ±  SEM, n =  3) o f soluble protein 
when resolved by ID  gel electrophoresis (1DGE) and analyzed 
by densitometry (data not shown) and up to 500 ±  50 nmol/g 
(mean ±  SEM, n = 4) tissue when analyzed using the QconCAT 
method for absolute quantification.13-15 MALDI-ToF spectra
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Figure 3. Time course of deamidation of the N-terminal peptide 
of GAPDH. Purified rabbit skeletal muscle GAPDH (Sigma, Dorset, 
U.K.; 1 mg/mL diluted to 0.2 mg/mL with 50 mM ammonium  
bicarbonate) was digested with trypsin (trypsin/protein 1:100) 
over 24 h at 37 °C. Proteolysis was stopped at 0, 2, 5, 10, 30, 60, 
120, 240, 480, and 1440 min by mixing 10 f i t  from the digestion 
mixture with 10 f i t  of 10% (v/v) formic acid. The resulting 
peptides were analysed by MALDI-ToF mass spectrometry, and 
deamidation was monitored during proteolysis for the N-terminal 
peptide of sequence VKVGVNGFGR at 1032.59 mlz. The propor­
tion of acid and amide variants was assessed as described in 
Experimental Section, from peak height data, and plotted as a 
function of time (closed squares). Peptide envelopes illustrating 
the conversion of acid to amide form in MALDI-ToF mass spectra 
corresponding to time points over 24 h are inserted above the 
data. To compare this with model peptide studies, the N-terminal 
peptide of GAPDH, of sequence VKVGVNGFGR and mass 1041.59 
Da, was synthesised by Sigma-Genosys (Dorset, U.K.) and was 
labelled at the arginine residue with both [13C6] and [1BNJ giving 
a 10 Da mass offset from the analyte peptide. This peptide was 
incubated in 50 mM ammonium bicarbonate at 37 °C, and a 
sample of the peptide was added to an equal volume of 10% 
(v/v) formic acid at selected time points. The relative amounts 
of acid and amide variants of the peptide were measured using 
MALDI-ToF MS, and this was used to calculate the rate of 
deamidation. These data are presented as open circles. The solid 
lines are the trajectories taken by first-order decay for the 
synthetic peptide and the proteolyzed glyceraldehyde 3-phos­
phate dehydrogenase.
for this protein, isolated by 1DGE and digested with trypsin 
prior to MS analysis are o f high quality, give very high 
probability identification o f this protein (not shown), and yield 
approximately 20 peptides, ranging from 805.5 m lz  to 2265.4 
m lz. Close inspection o f each peptide indicated that for most, 
the observed mass isotopomer distribution was as expected, 
and was in close agreement to the distribution predicted by 
the Mslsotope program (http://prospector.ucsf.edu/). One pep­
tide in particular (VKVGVNGFGR (M +H ]+ 1032.58 m lz ) was 
notably different from the others, inasmuch as the isotope 
distribution profile was far removed from the predicted profile 
(Figure 1). In particular, the relative intensity o f the monoiso- 
topic ion was diminished, and o f lower intensity than the first 
[13C] isotopomer, a relative intensity pattern that is unexpected 
for a peptide o f  mass 1031.58 Da, given an empirical formula 
o f C46H78N 150 12.
The mass isotopomer envelope is consistent with the analyte 
being a mixture o f  two peptides, one o f monoisotopic m lz
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Proteolysis
(A.)
VKVGVNGFGR -----------------► VKVGVDGFGR
Deamidation
(A,)
Proteolysis
(A,)
(A,)
%)
VK + VGVNGFGR-----------------► VK + VGVDGFGR
Figure 4. Model of proteolysis and deamidation of the N-terminal 
peptide of GAPDH. The simultaneous processes of proteolysis 
and release of the N-terminal peptide of GAPDH followed by 
deamidation of the asparagine residue to aspartic acid were 
modelled according to this scheme. The model also included the 
subsequent proteolysis of the N-terminal peptide (VKVGVNGFGR 
or VKVGVDGFGR) at the internal arginine residue to generate a 
dipeptide and a truncated peptide (VK+VGVNGFGR or VK+  
VGVDGFGR). In this scheme, we assumed that the rate of 
deamidation was the same, whether in the full length or 
truncated N-terminal peptide, and that the rate of removal of the 
N-terminal dipeptide was independent of theamide/acid variants.
1032.58 and a second at a monoisotopic m l z  o f 1033.58. The 
higher m l z  peptide could have been a contaminant or it could 
have been generated from the peptide at m l z  1032.58. In the 
latter case, the most probable explanation for the mass increase 
was deamidation o f the asparagine residue, which, by conver­
sion to an aspartate residue, would increase the mass by 0.985 
Da ( -N H 2 to -O H ). To prove that the atypical profile was a 
consequence o f deamidation, we esterified the peptide mixture 
to convert carboxyl groups to their methyl esters. The mass 
shift on esterification would be 14.03 Da. Because the peptide 
V2KVGVNGFGR10 would possess a single carboxyl group in the 
amide form (the alpha carboxyl group), and two in the acid 
form, esterification should therefore deconvolute the atypical 
peptide into two products, one esterified at a single position 
(+14.03 Da), and a second modified in two positions (+28.06 
Da). When the peptide mixture was analyzed after esterifica­
tion, the MALDI-ToF ions in the 1032-1036 m l z  region 
disappeared, and two new ions appeared, one representing the 
single modified amide ( m l z  1032.58 +  14.03 =  1046.61) and 
the second reflecting the double modified acid ( m l z  1033.58 
+  28.06 =  1061.64; Figure 2).
From this analysis, it was not possible to assess whether the 
residue had deamidated in vivo or was an artifact o f sample 
preparation and processing. To assess the extent o f deamida­
tion o f this peptide in the native protein, we treated purified 
rabbit GAPDH with trypsin and monitored the proteolysis and 
the partition between the acid and amide variants o f the 
peptide in MALDI-ToF mass spectra (Figure 3; the same 
experiments were repeated for an in-solution tryptic digest o f 
chicken skeletal muscle soluble proteins and the same behavior 
was apparent, results not shown). The N-terminal peptide o f 
GAPDH (VKVGVNGFGR) was released within a few minutes 
and was readily detected as the first analyte ion to appear in 
the MALDI-ToF spectrum. In the early stages o f  digestion, the 
mass spectrum o f this peptide was entirely consistent with it 
being exclusively in the amide form. However, as time pro­
gressed during proteolysis, the mass spectrum o f the peptide 
showed that the peptide was converted to a mixture o f the 
amide and acid variants, and after 10 h of digestion, the peptide 
was over 80% in the acid form. The first-order rate constant 
for this process was approximately 0.0017 m in-1, which was 
higher than the value derived from model peptides; for the 
sequence NH2GVNGGOH, the first-order rate constant was
research articlesAsparagine Deamidation/Role o f Higher Order Protein Structure
Figure 5. Absolute quantification of proteolysis of the GAPDH  
N-terminus. Purified rabbit skeletal muscle GAPDH (Sigm a, 
Dorset, U.K.; 1 m g/m L diluted to 0.2 m g/m L w ith  50 m M  
am m onium  bicarbonate) w as digested with trypsin (trypsin/ 
protein 1:10) over 24 h at 37 °C. The N-term inal peptide of 
GAPDH, of sequence VKVGVNGFGR and mass 1041.59 Da, was  
synthesised by Sigm a-G enosys (Dorset, U.K.) and w as labelled 
at the arginine residue w ith  both [13C6] and [15N J  giving a 10 Da 
mass offset from  the analyte peptide. For quantification of 
proteolysis, the synthetic peptide was added to digested material 
in 10% (v/v) form ic acid to stop digestion at selected tim e points. 
Peptides w ere analyzed by M ALDI-ToF M S, and the relative 
intensities of analyte peptide and internal standard w ere used 
to quantify the am ount of peptide released from  the protein 
during incubation w ith  trypsin at 37 °C. Both the N -term inal 
peptide (VKVGVNGFGR/VKVGVDGFGR; m /z 1032.59 [M + H ]+ ; 
closed triangles) and the shorter peptide produced by further 
proteolysis (VGVNGFGR/VGVDGFGR; m /z805 .59  [M + H ]+ ; open 
circles) were m onitored. As conversion of asparagine to aspartic 
acid alters the isotope envelope of the analyte peptide, the 
composite abundance of the entire isotopic envelope for both 
analyte and internal standard peptide was sum m ed in each case. 
The solid lines reflect the fitted curves for the transient appear­
ance o f the N -term inal peptide (VKVGVNGFGR/VKVGVDGFGR) 
and the truncated product (VGVNGFGR/VGVDGFGR), m odelled  
and fitted as sequential first-order reactions (see text).
previously measured at 0.0004 min-1.16 However, the buffer 
conditions for the two experiments are not identical, and pH 
has a large affect on deamidation rate. The rate o f deamidation 
under these buffer conditions was confirmed using a synthetic 
peptide o f the same sequence; for this peptide, the rate o f 
deamidation was 0.0023 min-1. The higher rate o f deamidation 
o f the synthetic peptide might reflect an association between 
the partially digested protein and the N-terminal peptide which 
introduced a degree o f conformational ‘freezing’ o f the peptide, 
diminishing the deamidation rate, but this remains conjecture 
at present.
To investigate the kinetics o f both deamidation and pro­
teolysis, a synthetic peptide o f sequence VKVGVNGFGR, mass 
1041.59 Da, was synthesized and was labeled at the arginine 
residue with both [13C6] and [15N4] giving a 10 Da mass offset 
relative to the natural peptide. This peptide, identical to the 
N-terminal peptide o f GAPDH, was used to monitor the be­
havior o f the peptide, and for quantification.17 Because the 
N-terminal peptide itself contains an internal tryptic cleavage 
site (VK - VGVDGFGR), the peptide VKVGVDGFGR (summed
across acid or amide forms) decreased slowly as digestion 
continued. W e created a model (Figure 4) that took into 
account the sequential first-order processes o f proteolysis UcJ 
o f the native protein (N naüve) to release the amide form o f the 
peptide (VKVGVNGFGR) followed by deamidation (A^) to 
generate the acid form (VKVGVDGFGR).
k kn
^native ^  VKVGVNGFGR —  VKVGVDGFGR
Furthermore, the model also included a secondary process 
o f proteolysis o f the released peptide in either the acid or amide 
form to release the ValLys dipeptide. The rate o f  appearance 
o f the deamidated peptide is given by
VKVGV(N/D)GFGR —■ VK +  VGV(N/D)GFGR
W e assumed that the rate o f deamidation (A¿) was indepen­
dent o f the N-terminal ValLys dipeptide and that the rate o f 
tryptic removal o f the N-terminal dipeptide (fc4) was the same, 
irrespective o f whether the peptide was in acid or amide form. 
The change in amount (relative to the initial amount o f pro­
tein, A/natjve(t=0)) o f the larger peptides (VKVGVNGFGR +  
VKVGVDGFGR, N  + D )  as a function o f time, is given by
N  +  D  =  +  e^ ' ) )  (»
As part o f the same process, the shortened peptide (VGVNGFGR 
+  VGVDGFGR, ¿V +  U ) appears according to
N '  +  D '  =  N naJ l  -  - r - r r r e - ^ '  +  - ¡ - e M  (2)
Assuming that the rate o f tryptic cleavage is consistent for 
both acid and amide variants, from these equations, we were 
able to calculate the second-order rate constants (first-order 
rate constant divided by protease concentration) for initial 
release o f the large peptide (k¡) and the rate o f  proteolysis o f 
this large peptide (A )^ (Figure 5). The value o f fc, was estimated 
tobe  1.22 ±  0.025 min-1 -//M and for 0.50 ±  0.008 min-1 -/¿M 
(trypsin =  0.2 fiM). As expected, the endoproteolytic release o f 
the longer peptide is faster than the release o f the N-terminal 
dipeptide, as trypsin is known to act poorly as a dipeptidyl 
peptidase. However, the release o f the longer peptide is likely 
to be suppressed by the three-dimensional structure o f the 
protein.
To investigate the effects o f the higher order structure o f 
GAPDH on proteolysis and subsequent deamidation, we ana­
lyzed the X-ray crystal structure o f rabbit GAPDH (PDB code 
1J0X.PDB). First, we used the tool NickPred,18 which although 
designed to predict sites o f  proteolytic attack, can generate a 
comprehensive analysis o f the environment o f every residue 
in a protein sequence. The N-terminal region o f GAPDH is 
rather constrained, exhibiting low temperature factors (B- 
values) and low protrusion and accessibility (results not shown). 
Close inspection o f the structure in the vicinity o f Asn6 revealed 
this region o f the polypeptide chain was folded in an extended 
/? configuration, constrained by 14 hydrogen bonds in a 
network that might be expected to constrain main chain 
flexibility and therefore reduce the propensity for asparagine 
deamidation (Figure 6). However, once the peptide was re­
leased by proteolysis, deamidation proceeded at a higher rate 
than that predicted from model studies. These experiments are 
consistent with the following propositions; that the residue in
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Figure 6. 3D structure of rabbit skeletal muscle GAPDH. X-ray crystal structure of the N-termlnal region of rabbit skeletal muscle GAPDH 
(PDB code 1J0X) highlighting the Asn6Gly7 deamidation site and the local hydrogen bonded environment. The green dashed lines 
denote hydrogen bonds.
Time (min)
Figure 7. The effect of denaturing protein structure by heating 
on the rate of deamidation. GAPDH (1 mg/mL diluted to 0.2 mg/ 
mL with 50 mM ammonium bicarbonate) purified from rabbit 
skeletal muscle (Sigma, Dorset, U.K.) was digested with trypsin 
in solution at a ratio trypsin/protein 1:100 at 37 °C for 24 h. Prior 
to digestion, GAPDH was incubated for 1 h at 4 °C (open 
triangles), 1 h at 60 °C (closed squares), and 1 h at 60 °C followed 
by 24 h at 37 °C (open squares). For each, deamidation was 
monitored over 24 h proteolysis and the proportion of acid and 
amide was calculated from the relative peak intensities of the 
two ions in MALDI-ToF mass spectra.
the intact protein is exclusively in the amide form, that the 
tryptic fragment containing the amide residue can undergo 
deamidation, and that deamidation is not an artifact o f the 
mass spectrometric analysis. Excision o f the peptide from the 
GAPDH structure relieves the constraint in the peptide back­
bone trajectory, permitting the deamidation reaction to take 
place. It followed therefore that prior dénaturation o f the 
protein might permit deamidation prior to digestion with 
trypsin. We conducted experiments in which we denatured 
GAPDH by heating to 60 °C for 1 h before proteolysis (Figure 
7), a dénaturation treatment that was not sufficient to cause 
the protein to precipitate. Subsequendy, when trypsin was 
added, the N-terminal peptide was again released rapidly, and 
the proportion o f amide and acid variants o f the peptide was 
assessed as previously described. Under these circumstances, 
the peptide first released was approximately 80% amide, with 
a significant proportion o f acid form being measurable. This
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contrasted markedly with proteolysis o f the native protein, 
when the peptide is initially all in the amide form. We attribute 
this behavior to the increased conformational flexibility o f the 
peptide in the heat-treated protein, such that the peptide could 
acquire a conformation that allowed deamidation. Further, this 
unfolded and flexible component might be expected to be 
hypersensitive to proteolysis and to be released first. As the 
digestion proceeded, additional peptide in the amide form was 
released, and the proportion o f amide therefore increased 
transiently, until the deamidation reaction dominated the 
peptide profile. When the functions derived previously were 
used, we obtained a value for deamidation o f 0.0023 min-1, in 
close agreement with that observed previously. I f  the heat- 
treated peptide was allowed to incubate at 37 °C for 24 h after 
the 60 min denaturation period at 60 °C, and then proteolyzed 
with trypsin, the peptide first released was now only 50% in 
the amide form, consistent with extensive deamidation prior 
to proteolysis, consequential to denaturation. Again, as ex­
pected, proteolysis led to the slower release o f peptide that was 
constrained and unable to deamidate, and there was a transient 
increase in the proportion o f amide which again decayed at 
the same rate as observed previously (h, =  0.0024 min-1). The 
behavior o f the system was consistent with the GAPDH 
preparation being 76% in the amide form, and 26% in a 
denatured form that was then rapidly proteolyzed to generate 
the free acid form o f the peptide. The effect o f denaturation 
on the availability o f the N-terminal peptide o f GAPDH for 
deamidation is quite striking and defines the importance o f 
monitoring the two processes o f proteolysis and deamidation 
simultaneously, especially as this effect is only observed upon 
loss o f  higher order structure, and not upon increasing 
concentration o f protease (results not shown).
Conclusions
Deamidation is recognized as a potential source o f micro­
heterogeneity in protein structure, and it may play a significant 
role as a biological ‘timer’ that is mediated nonenzymatically.1-5 
Although many studies have emphasized the deamidation of 
short, flexible peptides, protein deamidation can be limited by 
higher order structure and might only occur at the peptide level
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following proteolytic release.8 The ease with which some 
peptides deamidated could then lead to the erroneous inter­
pretation o f a deamidation event as occurring in the intact 
protein. Difficulties o f measuring deamidation have been 
discussed,19 and analyses often use electrospray ionization 
mass spectrometry6 and reversed-phase chromatographic ma­
trices8 to resolve acid and amide variants o f a peptide, 
precluding analysis o f complex mixtures. There is also consid­
erable scope for MALDI sample ionization, which, when 
coupled with a simple esterification reaction, can clearly 
identify and characterize such deamidation variants. We sug­
gest that there may be merit in closer examination o f the 
isotope distribution profile o f peptide mass fingerprints, to 
search for anomalies such as that noticed here. In particular, 
it is advantageous to monitor deamidation and proteolysis 
simultaneously when characterizing post-translational behavior 
of known proteins and peptides. This will also unravel informa­
tion about the higher order structure o f a protein, the influence 
o f which not only on proteolysis but also on subsequent 
modifications to newly accessible regions o f the protein, is 
paramount.
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Absolute Multiplexed Quantitative Analysis of 
Protein Expression during Muscle Development 
Using QconCAT*
Jenny Riversf, Deborah M. Simpsont, Duncan H. L. Robertson^, Simon J. Gaskell§, 
and Robert J. BeynontH
Stable isotope-labeled proteotypic peptides are used as 
surrogate standards for absolute quantification of pro­
teins in proteomics. However, a stable isotope-labeled 
peptide has to be synthesized, at relatively high cost, for 
each protein to be quantified. To multiplex protein quan­
tification, we developed a method in which gene design 
de novo is used to create and express artificial proteins 
(QconCATs) comprising a concatenation of proteotypic 
peptides. This permits absolute quantification of multiple 
proteins in a single experiment. This complete study was 
constructed to define the nature, sources of error, and 
statistical behavior of a QconCAT analysis. The QconCAT 
protein was designed to contain one tryptic peptide from 
20 proteins present in the soluble fraction of chicken 
skeletal muscle. Optimized DNA sequences encoding 
these peptides were concatenated and inserted into a 
vector for high level expression in Escherichia coli. The 
protein was expressed in a minimal medium containing 
amino acids selectively labeled with stable isotopes, cre­
ating an equimolar series of uniformly labeled proteotypic 
peptides. The labeled QconCAT protein, purified by affin­
ity chromatography and quantified, was added to a ho­
mogenized muscle preparation in a known amount prior 
to proteolytic digestion with trypsin. As anticipated, the 
QconCAT was completely digested at a rate far higher 
than the analyte proteins, confirming the applicability of 
such artificial proteins for multiplexed quantification. The 
nature of the technical variance was assessed and com­
pared with the biological variance in a complete study. 
Alternative ionization and mass spectrometric ap­
proaches were investigated, particularly LC-ESI-TOF MS 
and MALDI-TOF MS, for analysis of proteins and tryptic 
peptides. QconCATs offer a new and efficient approach to 
precise and simultaneous absolute quantification of mul­
tiple proteins, subproteomes, or even entire proteomes. 
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As the field of proteomics matures as a discipline, there is 
an increasing realization of the importance of abso lute  as well 
as relative  quantification, and considerable effort is being 
directed toward experimental strategies to achieve this goal. 
Most commonly, relative protein quantification by mass spec­
trometry has been based on differential stable isotope label­
ing implemented by metabolic incorporation (1, 2) or through 
derivatization strategies such as ICAT (3). The mass-coded 
abundance tagging method (4) avoids the use of stable iso­
topes but requires assumptions concerning mass spectro­
metric response factors. To achieve relative quantification of 
proteins without isotope labeling or chemical modification 
steps, quantitative comparisons have been made of equiva­
lent sets of mass spectrometric data by considering peptide 
detectability in repetitively acquired spectra or by comparing 
integrated extracted ion chromatograms following liquid chro­
matography-mass spectrometry analyses (5).
In principle, any of the approaches adopted for relative 
quantification may also be used for absolute quantification if 
reference standards are available for all analytes in known 
amounts. When unknowns and reference standards are co­
analyzed, such approaches exploit the well established pre­
cept in analytical chemistry of internal standardization in 
which a known amount of a stable isotope-labeled (or other­
wise differentiated) standard is added to the analyte such that 
the response ratio between analyte and the heavier internal 
standard can then be used to quantify the unknown. However, 
for quantification of individual proteins in a proteomics study, 
the true internal standard would be the corresponding protein 
expressed in pure and stable isotope-labeled form and quan­
tified. This would be challenging on many fronts, including the 
expression of a native protein in a heterologous system to 
effect labeling, purification of the protein, and subsequent 
mass spectrometric analysis of the complex isotopic profile of 
the analyte and standard protein. Rather than adopt a protein- 
based approach, absolute quantification using proteotypic 
peptides as surrogates for the protein of interest has emerged 
using stable isotope-labeled peptide internal standards as 
“signature” or “proteotypic” peptides that are chemically syn­
thesized and incorporate stable isotopes (6-9). Each protein 
to be quantified requires at least one stable isotope-labeled 
peptide that must be independently synthesized at relatively
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high cost. Moreover each peptide must be separately purified 
and quantified (10). There is clearly a need for approaches 
that make this process more streamlined especially if multiple 
proteins are to be quantified.
We have recently introduced an efficient alternative to the 
chemical synthesis of multiple stable isotope-labeled pep­
tides (11). In brief, artificial genes are designed d e novo  to 
direct the synthesis of novel proteins that are assemblies of 
signature Qpeptides derived from a number of discrete pro­
teins. Usually these Qpeptides are arginine or lysine termi­
nated at the C terminus as they represent and will be internal 
standards for tryptic peptides derived from digestion of the 
analyte proteins. Appropriately flanked with added features 
including an initiator codon, a purification tag, and protective 
sacrificial regions, the gene is transformed into and expressed 
in a heterologous system, usually bacterial. The expression 
strain is grown in a chemically defined medium, uniformly 
isotopically labeled (for example, using 15NH4CI as the sole 
nitrogen source) or containing specific stable isotope-labeled 
amino acids at a high isotope enrichment such that the arti­
ficial protein becomes fully labeled. The artificial protein 
(termed a “QconCAT” for “quantification concatamers”) is 
purified by virtue of the affinity tag and quantified using a 
suitable procedure (12). The QconCAT is mixed with a com­
plex mixture of analyte proteins, and subsequent proteolysis 
releases both the stable isotope-labeled standard and the 
cognate peptide from the analyte. The known quantity of 
standard added can then be used for absolute quantification 
of the analyte. Because quantification of the QconCAT protein 
will define in absolute terms the quantity of each of the sur­
rogate peptides, the QconCAT strategy provides an efficient 
means to multiplex absolute quantification. Tryptic peptides 
are typically 10-15 amino acids long; thus proteotypic Qpep­
tides from 50 proteins could be encoded in a protein com­
prising 500-750 amino acids. The Qpeptides are present, by 
design, in stoichiometrically known amounts (usually equimo­
lar) so that each analyte peptide (and therefore protein) is 
simultaneously quantified.
Qpeptides are concatenated in the QconCAT protein out of 
their normal primary sequence context, and it is formally 
correct to point out that this different context could influence 
the quantification data (13). However, this can only occur if 
either the QconCAT or the analyte proteins are incompletely 
digested such that the yield of each peptide is incomplete. It 
is generally accepted that for most general proteases, such as 
trypsin, the K m for proteins and peptides is relatively high, and 
proteolytic reactions operating at substrate concentrations 
below this value exhibit pseudo-first order kinetics (14-16). 
Thus, if the rate of digestion of either the QconCAT or analyte 
was so low that six or seven reaction half-times could not 
elapse during the proteolytic reaction, there might be discor­
dance between the yield of the standard and analyte peptide. 
However, the main determinant of the rate of proteolysis of 
native proteins is higher order structure, not primary se­
quence context. Tightly folded proteins, particularly those 
with a high proportion of |3 sheet, are intrinsically resistant to 
proteolysis (17,18). There is no reason, a priori, to expect that 
QconCATs would adopt such tightly folded structures. Indeed 
their propensity to form insoluble inclusion bodies and their 
recovery by dissolution in strong chaotropes both mitigate 
against structural impediments to proteolysis. By contrast, 
unless care is taken in the prior dénaturation of analyte pro­
teins, their higher order structure would almost certainly influ­
ence proteolysis and could impact absolute quantification. 
We stress, however, that the incomplete analyte digestion is 
as much an issue for quantification using synthetic peptides 
as those using QconCATs. We address the issue of QconCAT 
and analyte proteolysis here and show that it is a factor that is 
readily controlled.
Deployment of a QconCAT experiment has many aspects 
that must be optimized. We demonstrate the use of a Qcon­
CAT for absolute quantification of a group of proteins that 
demonstrate dramatic changes in expression during develop­
ment of skeletal muscle in the chicken posthatching. We 
assessed the scope of the method and the magnitude and 
sources of variance that the method contains. We confirmed 
the value of guanidination (19) as a strategy to enhance pep­
tide ion yields in MALDI-TOF MS and showed that effective 
quantification is attainable and equivalent in both MALDI-TOF 
and ESI-TOF analyses.
EXPERIMENTAL PROCEDURES
M a teria ls  a n d  R e a g e n ts — Trypsin (sequence grade) was obtained 
from Roche Diagnostics. All other chemicals and solvents (HPLC 
grade) were purchased from Sigma-Aldrich and VWR International 
Laboratory Supplies (Leicestershire, UK).
P ro te o m ic s  A nalys is  o f  C h icken  S k e le ta l M u s c le  S o lu b le  F ra c tio n — 
Chickens (Institut de Sélection Animale (ISA) Brown layer and Ross 
308 broiler) were grown to 30 days posthatch, and animals were 
culled at 1 ,3 , 5, 10, 20, and 30 days at which time pectoralis muscle 
was collected (the above procedures were performed at the Roslin 
Institute, Edinburgh, UK). To isolate the soluble fraction of chicken 
skeletal muscle, 100 mg of breast tissue was homogenized in 0.9 ml 
of 20 m M  sodium phosphate buffer, pH 7.0, containing protease 
inhibitors (Complete protease inhibitors, Roche Applied Science). The 
homogenized sample was centrifuged at 15,000 x  g  for 45 min at 
4 °C. The supernatant fraction, containing soluble protein, was then 
removed. This was repeated, homogenizing the insoluble fraction in 
the same volume of sodium phosphate, and the pooled supernatant 
fractions were used for all analyses. The total protein concentration of 
each preparation was measured using a Coomassie Plus Protein 
Assay (Pierce).
For 1D1 SDS-PAGE analysis, 10 i±g of soluble protein samples 
(volume, 5 -10  /¿I) from birds of different strains and ages were each 
mixed with an equal volume of reducing sample buffer (1 ml of 0.5 m  
Tris buffer, pH 6.8, 1 ml of glycerol, 0.02 g of SDS, 0.01 g of brom- 
phenol blue, 0.154 g of DTT) and resolved by 12.5% (w/v) SDS-PAGE 
prior to staining with Coomassie Blue (Bio-Safe, Bio-Rad). Gels were
1 The abbreviations used are: 1D, one-dimensional; GAPDH, glyc- 
eraldehyde-3-phosphate dehydrogenase; AK, adenylate kinase; CV, 
coefficient of variance.
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destained with 10%  (v/v) acetic acid, 10% (v/v) methanol.
P rep ara tio n  a n d  P u rifica tio n  o f  Q c o n C A T — The artificial QconCAT 
gene (11) was expressed in E s ch erich ia  c o li with a full complement of 
unlabeled amino acids or in the presence of [13C6]lysine (100 mg/liter) 
and [13C6]arginine (100 mg/liter) as the sole source of these two amino 
acids. Expression was induced with isopropyl /3-D-thiogalactopyran- 
oside, and the cells were harvested by centrifugation at 1400 x  g  at 
4 °C for 15 min. Inclusion bodies containing QconCAT (as proven by 
digestion with trypsin and MALDt-TOF MS analysis; data not shown) 
were recovered by breaking cells using BugBuster Protein Extraction 
Reagent (Novagen, Nottingham, UK). Inclusion bodies were resus­
pended in 20 mM phosphate buffer, 6 m guanidinium chloride, 0.5 m 
NaCI, 20 mM imidazole, pH 7.4. From this solution, [13Cs]lysine/ 
arginine-labeled and unlabeled QconCAT proteins were purified sep­
arately by affinity chromatography using a nickel-based resin (HisTrap 
HP kit, Amersham Biosciences). Following sample loading, HisTrap 
columns were washed with 20 mM phosphate buffer, pH 7.4, prior to 
elution of the sample with the same buffer containing a higher con­
centration of imidazole (20 mM phosphate, 0.5 M NaCI, 500 mM 
imidazole, 6 m guanidinium chloride, pH 7.4) during which phase 
fractions (1 ml) were collected. The purified QconCAT was desalted 
by three rounds of dialysis against 100 volumes of 10 mM ammonium 
bicarbonate, pH 8.5, for 2 h using fresh buffer each time.
P ro te o m ic s  A n a ly s is  o f  Q c o n C A T  fo r  Q u an tifica tio n  o f  C h icken  
S ke le ta l M u s c le  P ro te in s — The QconCAT protein was diluted to 5 /xm 
in 50 mM ammonium bicarbonate and digested with trypsin (20:1 
substrate:protease) at 37 °C for 24 h after which the digest was 
incubated with additional trypsin (20:1 substrate:protease) to ensure 
complete digestion. Peptides were analyzed by MALDI-TOF MS 
(M@LDI, Waters, Manchester, UK). For this, 1 /xl of digested material 
was mixed with an equal volume of «-cyanohydroxycinnamic acid in 
50% (v/v) acetonitrile, 0.1 % (v/v) trifluoroacetic acid. This was allowed 
to dry, and peptides were acquired over the mass range 900-3000 
m /z . For each combined spectrum, 20-30 spectra were acquired 
(laser energy typically 30%) with 10 shots per spectrum and a laser 
firing rate of 5 Hz. Data were processed using MassLynx software to 
subtract background noise using polynomial order 10 with 40% of the 
data points below this polynomial and a tolerance of 0.01. Spectral 
data were also smoothed by performing two mean smooth operations 
with a window of three channels.
C o -d ig e s tio n  o f  Q c o n C A T  a n d  C h icken  S k e le ta l M u s c le  S o lu b le  
P roteins fo r  Q u a n tific a tio n — QconCAT protein was added in a 1:10 
(QconCAT:chicken skeletal muscle protein) ratio to chicken skeletal 
muscle soluble fraction samples taken from both broiler and layer 
strains at six time points during growth. For each time point, four birds 
were analyzed. The mixture was diluted 10-fold with 50 mM ammo­
nium bicarbonate, and 10% (v/v) acetonitrile was added prior to 
addition of trypsin (20:1 substrate:protease). The reaction mixture 
was incubated at 37 °C for 24 h, after which the digest was incubated 
with additional trypsin (20:1 substrate:protease) to ensure complete 
digestion. 1 /xl was analyzed by MALDI-TOF MS.
M o n ito re d  P ro te o ly s is  o f  Q c o n C A T  a n d  A n a ly te  P ro te in s — For 
QconCAT digestion, 150 /xg of protein was digested with trypsin at a 
ratio of trypsin:protein of 1:20 and 1:100 and stopped at selected time 
points after addition of enzyme by removing 15 /xl (containing 3 /xg of 
protein) and adding to an equal volume of 10% (v/v) formic acid. For 
analyte protein digestion, 50 /xg of protein was digested with trypsin 
at a ratio of trypsin:protein of 1:20 and stopped at 0 min, 30 min, and 
24 h after addition of enzyme by removing 25 /xl (containing 6 /xg of 
protein) and adding an equal volume of 10% (v/v) formic acid. The 
fractions were subsequently stored at - 2 0  °C until the end of the time 
course. For gel electrophoresis, fractions were dried down in a vac­
uum centrifuge and reconstituted in 10 /xl of reducing sample buffer 
prior to separation by 12.5% (w/v) 1D SDS-PAGE at 200 V for 45 min.
Analyte proteins were also digested in a solution containing 10% ACN 
(v/v) and with addition of enzyme following a 1-h incubation of the 
protein at 60 °C. To quantify proteolysis of analyte proteins, digestion 
of chicken skeletal muscle soluble proteins in solution with trypsin (as 
described above) was stopped at various time points during 24-h 
incubation at 37 °C by removing 20 /xl (containing 5 /xg of protein) and 
adding an equal volume of 10% (v/v) formic acid containing 0.5 /xg of 
predigested QconCAT peptides. Each fraction was analyzed by 
MALDI-TOF MS. This experiment was repeated using protein dena­
tured by incubation at 60 °C for 1 h prior to trypsin addition for 
comparison.
G u a n id in a tio n — To enhance the signal intensity of lysine-termi­
nated peptides in MALDI-TOF MS, lysine residues were converted to 
the more basic homoarginine by guanidination (20). This reaction was 
carried out by drying down the peptide mixture and reconstituting it in 
10 /xl of 7 m ammonia solution to which was added 5 /xl of 0.5 m 
O-methylisourea (in double distilled H20). This was mixed thoroughly 
and incubated overnight at room temperature prior to drying down 
and desalting using C 18 ZipTips (Millipore, Watford, UK).
L C - M S —  Peptide mixtures were analyzed by LC-ESI-Q-TOF MS 
using an EASY-nLC (Proxeon, Odense, Denmark) nanoflow system 
coupled to a Q-Tof micro (Waters). Nanoflow HPLC at 200 nl/min was 
used to resolve peptides (in 0.1%  (v/v) formic acid) over a 50-min 
acetonitrile gradient (0 -100% ). Peptides were acquired over the mass 
range 400-2000  m /z  with the capillary voltage set at 1900 V, collision 
energy set at 10 V, and sample cone set at 55 V for the entire 50-min 
gradient. The same reversed phase separation method was used to 
collect fractions (200 nl) directly onto a MALDI-TOF target for analysis 
by LC-MALDI-TOF MS.
A ss e s s in g  A na ly tic a l a n d  B io lo g ica l V ariance  in Q u a n tific a tio n — Ten 
identical aliquots of a chicken skeletal muscle soluble protein prep­
aration, to each of which was added a known amount of 
[13C6]arginine/[13C6]lysine-labeled QconCAT, were digested in solu­
tion with trypsin and analyzed to investigate analytical variance. This 
was compared with biological variance (four animals at each time 
point) achieved through quantification by MALDI-TOF MS (with and 
without guanidination), LC-ESI-Q-TOF MS, and LC-MALDI-TOF MS.
C o m p a riso n  o f  Q c o n C A T  M e th o d  w ith  A b s o lu te  Q u an tific a tio n  U s­
in g  a  S ta b le  Is o to p e -la b e le d  S y n th e tic  P e p t id e — Quantification by the 
QconCAT method was also compared with that achieved using a 
stable isotope-labeled synthetic peptide to quantify a single analyte 
protein also represented in the QconCAT. The peptide of sequence 
LVSWYDNEFGYSNR and mass 1748.77 Da representing the abun­
dant protein GAPDH was synthesized by Sigma-Genosys (Dorset, 
UK) and was labeled at the arginine residue with both 13C6 and 15N4 
giving a 10-Da mass offset from the analyte peptide. For quantifica­
tion, the synthetic peptide was added to broiler chicken skeletal 
muscle samples corresponding to six time points during growth with 
four replicate animals at each time point. Quantification data were 
obtained from analysis by MALDI-TOF MS using the relative intensi­
ties of the analyte and standard peaks as with QconCAT analysis.
In ves tig a tio n  o f  th e  A c c u ra c y  o f  Q u an tifica tio n  U s in g  Q c o n C A T — 
Purified adenylate kinase (AK; Sigma) was added to chicken skeletal 
muscle soluble fraction from a 30-day broiler. AK was added from 0 
to 0.02 nmol resulting in a final protein concentration of 0 -3 0 0  
nmol/g, and the amount of AK in the tissue was quantified by adding 
0.015 nmol of QconCAT prior to digestion with trypsin. Proteolysis 
was allowed to continue for 24 h after which peptides were analyzed 
by MALDI-TOF MS.
RESULTS
The QconCAT was designed to include surrogate peptides 
for 20 chicken skeletal muscle proteins. As chicken skeletal 
muscle matures posthatch, the protein distribution in the tis-
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sue changes dramatically from a large number of proteins that 
are expressed in similar amounts at hatch to a relatively few 
high abundance proteins after 30 days of growth (Fig. 1). From 
previous identification studies (21), the most abundant pro­
teins present in the soluble fraction of chicken skeletal muscle 
at this stage are predominantly the glycolytic enzymes. Other 
proteins, notably actin, have disappeared from the soluble
Broiler Layer
200 —
116 ~
— » «■» —-  ------- Glycogen phosphorylase
Albumin 
Pyruvate kinase
Beta enolase 
Creatine kinase 
Aldolase 
GAPDH
Lactate dehydrogenase
Phosphoglycerate mutase 
Triosephosphate isomerase 
Adenylate kinase
a.
Fig. 1 .1 D SDS-PAGE analysis of the soluble fraction of chicken 
skeletal muscle. Two different birds were compared at 1 and 30 days 
(d) after hatch for each strain. Soluble proteins (10 ^g; volume, 5-10  
juJ) were mixed in an equal volume with reducing SDS sample buffer, 
boiled for 5 min, and loaded onto a 12.5% (w/v) large format acryl­
amide gel prior to staining with Coomassie Blue (Bio-Safe, Bio-Rad). 
Gels were destained with 10% (v/v) acetic acid, 10% (v/v) methanol. 
Major proteins were identified by MALDI-TOF peptide mass 
fingerprinting.
.-aAAaAaaI IL .
L H
m m i  W  Wm
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L H
13 nm ol/g 23 nmol/g 72 nm ol/g 263 nmol/g
fraction of muscle by 10 days of growth, presumably reflect­
ing repartitioning and assembly of the myofibrillar apparatus. 
Finally serum proteins are detectable In muscle preparations 
at hatch but rapidly disappear during development. We as­
cribe this change to the increased exclusion of interstitial fluid 
as the muscle develops (22). To measure the absolute con­
centrations of specific proteins at various time points, we 
selected a group of 20 to be quantified using a single Qcon­
CAT. For each of the proteins, we chose a proteotypic peptide 
that gave a strong signal in previous MALDI-TOF MS analyses 
of tryptic digests. The peptides were used to guide construc­
tion of the DNA sequence of the QconCAT, which was syn­
thesized, inserted into a pET21a vector, and expressed in 
E. coli. Full details of the design and expression are given 
elsewhere (12).
For QconCAT expression, a typical bacterial culture of 200 
ml was induced at an A 600 of 0.6-0.8, which generated 5-10 
mg of QconCAT after cell breakage, recovery of inclusion 
bodies, and affinity chromatography of guanidinium chloride- 
solubilized protein on 1-ml nickel-nitrilotriacetic acid columns. 
After induction, the QconCAT protein was visible as a major 
band in 1D SDS-PAGE of a broken cell preparation (results 
not shown). After purification, the protein was homogeneous 
on 1D SDS-PAGE and was used without further purification 
(results not shown).
QconCAT protein was added in a 1:10 (QconCAT:chicken 
skeletal muscle protein) ratio to chicken skeletal muscle sol­
uble fraction samples taken from both broiler and layer strains 
at six time points during growth. For each time point, four 
birds were analyzed. This ratio was selected pragmatically 
based on the abundance of the major proteins in chicken 
skeletal muscle soluble fraction. The influence of dynamic
Raw spectral data
1D SDS-PAGE 
-----GAPDH
Spectral data 
normalised to a 
constant intensity of 
Internal standard
Quantification by 
QconCAT
f »
JLl IlJIl*
437 nm ol/g 448 nmol/g
1 3 5 10 20 30 Age <d)
Fig. 2. Quantification of GAPDH expression in chicken skeletal muscle. Soluble muscle proteins were prepared from pectoralis skeletal 
muscle of birds from 1 to 30 days (o) posthatching. Each sample (70 jug of protein) was mixed with a constant amount of QconCAT (7 p.g) and 
digested to completion with trypsin before analysis by MALDI-TOF mass spectrometry. The change in expression is measured using the 
relative peak intensity of the analyte and internal standard peptide at each time point. The dramatic increase in protein expression is more 
apparent when the spectra are normalized to a constant intensity of the internal standard. This change In protein expression Is also apparent 
by 1D SDS-PAGE analysis of chicken skeletal muscle soluble proteins in which a constant 10 f ig  of protein was applied to each lane. The 
amount of GAPDH at each time point during growth is also expressed as nmol/g of tissue as quantified using QconCAT.
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Fig. 3. Monitored proteolysis of 
QconCAT and analyte proteins by 1D 
SDS-PAGE. QconCAT protein (150 ¡xg) 
was digested with trypsin at an enzyme: 
protein ratio of 1:20 and 1:00. The diges­
tion was stopped at selected time points 
after addition of enzyme with 10% (v/v)
K formic acid. Chicken skeletal muscle soluble protein (50 yxg) was digested with trypsin at an enzyme:protein ratio of 1:20 and stopped at 0 min, 30 min, and 24 h after addition of enzyme with 10%  (v/v) formic acid. For gel electrophoresis, fractions from QconCAT protein diges­tion (a) and chicken skeletal muscle sol­
uble protein digestion (b) were dried 
down in a vacuum centrifuge and recon­
stituted in 10 /x\ of reducing sample 
buffer prior to separation by 12.5% (w/v) 
1D SDS-PAGE at 200 V for 45 min. Ana­
lyte proteins were also digested in a  so­
lution containing 10% ACN (v/v) and with 
addition of enzyme following a 1 -h incu­
bation of the protein at 60 °C. C K , crea­
tine kinase; B  e n o , /3-enolase.
QconCAT protein 
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Analyte protein 
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range on absolute quantification of proteins in complex bio­
logical systems is discussed below. After co-digestion of 
chicken skeletal muscle soluble fraction and [^CeJarginine/ 
lysine-labeled QconCAT, MALDI-TOF MS analysis of peptides 
produced highly complex mass spectra. However, 10 of 20 
proteotypic peptides could be identified in the composite 
spectrum without further sample processing and were there­
fore used for quantification. For these 10 proteins, for exam­
ple glyceraldehyde-3-phosphate dehydrogenase (Fig. 2), the 
change in protein expression can be measured during growth 
from 1 to 30 days posthatch by converting relative signal 
intensities of analyte and internal standard peptide ions into 
absolute quantities of analyte protein expressed as nmol/g of 
net weight breast muscle tissue.
The QconCAT was completely digested within 2 min such 
that no intermediate fragments were visible on SDS-PAGE 
(Fig. 3). When the trypsin was reduced to much lower levels 
(100:1 substrate:protease) and the digestion reaction was 
sampled at very short time intervals, there was some evidence 
for the appearance of partially fragmented intermediates, al­
though MALDI-TOF MS analysis of these bands, once di­
gested with trypsin, demonstrated that each “band” com­
prised multiple species, consistent with simultaneous tryptic 
attack on all scissile bonds at very similar rates. MALDI-TOF 
MS of peptides confirmed rapid digestion with all peptides 
detected within the first 2 min of digestion (data not shown).
By contrast, if the protein preparation from skeletal muscle 
was subjected to trypsin digestion at a ratio of 20:1 substrate: 
protease, many proteins were digested slowly, and even after 
24 h, undigested proteins were clearly visible including /3-eno- 
lase, creatine kinase, and triose-phosphate isomerase. If a
low concentration (10%, v/v) of acetonitrile was included in 
the digestion reaction, proteolysis was faster. If the protein 
mixture was denatured by heating to 60 °C for 1 h before 
digestion, the loss of higher order structure of the substrate 
proteins meant that the digestion reaction was essentially 
complete within 30 min.
To demonstrate the importance of complete proteolysis for 
accurate quantification, we conducted extended digestion 
reactions with chicken skeletal muscle proteins from 1- and 
30-day skeletal muscle. As reported previously and quantified 
here, these two preparations are dramatically different in the 
protein expression profiles (Fig. 1), providing different envi­
ronments for proteolysis. The protein preparations were di­
gested without treatment or after denaturation at 60 °C for 
1 h, and the appearance of the analyte peptide used for 
quantification was determined by the QconCAT methodology; 
we have previously shown (Fig. 3) that the QconCAT was 
efficiently and completely digested within 2 min. In all in­
stances, the analyte proteins were digested between 1.3 (AK) 
and 86 (/3-enolase) times faster after denaturation, and in 
some instances (for example, GAPDH from 1 -day muscle) the 
rate of digestion was very similar (Fig. 4). This is consistent 
with a model for proteolysis of the native protein in which the 
initial proteolytic attack exerts a destabilizing effect on the 
remaining structure such that the rate of proteolysis is in­
creased; the initial proteolysis is effectively rate-limiting. How­
ever, in the highly specialized 30-day muscle sample, there 
was virtually no digestion even after 6 h of proteolysis. Indeed 
for all proteins studied, the rate of proteolysis of native pro­
teins was diminished in the 30-day muscle sample; we sug­
gest that the acute specialization of this tissue, leading to a
>
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Fig. 4. Quantification o f proteolysis 
of analyte proteins using QconCAT.
Chicken skeletal muscle soluble protein 
(50 /xg) was digested with trypsin at an 
enzyme:protein ratio of 1:20 and 
stopped at selected time points with 
10% (v/v) formic acid and mixed with 0.5 
/xg of predigested QconCAT peptides for 
quantification. Each fraction was ana­
lyzed by MALDI-TOF MS. This experi­
ment was repeated using protein dena­
tured by incubating at 60 °C for 1 h prior 
to trypsin addition for comparison. Data 
are presented for four Individual proteins 
at both 1 and 30 days (d) after hatch 
digested over 30 h (for which the first 
500 min are shown) with trypsin both 
with (c lo s e d  triang les ) and without (o p en  
triangles) prior denaturation. For each, 
the rate constant (k) for digestion is ex­
pressed as h 1. C K , creatine kinase; B  
e n o , 0-enolase.
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Fig. 5. Isolation o f analyte-standard  
peptide pairs by reversed phase chro­
m atography. QconCAT protein (7 /xg) 
was added to chicken skeletal muscle 
soluble fraction (70 /xg of protein). This 
mixture was digested with trypsin and 
analyzed by LC-ESI-Q-TOF mass spec­
trometry. All peptide pairs for quantifica­
tion were present as doubly charged 
ions; there was no evidence of triply 
charged species. The u p p e r  p a n e l is the 
total ion chromatogram (T/C; base peak 
intensity) of the elution profile from 16 to 
29 min. The lo w e r  p a n e ls  are the ex­
tracted ion chromatograms (X/C) for rep­
resentative QconCAT peptides of doubly 
charged ions (j3-enolase, 699.6 m /z , 
eluted at 23.08 min; glycogen phospho- 
rylase, 725.0 m /z , eluted at 23.90 min; 
and triose-phosphate isomerase, 805.2 
m /z , eluted at 25.09 min) with corre­
sponding mass spectra showing analyte 
and QconCAT peptide ion pairs used for 
quantification presented as in sets  on the 
rig h t. L , light; H , heavy.
predominance of relatively few proteins, might introduce other 
factors that impede digestion, such as aggregation into su- 
pramolecular assemblies or partial inhibition of the trypsin. In 
all instances, extended digestion times (greater than 24 h) 
resulted in complete digestion and the same quantification 
value irrespective of the initial state of the analyte protein 
preparation.
Variation in ion signal response is inherent with MALDI-TOF 
MS analysis (23). In particular, arginine-terminated peptides 
are known to yield more abundant signals than those termi­
nated with lysine (24). In a complex MALDI-TOF mass spec­
trum, peptides that are abundant and have a high response 
factor dominate the spectrum. Theoretically proteolysis of a 
complex proteome (for illustration, 10,000 proteins) could
aos
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Fig. 6. Quantification using M ALDI-TOF or ESI-MS. Soluble pro­
teins from chicken skeletal muscle (70 /xg, n  =  4, covering 1 to 30 
days posthatch) were individually mixed with QconCAT protein (7 jug) 
and digested to completion with trypsin. The entire peptide mixture 
was analyzed by MALDI-TOF MS or by nanoflow reversed phase 
HPLC prior to ESI-MS, and the absolute tissue content of each of four 
proteins (triose-phosphate isomerase, glyceraldehyde-3-phosphate 
dehydrogenase, (3-enolase, and a-actin) was assessed from relative 
intensities of light (analyte) and heavy (standard) pairs. The absolute 
amount of each protein was compared using the alternative forms of 
mass spectrometric analysis.
generate 10s-106 peptides (at ~50 tryptic peptides per pro­
tein), the dynamic range of which will be such that only the 
most abundant peptides and those that ionize particularly well 
will be identified. To achieve increased signal intensity from 
lysine-terminated peptides, guanidination has been used to 
convert lysine into the more basic homoarginine by reaction 
with O-methylisourea (20). Guanidination of a tryptic digest 
was effective at increasing the signal intensity of lysine-termi­
nated peptides in the QconCAT and the analyte sample to 
allow quantification of two more analyte proteins by MALDI- 
TOF MS. To improve resolution of peptides for quantification, 
samples were also analyzed by LC-ESI-Q-TOF MS (Fig. 5). 
The alternative ionization mode coupled with the benefit of 
separation of peptides by reversed phase chromatography 
allowed quantification of a further six proteins previously not 
identified by MALDI-TOF MS and confirmed quantification 
data for many of those that had previously been analyzed. 
Extracted ion chromatograms for unlabeled (analyte) and la­
beled (QconCAT) peptides were used to locate the ions, and 
the chromatographic boundaries of the coincident pair of 
peptides were used to delineate the combined mass spectra 
from which peptides were quantified by mass spectrometric 
intensities of the doubly charged ions; there was no evidence 
of multiply charged ions, for example [M +  3H]3+ correspond-
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F ig . 7. Quantification o f chicken skeletal muscle protein ex­
pression by QconCAT. Soluble protein derived from broiler and layer 
chickens (70 jxg) was mixed with QconCAT protein (7 /¿g) and di­
gested to completion with trypsin. The digests were analyzed by 
MALDI-TOF MS (with or without with guanidination) or LC-ESI-Q-TOF 
MS. For five proteins (triose-phosphate isomerase, a-actin, /3-eno­
lase, glyceraldehyde-3-phosphate dehydrogenase, and actin polym­
erization inhibitor) multiple methods were used to quantify a single 
protein during growth; these data have been plotted separately ad­
jacent to the alternative data set, and these have been grouped below 
the x  ax is . Each cluster of data represents six time points during 
growth (1 ,3, 5 ,1 0 , 20, and 30  days (d)) for four birds of each strain at 
each time point. The data are presented as the absolute tissue 
amount and expressed as mean ±  S.E. Mass spectra are included for 
proteins adenylate kinase, a-actin, and tropomyosin A to highlight the 
difference in relative signal intensity. For proteins expressed as 0  
nmol/g, ions corresponding to analyte peptides were not present in 
the spectrum (see spectral data for tropomyosin (T M ) A). TP I, triose- 
phosphate isomerase; E n o , enolase; M y o , myosin; A P I, actin polym­
erization inhibitor; PK, pyruvate kinase; CK, creatine kinase; L D H , 
lactate dehydrogenase; GP, glycogen phosphorylase; H , heavy; L, 
light.
ing to analyte-QconCAT pairs (Fig. 5). Quantification data for 
four proteins over 30 days of growth obtained by both meth­
ods of MALDI-TOF MS and LC-ES-Q-TOF MS showed excel­
lent agreement such that the correlation coefficient was 0.977 
(Fig. 6). All proteins that could be quantified by MALDI-TOF 
MS (with and without guanidination) and LC-ESI-Q-TOF MS 
were expressed as nmol/g of pectoralis muscle tissue. The 
data were obtained during growth from 1 to 30 days post-
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Fig. 8. Sources of variance in a QconCAT experiment. Soluble 
protein from chicken pectoralis muscle (70 p,g) was mixed with Qcon­
CAT protein (7 pg) in four technically replicated experiments and 
digested to completion with trypsin. For each protein, individual data 
points are plotted to the le ft  of mean ±  S.E. for the same bird where 
n  =  4 (a) and for four different birds to demonstrate biological vari­
ance (to). 6  e n o , /3-enolase; C K , creatine kinase; P K , pyruvate kinase.
hatch for four birds at each time point for chickens of the layer 
and broiler strains (Fig. 7). Some proteins demonstrated mas­
sive pool expansion, whereas others declined to a similar 
degree, covering a measurable dynamic range across all pro­
teins of 10-550 nmol/g for a single protein (GAPDH) and as 
low as 2 ±  1 nmol/g (a-enolase; 1-day broiler). Thus, in a 
single experiment we were able to assess protein concentra­
tions over a 300-fold range.
To assess variance due to the analytical procedure, four 
identical protein mixtures (100 pi of chicken skeletal muscle 
(2.6 pg/pl) with 9 pi of QconCAT (2.9 pg/pl)) were digested 
with trypsin, and the surrogate peptides were used to quantify 
proteins by MALDI-TOF MS. Quantification data were col­
lected and used to assess analytical variance (Fig. 8a). The 
reproducibility of the method was high, and the variance was 
similar whether four or 10 replicates were used. In both in­
stances, the analytical variance was significantly lower than 
that for quantification data measured for four different birds of 
each strain (Fig. 8b). For example, the analytical variance (CV 
of 6.0% for /3-enolase, n =  4) compared favorably to biolog­
ical variance (CV of 24.0% for /3-enolase, n =  4). Increasing 
the number of analytical replicates to 10 had very little effect 
on analytical variance (CV of 6.0% for /3-enolase, n  = 10; data 
not shown).
For some aspects of quantitative proteomics, MALDI-TOF 
MS has advantages. Data can be accumulated for a variable 
number of laser shots, ensuring comparable signal intensities 
between replicates. Virtually all of the signal resides in the 
singly charged [M + H]+ ion, whereas with electrospray ion­
ization, the signal can be distributed over a number of differ­
ently charged species. However, for complex analytical mix­
tures, the complexity of a MALDI-TOF mass spectrum, 
coupled with a noisy signal base line, can compromise quan­
tification. One approach to simplification of a MALDI-TOF MS 
analysis relies on prior fractionation of the peptide mixture 
before deposition of successive fractions on the MALDI target 
(25). Chicken skeletal muscle with added QconCAT was di­
gested and separated by reversed phase liquid chromatogra­
phy, and fractions (200 nl) were collected onto a MALDI target 
at 1 -min intervals for analysis by MALDI-TOF MS (Fig. 9). This 
provided an efficient detection system with peptides fixed in 
the solid phase for continued interrogation when acquiring 
data for quantification. LC-MALDI-TOF MS was used for anal­
ysis of a single chicken skeletal muscle sample to highlight the 
potential benefit of this method. This approach allowed quanti­
fication of the majority of proteins selected for incorporation into 
the QconCAT protein and consequently contributed additional 
information for quantification. Comparing quantification by LC- 
MALDI-TOF MS with both MALDI-TOF MS and LC-ESI-Q-TOF 
MS confirmed that all three methods of analysis give consistent 
and comparable quantification. This quantification can be sub­
tle, for example in monitoring isoform changes from embryonic 
to adult myosin as well as a change in state from free, soluble 
protein to that assembled within the myofibrillar apparatus (ac- 
tin). It is also possible to monitor expression of isoforms of the 
same enzyme for which Qpeptides differ only in a single amino 
acid (lactate dehydrogenases A and B).
Although there is nothing formally different between a 
chemically synthesized peptide and a peptide excised from a 
QconCAT by proteolysis, we compared the quantification of a 
single protein (GAPDH, which exhibits a dramatic change in 
abundance during posthatching development) using the 
QconCAT-derived peptide and the identical synthetic peptide. 
The correlation between data obtained using QconCAT and 
that obtained using the synthetic peptide was high (correla­
tion coefficient, 0.998) (Fig. 10), and quantification data were 
consistent using either internal standard. A small consistent 
discrepancy (less than 10%) between the two methods could 
be attributable to the method of quantification used for the 
two standards. The discrepancy between the synthetic pep­
tide and the QconCAT was reduced if we used the latter to 
quantify the former but was still present. We do not have an 
explanation for this residual discrepancy at present. We are 
confident, however, that the discrepancy is not attributable to
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Fig. 9. Quantification of proteins by LC-M ALDI-TOF MS. QconCAT protein (7 /ng) was added to a preparation of chicken skeletal muscle 
soluble fraction (70 /u,g of protein) in a ratio of 1:10. This mixture was digested with trypsin and analyzed by LC-MALDI-TOF MS. Peptides were 
separated over a  50-min reversed phase acetonitrile gradient (0-100% ), and fractions of 1 min (200 nl) were collected directly onto a Waters 
MALDI target. The u p p e r  p a n e l is the MALDI-TOF mass spectrum of the entire digest; the lo w e r  p a n e ls  illustrate three fractions collected from 
the reversed phase eluate at 23, 25, and 27 min. Representative pairs of analyte-standard peptides are highlighted. H , heavy; L , light.
incomplete digestion of the QconCAT (see Figs. 3 and 4). In 
the case of the QconCAT, we used a protein assay to deter­
mine the amount of protein as this was the same method used 
to quantify total protein in the analyte. For the synthetic pep­
tide, the quantity supplied by the manufacturer is too small for 
independent quantification, and it was necessary to assume 
that the quantity in the vial was indeed that specified by the 
manufacturer. The difference between the two standards was 
minor compared with the biological variance within the sys­
tem, would not contribute significant errors, and would be 
readily controlled by alternative QconCAT quantification strat­
egies (see “ Discussion”).
To assess the accuracy of a QconCAT experiment for quan­
tification, we spiked a known amount of AK into chicken 
skeletal muscle soluble fraction from a 30-day broiler. The 
amount of AK added was converted into protein concentra­
tion as nmol/g tissue and compared with the total concentra­
tion of AK in the tissue (nmol/g) as quantified using QconCAT 
(Fig. 11). As expected, there was a strong correlation (R2 = 
0.9992) with a slope of 1, indicating the lack of any systematic 
quenching effects over an extended dynamic range. Quanti­
fication of selected muscle proteins by the QconCAT strategy 
was also compared with densitometric quantification from 1D 
SDS-PAGE; the correlation of these methods was poor (data
not shown; R2 = 0.67), although the stain intensity was 
strongly proportional to the amount of protein loaded on the 
gel (data not shown; R 2 =  0.995). This is most probably due to 
the different affinity of individual proteins for the stain.
DISCUSSION
QconCAT methodology has considerable potential to en­
hance the scope and scale of quantitative proteomics by 
multiplexing stable isotope dilution assays using proteotypic 
peptides as surrogates for the proteins of interest. The spe­
cific novelty of the QconCAT approach is derived from the 
efficient means of simultaneous production of multiple inter­
nal standards. Unlike chemical synthesis, biological synthesis 
d e novo  is not beset by “difficult” peptides (for example those 
with runs of serine residues or with a large hydrophobic 
content) that can be problematic to synthesize chemically in 
high purity. Moreover QconCAT proteins can be labeled using 
any metabolic precursor from the remarkably inexpensive 
uniform 15N labeling using 15NH4CI as the sole nitrogen 
source in the medium to specific labeling with [13C6]Lys/ 
[13Ce]Arg, which ensure that, for tryptic proteotypic peptides, 
each has a constant mass offset of 6 Da. Incorporation of a 
second labeled amino acid that is variably represented in the 
QconCAT can also facilitate mass isolation of the standard.
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quantified by synthetic peptide
Fig. 10. C o m p a riso n  o f Q conC AT and syn th e tic  pep tide  fo r  
q u an tifica tio n . For one protein (glyceraldehyde-3-phosphate dehy­
drogenase), quantification was achieved relative to a QconCAT pep­
tide and the same peptide chemically synthesized. For both methods, 
the internal standards (2 p.g of QconCAT protein or 0.05 jug of syn­
thetic peptide) were added to 20 p.g of chicken skeletal muscle 
soluble protein prior to digestion with trypsin, and data were acquired 
using MALDI-TOF MS. The quantification by either method correlated 
strongly (u p p e rp a n e l) . The time-dependent developmental expansion 
of GAPDH (nmol/g of tissue, mean ±  S.E., n =  4) in broiler was 
monitored by QconCAT or synthetic peptide (lo w e r  p a n e l), d , days.
The imaginative application of metabolic labeling without the 
need for resynthesis of the QconCAT gene is an advantage of 
the approach that has yet to be fully exploited.
The QconCAT approach is robust to the choice of mass 
spectrometric method used. Each of the three methods used 
(MALDI-TOF MS, LC-ESI-Q-TOF MS, and LC-MALDI-TOF 
MS) allows quantification of individual proteins that are not 
detected using the alternative techniques, for example adult 
myosin and pyruvate kinase have only been quantified using 
MALDI-TOF MS, myosin-binding protein C and phosphoglyc- 
erate kinase have only been quantified using LC-MALDI-TOF 
MS (data not shown), and lactate dehydrogenase A has only 
been quantified using LC-ESI-Q-TOF MS. The ability to detect
and quantify each peptide incorporated in the original Qcon­
CAT protein is very dependent on the analytical context. 
Although the target Ionization method can influence the 
choice of proteotypic peptides, the opportunity remains to 
switch to other separation and ionization methods to gain 
quantification data for large numbers of proteins.
Although a chemically synthesized peptide and a QconCAT 
peptide are formally equivalent at the analytical stage, we 
compared the two approaches. Interestingly the two methods 
gave highly precise estimates of protein levels, but the meas­
ured values were different such that there was a consistently 
lower estimate of protein amount using the synthetic peptide 
when compared with QconCAT. Quantification of the Qcon­
CAT protein was achieved by colorimetric assay using the 
same method as used for the assessment of total protein 
concentration in the biological samples. Quantification of the 
synthetic peptide is based on amino acid analysis conducted 
by the supplier and was completed separately and prior to 
analysis with the mixture of analyte proteins. Indeed the quan­
tity of the synthetic peptide supplied (five vials of 1 nmol) was 
sufficiently low that independent quantification by the end user 
could be problematical. By contrast, we routinely prepare 5-10 
mg (approximately 250 nmol) of the QconCAT used here. The 
errors introduced by the method of standard quantification are 
small and, relative to the biological changes we measure here, 
are not significant. Flowever, future iterations of QconCAT pro­
teins will incorporate a common peptide for internal standard 
quantification by a synthetic peptide that can be labeled or 
unlabeled, depending on the labeling status of the QconCAT 
protein. This peptide, chosen because it ionizes well under 
MALDI or ESI, could then be used to quantify each QconCAT, 
normalizing all QconCAT data to a common, absolute standard. 
This common peptide, which is chemically synthesized, would 
be required in large amounts, and as such, purification and 
quantification of this peptide could be conducted to a very high 
level of confidence. By creating such a “gold standard” for 
quantification, data from all laboratories using QconCATs (the 
same or different) could be compared directly.
The application to absolute quantification of multiple pro­
teins within complex biological systems and the adaptable 
nature of the QconCAT to a variety of analytical systems is 
clear. For development of strategies for absolute quantifica­
tion, the QconCAT method provides a reproducible and rela­
tively simple system in which multiple proteins can be quan­
tified using alternative methods of mass spectrometry with 
chromatographic separation and chemical derivatization. We 
have made approximate estimates of the costs involved, and 
to quantify 50 proteins at one Qpeptide per protein, a Qcon­
CAT strategy is about 15% of the cost of comparable syn­
thetic peptides and would yield about 250 nmol of protein 
compared with 5 nmol of each synthetic peptide. The error in 
analytical replicates is small, but there can be no “holy grail” 
target performance of the analytical analyses. First provided 
that analytical variance can be demonstrated to be substan-
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Fig. 11. Investigation of the accu­
racy of quantification using QconCAT.
Purified AK was added to chicken skel­
etal muscle soluble fraction from a 30- 
day (d) broiler. AK was added from 0 to 
0.02 nmol, which resulted In a  final pro­
tein concentration of 0 -3 0 0  nmol/g, and 
the amount of AK in the tissue was quan­
tified by adding 0.015 nmol of QconCAT 
prior to digestion with trypsin. Proteoly­
sis was allowed to continue for 24 h after 
which peptides were analyzed by 
MALDI-TOF MS. The u p p e r  p a n e l shows 
the correlation between AK added and 
that quantified in the muscle using 
QconCAT after digestion with trypsin. 
Spectra showing the change in MALDI- 
TOF mass spectral signal intensity over 
the range of protein concentrations used 
in this experiment are shown b e n e a th .
<Uc
ou
O -£ 
cn =>
% I<u
E
<
1044.49
1045 49I
Onmol AK added
tially smaller than biological variance (as we have demon­
strated here and indeed the normal expectation), it might be 
argued that there is a much reduced need to perform analyt­
ical replicates and that the effort should be directed toward 
acquisition of greater biological insight by adding new biolog­
ical replicates.
For identification proteomics, little regard is paid to the 
completeness of the digestion of the analyte peptide; the goal 
is to generate sufficient peptides that are readily ionized 
and/or fragmented for unambiguous identification. Indeed 
most search engines are tolerant of and include options to 
match one or more than one “missed cleavage.” However, 
when the goal shifts to the more demanding task of peptide- 
based quantification, it is essential that due cognizance is 
given to the proteolytic reactions that generate the peptides 
that are to be used for quantification irrespective of the 
method. The goal has to be complete digestion, and there are 
several approaches that can be taken to ensure that this has 
occurred. This should also be checked experimentally. It 
would also be feasible to embed two Qpeptides for each 
protein in a single QconCAT or even two different QconCATs 
to enhance confidence, but we do not subscribe to the view 
that this is necessary in many instances. Finally our experi­
ence with a large number of QconCATs2 is that they are 
proteolyzed at rates that are far higher than analyte proteins.
2 J. Rivers, D. M. Simpson, D. H. L. Robertson, S. J. Gaskell, and 
R. J. Beynon, unpublished observations.
30d broiler
AKadded (n m o l/g  tissue)
In all of these QconCAT constructs, we made no attempt to 
preserve the primary sequence context of the Qpeptides, and 
it is clear that this is not an important factor in QconCAT 
design; the selection of suitable proteotypic peptides in the 
design phase is much more critical. In this regard, the recent 
work by Aebersold and co-workers (26) points the way toward 
more effective nomination of Qpeptides for QconCATs.
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ABSTRACT
Motivation: High-resolution mass spectrometers generate large 
data files that are complex, noisy and require extensive processing 
to extract the optimal data from raw spectra. This processing 
is readily achieved in software and is often embedded in 
manufacturers’ instrument control and data processing environ­
ments. However, the speed of this data processing is such that it is 
usually performed off-line, post data acquisition. We have been 
exploring strategies that would allow real-time advanced processing 
of mass spectrometric data, making use of the reconfigurable 
computing paradigm, which exploits the flexibility and versatility 
of Field Programmable Gate Arrays (FPGAs). This approach has 
emerged as a powerful solution for speeding up time-critical 
algorithms. W e describe here a reconfigurable computing solution 
for processing raw mass spectrometric data generated by 
MALDI-ToF instruments. The hardware-implemented algorithms for 
de-noising, baseline correction, peak identification and deisotoping, 
running on a Xilinx Virtex 2 FPGA at 180 MHz, generate a mass 
fingerprint over 100 times faster than an equivalent algorithm written 
in C, running on a Dual 3 GHz Xeon workstation.
Contact: D.Coca@sheffield.ac.uk
1 INTRODUCTION
The phenomenal advances in proteomics that have been made 
in recent years are readily attributed to advances in mass 
spectrometry (MS), notably soft ionization modes and tandem 
instrumentation, coupled with new tools for processing spectral 
data and database searching. The sensitivity and selectivity o f 
the current generation o f mass analysers is notable, and useable 
mass spectra can be recovered from vanishingly small amounts 
o f material. Perhaps the simplest MS method in proteomics is 
that o f peptide mass fingerprinting (PM F). PM F is a protein 
identification technique in which a protein is proteolyzed using 
an endopeptidase o f  defined specificity (usually trypsin) and the 
masses o f the ensuing limit peptide fragments are measured. 
The proteins are identified by matching the measured molecular
*To whom correspondence should be addressed.
masses o f these peptide fragments against theoretical peptide 
mass profiles generated from protein sequence database. 
PM F is readily delivered at high sensitivity through routine 
instrumentation such as M A LD I-ToF  mass spectrometers 
and although tandem MS approaches can recover more 
information from single peptides, PM F still plays an important 
role. Indeed, as more genomes are sequenced, and cross-species 
matching methods are developed, PM F may assume greater 
importance for many sub-proteome studies.
PM F involves two basic operations. The first is processing 
o f the raw mass spectrum to derive a mass fingerprint, 
generating a data set in which the only variable is the mass o f 
each peptide (relative intensities o f different ions are not 
routinely used in PM F). When the mass spectrum has been 
processed, the list o f masses are first filtered to remove spurious 
masses such as those derived from trypsin or matrix clusters, 
and the remaining peptide masses constitute the fingerprint 
that is used to search the protein databases for a possible 
match. A  correlation score is computed between the data­
base entries and the unknown peptide fragment mass list. 
The matches with the highest score form the final candidate 
protein list to be returned to the user.
A t present, the time required for processing o f the raw mass 
spectrum and the subsequent database search can exceed that 
o f acquisition o f the mass spectrometric data, especially 
by M ALD I-ToF, which boasts acquisition rates o f up to 200 
spectra/s. I f  PM F is to remain as a key method in proteomics, 
one compelling gain would be a system in which the raw spectra 
are processed and searched against the protein database in 
the same time frame as acquisition— this would give ‘real-time 
PM F ’ (RTPM F). However, for the goal o f R TPM F  to be 
realized, there remains the need for substantial acceleration of 
these two stages (spectrum processing and database searching).
A  very effective approach to speed up the computations is based 
on the development o f dedicated hardware processors that are 
optimized to perform specific algorithms. The acceleration, 
compared with the standard sequential microprocessor, is achieved 
by concurrent implementation o f different arithmetic and logic 
operations that make up a computational loop and by concurrent 
execution o f several computation loops. A  major drawback 
o f this approach used to be the prohibitive costs associated 
with manufacturing a dedicated integrated circuit (ASIC).
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However, the hardware implementation has become a 
much more cost effective solution due to the availability 
o f high-density field programmable gate arrays (FPGAs) and o f 
high-level system design and development tools, which make 
possible the implementation o f very complex hardware designs 
with almost the same ease as the software implementation. 
An FPGA is a large-scale integrated circuit that can be 
programmed (and re-programmed) after it has been manufac­
tured. Early attempts to use FPG A devices in bio-computation 
were made to accelerate gene sequence analysis (Fagin el al., 
1993). FPGAs, which are well suited for high-performance, 
high-bandwidth and parallel processing applications, have been 
successfully employed to speed up D N A  sequencing algorithms 
(Hughey 1996; Guerdoux-Jamet et al., 1997; Wozniak 1997; 
Lavenier, 1998; Guccione et al., 2002; Simmler et al., 2004). 
FPGAs were also used in the attempt to accelerate search o f 
substrings similar to a template in a proteome (Marongiu et al., 
2003). More recently, FPGAs have been used to accelerate 
sequence database searches with MS/MS-derived query 
peptides (Anish et al., 2005). This hardware-based solution 
can reportedly locate a query within the human genome about 
32 times faster than a software implementation running on 
a 2.4 GHz processor. A  hardware sequence alignment tool 
implemented in FPG A  is also available (Oliver et al., 2005).
In addition to developing approaches for real-time database 
searching, we have implemented FPG A solutions for proces­
sing o f raw mass spectra. This article describes the design and 
hardware implementation o f a mass spectrum processor which 
performs all computational tasks involved in the generation o f 
a mass signature from a raw spectrum namely, smoothing, 
peak detection and the coalescence o f natural isotopomers into 
a single mass ( ‘deisotoping’)- The mass spectrum processor, 
which is implemented on a Xilinx XC2V8000 FPG A and runs 
at 180 M Hz, achieves more than 100-fold speed-up compared 
with a C software implementation running on a dual 3 GHz 
Xeon Server with 4 GBytes o f memory.
2 METHODS
A  M A L D I-T oF  mass spectrum o f a typical tryptic digest o f  a protein
generates pairs o f  mass-to-charge (m/z) and abundance values.
Typically, the number o f  points in the spectrum ranges from a few 
thousand to a few hundred thousand. The determination o f experi­
mental peptide masses (the so called peptide mass fingerprint) requires
relatively complex processing o f  the raw mass spectrum in order to
discriminate between spectral peaks that correspond to digested
peptides and the associated isotopomer peaks and the spurious peaks
caused by noise and sample contamination.
To create the raw data used to evaluate the FPG A  implementation,
single proteins and complex protein mixtures were diluted with 50 mM
ammonium bicarbonate and digested with trypsin at a ratio o f  protein:
enzyme o f  50:1. One protein that was used was an artificial QconCAT
protein chosen designed so that all tryptic fragments fell within the 
range 1000-2500m/z (Beynon et al., 2005; Pratt et al., 2006). Digestion 
was carried out at 37°C for 24 h after which time, 1 pi digested material 
was spotted onto a M A L D I target. This was mixed with 1 pi a-cyano 
hydroxycinnamic acid matrix and analysed using a Micromass 
M @ LD I mass spectrometer (Waters, Manchester, U K ) typically over 
the m/z range 800-4000.
The F P G A  spectra processor was designed to implement, with some 
variations, the algorithm proposed by Samuelsson el al. (2004).
The major difference is the method used by the F P G A  processor to 
implement aggregation o f  natural isotopomers (due primarily to the 
natural abundance o f  2 *13 *C and 1SN )— the algorithm implemented in 
F P G A  uses Poisson distributions to approximate the isotopic patterns 
for every peptide (Breen el al. 2000).
The algorithm described in Samuelsson et al. (2004) has several steps. 
First the baseline and noise levels are estimated over an arbitrary 
interval adjusted by user parameters, (<u and Cl) which divides the raw 
spectrum. The data points in the spectrum are classified compared with 
the level o f  noise and the baseline into noise, baseline and signal points. 
Then, peaks are constructed from a group o f  data points where at least 
one point has to be signal. In the next step the constructed peaks are 
grouped into clusters that are further processed to identify the 
monoisotopes.
The deisotoping algorithm proposed by (Breen et al., 2000), was 
preferred for F P G A  implementation. Here Poisson modelling is applied 
to determine monoisotopic masses (deisotoped peaks) from isotopically 
resolved groups (clusters). The abundances o f  the higher isotopic 
contributions for a monoisotopic peak are computed using Poisson 
distribution models that have been shown to match very well theoretical 
distributions (Breen et al., 2000).
A  good test o f  such an algorithm is in the deconvolution o f the 
overlapping mass spectra o f  a peptide containing an asparagine residue 
( ‘amide’) and its cognate acid product in which the side chain amide 
residue has been deamidated. The two mass spectra overlap by 1 Da, 
and effective deconvolution would be able to apportion the signal into 
the relative proportions o f  acid and amide.
The block diagram o f  the hardware processor is depicted in Figure 1. 
The implementation has two major functional blocks: a peak detection 
unit, which identifies all significant spectral peaks and a peptide 
identification unit that generates the final list o f  peptide masses and 
associated abundances.
The peak detection unit implements smoothing, baseline and noise 
level estimation in order to discriminate between signal and noise peaks. 
The first block implements a Savitzky-Golay smoothing filter (Savitzky 
et al., 1964) with a user-defined window that can be chosen according to 
the instrument resolution (number o f data points recorded per 1 Da). 
The smoothing operation is optional; the user can specify i f  the data is 
pre-processed or not. The Savitzky-Golay smoothing operation is 
implemented as a convolution o f the filter coefficients with the 
abundance input stream. A  delay equal to the filter latency (D E L A Y  
A  in Fig. 1) is applied to the mass values data stream in order to 
preserve synchronicity between the mass and abundance values. The 
number o f coefficients depends on the chosen window size. The 
maximum window size allowed is 43 which correspond to 43 x 43 
coefficients. The coefficient matrix is loaded into the F P G A  memory 
before processing operation starts. The smoothing operation is 
implemented as a single channel parallel filter using a Xilinx Logicore 
block (Xilinx, 2004). Smoothing improves the shapes o f  peaks which 
helps peak detection but slightly degrades the abundance values. Minor 
corrections can however be implemented to compensate the small 
diminution in abundance. Figure 2 shows the effect o f  smoothing a 
segment o f  real data with a Savitzky-Golay filter that has a polynomial 
order o f  11 and window (or frame) size o f 23.
The Y , Z, W  computation block computes the minimum (Z), 
maximum (Y ) abundances and their difference (W  =  Y  —Z ) over a 
small sliding window o f maximum length o f ai =  16 points, as described 
in Samuelsson et a l . ,  (2004). It has a structure similar to that o f a 
median filter that sorts in ascending order its input data stream over its 
filter length. Instead o f  computing the median, the maximum and 
minimum values are found.
The baseline and noise estimation block uses Y ,Z ,W  values to 
compute the baseline (Y  base) and noise level (Y  noise) over a larger 
moving window o f  length 12 x a> points, where 12 is a user-defined
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Fig. 1. Block diagram o f  the mass spectra processor implemented in FPG A .
Effect of smoothing
Fig. 2. Raw (dotted line) and Savitsky-Golay smoothed (solid) mass 
spectrum segment.
parameter (Samuelsson et a!., 2004). The (Y  noise) and (Ybase) values 
are used to compute the signal-to-noise ratio (S„) for every data point in 
the spectrum. This is compared with a threshold (r^ , which can be set 
by the user. Each abundance value is classified as noise, support or 
signal depending on whether the associated S„ value is S„ <  1,1 <  S„ <  r] 
or S„> ri, respectively. The outputs o f  the baseline and noise estimation
block are a 2-bit classification flag (flag =  1 -noise, flag =  2-support and 
flag =  3-signal) and the estimated baseline (32 bits) calculated for each 
abundance value. This data stream is aligned with the original 
mass-abundance pairs o f the input spectrum (Fig. 1).
The peak construction state machine generates a list o f valid peaks 
based on the 2-bit classification flag. A  peak is defined as the set o f 
mass/abundance data pairs that are either support or signal (flag =  2 or 
flag =  3) and are bounded by noise (flag =  1). The mass and abundance 
associated with each identified signal peak are calculated as the centred 
mass and the (baseline subtracted) peak maximum, respectively. The 
effect o f  the baseline subtraction is shown in Figure 3. The resulting 
peak list is written in a dual port R A M  block for further analysis.
The peptide identification unit consists o f  a clustering and a 
deisotoping unit. The peaks in a cluster correspond to the isotopes o f 
one or more singly charged chemical compounds, separated by the mass 
o f  a neutron. Clustering involves grouping together peaks so that the 
m/z distance between two successive peaks is between 1 -  r2 and 1 +  r2 
where r2 is another user selectable value, typically set to 0.2 
(Samuelsson el al., 2004).
The first block o f  the clustering unit ( ‘Cluster flag computation’) 
computes the distance between all consecutive signal peaks from a 
distance o f 1 + r 2 starting with the lowest mass value m,. To  speed up 
computations, there are p circuits that compute mass differences
m2 —nt].......mp+i —mi between ni] and the following p consecutive
mass values mt <m 2< .. .  <m p<m p+1 in parallel. In our design, p is an 
adjustable parameter, which is selected according to mass spectrometer 
resolution, to be equal to the maximum number o f  signal peaks that are 
registered within a window o f 1 +  r2. The parallel processing o f these 
peaks is implemented by a F IFO  (first in first out queue) structure 
o f length p. The data flow  through this circuit is depicted in Figure 4.
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Effects of baseline detection
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Fig. 3. Effects o f  baseline detection.
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Fig. 4. Data flow  for cluster flag generation.
This is the only example o f  explicit algorithm parallelization. The main 
approach used to speed-up computations is through instruction 
pipelining. This technique is particularly suited for mass spectra 
processing where the same sequence o f  operations is applied to a long 
data stream.
In the current configuration, for each mass value that is being 
processed, the clustering unit generates a p-bit cluster flag/. Typically 
about 50-100 samples per m/z unit are taken, so the F IFO  length is 
greater or equal to the number o f possible peaks in 1.2 m/z distance. 
Assuming that at least three measurement points define a signal peak, 
and there are 100 measurements in a unit o f  m/z, the maximum number 
o f constructed peaks in one m/z unit is 33 and in 1.2 m/z unit is 40. 
In the current design, p  is 32.
I f  the distance between m, and mk is within the range 1 ±  r2, the k -1 bit 
o f this word is set to 1 indicating that mk is a potential isotopomer o f  m ] . 
The mass values, abundance values and associated cluster flags are 
concatenated and stored in R A M  (A ) at consecutive memory locations 
(increasing mass) as a 3 2 +  32 +  32 + 1 2  bit word (32 for mass, 32 for 
abundance, 32 cluster flag and 12 bits reserved for further processing) 
as shown in Figure 5. These records are processed to group signal peaks 
into clusters. I f  all the bits o f the /  flag corresponding to mi are zero 
this indicates that m j has no isotopes. I f  the Jfcth bit o f  this word is 1 this 
indicates that the peak corresponding to the mk+i mass value is part o f 
the cluster having as the monoisotopic ion. Next, by analysing the
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32 32 12 32
MEMORY
bits bits bits bits
<5 k-ttl b it
0
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Fig. 5. Memory operations during clustering.
index f k associated with mk, it is possible to identify other peaks that 
belong to the same cluster. The process continues until the cluster flag 
associated with the last signal peak added to the cluster has only 
zero entries.
Clustering is implemented as a state machine that sequentially 
analyses the data stored in the first dual port R A M (A ) and generates 
clusters that are stored in the second dual-port R A M (B ). Each R A M  
block was configured to have 432 Kbits storage space (4 K b  address 
space and 108 bits word length) which can store 4096 peaks. The cluster 
flag associated with the latest signal peak added to the cluster is used to 
compute the memory address o f the next peak to be included in the 
cluster from R A M (A ). The peaks identified as belonging to one cluster 
are stored at consecutive memory locations in R A M (B ). Each cluster is 
also indexed with a number o f  12 bits called cluster index, a unique 
identification value for every cluster, stored with the member peaks. 
The memory content o f R A M (A ) before clustering and R A M (B ) after 
clustering is shown in Figure 5. The first peak from address 0 has a 
single bit set to one at the k-th position o f its cluster flag. This indicates 
that the peak stored at address k is part o f  the same cluster as the first 
peak. As a result the peaks 1 and k+ 1 will be stored in R A M (B ) at 
successive memory locations. In addition, to indicate that they are part 
o f the first cluster, both peaks will have their 12 bits cluster indexes set 
to 1, The cluster will not include more peaks because the peak at 
address k has its cluster flags null. The clustering process continues 
until all the peaks from R A M (A ) are visited. The result in R A M (B ) 
will be the same list o f  peaks, this time ordered by increasing cluster 
indexes and increasing mass values for peaks belonging to the 
same cluster.
For example, a cluster o f  eight peaks is shown in Figure 6. The peaks 
are situated at ~1 Da distance with m/z values: mi =2265.35,
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Clustered peaks
m/z
Fig. 6. Results o f clustering.
m2 =  2266.35 Da, m3 =  2267.34 Da, m4 =  2268.37 Da, m5 =  2269.37 Da, 
m6 =  2270.36Da, m7=  2271.39Da, m8 =  2272.29Da. In practice such a 
cluster has to be processed further since one cluster may contain more 
than one monoisotope, that is, the peaks in a cluster can be viewed as a 
superposition o f isotopic distributions.
The deisotoping unit isolates all monoisotopic masses in a cluster and 
calculates the total abundance o f  the peptide by summation o f  the 
intensities o f all o f  the isotopomers. The hardware algorithm 
implements deisotoping based on an approximation o f isotopic patterns 
by a Poisson distribution as proposed by Breen et al., (2000). Starting 
with the first peak in a cluster (usually the monisotopic peptide), the 
algorithm generates the theoretical isotopic distribution based on peak 
height (abundance) and mass value. The computed abundance values 
are then subtracted from the original peaks at the corresponding m/z 
values. Following subtraction, any abundance value below a user- 
specified threshold is set to zero. The step is then repeated, with the 
remaining (height adjusted) peaks. A t each step, the monoisotopic mass 
value, the original detected abundance and the total abundance are 
recorded in the final peak list. The deisotoping unit processes previously 
computed clusters from the dual port R A M  (B), writes back partial 
results in R A M  (B ) and the final peak list in R A M  (A ).
When the last peak from the cluster is visited, the total peptide 
abundance for every monoistope detected is stored back to R A M (A ), in 
the 32 bit area previously used to store the cluster flag f k+1. A t the same 
time, the cluster index information (last 12 bits) is overwritten with a 
flag set to 1 or 0 depending on whether the monoistopic peak at that 
address is above or below the threshold r3.
For example, the monoisotope peaks recovered from the previously 
clustered fragment displayed in Figure 6 are shown in Figure 7. In this 
example, two consecutive overlapping monoisotopomers are detected. 
The abundances o f  all the higher isotopes o f  each monoisotope are 
added to its original monoisotopic abundance. The first monoisotope 
has its summed abundance o f  867.7146 while for the second 
monoisotope the corresponding overall abundance is 4333.5933. 
When processing ends, the harvested peak list in R A M (A ) is ready to 
be used to search the protein database.
3 RESULTS
The processor was implemented on a FPG A motherboard 
equipped with a Xilinx Virtex-II XC2V8000 FPG A (8 million
Deisotoped peaks
Fig. 7. Deisotoping results. The cluster o f  peptide ions in the Figure are 
deconvolved into two species with overlapping isotopomer profiles.
gates) and 4 Mbytes ZBT RAM , communicating with the host 
PC server via a PCI interface (32 bit, 33 MHz).
On the motherboard there are two FPG A devices (Fig. 8). 
The bigger one (Virtex-II XC2V8000 FPG A ) is used to 
implement user designs— in our case the spectrum processor. 
The Xilinx Spartan-II FPG A implements the PCI interface 
between the server PC and the user FPG A from the mother­
board. Communication between these two FPG A devices is at 
40 M Hz on a 32 bits wide data bus. The motherboard has 
4 MB o f ZBT R A M  connected to the user FPG A as shown in 
Figure 9. This is enough to store 512 K  samples o f  mass- 
abundance pairs on 32 bits each.
The actual design occupies about 70% o f the FPG A ’s logic 
resources and 18% o f the F PG A ’s I/O resources. The server is a 
Dual 3.06 GHz Xeon processor machine with 4 GBytes RAM . 
The block scheme o f the system is given in Figure 8.
The mass spectrum is transferred into the ZBT R A M  via the 
PCI interface in two steps, first the mass and second the 
abundance data vectors.
The design can be easily ported, however, to a new version o f 
the motherboard that supports PCI-X standard (64 bits at 
133 M H z) which will allow transfer o f the abundance and mass 
data streams at the same time.
A ll arithmetic operations are performed using 32-bit signed 
fixed-point binary number representation o f mass and abun­
dance values, with 12 bits after the radix point.
3.1 Spectral processing
The basic steps in processing a mass spectrum are largely the 
same, irrespective o f the software used: smoothing, baseline 
subtraction and centroiding/deisotoping. For the FPG A based 
approach to be useful, the quality o f the processed spectra 
should be at least as acceptable as those processed by software. 
A  recombinant protein designed as an internal standard for 
multiplexed absolute protein quantification (Beynon et al., 
2005; Pratt et al., 2006) was digested with trypsin to release
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Fig. 8. Block scheme o f  the system.
20 limit peptides o f known identity. Digested material was 
analysed by M A LD I-ToF  MS and raw data was processed 
separately using MassLynx, a commercial mass spectrometry 
software, and FPGA.
Data was processed using MassLynx software to remove 
background noise using polynomial order 10 with 40% o f the 
data points below this polynomial curve and a tolerance o f 0.01. 
Spectral data was also smoothed by performing two mean 
smooth operations with a window o f three channels. The 
processed spectra were compared as a scatterplot o f the centroid 
intensity values (relative to base peak) for data analysed in each 
way. The centroided spectra are highly comparable and the 
FPGA identifies the same peaks as the commercial product 
(Masslynx). Moreover, the intensities o f the different peaks 
correlated well, irrespective o f  the method used to process the 
spectrum (Fig. 10) identified by the software.
3.2 Deconvolution
A valuable test o f effective deisotoping is provided by the 
resolution o f isotopomer distributions derived from asparagine 
containing peptides and the deamidated cognate peptide. 
I f  a peptide contains the sequence Asn-Gly in particular there 
is a marked propensity for this to be converted non-enzymically 
to Asp-Gly, with the result that the deamidated peptide is 
IDa heavier (-N H 2 to -O H ). We tested this part o f the analysis 
using M A LD I-ToF  peptide mass spectra derived from in-gel 
digestion o f glyceraldehyde 3 phosphate dehydrogenase. 
A  peptide generated by tryptic digestion has the sequence 
VKVG VNG FG R  (monoisotopic mass 1031.59Da, creating 
a singly charged ion [M +  H ]+ o f 1032.59m/z) which is 
readily deamidated to V K V G VD G FG R  (monoisotopic 
mass 1032.57 Da, creating a singly charged ion [M +  H ]+ o f 
1033.57m/z). To assess the ability o f  the FPG A  implementation 
to deconvolute complex and overlapping spectral data, 
we generated a set o f spectra for this peptide. The IDa mass 
shift on deamidation generates a series o f mass spectra that 
are strongly overlapping (Fig. 11).
Previously, we have assessed the proportion o f acid and 
amide by a non-linear least squares iterative curve fitting 
procedure that explains the observed mass spectrum by
1000 m /z  2000
Fig. 9. A  recombinant protein designed as an internal standard 
for multiplexed absolute protein quantification (Beynon el a!., 2005; 
Pratt et al., 2006) was digested with trypsin to release 20 limit peptides 
o f known identity. Digested material was analysed by M A L D I-T oF  
MS and raw data was processed separately using MassLynx software 
and FPG A .
optimizing the proportion o f acid and amide variants, 
from theoretical spectra for the acid and amide species 
generated using the Protein Prospector MSIsotope tool 
(http://prospector.ucsf.edU/ucsfhtml4.0/msiso.htm). The corre­
lation between the calculation o f acidiamide proportion 
was exactly the same, irrespective o f whether the FPG A 
implementation or the non-linear least squares method was 
used (Fig. 12). Thus, the hardware solution was able to 
deconvolute overlapping spectra with ease and yield the same 
results as previous methods.
3.3 Speed gains
The impact o f  the spectral length on processing time was 
measured using spectra with various lengths but constant 
isotopic composition and noise levels. The reference design was 
compiled in C and was simulated on a dual processor server 
using 3.06 GHz Xeon devices running Windows XP Professional 
operating system. The FPG A processor had an internal clock 
frequency o f 180 MHz. In order to evaluate how the number o f
729
¡.Bogdan et al.
-10 Peak intensity relative to base peak, MassLynx
Fig. 10. Measurement o f peak intensity by FPGA and commercial 
software.
data points in a spectrum relates to speed gain, spectra with 
different number of mass-abundance pairs were processed. The 
software processing routine was repeated 30 times for each mass 
spectrum data set and timed. The average time was used to 
calculate speed gains. It should be mentioned that the software 
processing time does not account for data transfers and memory 
initialization operations. Only the main computational loop was 
timed. Initializations for example, add on average 30 ms to the 
C processing time. The results are summarized in Table 1.
The average speed gain for processing spectra of different 
lengths is 122. Of course, implementations in instrument 
manufacturers’ software are somewhat slower, and spectral 
processing such as obtained here can take several tens of seconds.
It is interesting to note that on a single processor server 
having the same configuration as the dual processor—except of 
the number of processors—the average time of processing the 
largest spectrum of 200976 mass-abundance pairs was 
204.71 ms which corresponds to a speed gain of about 180.
Processing time is less dependent on the number of signal 
peaks in the mass spectrum. Although, clustering and 
deisotoping processes are time consuming and depend on the 
spectral composition (i.e. the higher the isotopic abundance, 
the larger the number of iterations that have to be performed), 
the number of monoisotopes and their isotopic contributions is 
far less then the entire spectrum data. As a consequence, peak 
identification, which involves processing the entire spectrum, 
represents the most time consuming operation, giving the bulk 
of the total processing time.
4 DISCUSSION
We have successfully demonstrated that processing of a mass 
spectrum can be very effectively implemented as a hardware 
solution in a high-density FPGA. The performance is
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Fig. 11. Test data for deconvolution o f mass spectra. A series of 
spectra were acquired for a peptide that undergoes deamidation using 
M A LDI-ToF mass spectrometry (left hand column). After processing 
the data with the FPGA implementation, the proportions of acid 
([M +  H ]+ =  1032.59m/z and amide ([M +  H)+ =  1033.59m/z) were 
calculated, and indicated on the processed spectra by vertical drop lines, 
headed by asterisks (right hand column).
comparable in terms of quality of the processed spectrum, 
and spectra can be processed at much higher rates than 
obtained through software alone. For example, our FPGA 
implementation of the PMF algorithm can process in 1 s over 
900 mass spectra consisting of 200 000 mass-abundance pairs. 
When implemented alongside a hardware implemented data­
base search algorithm, which should deliver a match in 
<100 ms, the goal of real-time peptide mass fingerprinting 
seems eminently achievable. Another very exciting prospect is 
that FPGAs will enable the fast execution of ‘intelligent’ 
optimization protocols of instrument settings and spectrum 
processing, which take prohibitively long time to run even on a 
high-end workstation. For example, the closed-loop multi- 
objective optimization approach proposed recently by O’Hagan 
et al. (2005), which employs Genetic Algorithms and Genetic 
Programming to determine optimal instrument settings and 
remove noise, reportedly takes from 20 min and up to 118 h to 
run.
The motherboard can be configured to have up to three 
additional FPGA modules that can be plugged into dedicated 
motherboard slots. These modules will be used to implement 
the database search. Each FPGA module has one Virtex-II 
XC2V8000 FPGA device and 1GB of DDR SDRAM that can
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% acid (least squares)
Fig. 12. Performance of the FPGA implementation in spectra 
deconvolution. The set o f mass spectra described in Figure 7 were 
used as source data for the calculation of the proportion o f  acid and 
amide whether assessed by a least squares method or using the FPGA 
implementation.
T ab le  1. Benchmark results o f the spectrum processor implementations
Spectrum
size
Timing [ms]: 
Dual Xeon 
3GHz processors
Timing [ms]: 
Virtex-II FPGA, 
180MHz clock
Speed gain
25488 20.27 0.1632 124.20
50448 31.23 0.3105 100.56
75168 47.33 0.4557 103.86
101 040 62.50 0.5607 111.46
125184 79.17 0.7557 104.76
150114 114.33 0.8547 133.76
175104 130.20 1.0024 129.88
200976 188.63 1.1219 168.13
easily hold the entire protein database. Each module is 
connected with the motherboard user FPGA implementing 
the spectrum processor and with other two modules via a 64 bit, 
66 MHz local bus. This architecture will enable the implemen­
tation of parallel searches at FPGA level as well as across 
modules.
There are three types of proteomics: identification proteo­
mics, characterization proteomics and quantitative proteomics. 
The core technology in many of these applications is mass 
spectrometry, but power of modern instrumentation brings
with it the penalty of highly information-rich data streams at 
very high rates. As such, the bottleneck is moving from data 
acquisition to data processing. In identification proteomics and 
in quantification proteomics in particular, hardware solutions 
such as described here, could solve this bottleneck, and increase 
proteomics throughput considerably.
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An important area of proteomics involves the need for quantification, whether relative or absolute. Many methods now exist for 
relative quantification, but to support biomarker proteomics and systems biology, absolute quantification rather than relative 
quantification is required. Absolute quantification usually involves the concomitant mass spectrometric determination of signature 
proteotypic peptides and stable isotope-labeled analogs. However, the availability of standard labeled signature peptides in 
accurately known amounts is a limitation to the widespread adoption of this approach. We describe the design and synthesis of 
artificial QconCAT proteins that are concatamers of tryptic peptides for several proteins. This protocol details the methods for the 
design, expression, labeling, purification, characterization and use of the QconCATs in the absolute quantification of complex protein 
mixtures. The total time required to complete this protocol (from the receipt of the QconCAT expression plasmid to the absolute 
quantification of the set of proteins encoded by the QconCAT protein in an analyte sample) is ~29 d.
INTRODUCTION
Most proteomics studies to date have delivered relative quantifica­
tion, expressing the changes in the amount of proteins in the 
context of a second cellular state or control sample1-3. Such studies 
do not facilitate the generation of large databases of results, with 
data not being transferable between different laboratories.
If proteomics is to support the emergent fields of protein 
biomarker discovery (whether in medical diagnostics or toxicology 
for drug discovery) or to provide the rigorous data needed for 
systems biology, absolute quantification is needed. Absolute quan­
tification relies on the well-established precepts of stable isotope 
dilution, specifically the use of labeled peptide internal standards 
that are characterized and quantified by mass spectrometry 
(MS)4,5. These internal standards are currently synthesized 
de novo by chemical methods. This requires the individual synthesis 
in labeled form, purification and quantification, of each peptide for 
use as an internal standard. Complex studies would require the 
synthesis of large numbers of peptides at significant cost, and each 
would have to be quantified individually.
We describe here a method for the design, expression and use of 
artificial proteins (QconCATs) that are concatamers of Q peptides, 
generated by chemical or endoproteolytic cleavage, for a group of 
proteins under study6. The QconCAT proteins are expressed in 
Escherichia coli and are readily labeled with stable isotopes by growth 
in the presence of stable isotope-labeled precursors. The labeled 
QconCAT proteins are then purified, quantified and added to com­
plex protein mixtures in known amounts. Endoproteolytic (and/or 
chemical) fragmentation of the QconCAT-analyte mix releases each of 
the QconCAT peptides in a strict stoichiometry of 1; 1, and MS analysis 
allows the quantification of each represented peptide of the analyte 
(see Fig. 1 for a schematic of the overall process). In the specific 
protocol described here we focus on the use of trypsin as the 
endoproteinase, but other endoproteinases and/or chemical cleavage 
could be used as an alternative method of generating suitably
sized peptides from the analyte and identical peptides, to act as 
internal standards, from the labeled QconCAT protein.
Unlabeled QconCAT proteins could also provide the basis for 
absolute quantification if differential isotope labeling via derivati- 
zation of proteins or peptides is incorporated in the analytical 
procedure. Use of the same QconCAT protein for each quantifica­
tion experiment allows direct comparison of results between each 
experiment and between laboratories, and will facilitate the con­
struction of the large data sets needed for toxicological and 
diagnostic studies in which even control samples vary considerably. 
We will also describe a refinement to the technique that even allows 
the quantification of the QconCAT standard between laboratories. 
Because the quantification data are in absolute terms—expressed, 
for example, as picomoles of protein per gram of tissue or per 
number of cells—knowledge of the number of molecules of a 
protein present per cell in a given state will underpin the generation 
of testable mathematical models in systems biology.
APPLICATIONS
QconCATs can be applied to the absolute quantification of any 
peptide that can be reproducibly generated by endoproteolytic or 
chemical cleavage from any sample source. Here we discuss only a 
sampling of the potential applications.
General
•  In comparative proteomics the shift from relative to absolute 
quantification permits comparison of results, not only 
between different cellular states within an experiment, but 
also between different experiments and different laboratories.
•  An unlabeled QconCAT could be subjected to labeling in vitro 
using one of the many reagents that have been advocated for 
comparative proteomics, enhancing all of these technologies 
to absolute quantification.
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Set of proteins to be quantified
•
•  For routine diagnostic tests, QconCATs could allow determi­
nation of levels of key biomarkers in clinical samples includ­
ing blood, urine, cerebrospinal fluid (CSF), synovial fluid and 
bronchoalveolar lavage.
•  QconCATs could allow the monitoring of changes in protein 
levels in response to exposure to drugs, as well as identifying 
changes relating to toxicology and routine monitoring of 
protein biomarkers to accelerate the process of drug discovery.
C .C
Assemble and design gene to 
encode concatenated signature peptides 
Synthesize gene and insert into expression vector 
Express protein labeled with stable isotopes
W
Mix QconCAT and analyte proteins 
Proteolyse to  completion
Purify and quantify QconCAT protein
MS analysis of ion intensities 
\  of each heavy:light pair yields 
..absolute amount of each protein
Figure 1 | General principle o f a QconCAT quantification experiment. *•
•  Systems biology requires absolute quantification, including 
the definition of processes in molecular terms and the gen­
eration of data to allow mathematical modeling.
•  Determination of the absolute stoichiometry of components 
in subcellular particles requires absolute quantification.
•  Analysis of isoform expression patterns (e.g., cytochrome 
P450s) is possible using this process. Each QconCAT peptide 
would report on a peptide that contains the variant amino 
acid(s), permitting one to distinguish among several variants.
•  QconCATs could be used to quantify many or all proteins 
expressed in a control strain or cell culture grown under 
standardized conditions. Subsequently, the same strain or cell 
culture would be labeled by growth in the presence of stable 
isotope precursors under the same conditions. These fully 
labeled cells would then be used as quantification standards in 
comparative studies. The indirect quantification approach has 
the advantage that, for the second quantification phase, any 
labeled peptide (not only those embedded in QconCATs) 
could be used, providing the opportunity for alternative 
enrichment and quantification approaches.
Medical
•  Diagnostic/protein biomarker validation and analysis could 
be facilitated by QconCATs for accurately measuring changes 
in the protein components of body fluids and thereby adding 
another dimension to computer training sets for identifying 
patterns indicative of disease.
Agricultural
This technology could be used in routine determination of levels 
of proteinaceous contamination from other sources in foodstuffs, 
for example, signatures from genetically modified sources. It 
would also facilitate monitoring of the effect of pesticides and 
herbicides.
Protein chemistry
QconCATs introduce the concept of ‘designer protein to proteo- 
mics. Specific QconCAT proteins could therefore be used to assess 
the properties of defined peptides in MS and MS/MS analysis.
Post-translational modifications
The use of QconCATs to study some post-translational modifica­
tions is limited, because only the unmodified analyte peptide can 
be quantified using a Q-peptide. Nevertheless, we can envisage 
two methods of using QconCATs to provide a preliminary study of 
post-translational modifications. One approach involves selecting 
a minimum of two peptides for each protein of interest; one 
peptide is not modified and the other is modifiable. Comparison 
of the quantification of the two peptides should allow the deter­
mination of the amount of modified peptide present. The second 
approach is to select the modified peptide as the Q-peptide to 
report on the protein and carry out the quantification before and 
after treatment of the sample to remove post-translational modi­
fications—for example, alkaline phosphatase to hydrolyze phos- 
phopeptides. Quantification before and after treatment will reveal 
the quantity of protein in the modified state. These methods are 
not, however, immediately applicable to the unraveling of more 
complex patterns of post-translational modification, in which 
several sites of modification are possible on the same peptide.
For some modifications, such as the primary sequence change 
elicited by limited proteolysis (such as apoptosis), it might be 
argued that QconCAT-type approaches are the only ways to 
accurately quantify the proteolysed and unproteolysed variants of 
the target analyte.
EXPERIMENTAL DESIGN
There are two stages in a QconCAT experiment: the design 
phase and the implementation phase leading to the construction 
of a QconCAT (Fig. 2). Once the design exists as a DNA sequence 
it can then be inserted into a suitable vector, transferred to a 
suitable expression system, expressed, labeled and used in quanti­
fication experiments. The first stage reflects the analytical and 
decision-making processes that encompass the nomination of 
candidate proteins and peptides, followed by their realization 
as a codon-optimized sequence in which opportunities for 
stable RNA secondary structure formation are minimized. A 
Gantt chart outlining the timeline for the procedure is given 
in Figure 3.
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Figure 2 | Overall workflow  for QconCAT quantification. A QconCAT experiment consists o f the design phase and implementation phase.
Design of QconCAT genes and construction of plasmids 
encoding QconCAT proteins
To quantify the group of proteins, a unique peptide (a Q-peptide) 
P  must be selected as a surrogate ‘signature’ peptide for each protein
to be quantified. This selection depends on the inherent properties 
of the peptide and the cleavage method chosen for the analysis of 
the analyte. There are no restrictions on the protein-containing 
samples that can be quantified using QconCAT technology. 
However, in the absence of complete genome information, full 
sequencing of the signature peptide (probably by tandem MS) 
would be required before incorporation of this peptide into a 
designed QconCAT.
Selection of cleavage method
Most proteomics studies have used trypsin as the method of 
I  cleavage of proteins into peptides suitable for MS analysis. Trypsin
has the advantage of a rigorously expressed sequence specificity 
(cleaves C-terminal to arginyl and lysyl residues, except arginyl- 
prolyl and lysyl-prolyl sequences, which are not cleaved) and 
minimal autoproteolysis (recombinant trypsin). For many proteins 
cleavage with trypsin generates a good distribution of peptides 
within the range 600-4,000 Da, ideal for analysis by MS. Because 
only one peptide is required in a QconCAT protein to represent 
each protein under study, if trypsin does generate a suitably sized 
peptide, with the additional properties described in the next 
section, trypsin will be the endoproteinase of choice. Moreover, 
tryptic peptides readily generate doubly charged ions ([M+2H]+) 
that extend the usefulness from MS to MS/MS analysis and increase 
the scope of quantification to include monitoring of single or 
multiple reactions. However, for integral membrane proteins, with 
several membrane-spanning regions, there is an under-representa­
tion of lysyl and arginyl residues. In addition, cleavage sites may be
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Figure 3 | Gantt chart fo r a typ ica l QconCAT experiment.
inaccessible to endoproteinases because of steric hindrance from 
the lipid bilayer or localization of cleavable sequences within the 
lumen of membrane vesicles. More efficient study of these proteins 
requires alternative solubilization7,8 and cleavage strategies9. 
Methods that have been developed include (i) chemical cleavage 
at methionine residues using cyanogen bromide7, in combination 
with trypsin9 and (ii) chymotrypsin (which cleaves C-terminally 
at phenylalanyl, tyrosyl and tryptophanyl residues), and staphylo­
coccal peptidase I (which cleaves at glutamyl residues), either in 
combination or singly9. However, for some of these peptidases, the 
specificity is sufficiently relaxed that preliminary experiments will be 
needed to ensure exclusive release of a suitable peptide (with no 
overlapping or alternative cleavages). The cleavage strategy should 
therefore be decided and tested for the group of proteins to be 
quantified before QconCATs are designed, so that the appropriate 
peptides can be selected for inclusion to match the planned analyte 
protein fragmentation strategy. A relaxed specificity can be tolerated 
provided that the same peptide is generated quantitatively from both 
QconCAT and analyte; in practice this might be difficult to achieve.
Selection of Q-peptides
Q-peptides are selected for uniqueness of mass, propensity to 
ionize and detectability in MS, the presence of specific amino 
acid residues required for labeling and the absence of amino 
acid residues that can cause problems (cysteine, methionine) (see 
http://www.qconcat.com for additional guidelines). The propensity 
of a selected peptide to ionize is often known, because the sample 
has been analyzed by MS previously. It is not yet possible to predict 
ion intensities using knowledge-based approaches, but this may 
make peptide selection easier in the future. At the moment we favor 
a pragmatic solution. The inclusion of two Q-peptides per protein 
might reduce the risk associated with poorly ionizing or otherwise 
difficult peptides. In addition, an improvement in ion intensity of 
peptides lacking arginine, but carrying lysine, can be achieved by 
guanidination, and this can be included as a relatively simple step 
before analysis by MS10-12.
In some instances it will be impossible to avoid inclusion of 
peptides containing cysteinyl and methionyl residues, for example. 
For these QconCATs it is essential to be aware of the need to
maintain conditions that ensure that the oxidation state of the 
Q-peptide is the same as the analyte, because any discrepancy 
between the two would compromise the quantification. Finally, 
for those groups that have been using individual chemically synthe­
sized peptides, for comparison of quantifications using QconCATs 
with chemically synthesized stable isotope-labeled peptides, a pep­
tide available in purified form could be included in the QconCAT 
sequence and its behavior as part of a QconCAT compared to that 
when present in an analyte mixture, as a purified, quantified peptide.
Construction of QconCAT genes
The Q-peptide sequences once selected are randomly concatenated 
in silico and used to direct the design of a gene, codon-optimized 
for expression in E. coli. The predicted transcript is analyzed for 
RNA secondary structure that might diminish expression, and if 
undesirable secondary structure features are present, the order of 
the peptides is altered. N-and C- terminal sequences are added as 
sacrificial structures, protecting the assembly of true Q-peptides 
from exoproteolytic attack during expression. Additional peptide 
sequences are added to provide an initiator methionine and, if 
appropriate, a single cysteinyl residue as an alternative means of 
quantification. The QconCAT genes are synthesized by companies 
(e.g., Entelechon GmbH) who specialize in gene synthesis for 
the generation of recombinant proteins. The construction and 
synthesis of the gene to encode a QconCAT is not described here 
(see Supplementary Methods in ref. 6), and the protocol assumes 
that the experimenter is starting with a QconCAT plasmid.
Expression and purification of QconCAT proteins
Once an expression plasmid encoding the QconCAT protein has 
been generated (pQconCAT), the plasmid is introduced into an 
appropriate E. coli expression strain. A single transformant is then 
grown in rich medium and the expression of the QconCAT protein 
is induced and analyzed by SDS-PAGE; finally, the QconCAT band 
is subjected to in-gel proteolytic digestion and analysis by MS. 
This simple characterization allows rapid confirmation of adequate 
QconCAT protein expression and also allows an early evaluation 
of the signal intensities of the chosen Q-peptides. These prelimi­
nary characterizations of the QconCATs are advisable, before
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proceeding to labeling with relatively expensive heavy isotope- 
labeled precursors.
Because QconCAT proteins are concatenations of short peptides 
(typically 10-20 amino acids) from different proteins, it is difficult 
to predict their properties. However, it might be anticipated 
that expression and purification of QconCAT proteins should 
be straightforward, because these proteins do not have to be 
functionally folded. Furthermore, they can be purified and used 
in denatured form, because the only requirement is that they 
be susceptible to digestion by endoproteolytic enzymes (trypsin, 
endopeptidase ArgC, endopeptidase LysC, chymotrypsin, endo- 
peptidase Asp-N, staphylococcal peptidase I) or by chemical 
cleavage. Therefore, expression of a QconCAT does not bring the 
complexities that are sometimes encountered when a protein must 
be heterologously expressed and folded in the correct form.
Stable isotope-labeling strategy
Labeled QconCAT proteins are generated by heterologous expres­
sion, most simply by growth of the E. coli host carrying the 
pQconCAT in defined medium supplemented with an appropriate 
stable isotope-labeled precursor. An alternative method would be to 
use QconCAT expression plasmid DNA to prime a cell-free coupled 
transcription/translation system, supplemented with the chosen 
heavy isotope precursor(s). Generation of QconCAT proteins in 
the latter system may be more compromised in terms of sequence 
fidelity and also gives lower yields. However, constructs that are 
toxic to E. coli or are extremely unstable (as a result of proteolysis) 
may be expressed in vitro when they cannot be expressed in E. coli.
Uniform labeling with 13C or 15N would ensure that every 
QconCAT peptide is comprehensively labeled; however, each 
labeled (heavy) peptide will be separated in mass by differing 
amounts from its unlabeled (fight) counterpart, complicating the 
mass spectroscopic analysis. If Q-peptides are selected that contain 
at least one instance of a specific amino acid, that amino acid can be 
incorporated in stable isotope-labeled form. Perhaps the preferred 
strategy reflects that because most QconCAT proteins are assem­
blies of tryptic peptides, incorporation of [13C6] lysine and 
[13Ce] arginine would ensure that most Q-peptides would be singly 
labeled and the mass offset between heavy and light peptides would 
be a constant 6 Da. Q-peptides that contain internal Arg-Pro or 
Lys-Pro sequences will of course contain two instances of the 
labeled amino acid, yielding a mass offset of 12 Da. We advocate 
the use of 13C-labeled amino acids instead of 2H-labeled amino 
acids, because of the difference in elution time of peptides contain­
ing 2H-labeled amino acids in liquid chromatography and the 
probable decrease in quantification accuracy caused13. Alterna­
tively, unlabeled QconCATs could be labeled in vitro using one of 
the many reagents that have been advocated for comparative 
proteomics.
Extent of proteolysis
The next stage is to determine the conditions for complete 
digestion of both the analyte and QconCAT proteins. First, 
a true internal standard will, apart from the stable isotope labeling, 
be otherwise exactly the same as the analyte. In the QconCATs, 
this is clearly not the case, because each surrogate peptide in 
the concatamer is in a sequence context that is different from 
the same peptide in the analyte protein. This means that the 
sequence contexts of the scissile bonds differ, and rates of hydrolysis
could therefore be different for the QconCAT and the analyte 
proteins. Our experience with QconCATs thus far is that they 
lack higher order structure and are readily and rapidly digested by 
endopeptidases such as trypsin or endopeptidase LysC. Proteolytic 
digestion of the analyte proteins, on the other hand, is mostly 
impeded by the presence of higher order structure, which restricts 
access to proteases14-18. However, provided that the analyte pro­
teins are extensively denatured and that the reaction is allowed 
sufficient time to proceed to completion, this need not be a serious 
issue. We have used the following methods to denature protein 
mixtures in anticipation of proteolysis for quantification.
•  Precipitation with an acid such as 10% (wt/vol) trichloroa­
cetic acid. The ether-washed pellet (analyte plus QconCAT) 
can then be proteolysed back into solution.
•  Heat treatment (95 °C for 10 min). Again, precipitated 
material can be resolubilized by proteolysis.
•  Treatment with a chaotrope such as urea or guanidinium 
hydrochloride, which would then have to be removed before 
proteolysis.
Acetone precipitation may not be a sufficiently potent denaturation 
step to enhance proteolysis of many proteins— indeed, it has been 
used as a precipitation step in protein purification protocols where 
activity is preserved.
If the analyte proteins contain disulfide bonds, it is also necessary 
to reduce and alkylate cysteinyl residues. If the QconCAT must 
contain cysteinyl residues as well, then the analyte-QconCAT 
should be mixed before reduction/alkylation.
The rapid digestion (usually within 1 min at typical substrate- 
to-protease ratios of 50:1 for trypsin) of the QconCAT means that it 
can also be used as a reference in pilot studies designed to assess the 
degree of proteolysis of the analyte mixture. We would stress that 
the requirement for complete digestion has rarely been specifically 
addressed in any quantification studies, and that this step is critical 
to any such experiment, whether relative or absolute. Even single­
protein quantification by peptide chemical synthesis requires 
complete hydrolysis of the analyte. For identification proteomics, 
complete digestion may not be required, and the extent of digestion 
may not therefore be routinely assessed, but we must emphasize 
that incomplete digestion means incorrect quantification.
Quantification of the QconCAT
Because the absolute quantification strategy involves relative quan­
tification against an accurately determined internal standard, it is 
worth emphasizing the principles that are involved.
Absolute quantification with a QconCAT is only as good as the 
quantification of the QconCAT itself. The first step of any Qcon­
CAT experiment is thus the determination of the concentration of 
His-tag purified QconCAT. Several approaches are possible.
•  Determination of a QconCAT by protein assay. It is possible to 
determine the QconCAT concentration by protein assay, and 
this will provide an acceptable degree of accuracy for many 
purposes. However, different methods of protein assay yield 
different results. Furthermore, it is not possible to use the 
exact protein as a reference, and often a protein such as BSA 
must be used. Of the different protein assays available, the 
biuret method, which is insensitive to the nature of the 
protein being assayed, is preferred. This method can consume 
a lot of protein (1 mg for a 1-ml assay), but microbiuret 
methods are available. Moreover, new spectrophotometric
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instruments are capable of operating on vanishingly small 
volumes, and thus sample consumption might be less of a 
problem.
•  Determination of QconCAT by densitometry. It is possible to 
run the QconCAT on a one-dimensional SDS-PAGE gel and, 
in parallel lanes, to include known amounts of a protein 
standard. After staining, densitometry of the lanes allows 
interpolation of the amount of the QconCAT relative to the 
standard; thus, its concentration can be assessed. However, 
this method also suffers from different response factors to 
staining protocols.
•  Determination of QconCAT by Kjeldahl assay. This approach 
measures total nitrogen by a complex and fairly hazardous 
process, and although it probably delivers excellent results, its 
use is not warranted.
•  Determination of QconCAT by amino acid analysis. Com­
plete acid hydrolysis (6 M HC1,110 °C, oxygen-free environ­
ment) of a QconCAT would release free amino acids, which 
can then be assessed by any one of the many methods for 
amino acid analysis. In nearly every method the amino acid 
content of the QconCAT will itself be assessed relative to a set 
of standards, which must obviously be carefully prepared. 
However, acid hydrolysis affects many amino acids: valine and 
isoleucine bonds are less easily hydrolyzed, threonine and 
serine are partially destroyed, methionine can be oxidized 
during acid hydrolysis, asparagine and glutamine are both 
converted to the respective acidic residue, and tryptophan is 
completely destroyed.
•  Assay based on specific amino acids in the QconCAT. There is 
a series of assays that could be used to determine the 
concentration of specific amino acids in the intact QconCAT. 
For example, a reagent reactive to primary amino groups 
(lysine and the a-amino group of the N terminus) such as 
fluorescamine or o-phthaldialdehyde-N-acetylcysteine could 
be used. The advantage of this approach is that fluorescence- 
based assays are sensitive, there will usually be several reaction 
sites in a QconCAT and the fluorescence yield of all primary 
amines is very similar—meaning that a simple amine reagent 
can be used as a standard.
Colorimetric assays for specific amino acids in intact proteins are 
not common. We have previously included a single cysteine residue 
in a QconCAT to facilitate determination by Ellman’s reagent 
(DTNB, dithio fozs-2-nitrobenzoic acid). However, the extinction 
coefficient of DTNB is 13,600 M-1 cm-1 at 412 nm, thus, it cannot 
be used convincingly with a QconCAT concentration of <  0.01 mM 
(A412 =  0.136). A typical QconCAT (molecular weight ~40 kDa) 
would, at 0.01 mM, be 0.4 mg ml-1, and this method therefore 
consumes a lot of QconCAT. •
•  Assay based on a common synthetic peptide. An alternative 
strategy for quantification of QconCATs would be the pur­
chase of an accurately quantified synthetic peptide (in a less 
expensive unlabeled form, because we are interested in 
quantifying the labeled QconCAT). Again, we stress that 
this quantification is only as good as the quantification of 
the synthetic peptide. However, it would be possible to design 
a common peptide into every QconCAT and to quantify every 
protein relative to the same synthetic peptide using MS. For 
example, the His-tag peptide in the construct described here
gives a good mass-spectrometric signal and could be made 
common to every artificial protein. A common quantification 
protocol could then be widely disseminated and diminish 
problems of different peptide or protein quantification.
The quantification of any protein is not without problems, and 
QconCAT technology brings the same challenges. However, it is 
essential to recognize the importance of quantification of the 
QconCAT in the correct analytical context. The QconCAT method 
has, for any one peptide, an experimental coefficient of variance of 
~2% , and this therefore sets the limit on the precision that is 
available for quantification. However, in many experiments the 
biological variance will be substantially greater than any analytical 
step, and again, this defines the quality of the protein quantification 
that is required. It might be argued that the goal of any analytical 
method is to make the analytical variance sufficiently small, relative 
to biological variance, that the emphasis should always be on 
biological variation. Thus biological replicates are prioritised over 
technical replicates.
We would venture to suggest that for many experiments a simple 
colorimetric protein assay is acceptable (either dye binding or 
biuret), but that for extremely high-precision work, determination 
of several amino acids or total nitrogen might be best. For many 
experiments such stringent quantification methods might be 
considered to be unnecessary. Finally, once a QconCAT has been 
quantified, there is merit in then determining the A280 (1%) of the 
protein, so that future quantification can be based on simple, 
nondestructive spectrophotometric measurement.
Comparison between absolute quantification by QconCATs 
or synthetic peptides
So far a direct comparison between peptides prepared by chemical 
synthesis and by QconCAT has not been undertaken, so we can 
only discuss the probable pros and cons of the two methods. First, 
if only a small number of proteins (e.g., <  10 proteins) is to be 
quantified, the synthetic peptide approach is probably more 
appropriate and economical. For the absolute quantification of 
larger numbers of proteins, because each constituent peptide of a 
QconCAT is assayed simultaneously, the method is far superior to 
the quantification of several synthetic peptides in independent 
experiments, although this feature increases the demand for good 
QconCAT protein quantification. If the proteins in the group under 
study differ in concentration by orders of magnitude, it is perhaps 
easier to add varying amounts of internal standard if they are 
available as synthetic peptides. However, when designing several 
QconCATs to cover the range of proteins of interest, it is sensible to 
group together those proteins of similar abundance within the 
same QconCAT and adjust the amount of each QconCAT added 
accordingly. One advantage of a QconCAT is that once the gene has 
been constructed, a range of labeling methods is available (e.g., Arg, 
Lys labeling, or complete labeling with 15N), whereas with synthetic 
peptides the choice of label must be made in advance of the one- 
shot synthesis.
Laboratories specializing in proteomics and MS alone
The protocol described below is a step-by-step walk through the 
whole process from the design of the QconCAT to its use in the 
absolute quantification of complex protein mixtures. This necessa­
rily covers a range of different techniques, which may not be 
within the capabilities of a typical proteomics laboratory. For
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those laboratories at which work with genetically manipulated 
organisms is not permitted or the required expertise is not 
present, purified, labeled QconCATs can be obtained commercially 
(http://www.qconcat.com). Once the group of proteins that you 
wish to quantify has been decided and the set of surrogate peptides 
elected, a QconCAT gene can be designed, synthesized, expressed 
in labeled form, characterized and delivered to the client for 
immediate use in absolute quantification experiments (http:// 
www.qconcat.com).
Sources of proteinaceous samples
Potential analyte sources include human, animal, plant (grasses, 
shrubs, trees, algae, food), microorganisms, body fluids (blood, 
serum, CSF, bronchial lavage, semen, vaginal secretion, tears, saliva, 
sweat, sputum and urine), as well as feces, tissues, cells, cell lines, 
hair, food, soil, water (as from rivers or the ocean) and sewage. In 
this exemplar protocol we have included the quantification of 
proteins in the soluble fraction of chicken skeletal muscle during 
development immediately after hatching.
>
»
MATERIALS
REAGENTS
• 15NH4C1 (99% atom percent excess) (OIL Inc.)
• L-arginine hydrochloride (U -13Cs, 98%; OIL Inc.)
•L-lysine hydrochloride (U-13Cs, 98%; CIL Inc.)
• 20 mM phosphate
• 20 mM, 500 mM imidazole
• 6 M guanidinium chloride
•Protease inhibitors (Complete Protease Inhibitors; Roche)
•Coomassie Plus Protein Assay (Pierce)
■E. coli BL21(kDE3) (Stratagene; Promega; Genlanatis)
• Plasmid vector pET21a (Novagen, Merck)
• Luria broth (LB; Merck)
• Luria agar (LA)
•HC1
•NaOH
• Ampicillin sodium salt (Sigma cat. no. A9518-5G)
•Isopropyl |B-D-thiogalactopyranoside (IPTG) (Sigmacat. no. 16758-1G)
• Glycerol
• Bromophenol blue
• Ammonium bicarbonate solution 
•Trypsin, sequencing grade (Roche)
• Formic acid
• Acetonitrile (ACN)
• Iodoacetamide
• Trifluoroacetic acid (TFA)
• a-cyano- 4-hydroxycinnamic acid
• Bugbuster Protein Extraction Reagent (Novagen; EMD Biosciences)
• Lysozyme (from chicken egg white; Sigma cat. no. L-7651)
• HisTrap HP (GE Healthcare UK, Ltd.)
• StrataClean Resin (Stratagene)
• 7 M ammonium hydroxide
• Sodium phosphate buffer, pH 7.0 
•Na2H P04*7H20
• k h 2p o 4 
•n h 4ci
•MgSO„
• Glucose
• Thiamine 
•CaCl2
• Amino acids 
REAGENT SETUP
Bacterial strains E . co li BL21(kDE3). BL21 has the following genotype: F -, 
o m p T , hsdS$  (r/m ^- ) g a l, d c m . Frozen competent cells o f BL21(XDE3) can be 
obtained from many suppliers, including Stratagene, Promega and Genlanatis. 
BL21(kDE3) has a recombinant X  phage carrying the T7 RNA polymerase, 
stably integrated into the chromosome. ! CAUTION Use good microbiological 
practice in manipulating and disposing of this E. co li laboratory strain. 
BL21(ADE3) does not require additional amino acids to grow in minimal 
medium (MM). If you are using a different host strain, check the genotype and 
add amino acids as appropriate for growth. If you are unsure about the 
requirements, the supplier of the strain (or transformation-competent cells) 
should be able to provide you with a recipe for defined growth medium for 
a particular strain.
Plasmids The recombinant plasmids encoding the QconCAT proteins are called 
pQconCATs, and these carry QconCAT genes cloned into the N d e l - H i n d m  
restriction sites o f pET21a, although other restriction sites are available.
Tris-EDTA buffer Prepare 100 ml 10 mM Tris HC1,1 mM EDTA, pH 8.0 (TE). 
Sterilize by autoclaving for 15 min at 121 C, and store at room temperature 
(RT, 20-25 °C).
LB Dissolve 25 g o f LB powder in 1 liter of distilled water. The pH should be 
7.0 ± 0.2 at 25 °C; if it is not, adjust with HC1 or NaOH as appropriate. Sterilize 
by autoclaving for 15 min at 121 °C.
Ampicillin sodium salt Prepare a 20 mg ml-1 solution in sterile distilled water, 
freeze in 1-ml aliquots and store a t-20  “C for several months, or store at 4 °C for 
no longer than 1 week. For the growth of BL21(kDE3)-pQconCAT strains use 
a final concentration of 50 pg ml-1 to maintain selection for the recombinant 
plasmid.
IPTG Prepare a small volume of a 1 M solution in sterile distilled water.
2X SDS-PAGE sample buffer 0.5M Tris HC1, pH 6.8 (2.5 ml, for a final 
concentration of 0.125 M); 10% (wt/vol) SDS (4.0 ml, for a final concentration 
of 4% (wt/vol)); glycerol (2.0 ml (density 1.26 g ml*1), for a final concentration 
of 20% (vol/vol)); DTT (0.31 g, for a final concentration of 0.2 M); bromo­
phenol blue 0.5% (wt/vol), (40 pi). Add double-distilled water to the 2x SDS- 
PAGE sample buffer to a final volume of 10 ml, divide into 1-ml aliquots 
and store at -20 °C. ! CAUTION DTT solid is harmful by inhalation, in contact 
with skin and if swallowed. It is irritating to eyes, skin and the respiratory 
system.
Tryptic digestion solution 25 mM and 50 mM ammonium bicarbonate 
solution (no pH adjustment needed); Trypsin, sequencing grade. Prepare 
10 ml of 10% (vol/vol) formic acid in distilled water for use in time course 
experiments. ! CAUTION Formic acid is harmful by inhalation; it causes 
severe bums.
Solution for in-gel digestion and reduction and alkylation of cysteine- 
containing proteins Prepare 20 ml of a 2:1 mixture of 25 mM ammonium 
bicarbonate-ACN.
DTT Prepare 10 ml of 10 mM DTT in 25 mM ammonium bicarbonate for 
in-gel digestion. Prepare 10 ml of 100 mM DTT stock solution in 25 mM 
ammonium bicarbonate for addition to analyte-QconCAT mixtures to a final 
concentration of 10 mM.
lodoacetamide Prepare 10 ml of 55 mM iodoacetamide in 25 mM ammonium 
bicarbonate (cover the bottle with foil to exclude light) for in-gel digestion.
! CAUTION Iodoacetamide is toxic if swallowed. It may cause sensitivity by 
inhalation and skin contact. Do not breathe the dust. Wear suitable protective 
clothing and gloves.
Matrix for matrix-assisted laser desorption-ionization-time of flight 
(MALDI-ToF) MS Prepare 50 ml of 50% (vol/vol) acetonitrile-0.1%
(vol/vol) TFA; store at RT. Prepare a fresh saturated solution of ~  10 mg of 
a-cyano-4-hydroxycinnamic acid in 1 ml 50% (vol/vol) ACN-0.1% (vol/vol) TFA. 
! CAUTION ACN is highly flammable and is harmful by inhalation, contact with 
skin and if swallowed. It is also irritating to the eyes. TFA is harmful 
by inhalation and causes severe burns, ot-cyano-4-hydroxycinnamic acid is 
irritating to the eyes, respiratory system and skin.
Solution for electrospray ionization (ESI) MS Prepare 500 ml 50% (vol/vol) 
ACN-1% (vol/vol) formic acid. ! CAUTION Formic acid is harmful by 
inhalation; it causes severe bums.
Guanidinium chloride binding buffer 20 mM phosphate, pH 7.4; 0.5 M NaCl; 
20 mM imidazole; 6 M guanidinium chloride.
Elution buffer 20 mM phosphate, pH 7.4; 0.5 M NaCl; 500 mM imidazole;
6 M guanidinium chloride.
Dialysis buffer lOmM ammonium bicarbonate, pH 8.5-1 mM DTT; the pH 
is adjusted with a solution of 7 M ammonium hydroxide.
Protein assay Coomassie Plus Protein Assay (Pierce); BSA for the protein 
calibration curve.
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PROTOCOL
Preparation of chicken skeletal muscle soluble fraction Add one tablet 
Complete Protease Inhibitors to 20 ml of 20 mM sodium phosphate 
buffer, pH 7.0.
Bacterial growth media The minimal medium (MM) is a chemically defined 
mixture into which the stable isotope-labeled precursor to be used as a label can 
be added. For labeling with stable isotope-labeled amino acids, the following 
sterile stock solutions are made.
5X M9 salts To 90 ml of distilled water add the following, sequentially, allowing 
each salt to dissolve before adding the next 6.4 g Na2HP04 • 7H20 ;
1.5 g KH2P 0 4; 0.25 g NaCl; 0.5 g NH4C1. Make up to 100 ml with distilled water, 
and autoclave at 121 °C for 15 min. Also prepare: 1 M MgS04 (autoclave); 
20% (wt/vol) glucose (filter sterilize); 0.5% (wt/vol) thiamine (filter sterilize); 
0.1 M CaCl2 (autoclave).
Amino adds Prepare a 10 mg ml-1 mixture induding all the amino adds except 
those to be used for labeling. Vortex-mix the suspension vigorously (not all 
amino adds will dissolve fully), and immediately dispense in 2-ml aliquots and 
store at -20 °C (stable for several months). If you intend to use a variety of 
labeled amino acids in future experiments, omit all of these from this mixture so 
that you only have to make it once.
MM with amino acids Prepare MM by mixing the following volumes 
o f the above stock solutions: 5x M9 salts (40 ml); 1 M MgS04 (0.2 ml);
20% (wt/vol) glucose (2 ml); 0.1 M CaCl2 (0.2 ml); 0.5% (wt/vol) thiamine 
(20 pi); amino add mix lacking chosen labeled amino acid(s) (2.0 ml); sterile 
water to make 200 ml.
Labeled amino acid—supplemented MM The medium used for growth 
should contain all 20 amino acids. The amino acid(s) chosen for labeling is 
weighed and added as a solid to the above MM plus amino acids. If you have 
left out other amino adds you should add these individually in unlabeled 
form.
Therefore, add 10 mg of either labeled or unlabeled amino add per 100 ml of 
the MM with amino acids, filter sterilize and store at 4 °C for as long as 48 h. 
MM for labeling with I5NH4C1 For 15NH4C1 as the labeled precursor, it is 
essential that you choose an E. co li strain (like BL21(7JDE3)) that does not 
require amino acid supplements to grow. Check the genotype of your host 
strain, and select a different host strain if appropriate. E. coli will grow more 
slowly in the absence o f amino adds, so times required for growth and induction 
will be extended ~  50%.
15N-labeled 5X M9 salts Na2H P 04 (3.39 g; anhydrous Mr 141.96); KH2P 0 4 
(1.5 g); NaCl (0.25 g); 15NH4C1 (0.5 g); distilled water to make 100 ml. Autodave 
in 20-ml aliquots.
MM containing l5N Mix the solutions as follows and store the medium at 4 °C 
for as long as 48 h: 15N-labeled 5x M9 salts (20 ml); 1 M MgS04 (0.1 ml); 
20% (wt/vol) glucose (1 ml); 0.1 M CaCl2 (0.1 ml). Add sterile distilled water to 
make 100 ml. Note: thiamine is not added, because this is a possible source 
of unlabeled nitrogen (14N).
EQUIPMENT
• Standard spectrophotometer (for absorbance readings in the visible range, 
including 600 nm)
• Peristaltic pump
■MALDI-ToF MS instrumentation (e.g., Waters-Micromass Q-ToF micro 
mass spectrometer)
• ESI MS instrumentation 
•HisTrap column (GE Healthcare)
• Multiskan plate reader (Thermo Electron)
• Ascent software 
•Syringe pump (Harvard)
• MaxEnt 1 module of the MassLynx software
• Jouan centrifugal evaporator (Thermo Electron)
»
PROCEDURE
Transformation of expression host £. coli BL21(XDE3) with a QconCAT plasmid
1| Dissolve the QconCAT plasmid (pQconCAT), which is typically delivered as a lyophilized powder, in ~  100 p i Tris EDTA 
buffer and store i t  a t -20 °C.
2| Prepare a 1 ng /p l solution of the pQconCAT plasmid in Tris EDTA buffer.
3| Prepare BL21(XDE3) cells competent for transformation (using basic transformation methods; see ref. 19), or purchase 
frozen competent cells and introduce the pQconCAT plasmid by transformation using standard procedures (as described in the 
notes that accompany frozen competent cells).
! CAUTION Use good microbiological practice.
4| Select colonies on LA plates with 50 pg ml"1 ampicillin by growing overnight at 37 °C.
5| Take a single colony and streak onto a fresh LA plate with 50 pg ml"1 ampicillin. Store the freshly streaked plate 
at 4 °C for as long as a month.
Preparation of frozen cultures of BL21(7.DE3)-pQconCAT
6| Inoculate 10 ml of LB-50 pg ml"1 ampicillin, with a single colony of BL21(X,DE3)-pQconCAT, and grow overnight 
at 37 °C with shaking.
7| Add sterile glycerol to  30%, mix well, aliquot 1 ml into sterile microcentrifuge tubes and store at -70 °C.
■  PAUSE POINT Frozen cells may be kept in this way for several years.
8 1 To prepare a fresh plate, place an aliquot of frozen culture on ice and thaw a small amount o f the top; use 20 
a fresh LA plate containing ampicillin, return the frozen culture to the freezer and incubate the plate overnight at
■  PAUSE POINT Plates can be kept for as long as a month under refrigeration, but i t  is best to  inoculate cultures 
colony from a fresh plate.
Induction of expression of QconCAT proteins in BL2 1 (/.DE3)-pQconCAT and confirmation of expression by SDS-PAGE
9| Using a single colony of BL21(X,DE3)-pQconCAT, inoculate 10 ml LB containing ampicillin (50 pg ml"1) and incubate 
overnight at 37 °C with shaking.
p i to  streak 
37 °C. 
using a
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10| Transfer 500 p i o f the overnight culture to 50 ml of prewarmed (to 37 °C) fresh LB medium (a 1:100 dilution) containing 
ampicillin (50 pg ml-1), and incubate the culture with shaking. Remove 1-ml samples at hourly intervals, and determine the 
absorbance at 600 nm using a spectrophotometer.
111 When an A6oo of 0.6-0.8 is reached (usually ~2 .5  h) add 50 p i of 1 M IPTG (final concentration of ~ 1  mM) to induce 
expression of the QconCAT protein.
12| Remove 1-ml samples at time 0 and then every 1-2 h (up to 6 h), measure the A600 immediately, transfer the equivalent 
of 0.6-0.8 A goo of cells to labeled microcentrifuge tubes and hold on ice.
1 3 1 Centrifuge the samples at 8,000g in a microfuge at 4 °C for 10 min. Remove and discard all the supernatant using 
a micropipette, and suspend the pellet in 100 p i of distilled H20 by vigorous vortexing.
■  PAUSE POINT I f  the intention is to perform the SDS-PAGE analysis at a future date, place at -20 °C at this stage.
14| Transfer the remainder of the culture to a preweighed 50-ml centrifuge tube, and centrifuge at 1,450 g for 10 min at 4 °C.
151 Decant the supernatant, and weigh the tube again to  determine the wet weight of the cell pellet. Freeze at -20 °C until 
required for purification of QconCAT after confirmation by SDS-PAGE of sufficient levels of induction.
161 Add 100 p i double-strength SDS sample buffer to samples from Step 13, mix well and place in a boiling water bath for 
4 min. Analyze 20 p i of each sample by SDS-PAGE mini-gel, carry out electrophoresis, and stain and destain the gel 
(e.g., with Coomassie blue).
171 The QconCAT protein should appear as a clearly visible band that is either not present or much fainter in the time 0 sample. 
Check that the molecular weight is close to  tha t calculated for the QconCAT, and i f  all is as expected proceed to the next stage.
Analysis of QconCAT by MALDI-ToF MS after in-gel digestion of SDS-PAGE gel band with trypsin
1 8 1 Using a Pasteur pipette, cut a plug of gel from the band corresponding to the QconCAT protein, transfer the plug to a 
1.5-ml microcentrifuge tube, add 25 p i of 25 mM ammonium bicarbonate and incubate at 37 °C for 15 min. Discard any liquid.
1 9 1 Add 25 p i o f 25 mM ammonium bicarbonate-ACN (2:1), and incubate at 37 °C for 15 min. Discard any liquid.
! CAUTION ACN is flammable and toxic.
20| Add 25 p i o f 25 mM ammonium bicarbonate, and incubate at 37 °C for 15 min. Discard any liquid. Repeat Steps 19 and 20 
using alternate washes until the plug is fully destained. Note: I f  cysteine residues are present, alkylate the QconCAT protein by 
performing these three steps: (i) Add 25 p i of 10 mM DTT in 25 mM ammonium bicarbonate, and incubate at 56 °C for 60 min. 
Discard any liquid, ( ii)  Add 25 p i 55 mM iodoacetamide in 25 mM ammonium bicarbonate, and incubate in the dark at 37 °C 
for 45 min. Discard any liquid, ( iii)  Repeat alternate washes (Steps 19 and 20), finishing with a wash in 25 mM ammonium 
bicarbonate-ACN (2:1). These three steps can be omitted i f  cysteine residues are not present in the QconCAT protein.
211 Add 10 p i o f 25 mM ammonium bicarbonate containing 0.1 mg ml-1 trypsin giving a final concentration of 12.5 ng p i-1.
g&k
2 2 1 Hold samples on ice for 30 min before incubation at 37 °C overnight. Ensure that the gel plug is covered with liquid; 
i f  i t  is not, add 25 mM ammonium bicarbonate until covered.
231 Spot 1 p i o f digest on a MALDI target, and overlay with 1 p i of matrix.
24| Acquire spectra using a MALDI-ToF mass spectrometer. Acquire mass spectra over the range 800— 3,500 m/z.
Evaluation of MALDI ToF results
251 Analyze spectra. Peaks due to each peptide in the QconCAT with masses larger than 800 m/z should be clearly visible. 
Confirm that all the expected peaks are present, and confirm that digestion has gone to completion— meaning there are no 
peaks due to missed cleavages.
Purification and analysis of QconCAT proteins
261 Thaw the induced cells from Step 15. The QconCAT is generally present in inclusion bodies, but i t  is important to  confirm 
this. Inclusion bodies are first recovered by breaking cells using BugBuster Protein Extraction Reagent (Novagen). The following 
method is adapted from the Novagen protocol.
271 For < 1  g o f wet cell pellet add 2.5 ml of BugBuster (BB) and, to  ensure good resuspension, place cells on a rocker platform 
m at RT for 15 min. Remove 20 p i for analysis by SDS-PAGE (total fraction).
PROTOCOL I
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281 Centrifuge the cells at 16,000g for 20 min at (4 °C). Set the braking speed low to give a gentle rotor deceleration.
291 Collect the supernatant by pipetting carefully to  a fresh tube, transfer 20 p i to  a labeled microcentrifuge tube for analysis 
(soluble fraction) and store the remainder at -20 °C. Resuspend the pellet in 2.5 ml of BB by drawing the cells up into a Pasteur 
pipette and by gentle vortexing.
▲ CRITICAL STEP Thorough resuspension is critical to  obtaining a preparation of high purity.
30| Add 50 p i o f lysozyme (10 mg ml-1 in BB), mix gently by vortexing and incubate at RT for 5 min.
3 1 1 Add 15 ml of 1:10 dilution of BB in distilled water, and mix by vortexing for 1 min.
3 2 1 Centrifuge at 15,000(7 for 15 min at 4 °C.
A CRITICAL STEP This is a much higher speed than recommended in the Novagen protocol, but i t  generates a firmer pellet, 
which facilitates handling. Carefully decant the supernatant and discard.
331 Resuspend the pellet of inclusion bodies in 20 ml of 1:10 BB, and mix by vortexing (low speed), then centrifuge at 
15,000g for 15 min at 4 °C. Discard the supernatant.
34| Repeat Step 33 twice more, finishing by centrifuging at 16,000g for 15 min. Store the pellet of inclusion bodies at -20 °C 
in the 50-ml centrifuge tubes.
■  PAUSE POINT Inclusion body pellets can be stored at -20 °C indefinitely.
3 5 1 Analyze the to ta l fraction (Step 27) and soluble fraction (Step 29) by SDS-PAGE.
361 Add 20 p i o f 2x  SDS-PAGE sample buffer to  each sample, heat in a boiling-water bath for 4 min and load 20 p i onto a gel.
371 From the Coomassie blue-stained gel determine the location of the QconCAT and, i f  largely absent from the soluble fraction 
(compared with the to ta l fraction), proceed with the purification of the QconCAT protein from the inclusion bodies.
38| Resuspend the inclusion bodies in 20 ml of binding buffer at room temperature. ( I f  the QconCAT is in the soluble fraction, 
add this fraction to 20 ml of binding buffer.)
391 Centrifuge at 8,000 r.p.m. ( ~  5,000(7) for 5 min at room temperature, and collect the supernatant in a fresh tube. Place 
20 p i of the supernatant into a microcentrifuge tube; this sample is the starting material (SM) for SDS-PAGE analysis.
4 0 1 Apply the remainder of the supernatant, with the aid of a peristaltic pump set at a flow rate of 0.25 ml m in '1, to  a 1-ml 
HisTrap HP column equilibrated in the same buffer.
4 1 1 Collect the unbound sample in a 25-ml Universal tube. Place 200 p i of the eluate into a microcentrifuge tube and hold at 
room temperature; this sample is the unbound material (UM).
4 2 1 Wash the column with 10 ml of 20 mM phosphate, pH 7.4, 20 mM imidazole, 0.5 M NaCl, 6 M guanidinium chloride using 
an increased flow rate of 0.5 ml m in '1, and collect the wash. Transfer 200 p i of the wash into a microcentrifuge tube, and hold 
at room temperature; this sample is the wash (W).
4 3 1 Elute the bound protein with 5 ml 20 mM phosphate, pH 7.4, 500 mM imidazole, 0.5 M NaCl, 6 M guanidinium chloride at a 
flow rate of 0.25 ml m in '1, and collect five 1-ml fractions. Place 20 p i of each fraction into a microcentrifuge tube, and hold at 
room temperature; this sample is the eluted bound material (EBM). Hold the eluted fractions on ice.
■  PAUSE POINT Samples can be stored at -20 °C.
44| To identify the fractions containing the QconCAT, prepare each of the 20-pl fractions for SDS-PAGE analysis. Collect the 
samples SM, UM, W and EBM (Steps 39-43), and add 10 p i of a StrataClean Resin (Stratagene) bead suspension to each tube 
(use the same volume of beads for the 200-pl W and UM samples).
A CRITICAL STEP The guanidinium chloride interferes with the SDS-PAGE and so must be removed.
45| Vortex each sample for 1 min, centrifuge for 2 min at 230 g at RT, and remove and discard the supernatant.
46| Resuspend pellets in 1 ml of distilled H20, vortex briefly to mix and centrifuge at 230g for 2 min. Discard the 
supernatant.
471 Add 10 p i of 2 x SDS sample buffer to the beads, boil for 4 min and then load both sample and beads onto the gel.
48| Stain (with Coomassie blue) and destain the gel.
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4 9 1 Pool the eluant fractions containing pure QconCAT protein, and remove denaturant by dialyzing against 100 volumes of 
10 mM ammonium bicarbonate, pH 8.5,1 mM DTT, at 4 °C, for 2 h. Repeat twice more with fresh buffer.
501 Determine the protein concentration. For th is one can use Coomassie Plus Protein Assay (Pierce) and BSA as the standard, 
and a LabSystems Multiskan plate reader using Ascent software.
511 Prepare 1:50 and 1:100 dilutions of the purified QconCAT protein with a protein assay ranging from 0 to 50 pig.
The concentration of the QconCAT protein is likely to be in the range of 0.2-4 mg ml-1.
Analysis of QconCAT proteins using ESI MS (Q-ToF)
521 Dilute purified and dialyzed QconCAT protein directly into 50% (vol/vol) ACN-1% (vol/vol) formic acid to a final 
concentration of 60-100 fmol p i"1.
531 Directly infuse the sample into the source at a flow rate of 0.5 p i min"1 using a syringe pump (Harvard). The capillary 
voltage may be set between 1,600 and 2,100 V and data acquired over a mass range of 400-1,500 m/z with a scan/interscan 
speed of 2.4/0.1 s.
541 Combine the scans and subtract the spectra before transformation using the MaxEnt 1 module of the MassLynx software. 
This permits deconvolution of the spectrum into an intact mass measurement w ithin 2 Da of the predicted mass.
Growth of BL21().DE3)-pQconCAT in minimal medium and labeling with stable isotopes
551 Using sterile technique, pipette 10 ml of MM without amino acids into a sterile 50-ml conical flask, and add 25 p i of 
20 mg m l'1 ampicillin in sterile distilled water.
561 Inoculate w ith a single colony of BL21(XDE3)-pQconCAT, and incubate overnight at 37 °C with shaking.
57| Using sterile technique, transfer 50 ml MM plus amino acids and 50 ml MM plus labeled amino acids to two sterile 250-ml 
conical flasks. Add 125 p i of 20 mg m l'1 ampicillin in sterile distilled water to each, and warm to 37 °C.
▲ CRITICAL STEP Amino adds are included in this step to increase the growth rate in MM. This shortens the time before induction 
can commence and prevents the recycling of labeled amino adds.
581 Determine the A60o of the overnight culture and, using sterile technique, transfer enough culture to each flask to give a 
starting A600 of 0.06-0.1.
59| Monitor the A6Q0 of the cultures at hourly intervals until an A60Q of 0.6-0.8 is reached (this should take 3.5-4.5 h 
depending on the starting A6oo, the E. coli strain and the growth medium used).
60| Add 50 pL 1 M IPTG to each flask to induce protein expression. Remove a 1-ml sample at 0 and 5 h after induction, 
measure the A600 and prepare for gel analysis exactly as described in Steps 13, 16 and 17.
611 Centrifuge the remainder of the 5-h induced cells in preweighed centrifuge tubes, at 1,450 g for 15 min at 4 °C, decant and 
discard the supernatant, record the weight of the cell pellets and store the cell pellets in the centrifuge tubes at -20 : C.
621 Process exactly as described in Steps 26-54, for purification and analysis.
Comparison of labeled and unlabeled QconCAT tryptic 
peptide profiles
631 Mix unlabeled (L, light) and labeled (H, heavy) QconCAT 
protein to give a to ta l of 10 pg (e.g., L/H ratios of 10:0, 9:1, 
7:3, 5:5, 3:7, 1:9 and 0:10), and add 50 mM ammonium 
bicarbonate to a volume of 20 pi.
64| Add trypsin in a ratio of trypsin to QconCAT of 1:50, and 
incubate at 37 °C overnight.
65| Analyze four 1-pl fractions by MALDI-ToF MS as described 
in Steps 23 and 24.
661 Measure the peak intensities, and confirm that the 
quantification is as expected from the prepared ratios.
200 kDa— .
0 1 2 3 4 5 6 
Time after IPTG 
induction (h)
Figure 4 | Induction of QconCAT protein in  BL21(a DE3) cells grown in Luria 
broth. BL21(A.DE3)-pQconCAT cells were grown to  an A60o o f 0.8, and IPTG 
added to  a fina l concentration o f 1 mM. Cells equivalent to  0.08 A 600 units 
were analyzed by SDS-PAGE and Coomassie blue staining.
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►
I
5 0 0  m M  im idazole
1
SM UM W  EBM
Figure 5 | HisTrap purification of QconCAT. SM, starting material (solubilized 
inclusion bodies), UB, unbound material (flowthrough); W, wash fraction; 
EBM, eluted bound material (sequential 1-m l fractions). The middle two 
fractions containing the  eluted QconCAT protein are pooled fo r use._________
Determination of conditions required for complete digestion 
of the intended analyte and confirming the digestion of 
analyte and QconCAT protein mixtures
671 Label 12 0.5-ml microcentrifuge tubes, pipette 10 p i of 
10% (vol/vol) formic acid into each tube and hold on ice.
681 Dilute ~ 2 0  pg of analyte protein 1:10 with 50 mM 
ammonium bicarbonate solution. This typically gives a volume 
of 200-300 pi.
691 Add trypsin in a ratio of trypsin to analyte of 1:50, mix 
and immediately transfer 12 p i into the first tube previously 
prepared in Step 67.
701 Incubate the analyte-trypsin mixture at 37 °C, and take 
12-pl samples over a 24-h period. Suitable time intervals are 
0, 1, 2, 5, 10, 30, 60, 90, 120, 240, 480 and 1,440 min. Store 
samples at -20 °C.
71| Thaw the samples, and spot 1 p i of each sample onto two positions on a MALDI target; that is, perform in duplicate. 
Analyze by MALDI-ToF MS exactly as described in Steps 23 and 24. I f  digestion is complete, the peptides of the proteins under 
study (i.e., chosen for inclusion in the QconCAT) should be readily seen. At early time points partial digestion products w ill be 
seen for some proteins; this analysis allows the monitoring of these more slowly digested portions of the protein, which should 
be fully digested w ithin 24 h i f  conditions are appropriately optimized.
721 Dry down the remaining sample (10 p i) for 2 h by heating under vacuum (Jouan centrifugal evaporator (Thermo Electron)), 
and resuspend the residue directly in 10 p i l x  SDS sample buffer.
731 Heat samples in a boiling-water bath for 4 min, and load the entire sample onto an 12.5 % SDS-PAGE gel. After 
electrophoresis stain the gel with Coomassie blue; no protein should be visible on the gel after 24 h of digestion.
74| I f  digestion of the analyte is incomplete, increase the protein-to-trypsin ratio from 50:1 to 20:1; also, an organic solvent 
such as ACN can be added (e.g., to  10%). Complete digestion of the analyte proteins is measured by the absence of all bands 
in an SDS-PAGE gel.
751 Once you have optimized digestion conditions for the analyte, repeat the digestion but add the labeled QconCAT protein 
in a 1:10 ratio w ith the analyte.
761 Analyze 1 p i by MALDI-ToF MS, and confirm the complete digestion of the QconCAT when present in a mixture with the analyte.
Quantification of QconCAT proteins for use in absolute quantification
771 Quantify the labeled QconCAT by a method of suitable 
accuracy for the intended experiment (see section on 
"Quantification of the QconCAT" in the EXPERIMENTAL DESIGN 
section). So far we have used a dye-binding assay to 
determine the protein concentration of both the QconCAT and 
the analyte proteins. This method gives acceptable accuracy 
and does not require the use of significant quantities of the *1
Figure 6 | ESI-MS to  measure the in tac t mass of QconCATs. Purified and 
dialyzed, labeled and unlabeled, QconCAT protein was diluted in to  
50% (vo l/vol) ACN-1% (vo l/vo l) formic acid to  a fina l concentration of 
60-100 fmol p i-1 and infused directly in to  the source o f a Q-ToF MS at a flow  
rate of 0.5 p i min-1 using a syringe pump (Harvard). The capillary voltage 
was set between 1,600 and 2,100 V and data acquired over a mass range of 
400-1,500 m/z w ith  a scan/interscan speed o f 2.4 /0 .1  s. Scans were 
combined and the spectra subtracted before transformation using the  MaxEnt
1 module of the MassLynx software, which allows deconvolution o f the 
spectrum in to  an in ta c t mass measurement w ith in  2 Da of the predicted mass 
(a) Unlabeled QconCAT (predicted mass: 34,684); (b) QconCAT labeled w ith  
[13C6]lysine (predicted mass 34,780).
100-1 a 34 ,6 8 2 .1 3
%
3 4 ,7 2 4
0 -
34 ,6 4 9
■ ■ v »  * - I  ■■ *-■ ...................... / U z - T -  ,
100-1 b 3 4 ,7 7 8
%
34 ,8 1 4
o - r »  ■<> ^  t  , ,  ....................... ..  ............. .................................. ■ m z .
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Figure 7 | Incorporation o f label in to  peptides 
derived from QconCATs. QconCAT proteins labeled 
w ith  [13C6 ] lysine and [13C6 Jarginine (upper 
spectrum) and unlabeled (lower spectrum) were 
digested w ith  trypsin and each digestion analyzed 
directly by MALDI-ToF MS. Only a portion of the 
spectrum is shown so th a t the  mass sh ift o f the 
labeled peptides can be seen. Peptide T17 differs 
from its unlabeled counterpart by 12 Da as a result 
o f the uncleaved argin ine-proline sequence in the 
peptide; a ll the other peptides show a sh ift to  
6 Da heavier in the labeled peptide.
purified QconCAT. We are currently 
exploring the use of other methods that 
are more accurate but utilize small 
amounts of the purified QconCAT.
Use of a QconCAT protein in absolute 
quantification: quantification of 
proteins in chicken skeletal muscle
781 Take 100 mg of chicken breast tissue from chickens of different ages (for example), and homogenize in 1 ml 20 mM sodium 
phosphate buffer, pH 7.0, containing protease inhibitors.
791 Centrifuge at 15,000g for 45 min at 4 °C. Collect the soluble fraction, and store at -20 °C in 100-|il aliquots. I t  may be 
necessary to rehomogenize/recentrifuge the in itia l pellet to recover all of the soluble material.
8 0 1 Determine the to ta l protein concentration in each sample of chicken skeletal muscle soluble fraction (CSM) and the 
concentration of the labeled purified QconCAT protein using a Coomassie Plus Protein Assay.
8 1 1 Dilute samples 1:10 with 50 mM ammonium bicarbonate, and mix the CSM and labeled QconCAT in known concentrations. 
For in itia l pilot studies a ratio of 1:10 (QconCAT/CSM) is suitable, and to ta l protein in the range of 20 pg.
8 2 1 Add ACN to  10% and trypsin in a 20:1 (protein to enzyme) ratio, and incubate at 37 °C for 24 h.
8 3 1 Spot four 1-p l (four replicates) of each digest onto a MALDI target, and overlay with 1 p i of matrix.
84| Acquire spectra, for example using a MALDI-ToF mass spectrometer, over the range 800— 3,500 m/z, or use a lower m/z 
maximum i f  peptides under study fall well below this maximum mass.
8 5 1 Record the intensity of the monoisotopic peak for each analyte peptide and the corresponding QconCAT peptide, and 
convert these values into nanomoles of protein per gram of tissue using the known concentration of the QconCAT protein. 
Determine the standard error for each ratio.
? TROUBLESHOOTING
Troubleshooting advice can be found in Table 1.
TABLE 1 | Troubleshooting the QconCAT design, expression and labeling steps.
PROBLEM POSSIBLE REASON
Expression of the Multiple potential reasons, see below
QconCAT is very poor
Gene sequence incorrect 
Protein instability
Problems with mRNA secondary structure 
occluding expression
SOLUTION
I f  expression is low but just detectable, sufficient QconCAT 
protein can be obtained by processing larger volumes of 
induced cultures.
Check the gene sequence. Look at transcript and predicted 
translation product. I f  incorrect, the gene must be reconstructed.
Vary the induction conditions (times, temperature) to try 
to improve expression. Try a different host £. coli strain.
Monitor RNA production upon induction to confirm that 
transcription is proceeding well. I f  this is not the problem, alter 
the order of the peptides near the N terminus of the QconCAT 
to generate a new gene construct.
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TABLE 1 | Troubleshooting table (continued).
Protein toxicity I f  the expression problem is due to toxicity the cells are 
likely to lyse upon induction; monitor the A60o of the culture during 
the induction phase. Alter the order of the peptides near the 
N terminus of the QconCAT to generate a new gene construct.
Poor ion intensities 
of selected Q-peptides
Many of the peptides terminate with lysine Specific to MALDI-ToF MS. Investigate whether guanidination 
of the QconCAT peptides overcomes the problem10-12.
Peptide ionizes poorly by chosen MS ionization 
method
Try alternative ionization methods. Peptides that are known 
to yield poor signals in MALDI-ToF may perform well in 
ESI MS.
Peptide chosen ionizes very weakly using any 
MS approach
Select another peptide to represent the protein in question.
This requires generating a new gene. Fortunately this only involves 
changing a few of the oligonucleotides used for gene synthesis, and 
a new version can be rapidly and economically generated.
Incomplete labeling 
of QconCAT protein 
with stable isotopes
Precursor pool is incompletely labeled. Either 
the isotope has a relative isotope abundance 
less than 0.99 or endogenous, unlabeled 
amino acids are diluting the labeled precursor 
pool.
Minimal medium is contaminated with unlabeled 
versions of heavy-isotope precursors.
Re-prepare minimal medium from pure reagents.
Too large an inoculum of the overnight culture 
grown in MM plus all amino acids was used to 
start the culture for the labeling step.
Decrease the size of the inoculum.
Insufficient heavy isotope-labeled precursor 
is added, forcing f.  coli to synthesize amino 
acids de novo, which are not labeled.
Add more heavy-isotope precursor for growth and induction, 
or use an auxotroph for the amino acid.
Incomplete digestion 
of analyte proteins 
and QconCAT
Insufficient trypsin Increase ratio of trypsin to analyte proteins. Alter digestion 
conditions to enhance proteolysis. Pretreat analyte proteins 
to increase susceptibility to digestion.
Conditions suboptimal Add organic solvent (e.g., ACN) to 10%.
Proteins are tightly folded Include a denaturant (e.g., urea 2-4 M), and increase the trypsin 
concentration because the denaturant will diminish trypsin activity.
Proteins are very hydrophobic membrane proteins, 
with cleavage sites unavailable due to steric 
hindrance or sequestration within membrane 
vesicles
Solubilize membrane preparations using, for example, 
organic solvents, organic acids or detergents7-9 
(e.g., nonionic detergent such as Rapigest; Waters 
(h t tp ^ www.wate rs.com)).
ANTICIPATED RESULTS
L During the course of the induction of expression of QconCAT proteins, a band corresponding to the expected molecular weight of the
"  QconCAT protein should be readily seen to increase in intensity, confirming good levels of expression (Fig. 4).
Purification and SDS-PAGE analysis confirms that the QconCAT was readily solubilized from the inclusion bodies, bound efficiently 
to the HisTrap column (i.e., was not present in the unbound fraction) and was the major band in the bound eluted fractions (Fig. 5).
ESI MS analysis of the intact QconCAT protein allows comparison of the experimentally derived molecular weight and the cal­
culated molecular weight (Fig. 6a). Loss of the N-terminal methionine can be predicted, and the degree to which other potential 
modifications to  the primary structure have occurred can be evaluated (e.g., oxidation of methionine). Analysis of the stable 
isotope-labeled QconCAT protein allows evaluation of the labelling step (Fig. 6b). Protein peaks that are present between the 
unlabeled and labeled protein predicted masses could indicate incomplete labeling with heavy isotope precursors.
MALDI-ToF analysis of labeled and unlabeled QconCATs (in this case labeled with [13C6 jlysine and [13C6]arginine) allows 
confirmation of the consistent 6-Da difference in mass between labeled and unlabeled forms of each peptide, unless an 
uncleavable sequence (e.g., RP) is present, as is the case with peptide T17, which differs from its unlabeled counterpart by 
f t  12 Da (Fig. 7).
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Seven peptides à)
300
Proportion H protein
Figure 8 | Quantification by QconCATs. Unlabeled (L, lig h t) and uniform ly 
labeled w ith  15N (H, heavy) QconCAT proteins were separately purified, 
quantified and mixed in  d ifferent ratios, before tryp tic  digestion and 
measurement o f peptide intensities by MALDI-ToF MS. The measured 
proportion of H peptide is p lotted relative to  the proportion o f H protein in 
the mixture for three replicates o f each o f seven peptides; error bars ± s.e.m., 
n =  7. The dotted lines define the 95% confidence lim its o f the fitted  line. 
(Adapted from reference 6.)______________________________________________
1 dQ
27 d I
i l*L F i  J Ì l i Jai l i
V v° Vr . ' P ' j f j? o'< r 0+- r f -
Figure 9 | Quantification o f bio logical samples by QconCAT. A preparation of 
soluble proteins from 10 mg o f chicken skeletal muscle a t 1 d and 27 d was 
mixed w ith  29 pg 15N-labeled QconCAT, digested w ith  trypsin overnight and 
analyzed by MALDI-ToF. The intensity  o f the monoisotopic peak fo r the 
analyte peptide and the corresponding QconCAT peptide were recorded and 
the data converted in to  nanomoles o f protein per gram o f tissue, to  give the
Statistical analysis of labeled and unlabeled QconCAT absolute amount of each Pratein-Eror bars- * n =3-For detais of
proteins, mixed in known proportions, digested and analyzed ---------------- ----------------------------- -—  ----------------------- -------------
by MALDI-ToF MS (Fig. 8) allows evaluation of the reproduci­
b ility  of the MALDI-ToF analysis. In addition, the behavior of each peptide within the QconCAT can be assessed and the 95% 
confidence limits, of the line fitted to the data and visualized.
The data shown in Figure 9 are adapted from ref. 6 and show the absolute quantification values, as well as standard errors, 
that can be obtained using QconCAT proteins as internal standards. Results are presented as nanomoles of each protein 
per gram of tissue.
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